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A. PLENARNA PREDAVANJA 
A. PLENARY LECTURES 
THE GROWING BURDEN OF NON COMMUNICABLE DISEASES – ARE THERE 
STRATEGIES TO CONTROL AND ADDRESS THEM? 
Eleni Jelastopulu 
Department of Public Health, School of Medicine 
University of Patras, Greece 
Over the last two decades, the global health landscape has undergone rapid transformation. 
People around the world are living longer, and the population is getting older. Many countries 
have made remarkable progress in preventing infant mortality. As a result, disease burden is 
increasingly defined by disability instead of premature mortality and people are experiencing 
more non-communicable diseases or chronic diseases, such as cardiovascular diseases, mental 
disorders,cancer and diabetes. 
With the “Global burden of diseases, injuries, and risk factors” (GBD), an approach to global 
descriptive epidemiology, we have a tool to demonstrate the size of the problem worldwide or 
in selected countries, to quantify the comparative magnitude of health loss due to diseases and 
other conditions or risk factors and to understand with various indicators, such as all-cause 
mortality, deaths by cause, years of life lost (YLLs), years lived with disability (YLDs), and 
disability adjusted life years (DALYs),in a given place, time, and specific population, what 
are the most important contributors to health loss.  
In terms of the number of years of life lost (YLLs) due topremature death in Serbia, ischemic 
heart disease,cerebrovascular disease, and trachea, bronchus, and lungcancers were the 
highest ranking causes in 2010.Overall, the top five leading causes in terms of years lived 
with disability (YLDs)for all ages were low back pain, anxiety disorders, major depressive 
disorder, falls, and diabetes.Of the 25 most important causes of burden, as measured 
bydisability-adjusted life years (DALYs), major depressive disordershowed the largest 
decrease, falling by 28% from 1990 to 2010, whereas Alzheimer’s disease shows the highest 
increase, followed by hypertension, colorectal cancer and diabetes.The leading risk factor in 
Serbia is dietary risks. 
Analyzing the epidemiological changes occurring in Serbia the last 20 yearsin terms of 
disease burdengivespolicymakers the crucial input for informed policy- and decision-making. 
Identifying a population’s true health challenges helps to implement the “best-buy” 
intervention strategies to prevent and manage NCDs and risk factors. 
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PUBLIC HEALTH IMPORTANCE OF INFECTIOUS DISEASES 
Zoran Radovanović 
Academy of Medical Sciences, Serbian Medical Society, Belgrade 
Objective: To present historical background, current situation and potential impact of 
infectious diseases on the global public health.  
Methods: Review of the scientific literature. 
Results: Infections had a major impact on the rise and fall of civilizations, and their killing 
power exceeded the combined effect of wars and famines (H. Zinsser). Classical infectious 
diseases have nowadays a negligible share in the developed nations’ mortality, while their 
role in the third world is diminishing. It should not be missed, however, that such a state of 
affair has been maintained only due to energetic and persistent preventive and control 
measures. Awareness of public health importance of microbes has got the momentum along 
with discoveries that they are responsible for many conditions previously considered non-
contagious. Moreover, viral permanent ability to evolve, as demonstrated recently by 
occurrence of new strains of avian influenza, SARS, and MERS (CoV), positions them as the 
most important single threat to the human dominance on the planet (J. Lederberg). 
Conclusion: The role of microbes in the occurrence of many diseases, including ulcer, 
different forms of cancer etc., points to their public health importance. The ease and 
unpredictability of microbial changes urges us to keep our guard on and develop ever 
improving means to confront them. 
Key words: public health, epidemiology, infectious diseases, burden of disease 
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1.IMUNSKI ODGOVOR NA BAKTERIJE IZ RODA HELICOBACTER 
IMMUNITY TO HELICOBACTER 
 
Biljana Miljković-Selimović1,2, Tatjana Babić1, Branislava Kocić1,2 
1Public Health Institute, Center for microbiology, NRL for Campylobacter and Helicobacter, 
Niš, Serbia 
2School of Medicine, University in Niš, Serbia 
 
ABSTRACT 
Genus Helicobacter comprises of more then 30 validated and candidatus species, some of 
them have been recognized in two last decades, with type species Helicobacter pylori (H. 
pylori). Virulence factors of H. pylori that prticipate in etiology of disease are numerous. 
Cytotoxin-associated gene pathogenicity island (cagPAI) is marker for Cag+strains. H. 
pylori peptidoglycane elicits stimulation of nucleotide-binding oligomerization domain 
(NOD). Vvacuolating cytotoxin A (VacA) possess several genotypes which of them vacA 
s1/m1 is the most often associated to severe diseases. Outer memrane proteins (OMPs) 
participates in adhesion and blood group antigen binding adhesion protein (BabA) enables 
binding H. pylori to Lewis b (Leb) blood groop antigens, as a receptor of H. pylori for gastric 
epithelial cells. Other virulence factors are outer inflammatory protein adhesion (OipA), sialic 
acid-binding adhesion (SabA), adhesion proteein for bindinf to sialic acid, proinflammatory 
lipopolysaccharide (LPS), urease etc.  
Althogh bacterial virulence play a key role in pathogenesis, human predisposition and human 
immune response can be blamed for etiology of the illness. Perhaps more then a half of 
human population is infected with H. pylori, yet only small number develope any type of 
disease. H. pylori infectin is folowed by Th1 immune response. Data indicate that individuals 
who can overcome the initial Th1-cell-dominated response, with a mixed Th1- and Th2-cell 
response to in the gastric mucosa, may maintain persistent colonization without 
manifestations of clinical diseases. Also, it is considereed that Th1 cellular immune response 
has a protective role in etiology of hypersensitivity contributing to the „hygiene theory“. 
There are also a Helicobacters that can cause gastric disorders in animals similar to human 
diseases: almost any animal has its own bacterium, although some species can infects sevesral 
hosts. However these Non Helicobacter pylori species (NHSP) can cause disease humans that 
have close contact to animals. NHSP can be for didactic reasons classified to gastric and 
enterohepatic helicobacters. Gastric helicobacters usually cause disease in animal host and 
they are rarely human parasites with exception of H. heilmannii. Some of the species also 
primary isolated in animals, enterohepatic helicobacters may be associated with human 
hepatobilliar disease, enterocolitis and even inflammatory bowel diseases (IBD). It is 
considered that in H. hepaticus infection IL-23 plays a key role in induced T cell–dependent 
colitis.  
Key words: Helicobacter pylori, helicobacters, immunity 
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H. pylori is a Gram-negative non spore forming, s-shaped or curved bacillus 0.5-0.9 µm by 2-
4 µm, with 1 to 3 turns when observed in vivo. In vitro spiral forms are less obvious with cells 
appearing more frequently as singly curved or u-shaped rods. It possesses up to six sheathed 
polar flagella. Bacteria are motile by action of flagella. It grows in microaerophilic conditions 
on supplemented blood agar at 37°C usually for 3-5 days. Colonies are grayish, circular (1-2 
mm) convex, translucent, sometimes with slight haemolysis in blood agar around colonies 
(Owen, 1998).  
The first time when gastric spiral bacteria were seen were in 1893 by Bizzozero, who 
described helical bacteria in the canine stomach, and then in 1896, by Salomon who reported 
similar microorganisms in the stomachs of cats and mice. Spiral bacteria in the human gaster 
were described in 1906, when Krienitz made his observation in patients with gastric 
carcinoma, and later Rosenow and Sanford reported on the presence of such type of spiral 
bacteria in the stomachs of patients with ulcer disease (Buckley and O’Moraint, 1998). These 
findings were considered contamination or artifacts for about a century. 
Discovery of H. pylori in the gaster of patients with gastritis and ulcer emphasized the 
association between bacterium and disease in 1982 from Australian medical doctors, Marshall 
Warren (Marshall et Warren, 1984), as well as proving the Koch’s postulates. Namely, 
Marshall and his co-worker ingested H. pylori suspension, which was followed by occurrence 
the disease and subsequently healing with antibacterial treatment. That discovery undermined 
conventional ideas that bacteria cannot live in the stomach and particularly that they cannot be 
responsible for etiology of gastritis and ulcer disease. Marshall’s and Warren’s long-term 
efforts rewrote the classic medical textbooks and in 2005 they were awarded Nobel Prize in 
Medicine.  
At first, H. pylori were classified in the genus Campylobacter as C. pyloridis, then  as C. 
pylori, but later work described new genus Helicobacter in 1989 (Goodwin et al., 1989) and it 
was removed into the family Helicobacteraceae. In 1991, Vandamme with coworkers 
proposed description of genus Helicobacter with the inclusion of two further species: H. 
cinaedi and H. fennelliae. H. pylori were positioned in the Delta and Epsilon subdivision of 
the Purple Bacteria (Proteobacteria). The most closely associated genera were Wolinella with 
one species, W. succinogenes, and Campylobacter (Owen, 1998). Nowadays, based on 16S 
rRNA sequences, the phylogenetic tree is represented with 18 validated Helicobacter species, 
two candidate species, and nine additional provisional species (Solnick and Vandamme, 
2001). H. baculiformis is the last formally named Helicobacter species isolated from the 
stomach of a cat (Baele et al., 2008) while H. callitrichis and H. macacae are isolates that will 
probably represent a new helicobacters (Moyaert et al., 2008). However, H. pylori is the type 
strain and genus representative.  
Transmission of H. pylori from human to animals is extremelly rare event and were not 
described until two outbreaks of increased mortality associated with gastric bleeding and 
weight-loss in a captive colony of the Australian marsupial, the stripe-faced dunnart 
(Sminthopsis macroura) (Every et al., 2011). 
Perhaps more than a half of human population is infected with H. pylori, yet only small 
proportion develops any type of disease. H. pylori infection is the most often related to human 
gaster and it appears as several non-malignant illness and malignancy. Non malignant 
diseases are gastritis, peptic ulcer, gastroesophageal reflux disease, gastric polyps, 
nonsteroidal-anti-inflammatory drug⁄aspirin-induced gastric injury and functional dyspepsia 
(Furuta et Delchier, 2009). Human malignancy caused by H. pylori is gastric carcinoma and 
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mucosa associated lymphatic tissue (MALT) lymphoma.   
Virulence factors of H. pylori are numerous. Cytotoxin-associated gene pathogenicity island 
(cagPAI) is marker for Cag+strains. H. pylori peptidoglycane elicits stimulation of 
nucleotide-binding oligomerization domain (NOD). Vacuolating cytotoxin A (VacA) possess 
several genotypes which of them vacA s1/m1 is the most often associated to peptic ulcer and 
gastric carcinioma. Outer memrane proteins (OMPs) participates in adhesion and blood group 
antigen binding adhesion protein (BabA) enables binding H. pylori to Lewis b (Leb) blood groop 
antigens, as a receptor of H. pylori for gastric epithelial cells. Other virulence factors are outer 
inflammatory protein adhesion (OipA), sialic acid-binding adhesion (SabA), adhesion proteein 
for binding to sialic acid, proinflammatory lipopolysaccharide (LPS), urease, etc. Numerous 
studies have demonstrated the phenotypic and genotypic diversity in H. pylori strains, 
responsible for different types of inflammatory responses in the host as well as versatile 
clinical outcomes of diseases (Kusters et al., 2006). 
It is supposed that CagA is a major virulence factor of H. pylori also involved in an increased 
cancer risk. CagA is the protein that mediated a type IV secretion system, localized in to inner 
surface of host cell membrane. CagA becomes phosphorylated on specific tyrosine residues 
within repeating penta-amino acid Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs. So far, four different 
motifs have been described according to the amino acid sequence. Existance of a higher risk 
for cancerogenesis is observed in strains with a high degree of phosphorylation in EPIYA 
motifs (Karlsson et al., 2012). 
VacA induces vacuolization in gastric epithelial cells as well as apoptosis via the 
mitochondrial pathway. DNA sequence analysis revealed that the VacA protein has a mosaic 
structure comprising allelic variations in the signal (s) and mid region (m) and being 
associated with gastric carcinoma and gastric mucosal atrophy. Besides these two structures, 
intermediate (i) region, located between the s and m regions and deletion (d) region has been 
described. The d region is located between the vacA i and m regions. This polymorphism in 
cagA and vacA genes play an important role in in H. pylori pathogenesis (Karlsson et al., 
2012).  
Investigations on the vacA gene, encoding the vacuolating toxin, indicate its presence in all 
strains. Substantial sequence polymorphisms within vacA can be found in the coding sequence 
for the s-region, and in the middle (m) region. It is considered that the strains of the s1/m1 
subtype produce higher levels of the vacuolating cytotoxin than other genotypes, while s2/m2 
strains do not secrete vacA (Marie 2012). Another group of investigators has found three 
genotypes: s1/m, s1/m2, and s2/m2. That study showed a significant correlation between the 
vacA s1/m2 genotype and gastritis and a significant correlation between vacA s1/m1 genotype 
and peptic ulcer. The results of that study might be useful for the identification of high-risk 
patients who are infected by vacA s1/m1 genotype of H. pylori strains. Finally, H. pylori 
strains with vacA type s1 as well combination of s1/m1 associated with peptic ulceration and 
the presence of cagA gene may serve as excellent marker for disease development (Marie, 
2012).  
H. pylori induce both innate and specific immune responses. The humoral immune response 
does not have a protective role in H. pylori infection, while cell immunity predominates and 
participates in disease etiology, disease outcome and perhaps could have protective role. 
Innate epithelial defense depends on TLR and NOD-like receptor (NLR) activation which 
induces a H. pylori specific T helper (Th) 1 immune response. The degree of mucosal damage 
is in correlation with neutrophilic infiltration. It seems that the H. pylori neutrophils activating 
protein (HP-NAP) is the key factor in the generation of Th1 response and interleukin 
synthesis in monocytes, dendritic cells, and neutrophils are the consequence of TLR2 
activation. Activation of TLRs differs from other Gram - negative bacteria: H. pylori LPS 
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activates TLR2 rather than TLR4 (Del Giudice et al., 2001), while H. pylori flagella which 
cannot activate the TLR5 in some degree may contribute evading immune response 
(Andersen-Nissen et al., 2005). H. pylori infection which activates Th1 subset can lead to the 
synthesis of proinflammatory cytokines: IFN-γ, IL-12, IL-18 and tumor necrosis factor 
(TNF)-α. The degree of gastritis is in correlation with TNF-α and IFN-γ expression. Peptic 
ulcers are associated with H. pylori specific local gastric Th1-cell responses (Bergman et al., 
2006). A strong Th1 mucosal response is associated not only with the progression of gastric 
mucosa damage, but also with atrophic gastritis and gastric adenocarcinoma (Kusters et al., 
2006). 
Another mechanism which enables H. pylori to induce gastric mucosal atrophy and ulcer 
development can be increased regulatory T cell (Treg) activation by bacterial antigens. This is 
the pathway for H. pylori for immune evasion from host immunity. However not only H. 
pylori gastritis is associated to Treg accumulation, yet in peptic ulcer disease, elevated Treg 
control the inflammation enabling bacterial persistence. Nevertheless, T reg cells have 
protective role from extensive gastric inflammation, gastric colonization and progression of 
H. pylori infection in malignancy (Kusters et al., 2006). Besides immune mechanisms, some 
studies emphasize the role of cagA genotypes in the development of gastroduodenal sequels 
while in contrast to other studies, they cconsidered that vacA genotypes were not related to 
disease progression or its outcome (Karlsson et al., 2012). 
In the subgroup of patients with asymptomatic chronic gastritis most H. pylori-specific gastric 
T cells are Th0 cells, which secrete both Th1 and Th2 cytokines (D’Elios et al., 1997) having 
mixed Th1- and Th2-cell response to H. pylori in gastric mucosa, and maintaining persistent 
colonization without developing clinical disease (Bergman et al., 2006). One of the proposed 
mechanism by which H. pylori persist on mucosal surface without any damage it is that some 
phase variants of H. pylori can bind a specific cell-surface receptor on dendritic cells, 
suppressing the development of Th cells into Th1 cells through IL-10 (Bergman et al., 2004). 
Variants of H. pylori that are selectively to specific DCs subsequently migrate to the gastric 
lymph nodes and suppress the development of Th cells into Th1 cells (Bergman et al., 2006). 
H. pylori have important role in two types of gastric malignancy: gastric carcinoma and 
MALT lymphoma. However, malignancy occurs only when individuals are infected with 
specific H. pylori strains and when specific host response occurs. Malignancy is associated 
with s1/m1 strains and some with s1/m2 strains which were exclusively i1, and s2/m2 that are 
exclusively i2. That why, i region may serve as an independent marker of gastric carcinoma 
and its typing may be sufficient for the identification of all pathogenic forms of H. pylori 
vacA and useful in cancer prevention (Rhead et al., 2007).  
In carcinogenesis a high level of pro-inflammatory cytokine IL-1 expression (IL-1β) and up 
regulation of IL1RN gene (which encodes the receptor antagonist of IL-1β) consecutively 
decrease gastric acid secretion and increase the risk for atrophic gastritis. These events 
associated with predominant corpus H. pylori colonization and pangastritis occur in 
individuals with increased risk of carcinogenesis (El-Omar et al., 2000; Furuta et al., 2002). 
Some polymorphic types of IL-1 and TNF-α gene-cluster play paramount role in etiology of 
carcinoma (El-Omar et al., 2003). Also, in anti-inflammatory cytokine IL-10 certain gene 
polymorphisms are associated with an enhanced anti-inflammatory response or decreased 
level of IL-10 favoring the pro-inflammatory response (Kusters et al., 2006). Indeed, H. 
pylori, can change the epithelial cells signaling contributing to the gastric carcinogenic 
process. A combination of CagA-dependent and CagA-independent signaling was both 
required to stimulate cancer cell motility (Snider et al., 2008). 
Apoptosis may be under the influence of the genotype of the infecting bacteria. Although H. 
pylori cagPAI-negative strains can induce this process, the expression of cagPAI promotes 
apoptosis more rapidly than in cagPAI negative strains (Minohara et al., 2007). The major H. 
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pylori-induced apoptotic pathway in gastric cancer (GC) cells requires the activation of 
caspases-3 and -9 (Zhang et al., 2007). However, gene that encodes β-catenin can function as 
an oncogene (Wang et al., 2008), increasing β-catenin production in patients with malignancy 
(Saldanha et al., 2004).  
In addition to genetic alterations, epigenetic changes are also involved in cancer development 
and progression. H. pylori infection may be linked to hypermethylation, thus increasing the 
rate of promoter methylation in E-cadherin, and death-associated protein kinase in the 
noncancerous gastric mucosa of GC patients (Kaise et al., 2008). In GC a shift to the Th2-
mediated humoral immunity can appear in the advanced stages of the disease. Elevated 
production of suppressive cytokine might lead to a decreased cytotoxic antitumor T-cell 
response in the stomach, contributing to tumor progression (Ferreira et al. 2008).  
In gastric MALT lymphoma, CD4+T cells stimulate the proliferation of neoplastic B cells. 
These B cells synthesize auto-antibodies and differentiate to varying degrees into mature 
plasma cells (Parsonnet et al., 2004). Although gastric mucosa does not normally contain 
lymphoid tissue, MALT appears in response to colonization with H. pylori. A monoclonal 
population of B cells may arise from this tissue and slowly proliferate to lymphoma (Kusters 
et al., 2006). Furthermore, studying the immunoproteome evidence showed the variability of 
the antigenic pattern among H. pylori strains, which represents the unusual extent of genetic 
heterogeneity due to the high rates of mutation and recombination events in vivo (De Reuse et 
Bereswill, 2007).  
There are also a helicobacters that can cause gastric disorders in animals similar to human 
diseases: almost any animal has its own bacterium, although some species can infects several 
hosts. However, these non-Helicobacter pylori species (NHSP) can cause disease in humans 
that have close contact to animals. NHSP can be for didactic reasons classified to gastric and 
enterohepatic helicobacters. Gastric helicobacters: Helicobacter heilmannii, H. felis, H. 
mustelae, H. acinonychis, Helicobacter nemestrinae, H. salomonis, H. bizzozeronii, "H. 
suncus", "candidatus Helicobacter bovis" usually cause disease in animal host and they are 
rarely human parasites with exeption of H. heilmannii.  
Adaptation of bacteria to gastric bile reflux may select for various gastric and intestinal 
Helicobacter species and to invade the biliary tract and human liver by an ascending infection 
or transport by blood borne macrophages. However, the continuous discovery of non 
culturable new species suggests that PCR-based as well as immunodiagnostic methods should 
be developed to study these infections and their relation to ulcerative colitis and other forms 
of inflammatory bowel disease (IBD), Sjögren syndrome, and possibly other autoimmune 
diseases (Wadström et Ljungh, 2002).  
Some of the species of enterohepatic helicobacters also primary isolated in animals as H. 
hepaticus, H. cinaedi, H. fennelliae, H. canis, H. pametensis, H. pullorum, H. canadensism, 
H. muridarum, H. rappini, H. bilis, H. trogontum, H. aurati may be associated with human 
hepatobilliar disease, enterocolitis and even IBD. 
Intestinal Helicobacter species can enter the bloodstream, and therefore can be expected that 
it could enter the liver. Despite detection of helicobacter 16s rDNA in liver tissues by PCR, 
there have been no published data of helicobacter cultivation or ultrastructural identification 
(O’Rourke et al., 2001). Helicobacters which may be cultured from human diarrheal samples 
include: H. cinaedi, H. canis, H. pullorum, H. fennelliae, H. canadensis, H. rappini and other 
unclassified but related organisms. The data obtained by studying symptomatic and 
asymptomatic individuals and experimental evidence implicate H. cinaedi and H. fennelliae in 
the etiology of human intestinal disease while H. pullorum and H. canadensis have been 
cultured from immunocompetent and immunodeficient human patients presenting with acute 
or chronic diarrhea. H. rappini and H. canis has been isolated in patients with gastroenteritis 
(O’Rourke et al., 2001). 
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The incidence of the chronic IBD, Crohn's disease (CD) and ulcerative colitis (UC) has 
increased during the last two decade. Healthy individuals maintain a symbiotic relationship 
with bacteria that populate their gastrointestinal tracts (Matharu et al., 2009).  
In the last decades, H. hepaticus is implicated in etiology of IBD. Individuals with IBD are at 
a higher risk of developing colon cancer than the general population because imbalances in 
both innate and adaptive immune cells, such as natural killer (NK) cells and T cell subsets, 
CD4+, CD8+T, and Treg cells. The inflammation and damage caused by increased secretion 
of inflammatory cytokines during an active disease state is thought to be triggered by 
cytotoxicity against the commensal bacteria. Induction of inflammatory cytokines synthesis 
can result from the disruption of the homeostatic balance between Treg and effector T helper 
(Th) cells. Elevated levels of pro-inflammatory CD4+T cells and extensive CD8+T cell 
infiltration are also important in the pathogenesis of UC in humans. Transforming growth 
factor (TGF)-β mediates many diverse biological functions on different cell types. TGF-β 
dysfunctions in one or more signaling pathways are commonly observed in human IBD and 
colon cancer development.  
Additionally, it is demonstrated that disruption of one of the transcription factor modulates 
colitis susceptibility following infection with certain Helicobacter spp. Among these, H. 
hepaticus may be of great importance. H. hepaticus induce a moderate inflammatory response 
in the cecum and colon of rodents, eventually leading to mucinous adenocarcinoma 
formation. It is generally accepted that chronic low levels of inflammation lead to cancer 
promotion and progression. There are data that imply that defects in some signaling process 
increase susceptibility to colitis induced by H. hepaticus involving aberrant activation 
function impairment of effector lymphocytes (McCaskey et al., 2012).  
Also, it is considered that in H. hepaticus infection, IL-23 plays a key role in induced T cell–
dependent colitis. Namely, IL-23 but not IL-12 is essential for the development of intense 
IBD. It is considered that IL-12 predominates in host defense against intracellular microbes 
(NK cell and IFN-γ production) stimulating differentiation of Th1 cells. Recently, IL-23 was 
identified as a new member of the IL-12 cytokine family secreted by activated DCs and 
macrophages. IL-23 was originally described to induce the proliferation and secretion of IL-
17 by CD4+T cells and such CD4+T cells were subsequently shown to be strong inducers of 
immune pathology. Recent studies have established that IL-17+ CD4+ T cells represent a 
novel subset of Th cells (Th17 cells) that also produces proinflammatory cytokines as IL-6 
and TNF-α, and mobilize neutrophils driving to chronic inflammation (Kullberg et al., 2006). 
IL-17–producing CD4+T cells alone are capable to induce autoimmune tissue reactivity. It 
seems that model in which IL-23 drives both interferon  and IL-17 responses that together 
synergize to trigger severe intestinal inflammation may be completely truthful (Kullberg et 
al., 2006). A quantitative and qualitative microbial imbalance in UC, defined as dysbiosis, has 
been characterized by an increase in numerous enterobacteria and more specifically 
enterohepatic Helicobacters were more prevalent in tissue sample from UC patients subjected 
to molecular detection methods, but not controls (Sasaki et Klapproth, 2012).  
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Abstract 
Lyme borreliosis is multisystem zoonosis caused by spirochaetes of the Borrelia burgdorferi 
sensu lato species complex. The most common clinical manifestation is erythema migrans.  
However, the infecting pathogen can spread to other tissues and organs, causing more severe 
manifestations that can involve a patient’s skin, nervous system, joints, or heart. Diagnosis of 
Lyme borreliosis is usually based on the recognition of a characteristic clinical presentation, 
exposure in an endemic area, and a positive antibody response to Borrelia burgdorferi. 
Serologic and microbiologic tests are available to assist when suspicion of illness exists but a 
clinical diagnosis cannot be made. The interpretation of serological test results must always 
be performed in context with the clinical data. 
 
Key words: Lyme borreliosis, clinical manifestations, microbiological diagnosis 
 
Lyme borreliosis is the most commonly reported tick-borne infection in Europe and North 
America caused by spirochaetes of the Borrelia burgdorferi sensu lato species complex. 
Borrelia burgdorferi sensu stricto is the only species known to cause human disease in North 
America. In Europe, at least five species of Lyme borrelia (Borrelia afzelii, Borrelia garinii, 
Borrelia burgdorferi, Borrelia spielmanii, and Borrelia bavariensis) can cause the disease1. 
Borrelia burgdorferi seems to be the most arthritogenic, Borrelia afzelii is mostly associated 
with skin manifestations, and Borrelia garinii seems to be the most neurotropic1,2.  
Ixodes scapularis and Ixodes pacificus are the main vectors of Lyme borrelia in USA, 
whereas Ixodes ricinus is the main vector in Europe1. When an infected tick takes a blood 
meal, Lyme borrelia carried in the midgut increase in number, and undergo phenotypic 
changes including the expression of outer surface protein C (OspC), which allows them to 
invade the host. Transmission occurs via the salivary secretions of ticks that have usually been 
attached and fed for more than 24-36 hours3. Primarily, an infected tick deposits spirochaetes 
into the skin of a host. Later, Lyme borrelia disseminate from that site through blood or 
perhaps tissue planes to other locations. Virulence factors that cause persistence include the 
spirochaete’s ability to downregulate expression of specific immunogenic surface-exposed 
proteins, including OspC, and to alter a surface lipoprotein known as variable major protein-
like sequence expressed (VlsE)1. OspC during and soon after transmission may be essential 
for early infection. VlsE can randomly recombine to produce a remarkable amount of 
antigenic variation that promotes resistance against humoral immunity and persistence of 
infection2. Most tissue damage seems to result from host inflamatory reactions. 
Lyme borreliosis is multisystem zoonosis with variable clinical presentations at different 
stages of infection. Localised infection is typically manifested by erythema migrans skin 
lesion, which eventually resolves, even without antibiotic treatment. However, Lyme borrelia 
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can spread to other tissues and organs, causing more severe manifestations that can involve a 
patient’s skin, nervous system, joints, or heart. Early disseminated disease is usually 
characterised by two or more erythema migrans skin lesions or as an objective manifestation 
of Lyme neuroborreliosis, Lyme arthritis or Lyme carditis. More than one erythema migrans 
skin lesion may be seen in approximately 10% patients with primary Lyme disease3. Borrelial 
lymphocytoma, a painless bluish-red nodule or plaque, usually found on the ear lobe, ear 
helix, nipple or scrotum is rare and occurs more frequently in children4. Early Lyme 
neuroborreliosis usually develops within a few weeks of infection. In adults, the disease 
typically presents as painful meningoradiculoneuritis (Garin-Bujadoux-Bannwarth syndrome) 
and unilateral or bilateral facial palsy4. Lyme arthritis usually manifests in one or a few large 
joints most commonly the knee. Lyme arthritis is one of the rare inflammatory joint diseases 
in which routine laboratory parameters of inflammation, such as ESR and CRP are often 
normal. The most common cardiac manifestation of Lyme borreliosis is first-degree 
atrioventricular (AV) block. Second degree and complete AV blocks, junctional rhythms, and 
asystolic pauses may be seen2. Ophthalmic changes (uveitis, papillitis, keratitis, and 
episcleritis) are apparently rare and usually present as conjunctivitis in the course of early 
manifestations of Lyme borreliosis4. Late Lyme borreliosis usually manifests as arthritis or 
the skin disorder known as acrodermatitis chronica atrophicans (almost exclusively seen in 
adults, predominantly women), but can also include specific rare neurological manifestations1. 
In one case series of patients with Lyme borreliosis, 89% had erythema migrans by itself, 5% 
had arthritis, 3% had early neurological manifestations, 2% had borrelial lymphocytoma, 1% 
had acrodermatitis chronica atrophicans, and less than 1% had cardiac manifestations1.  
Pregnant women with Lyme borreliosis have typical manifestations, with erythema migrans, 
fatigue, constitutional symptoms, and possibly arthritis or neurologic involvement. 
Transplacental transmission of B. burgdorferi has been documented, but it is unclear whether 
transmission has any effect on malformation or fetal demise2. In general, the clinical 
characteristics of childhood and adult Lyme borreliosis are similar, except for 
meningopolyradiculoneuritis and acrodermatitis chronica atrophicans, which manifestations 
are not typically seen in children. There is also evidence indicating that children experience 
shorter-lasting symptoms and have better outcomes5.   
Most cases of Lyme disease resolve without complication after appropriate antibiotic therapy. 
In rare cases, when the diagnosis of Lyme neuroborreliosis is made late in the course of 
disease, recovery from severe neurological symptoms may be incomplete (i.e. paresis, hearing 
deficits, ataxia, incontinence, cognitive impairment)4. However, 10–15% of ideally treated 
patients develop post-treatment Lyme disease syndrome (PTLDS), which is characterized by 
the persistence of a complex of symptoms for more than 6 months after treatment. The 
symptoms are nonspecific and include reduced performance, increased fatigue, 
musculoskeletal pain, irritability, emotional lability, and disturbances in sleep, concentration, 
and memory6. Patients with PTLDS may have  a heightened, but apparently non-specific 
production of antibodies to neural antigens. These antibodies may either be indicative of past 
injury to the nervous system during the active phase of the Lyme disease infection, resulting 
in the immune system being exposed to and activated by novel self antigens, or point to the 
enhanced B cell mitogenic effect of the borrelia pathogen in cases of delayed treatment and 
prolonged infection in genetically predisposed individuals7. 
Diagnosis of Lyme borreliosis is usually based on the recognition of a characteristic clinical 
presentation, exposure in an endemic area, and a positive antibody response to Borrelia 
burgdorferi3. Except in cases with the pathognomonic clinical manifestation erythema 
migrans, the diagnosis of Lyme borreliosis usually requires confirmation by means of a 
microbiological diagnostic assay. Antibody detection methods are mainly used for this 
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purpose whereas detection of the causative agent by culture isolation and nucleic acid 
techniques is confined to special situations, such as to clarify clinically and serologically 
ambiguous findings. Centers for Disease Control and Prevention (CDC) and the German 
Society for Hygiene and Microbiology (DGHM) have made similar recommendations for the 
microbiological diagnosis of Lyme borreliosis in both the United States and Europe1,4,8,9,10. 
For non-erythema migrans presentations of Lyme borreliosis, the mainstay of laboratory 
diagnosis is two-tier serological testing. One should proceed with an initial screening assay 
consisting of either an enzyme-linked immunosorbent assay (ELISA) or an indirect 
fluorescent antibody (IFA) test. Ambivalent or positive results should be followed by a more 
specific Western blot. The presence of several pathogenic genospecies in Europe with 
variability of immunodominant antigens, together with the slightly lower specificity of the 
single test approach, may limit successful application of such single tests.  Laboratory kits for 
the ELISA have traditionally assessed the antibody response to whole-cell Borrelia, but newer 
assays can use purified surface antigens or recombinant antigens known to be highly 
conserved in pathogenic variants.  Synthetic peptide antigens of VlsE or of C6, a single 
peptide created from an invariable sequence in the gene for VlsE, have reduced the potential 
for cross-reactivity, and have been suggested for potential use in a one-tiered ELISA11. 
Western blot is generally more sensitive and specific than ELISA in detecting antiborrelial 
antibodies. Commercial recombinant antigen immunoblots are better standardized than 
conventional blots. 
Serology is insensitive during the first several weeks of infection, with only 30% of patients 
with erythema migrans having a positive response to IgM. Furthermore, seroconversion in 
such patients may be absent because early antibiotic treatment can ablate antibody 
production3. Patients with multiple erythema migrans lesions are more likely to be 
seropositive than those with localized infection because of the greater contact of the pathogen 
with the immune system and the engagement of a larger number and variety of antigen-
presenting cells in patients with multiple lesions, larger antigen loads in these patients, 
differences in the virulence of the infecting strains of B. burgdorferi, or a combination of 
factors12. At present, detection rates for serum antiborrelial antibodies are 20–50% in 
localized and 70–90% in disseminated early disease. Six weeks or more after the onset of 
symptoms, 100% of patients with acute neuroborreliosis are seropositive8. In cases with late 
disease (acrodermatis and arthritis), IgG antibodies are detectable in all patients tested.  
IgM antibodies are usually positive 2 to 6 weeks after exposure, while 3 to 4 weeks after 
increasing IgG titers may be detected. IgM antibodies to a limited number of surface proteins: 
p21 (OspC), p35, p37 and p41 are produced in the early stages of Lyme borreliosis. OspC and 
p41 are immunodominant while OspC is highly specific for the IgM response. IgG antibodies 
are initially created to OspC, p37 and p41, then to p39, p58 in the early stages of 
dissemination, and finally to a large number of antigens (p100, p18, p39 and/or VlsE) in the 
late stage of the disease. VlsE is early marker of IgG response, but it may be part of immune 
response of late Lyme borreliosis associated with p100/or p18.  
IgM response may persist in cases of prolonged illness or reinfection, but can also be seen in 
asymptomatic patients previously treated for Lyme borreliosis. Repeated findings of an 
isolated IgM response with no IgG seroconversion are nonspecific. Thus, a positive IgM test 
without a positive IgG test is not diagnostic for late disease manifestations. An exception may 
be a patient who receives inadequate antibiotic therapy for early disease, but sufficient drug to 
abrogate the IgM to IgG class switch, or a very short duration of clinical symptoms8. Once 
IgG seroconversion is apparent, levels may stabilize and persist, creating an “immunologic 
scar” that indicates exposure, but not necessarily active disease. A negative IgG test may 
provide assistance in ruling out potential late Lyme borreliosis. After antibiotic treatment, 
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antibody titers decline slowly, but IgG and even IgM response may persist for months or even 
years after treatment3. Clearly, a positive serological test does not mean that patient 
necessarily has active Lyme borreliosis. As serological findings vary considerably and 
antibodies may persist for a long time in successfully treated individuals, serological follow-
up is not suitable for determining whether further antibiotic therapy is warranted. The 
interpretation of serological test results must always be performed in context with the clinical 
data.  
Antiborrelial antibodies can frequently be found in the CSF of patients with Lyme 
neuroborreliosis, especially in Europe. Intrathecal synthesis of specific antibodies is a 
mainstay of the diagnosis of Lyme neuroborreliosis1. ELISA and Western blot can be used to 
identify antiborrelial antibodies in the CSF . The analysis of paired serum and CSF samples 
obtained simultaneously is key to determining the specific CSF/serum antibody index (AI). A 
positive AI together with typical signs of inflammation in the CSF confirms a clinical 
diagnosis of Lyme neuroborreliosis4. The CSF/serum index may be positive in some cases 
when serum antibody tests are negative or equivocal, especially if the patient’s illness has 
been of short duration8. However, intrathecal synthesis of antibodies can persist for several 
months to several years after successful antibiotic treatment. 
Although erythema migrans will eventually resolve without antibiotic treatment, oral 
antibiotic treatment is recommended to prevent dissemination and development of later 
sequelae. Even without antibiotic therapy, our innate and adaptive immune response will 
control widely disseminated infection and generalized systemic symptoms wane within 
several weeks to months. However, without effective antibiotic therapy, spirochetes may 
survive in localized niches for several more years3. Treatment recommendations include oral 
antibiotics for early, uncomplicated disease and intravenous antibiotics for disseminated, late 
stage disease3,13. Doxycycline is preferred, but its use should be avoided in pregnant patients 
and children under 8 years of age. In children under 8 years of age with early disease, an 
excellent approach is oral amoxicillin. Acute disseminated disease with neurologic 
involvement generally requires more intensive treatment with intravenous antibiotics. Patients 
who develop third-degree atrioventricular block should be placed on a cardiac monitor and 
treated in the same way as acute neuroborreliosis. Patients with recurrent rheumatologic 
symptoms after the initial treatment may require repeat treatment with 4 weeks of oral 
antibiotics or 2 to 4 weeks of intravenous ceftriaxon13. Positive treatment effects of 
ceftriaxone in patients with PTLDS reveals that retreatment can be beneficial14. 
In many European countries, the incidence of Lyme borreliosis has increased in the past few 
years1. Most transmission to human beings, manifested by cases of erythema migrans, occurs 
from late May to late September, coinciding with the activity of nymphs and with the 
increasing recreational use of tick habitats by the public. Only about 50% of adults and 90% 
of children may display erythema migrans2. Most children with Lyme borreliosis are male, 
while a majority of adults diagnosed are female. The seasonal distribution of extracutaneous 
manifestations is less pronounced, because the time from infection until disease onset is 
variable and usually longer than it is for erythema migrans. In the USA, there is a bimodal age 
distribution with the highest incidences in children 5–9 years old and in adults 45–59 years 
old, but patients of all ages are at risk1. Lyme borreliosis can be prevented by avoidance of 
tick infested environments, and when in such environments, covering bare skin and using of 
tick repellents on skin or clothing. WHO and CDC recommend prompt forceps tick removal 
without rotation, chemical adjuvants, or cryotherapy13. After removal, the site of previous 
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The discovery of Helicobacter pylori (H. pylori) and its role in most diseases of the upper 
gastrointestinal tract constituted a breakthrough in the field of gastroenterology. Eradication 
of H. pylori reduces the risc of peptic ulcer recurrence, prevents the development of both ulcers 
and gastric cancer and benefits around 8% of patients with non-ulcer dyspepsia. However, the 
most commonly recommended empiric first line treatment with a proton pump inhibitor, 
amoxicillin and clarithromycin is now compromised due to increase in H. pylori antimcrobial 
resistance. In most European countries, the high rate of primary clarythromycin resistance 
(20% or more) no longer allows its empirical use. As an alternative to clarythromycin, the 
empirical use of levofloxacin has been proposed a decade ago, but the prevalence of 
resistance of H. pylori to quinolones has increased rapidly. Although highly prevalent, 
metronidazole resistance has only limited impact on the eradication rate and can be overcome 
in vivo by increasing the length of treatment or by bismuth-containing quadruple therapy. 
According to the Maastricht consensus/Florence IV report surveillance of primary H. pylori 
antibiotic resistance in order to guide clinicians in the therapeutic choice is recommended. 
Based on these recommendations, clarithromycin should be avoided without prior antibiotic 
susceptibility testing if local resistance exceeds 15–20%. Also, current guidelines advocate 
culture and antimicrobial sensitivity testing in patients who remain infected with H. 
pylori after two failed eradication attempts. Real-time PCR to detect point mutations 
conferring resistance to clarythromycin, levofloxacin and tetracycline is rapid and accurate 
alternative to technically demanding H. pylori culture, for both diagnosis and genetic 
detection of antibiotic resistance in H. pylori.  
In R. Serbia, until recently there were no antibiotic sensitivity data  of H. pylori isolates. 
The need for local national resistance surveys is essential to overcome the acquisition of 
antibiotic resistance in H. pylori. 
Key words: Helicobacter pylori, antibiotic resistance, local national resistance surveys 
 
Helicobacter pylori (H. pylori) plays an essential role in the pathogenesis of chronic active 
gastritis in the human stomach, peptic ulcer, gastric adenocarcinoma and lymphomas 
associated with mucosas (MALT) (1-4). All actual consensus guidelines recommend 
eradication of H. pylori in symptomatic patients (5, 6). Overwhelming evidence indicates that 
eradication of H. pylori prevents the development of peptic ulcer ddisease and reduces the risc 
of peptic ulcer recurrence. There is also evidence supporting the merits of H. pylori 
eradication in patients with atrophic gastritis, intestinal metaplasia, gastric adenocarcinoma 
and first-degree relatives of patients with gastric cancer. In addition, there is benefit in 
patients with some extra-gastric diseases such as iron deficiency anaemia, B12 deficiency and 
idiopathic thrombocytopenic purpura. H. pylori eradication may be appropriate for patients 
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with investigated functional dyspepsia in populations with a prevalence of H. pylori greater 
than 20% and without alarming signs or symptoms (7). 
Recently proposed “test-and-treat” strategies, based on the non-invasive diagnosis of H. pylori 
infection, is recommended in populations of dyspeptic patients with a moderate-to-high 
prevalence of H. pylori infection (≥10–20%), whereas the empirical proton pump inhibitor 
(PPI) strategy may be preferable in low-prevalence populations (8).  
Over recent decades, as a result of treatment, H. pylori - related peptic ulcer disease and 
prevalence of H. pylori infection have progressively declined throughout most of the 
industrialized countries (9). However, an excellent eradication rate (>95%) has not been 
attained in the numerous therapeutic strategies studied so far and a gradual increase in failure 
of HP eradication treatments is observed (10). Success of H. pylori eradication with 
conventional treatment (PPI, amoxicillin and clarithromycin) has become progressively less 
efficacious. Among several host factors that could explain the particular difficulty in 
eradicating H. pylori are non-compliance to therapy, gastric acid hypersecretion, genetic 
polymorphism of CYP 2C19 and underlined gastrouduodenal disease (11,12). Indeed, it was 
found that patients without ulcer disease carry more resistant clarithromycin and levofloxacin 
strains than patients with an endoscopic finding of ulcer disease (13). Primary resistance to 
antibiotics is the main bacterial factor that affects the treatment success, but also, there are: 
high bacterial load in the stomach that promotes an inoculums effect, bacterial coccoid forms 
of H. pylori, genetic variability (negative cagA status, s2m2 vacA allele status), intra-cellular 
location of bacteria and high rates of reinfection in developing countries (11,12). Other risk 
factors associated with H. pylori resistance are the formation of a bacterial bio-film and the 
presence of persistent or inactive cells highly tolerant to the presence of antibiotics (14). That 
is why susceptibility to an antibiotic does not guarantee the complete eradication of the 
bacteria (15). Recently it has been proposed the addition of antibiofilm substances with N-
acetyl cysteine to treatment could potentially improve efficacy of treatment regimens (10).  
Almost twenty years after the establishment of clarithromycin based – triple therapy, 
nowadays, fall in the eradication success from over 90% in the 1990s to <60% is observed 
(11). In particular, clarithromycin resistance has a major negative impact of the efficacy of the 
recommended first line triple therapy and when H. pylori strain is resistant the eradication 
rates decreases by 35–60%. Consequently, a progressive increase in the prevalence of 
resistance to this antibiotic may limit its empiric use. In the novel European multicentre study 
from 32 centres in 18 Europe countries the prevalence of primary antibiotic resistance of H. 
pylori among outpatients was examined (16). For adults, resistance rate was over 17% for 
clarithromycin, over 14% for levofloxacin and almost 35% for metronidazole, while the 
prevalence was around 1% for the amoxicillin, tetracycline and rifabutin (16). Furthermore, 
resistance rate to clarithromycin and levofloxacin was significantly higher in countries from 
West/Central and Southern Europe (>20%) than in Northern Europe (>10%). In comparison 
with a similar survey (17), the almost the doubling of the prevalence of clarithromycin 
resistance over the past ten years (from 9.8% to 17.5%) was found. This steady increase in 
clarithromycin resistance of H. pylori could have been anticipated given the long-lasting 
character of H. pylori infection when left untreated and the genetic basis of this resistance, 
that is, point mutations in the 23S rRNA gene which are transmited vertically (9). There are 
essentially three point mutations conferring resistance to clarithromycin which can occur at 
the two nucleotide positions of the 23S rRNA gene: transition A to G on position 2142 or 
2143, and transversion A to C on position 2142, that could be easily detected by Real time - 
PCR.  Selection for these resistant mutants occurs when a macrolide is prescribed, which 
impairs first line treatment, since only efficient remaining drug is amoxicillin or 
metronidazole. 
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As an alternative to clarithromycin, the empirical use of levofloxacin with amoxicillin and a 
PPI for ten days has been proposed a decade ago. But, the success rate of this rescue regime is 
also very much depended on the level of levofloxacin resistance which, also, increase very 
quickly (16). In contrast, metronidazole resistance remains at the same high level as ten years 
ago. Although highly prevalent, metronidazole resistance has only limited impact on the 
eradication rate and can be partly overcome in vivo by increasing the length of treatment or by 
bismuth-containing quadruple therapy with metronidazole (9).  
Nowadays, bismuth-based quadruple therapy (bismuth, tetracycline, metronidazole plus a 
PPI) appears to provide the rationale for empiric first-line use, since clarythromycin and 
levofloxacin have been avoided (9). Moreover, no resistance to bismuth salts has been 
described. Additionally, clinical impact of metronidazole resistance can be overcome by 
increasing the dose and duration of treatment. As regarding tetracycline, resistance to this 
antibiotic is rarely encountered because three adjacent point mutations are required and the 
change in the nucleotide triplet (AGA926-928 to TTC) is extremely low in the same 
microorganism (9).  
Alternative recent approach, sequential therapy (PPI and amoxicillin in the first phase 
followed by PPI, clarithromycin and metronidazole in the second phase) has been attempted 
to increase the eradication rate. The challenge of H. pylori clarithromycin resistance can be 
minimized when drugs are prescribed sequentially instead of concomitantly. The usage of 
amoxicilin and PPI in the first phase of this regimen for five days decreases the bacterial load 
eliminating most, if not all, of clarithromycin resistant mutants. Then, in the second phase, the 
next five days administration of drugs, allows eradication of remaining viable 
microorganisms. It was showed that when clarythromycin resistance strains were present 
efficiency was better with sequential therapy (72%) than with standard therapy (33%) (18). 
Since resistance for two major classes of antibiotics for treatment of H. pylori infection, 
quinolones and macrolides, is positively correlated with widespread use of these drugs in the 
outpatient community for infectious diseases other than H. pylori infection (16), the use of 
standard triple therapy has been recommended only in those areas where clarithromycin 
resistance is lower than 15–20% (5). Following Maastricht consensus/Florence IV report on 
the management of H. pylori susceptibility to clarithromycin should be tested or 
clarithromycin should not be used, if local resistance to clarithromycin is above 15–20% (5). 
Also, after two failed eradication attempts, current guidelines advocate antibiotic 
susceptibility testing. The standard methods using culture and antibiotic susceptibility testing 
(e.g. Epsilometer test, Etest) should be performed in specialist laboratories, as the procedure 
is labor-intensive and time consuming. Molecular based methods (e.g. Real-time polymerase 
chain reaction (PCR) - based assays) to detect point mutations predictive of clarithromycin, 
levofloxacin and tetracycline resistance are rapid and accurate alternative to H. pylori culture, 
for both diagnosis and genetic detection of antibiotic resistance in H. pylori. They are, unlike 
culture based methods, independent of cell viability, growth rate of bacteria, do not require 
specific transport conditions and are easy to perform. 
This culture and susceptibility testing for H. pylori approach is logical because even in the 
areas with high clarithromycin resistance the majority of patients could benefit from the 
standard triple therapy which is still considered the “gold standard” for H. pylori eradication 
(9). Culture and susceptibility testing for H. pylori are not commonly performed in routine 
practice and only a few microbiological laboratories routinely offer isolation of H. pylori (7). 
The emergence of multi-resistant strains of H. pylori, particularly seen in patients failing 
previous treatment, urges the antimicrobial susceptibility testing, thereby allowing 
antibiogram - adapted eradication. The duration of incubation for the isolation of H. pylori has 
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been recommended to be five to ten days in a microaerobic atmosphere. As culture is 
important in studying the profile of the antibiotic sensitivity of the isolate for the treatment of 
infections caused by H. pylori, a prolonged incubation time to obtain a higher isolation rate 
for H. pylori from clinical samples is suggested (19). 
Limited number of point mutations conferring clarithromycin resistance allows the 
development of PCR based methods, which can be applied on H. pylori isolates or directly on 
gastric biopsy specimens. Resistance to quinolones is caused by point mutations in the so-
called quinolone resistance-determining region (QRDR) of the gyrA gene (9). But, genotypic 
resistance to levofloxacin (gyrA mutations) do not always correlate well with phenotypic 
resistance, suggesting alternative mechanisms of resistance, or efflux system. Stable primary 
H. pylori resistance to amoxicillin, with a MIC of 8 mg/L, is very rare and occurs due to 
mutations in the pbp-1A gene (9). The need for triple mutations of 16S rRNA gene may 
explain the rarity of tetracycline resistance. Large panels of alterations within rdxA gene are 
of prime importance, but the exact mechanisms of resistance to metronidazole in H. pylori yet 
to be discovered in order to develop molecular approaches. So, until all genes involved in 
mutations would be identified, culture continues to be the “gold standard” allowing 
susceptibility in H. pylori.  
 In R. Serbia, susceptibility testing was performed for the first time in National 
Reference Laboratory for Campylobacter and Helicobacter, Center for microbiology, at 
Public Health Institute, Niš, Serbia, on clinical isolates of H. pylori obtained from gastric 
biopsy specimens of hospitalised patients with dyspepsia who had not been previously 
treated (20).  Primary H. pylori resistance to metronidazole is considerable (37.5%), and 
that to clarithromycin is higher than that in western Europe. There were no strains resistant 
to amoxicillin, tetracycline or rifabutin. 
The need for local national resistance surveys is essential to improve the effectiveness of 
current anti-H.pylori treatment regimens. The acquisition of antibiotic resistance can be, at 
least partially, overcome by continuous testing and monitoring the drug resistance of H. 
pylori strains before applying the treatment. Antimicrobial susceptibility testing should be 
performed particularly in patients previously treated unsuccessfully, due to increasing dual 
resistance to metronidazole and clarithromycin, thereby allowing tailored therapy that could 
optimize eradication regimens within the different countries. 
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Bacterial resistance to antimicrobials has been increasing because of the irrational  use of 
antimicrobial drugs. The emergence of resistance to carbapenem in Enterobacteriaceae is an 
important growing threat to public health. Carbapenems (currently ertapenem,imipenem, 
meropenem and doripenem, etc.) are the most effective and potent β lactam antibiotics, and 
they are reliably active against multidrug-resistant Gram-negative bacteria including 
Enterobacteriaceae.  Carbapenem-resistant Enterobacteriaceae (CRE) was first described  in 
the early 1990s  isolation of CRE  from clinical specimens has increased at an alarming rate in 
the recent past. The common mechanisms that are responsible for carbapenem resistance 
include changes in outer membrane proteins, overexpression of drug efflux pumps and 
carbapenem hydrolyzing enzymes. The production of carbapenem hydrolyzing 
enzymes.(carbapenemases) is the most important mechanism. The molecular classification 
scheme divides a large variety of carbapenemases in Enterobacteriaceae  into three classes- 
Ambler class A, B and D based on the amino acid sequences of the proteins. 
Enterobacteriaceae producing  a ‘big five’ carbapenemases (KPC, OXA-48, IMP, NDM and 
VIM) are spread worlvide. Suspected Carbapenem resistant bacteria detectied by MIC and 
disc-diffusion  method, should be further explored for carbapenemase production by 
phenotypical methods. Production of carbapenemase identified by disk approximation test 
using  EDTA as metal chelater.  Modified Hodge test can also be used for the same purpose. 
PCR has been successfully utilized for the detection of single or multiple carbapenemase 
genes directly from clinical samples. Accurate identification of carbapenemase producers in 
the clinical laboratory is an important first step in the control of CRE. The worldwide spread 
of Enterobacteriaceae expressing carbapenemases now represents a significant threat for the 
public health and requires efforts toward detection and infection control strategies. 
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One of the biggest problems in public health associated  with the antibiotic therapy is 
resistance, especially the emergence of resistance to carbapenem in Enterobacteriaceae. The 
World Health Organization identified antimicrobial resistance as one of the three greatest 
threats to human health(1).   
Enterobacteriaceae are rod-shaped, Gram-negative bacteria that are normal inhabitants of the 
intestinal flora. They are the source of community- and hospital-acquired infections, causing 
infections that range from cystitis to pyelonephritis, septicemia, pneumonia, peritonitis, 
meningitis, and device-associated infections. Enterobacteriaceae spread easily between 
humans by hand carriage as well as contaminated food and water. They also  have a 
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propensity to acquire genetic material through horizontal gene transfer, mediated mostly by 
plasmids and transposons(2) .This combination is why emerging multidrug resistance 
in Enterobacteriaceae  is of the utmost importance for clinical therapy. 
Carbapenems (imipenem, meropenem, ertapenem, and doripenem) are the latest developed 
and the most effective β-lactam antibiotics. They are reliably active against Gram-positive and 
Gram-negative aerobes and anaerobes including multidrug-resistant Gram-negative bacteria. 
These agents are used as an empiric therapy for the treatment of life threatening infections.  
Clinical use of these drugs were recently increased following the emergence and 
dissemination of Extended Spectrum β -Lactamase (ESBL) producers, which were capable to 
hydrolyze all β-lactams except carbapenems.The inevitable use of carbapenems is 
consequently bound to exert  greater selective pressure and  the emergence of carbapenem 
resistance all over the world (3,4). Carbapenem-resistant Enterobacteriaceae (CRE) was first 
described in the early 1990s (5) . The isolation of CRE occurred sporadically throughout the 
decade. However, the recovery of CRE from clinical specimens has increased at an alarming 
rate in the recent past6) . 
The common mechanisms that are responsible for carbapenem resistance include  reduced 
expression of outer membrane proteins or overexpression of drug efflux pumps along with the 
overproduction of β-lactamases possessing weak carbapenemase activity (like ESBL or 
AmpC enzymes). And production of carbapenem hydrolyzing enzymes.(carbapenemases) as 
the most important mechanism. The molecular classification scheme divides a large variety of 
carbapenemases in Enterobacteriaceae    into three classes- Ambler class A,B and D based on 
the amino acid sequences of the proteins, whereas functional groups have been assigned based 
on the hydrolysis and inhibition profiles of the enzymes (7) 
A variety of class A carbapenemases have been described; some are chromosome encoded 
(NmcA, Sme, IMI-1, SFC-1), and others are plasmid encoded (Klebsiella 
pneumoniae carbapenemases [KPC], IMI-2, GES, derivatives), but all effectively hydrolyze 
carbapenems and are partially inhibited by clavulanic acid KPCs are the most clinically 
common enzymes in this group. The first KPC producer (KPC-2 in K. pneumoniae)  was 
identified in 1996 in the eastern United States Within a few years (8), KPC producers had 
spread globally and have been described across the contiguous United States (still mostly in 
eastern coast states) and, in particular, in Puerto Rico, Colombia, Greece, Israel, and the 
People’s Republic of China (9). Outbreaks of KPC producers also have been reported in many 
European countries and in South America. ). A single K. pneumoniae clone (sequence type 
[ST]-258) was identified extensively worldwide, indicating that it may have contributed to the 
spread of theblaKPC genes.(10). KPC producers are usually multidrug resistant. Death rates 
attributed to infections with KPC producers are high (>50%) 11 Class B β-lactamases exhibit 
a broad spectrum of hydrolytic activity including all penicillins, cephalosporins, and 
carbapenems, with the exception of monobactam aztreonam. Their activity is not inhibited by 
commercially available β-lactamase inhibitors (clavulanic acid, tazobactam, or sulbactam). 
Hydrolysis is dependent on the interaction of the β-lactam with Zn2+ ion(s) in the active site, 
explaining the inhibition of their activity by EDTA, a chelator of divalent cations (2,7). 
Analysis of the blaIMP genetic environments most often revealed features of class 1 integrons. 
Resistance genes encode decreased susceptibility to unrelated antibiotic molecules (e.g. β-
lactams, aminoglycosides, sulfonamides, and chloramphenicol). Class B metallo-β-lactamases 
(MBLs) are mostly of the Verona integron–encoded metallo-β-lactamase (VIM) and IMP 
types and, more recently, of the New Delhi metallo-β-lactamase-1 (NDM-1) type. The first 
acquired MBL, IMP-1, was reported in Serratia marcescens in Japan in 1991(12). Since then, 
MBLs have been described worldwide. Endemicity of VIM- and IMP-type enzymes has been 
reported in Greece, Taiwan, and Japan, although outbreaks and single reports of VIM and 
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IMP producers have been reported in many other countries. NDM-1–positive 
 Enterobacteriaceae are now the focus of worldwide attention (13,14). Discovered in 2008 in 
Sweden from an Indian patient hospitalized previously in New Delhi (15). Since mid-August 
2010, NDM-1 producers have been identified on all continents except in Central and South 
America with, in most of the cases, a direct link with the Indian subcontinent. Few cases have 
been reported from the United States and Canada. Ret findings suggest that the Balkan states 
and the Middle East may act as secondary reservoirs of NDM-1 producers. Death rates 
associated with MBL producers range from 18% to 67% (16). 
Class D β-lactamases, also named OXAs for ‘oxacillinases’, possessing  some carbapenemase 
activity. With the exception of one variant (OXA-163) that has a very weak carbapenemase 
activity, carbapenem-hydrolyzing class D β-lactamases (CHDLs) do not hydrolyze expanded-
spectrum cephalosporins. Overall, the carbapenemase activity of CHDLs is weak and is not 
inhibited by either clavulanic acid or by EDTA (7).OXA-48 has been found only 
in Enterobacteriaceae. The first OXA-48 producer was identified from a K. 
pneumoniae isolate recovered in Turkey in 2003. Since then, OXA-48 producing strains have 
been extensively reported as sources of nosocomial outbreaks in Turkey, and identified in 
countries of Southern Europe and Africa.  
 Although all the resistant mechanisms are being increasingly identified worldwide, there are 
some clear endemic areas, such as KPC producers in the USA, Greece, and Israel, VIM 
producers in Greece, OXA producers in North Africa and Turkey, and NDM producers in 
India. Among the Enterobacteriaceae members, Klebsiella pneumoniae are the predominant 
carbapenemase producer followed by Escherichia coli –leading cause of hospital acquired and 
community acquired infections respectively [5]. 
Detection of carbapenem resistance- the ranges of carbapenem MICs for Enterobacteriaceae 
producing each of the ‘big five’ carbapenemases (KPC, OXA-48, IMP, NDM and VIM) span 
from below the susceptible breakpoints to high-level resistance. Nevertheless, the MICs of 
carbapenems for most carbapenemase-producing bacteria will be above the epidemiological 
cut-off (ECOFF) values defined by EUCAST even if some isolates are not clinically resistant. 
Detection of carbapenemaes production based on the following facts: elevated Minimum 
Inhibitory Concentration (MIC) to carbapenem; the zone diameter around a carbapenem disc 
indicates non-susceptibility (test a carbapenem against all clinically-significant isolates). 
Recomanded values from EUCAST are for meropenem and ertapenema MIC≥0,125µg/ml, 
breakpoint 25mm, for imipenem MIC≥1,0 µg/ml, breakpoint 23mm(17). Ertapenem has the 
best sensitivity among the available analogues, but poor specificity for carbapenemase 
producers. Meropenem and imipenem may have better specificity, but reduced sensitivity); 
colonies are obtained on any commercially-available agar for detecting carbapenem-resistant 
bacteria; automated systems should flag non-susceptibility to any carbapenem, irrespective of 
the expert interpretation given. Suspected Carbapenem resistant bacteria detection by MIC 
method, should be further explored for carbapenemase production by phenotypical 
methods(18). Production of metallo -beta- lactamase can be identified by disk approximation 
test (or double disk synergy test) using EDTA as metal chelater. In disk approximation test, 
clear zone (zone of inhibition) around the beta lactum disk, is increased in the presence of 
zinc chelator like EDTA. Modified Hodge test can also be used for the same purpose. This is 
a phenotypic test for confirming the presence of carbapenemase production. Cloverleaf 
indentation at the intersection of the test organism and standard strain, within the zone of 
inhibition of carbapenem disk shows positive result for carbapenemase production. Molecular 
tests are the only reliable means of detecting production of carbapenemases by an isolate. 
PCR has been successfully utilized for the detection of single or multiple carbapenemase 
genes directly from clinical samples. If stool samples or rectal swabs require screening for 
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CPE, the method chosen should have demonstrated performance at least equivalent to plating 
on to a commercially-prepared chromogenic agar medium specifically recommended for this 
purpose. 
Accurate identification of carbapenemase producers in the clinical laboratory is an important 
first step in the control of CRE. The early identification of carbapenemase-producing 
Enterobacteriaceae both in clinical infections and at the carrier-state is essential to prevent 
the development of untreatable infections.Because of the irrational use of antibiotics more and 
more microorganisms are developing resistance to available antibiotics (19). Resistance in 
Gram-negative pathogens is increasing at an alarming rate. Because multidrug resistance in 
Gram-negative bacteria is observed  in both  nosocomial and community isolates, eradication 
of these resistant strains is becoming more difficult (20). Infections caused by such bacteria 
are associated with high morbidity and mortality. Two classes of antibiotics i.e., polymyxins 
(colistin) and glycylcyclines (tigecyclines), have shown in vitro activity against CRE. 
Therefore, the worldwide spread of Enterobacteriaceae expressing carbapenemases now 
represents a significant threat for the public health and requires efforts toward detection and 
infection control strategies. 
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Apropriate hand hygiene before patient contact is a fundamental tool for the prevention of 
cross-transmited infections. In aim to improve HH among HCWs, IMHHA was implemented 
from January 2014 in University Clinic for Neprhology  in Skopje. An observational, 
interventional, prospective study was conducted from the same time, and follow up in next six 
months. The IMHHA includes following elements: administrative support, supplies 
availability, education and training, reminders in workplaces, process surveillances and 
performance feedback. Training was provided at the beginig of each month, poster reminders 
with 5 step-procedure of proper HH were displayed around hospital settings. HH practice was 
monitored by an observers without awarness of HCWs respecting “Five moments for HH” by 
WHO (sex, professional category, work shift, type of contact, type of ICU). Study achived 
100% administrative support and educated HCWs. According the results study there was a 
higher compliance, in nurses v.s. medical doctors, an invasive contact v.s. non-invasive 
contact and morning shift versus afternoon and evening shift. There was no significant 




2. LACTOBACILLUS RHAMONSUS LB-68 AS AN ACTIVE COMPONENT FOR 
MAKING A NEW VAGINAL TABLET FORMULATION  
 
Cvetković Vesna, Plješa T. 
Institute of Virology, Vaccines and Sera “Torlak” 
 
Lactobacillus species, as a part of physiological vaginal flora, help to maintain vaginal eco-
system balance with numerous mechanisms. Various internal and external factors such as 
certain conditions and illnesses, inadequate hygiene, antibiotic and hormonal therapies, radio 
and immunotherapy, spermicide agents’ frequent usage can lead to a reduction colony number 
of of lactobacilli or their complete destruction. Implantation of carefully selected lactobacilli 
with suitable probiotic properties can establish vaginal microflora balance, reduce risk of 
infection and protect the human health in a natural way. 
Aim of this study is investigation of Lactobacillus’s rhamnosus LB-68 probiotic properties as 
an active component for making a new vaginal tablet formulation.  
Material and methods: Strain was identified in the reference laboratory in Scotland 
(NCIMB) using PCR and API 50 CHL set. The experiments performed in the Institute Torlak 
included the following tests: strain viability test by growing and multiplying on the modified 
MRS medium, inhibitory effect on pathogenic bacteria and Candida albicans using strains 
from the Institute’s collection; antibiotic and spermicide agent (nonoxinol-9) susceptibility 
test by dilution method; H2O2 producing test on the tetramethilbenzidin medium, production 
of bacteriocin with small molecule mass of 6433.8 Dalton by chromatography; 
autoaggregation capability adopted as a manifestation of adherence to vaginal epithelial cells 
by colorimetric measuring and safety test on white mice.  
Results: Lactobacillus rhamnosus LB-68 demonstrated good viability and adherence ability 
to vaginal cells, inhibitory effect on the examined bacteria and Candida albicans, intermedial 
susceptibility to the most tested antibiotics, medial susceptibility to nonoxinol-9, bacteriocin’s 
producer and safety for use.  
Conclusion: Probiotic properties of the strain Lactobacillus rhamnosus LB-68 are suitable as 
an active component for making new formulation of vaginal tablets. 
Key words: Lactobacillus rhamnosus , vaginal flora, probiotic 
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3. IMUNOHEMILUMINISCENTNI TEST I ELISA TEST  KAO SKRINING   METODE U 
ISPITIVANJU UZORAKA  SERUMA  NA PRISUSTVO ANTITELA NA  BORRELIA 
BURGDORFERI 
3. IMUNOCHEMILUMINISCENCE TEST AND THE ELISA TEST AS A 
SCREENING METHODS TO TEST SERUM SAMPLES FOR ANTIBODIES TO 
BORRELIA BURGDORFERI 
 
Protić-Đokić Vesna1, Ristanović E.1, Atanasievska S.1, Tasić D.1, Janković-Mandić Lj.2 
1Military Medical Academy, Institute of Microbiology, Belgrade 
2University of Belgrade Institute of Nuclear Sciences Vinca, Belgrade 
 
Objectives: The increasing need for routine laboratory of Lyme borreliosis as effect has 
development of new techniques. One of these methods is imunochemiluminescence. The 
purpose of this paper was to investigate the serum samples for antibodies to Borrelia 
burgdorferi in the laboratory of the Department of microbial genetics and immunology, 
Military Medical Academy. 
 Materials and methods: Imunochemiluminescence LIAISON (DiaSorin), automated system 
that uses cold light illumination technique  and ELISA (Euroimmun), were used for testing 71 
samples of serum. 
 Results: In a small number of samples 33 (46%) we obtained the same results, of which 29 
(88%) samples were negative in both the screening tests. In 4 (9%) samples had positive 
results in the IgM class of antibodies in both assays. In the most of the treated serums 38 
(54%) the results were not the same. Of these 31 (82%) of the samples had a negative result in 
imunochemiluminescence, while the observed positive ELISA reactivity in the IgM or IgG 
class antibodies. 
Conclusion: The results confirm the recommendation that the routine serological diagnostics 
Lyme borreliosis recommends the use of two different screening tests.  
 





4.  DIJAGNOSTIČKA EVALUACIJA GROZNICE ZAPADNOG NILA U SRBIJI U 
SEZONI 2013. I 2014.GODINE   
4. DIAGNOSTIC EVALUATION OF THE WEST NILE FEVER IN SERBIA IN 2013 
AND 2014 
 
Vesna Kovačević-Jovanović , Protić J., Nedeljković J., Rakić S. 
Institute of Virology, Vaccines and Sera “Torlak”, Belgrade, Serbia 
 
In 2012, the first outbreak of WNV disease has occurred in Serbia, with 42 laboratory 
confirmed cases, followed by large number of patients in season 2013. 
Objectives: The aim of this study was to analyze the laboratory data  of a West Nile fever in 
season 2013. In addition, laboratory data from current season were also analyzed. 
Materials and Methods: Samples from 534  patients were tested during the season 2013 
(from 349 patients serum and CSF were collected and from 185 patients only serum was 
collected). Samples were tested at National Reference Laboratory for Arboviruses and 
Hemorrhagic fever, Institute of virology, Vaccines and Sera Torlak, Serbia for the presence of 
IgM and IgG antibodies using commercial ELISA (Euroimmun, Lubeck, Germany).  
Samples of  186 patients (186 sera and 78 CSF) were tested in actual season,  until August 20, 
2014. 
Results: Of the 534 patients of whom serum was collected, 266 (49.8 %) were West Nile IgM 
positive. Of the 349 patients with serum and CSF,  191 (54.7 %) were positive for West Nile 
virus  specific IgM antibodies in the both samples. Given that serological test were used, and 
since that according to the EU case definition,  laboratory criteria for case confirmation are 
WNV specific antibody response (IgM) in CSF, 191 persons meet laboratory criteria for case 
confirmation.  
In actual season, of the 186 patients of whom serum was collected, 27 (14.5 %) were West 
Nile IgM positive. On the othe hand, of the 78 patients with serum and CSF, 11 (14.1 %) 
patients were positive for West Nile virus  specific IgM antibodies in the both samples. 
Conclusion: In conclusion, this study presents number of laboratory confirmed cases in 
season 2013, but only for neuroinvasive disease (results for CSF). In the cases with non-
neuroinvasive WNV infection, for any positive results identified by ELISA, a second more 
specific confirmatory test should be applied, e.g. NT. Also, the results of molecular 
epidemiological studies need to help to clarify epidemiological links between cases of the 
disease and also in tracking movement of viruses which imposes the need to set up an 
effective system for monitoring the virus. 









1. SEROPREVALENCE OF WEST NILE VIRUS AND TICK-BORNE 
ENCEPHALITIS VIRUS IN SOUTH BACKA DISTRICT AND NISAVA DISTRICT 
 
Ivana Hrnjakovic Cvjetkovic1,2, Patic A1, Nikolic N1, Radovanov J1, Kovačevic G1 Jovanovic 
Galovic A1, Cvjetkovic D*2, Stefan Mikic, S*2 Petric D 3,Petrovic T4, Miloševic V1,2 
1Public Health Institute of Vojvodina, Serbia  
2Faculty of Medicine, University of Novi Sad, Serbia  
3Faculty of Agriculture, University of Novi Sad, Serbia  
4Veterinary Institute “ Novi Sad”, Serbia  
*Clinical Center Vojvodina, Novi Sad, Clinic for Infectious diseases 
Tick-borne encephalitis virus (TBEV) and West Nile virus (WNV) are ARBO viruses,    
family Flaviviridae.  
Objectives was to determine the seroprevalence of WNV and TBEV in human sera in Nisava 
and South Backa District. 
Materials and method: a serologic survey was conducted in June 2012. 80 healthy humans 
from Nisava district and 101 humans from South Backa district were included to the study. 
All the sera were tested for WNV immunoglobulin G(IgG) and for TBEV immunoglobulin 
G(IgG) by enzyme-linked immunosorbent assay (ELISA) (Euroimmun, Germani). 
Results: In Nisava distict no TBEV IgG positivity was detected. WNV IgG positivity in 
Nisava district was 2.5%(2/80). In South Backa district IgG antibodies against TBEV were 
detected in 7.9%(8/101) and IgG antibodies against WNV were detected against WNV 
9.9%(10/101). 
Conclusion: This study demonstrates the existence of WNV and TBEV in Sauth Backa 
District. Results for Nisava District suggest circulation of WNV among humans in that part of 
Serbia, but not of TBEV.  
Key Words: Seroprevalence, WNV, TBEV 
This paper was realized as the part of the projects  TR 31084 and III 43007 (2011-2014), 
financed by the Ministry of Education and Science of the Republic of Serbia, and 3511 (2013-




2. PREVALENCA HPV TIPOVA 16, 18, 6 I 11 KOD MLADIH ŽENA JUŽNO BAČKOG 
REGIONA 
2. PREVALENCE OF HPV TYPES 16, 18, 6 AND 11 IN YOUNG WOMEN IN SOUTH 
BACKA REGION 
 
Gordana Kovacevic1, Ivana Hrnjakovic Cvjetkovic1,2, Aleksandra Jovanovic Galovic1, Natasa 
Nikolic1, Dusan Vuleta3, Jelena Radovanov1, Aleksandra Patic1,2, Vesna Milosevic1,2 
1Public Health Institute Vojvodina, Novi Sad Serbia  
2Faculty of Medicine, University of Novi Sad, Serbia 
3Clinical Centre of Vojvodina, Department of Obstetrics and Gynecology  
Objectives 
Data on genotype-specific prevalence of HPV types infection in sexually active female 
population would be useful to predict potential benefits of HPV vaccination as well as post 
vaccination monitoring. The aim of this study was to determine human papillomavirus (HPV) 
types 16, 18, 6 and 11 distribution in young women of South Backa region.  
Materials and methods 
During the 2012 and 2013 specimens from 200 young women (age range, 16 to 26 years) 
were tested by the commercial HR HPV Real-TM kit (Sacace Biotechnologies, Italy). 
Results 
HPV DNA was identified in 129 of 200 samples (64.5%). Five most common HPV types 
circulating among young sexually active women were HPV 16, 31, 51, 18, and 52. Among 
HPV-positive samples, 50.2% had HPV16 infection; 12.0% had HPV18 infection and 17.7% 
were infected with LR types 6 and 11. 
Conclusion 
HPV 16 and 18 together accounted for 62.2% of positive cases and additional 17.7% of 
infections were caused by low risk HPV types 6 and 11. Results clearly suggest that HPV 
vaccines would have significant impact on the reduction of cervical carcinoma and genital 
warts burden in our region. 
 
Key words:  HPV, young women, vaccine 
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3. PRESENCE OF HEPATITIS B VIRAL INFECTION IN THE SOUTHERN BACKA 
DISTRICT POPULATION 
 
Nikolić Nataša1, Hrnjaković Cvjetković I1, 2, Patić A1, 2, Radovanov J1, Kovačević G1, Galović 
Jovanović A1, Milošević V1, 2 
1Public Health Institute of Vojvodina, Centre of Virology, Novi Sad 
2University of Novi Sad, Faculty of Medicine, Novi Sad 
 
Objectives:  
WHO has estimated that 350 million people worldwide are infected by hepatitis B virus 
(HBV) every year and over 780 thousand die due to complications, liver cirrhosis and 
hepatocellular carcinoma. Prevalence of HBsAg varies from 8% in Eastern Europe and 
Central Asia to 0.5% in Northern Europe. Objective of this study was to estimate the presence 
of HBV infection in risk groups and in general population of Southern Backa district. 
Materials and methods: From January 2013 to July 2014, 18869 serum samples were tested on 
HBsAg presence, by ELISA (“DS-EIA-HBsAg-0.01”, Italy). 
Results: Prevalence of HBV infection was 1.06%. Infections were significantly more present 
in male gender in total (1.94% vs. 0.57%, p<0.0001) and in all age groups, except for 15-25 
group and ≧65. HBsAg was found in 0.3% (18/5878) of pregnant women, where prevalence 
was the highest at the age from 15-25 (0.7%, 8/1088). Among the clients of the center for  
confidential volunteering testing, the highest prevalence was found in the category of 
intranasal drug users (6.25%, 1/16) and in the population of homosexuals/bisexuals (1.33%, 
2/150). 
Conclusion: Results of this investigation show low prevalence of HBV infection in the 
population of Southern Backa district. 





4. ROTA, NORO I ASTROVIRUSI KAO UZROČNICI GASTROENTERITISA 
4. ROTA, NORO AND ASTROVIRUSES AS CAUSES OF GASTROENTERITIS 
 
Patić Aleksandra1,2, Hrnjaković Cvjetković I1,2, Ilić S3, Nikolić N1, Kovačević G1, Jovanović 
Galović A1, Radovanov J1, Milošević V1,2 
1Public Health Institute of Vojvodina, Centre of Virology, Novi Sad 
2University of Novi Sad, Faculty of Medicine 
3Public Health Institute of Vojvodina, Centre for Control and Prevention of Diseases 
 
Objectives: Viral gastroenteritis is a major cause of morbidity worldwide. WHO reports put it 
among the top ten leading causes of death in the world. Rota, noro and astroviruses are the 
most common causes. The aim of this study was to determine the frequency of viral 
gastroenteritis in Vojvodina.  
Materials and Methods: In a two-year period, stool samples of 200 people of all ages from 
Vojvodina suffering from acute gastroenteritis were examined with Real-time RT-PCR assay 
(Sacace) for presence of rota, noro and astrovirus nucleic acid. 
Results: Of all examined, 50.5% of cases involved children aged 0-5. Among them, 53.46% 
had one of the 3 tested viruses.  
Most patients had rotavirus gastroenteritis (34.65%). Rotavirus infection was significantly 
more common in children aged 0-2 (40.32%), with most patients aged 2 (43.75%).  
Noroviruses were significantly more common in adults older than 20 (38.23%). Most patients 
were aged 20-29 (50.0%).  
Astrovirus infections were detected in 4 individual cases.  
Conclusion: Since a viral etiology of gastroenteritis was demonstrated in 51.5% of the cases, 
we conclude that this problem is present in Vojvodina. Therefore, molecular diagnostics 
should be introduced into routine laboratory work. 
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5. NAJČEŠĆI UZROČNICI GLJIVIČNIH INFEKCIJA GENITALNOG TRAKTA ŽENA 
5. THE MOST COMMON CAUSES OF GENITAL FUNGAL INFECTION IN 
WOMEN 
Suzana Otašević1,2, M. Ranđelović2, J. Kostić1,2, A. Ignjatović1,2, S. Momčilović2, D. 
Zdravković2 
1Public Health Institute Niš 
2University of Niš, Medical faculty  
 
Introduction: Candida-vulvovaginitis (CVV) is one of the most prevalent genital infection in 
women. Classification of CVV include: Candida colonization, sporadic CVV, and chronic 
CVV. Candida albicans (C.  albicans) was dominant cause with prevalence rate higher then 
90%. In last years  non- albicans species, that are known to be resistant to some antimicotics,   
and non- Candida species as   Saccharomyces cerevesiae  frequently cause genital fungal 
infection.  
Objectives: To determine the prevalence of Candida species and  Saccharomyces cerevesiae  
caused symptomatic vulvovaginitis is the aim of this study.  
Material and methods: Research included a mycological examination of vulvo-vaginal 
swabs of 1439 female patients. Candida spp. were isolated using the standard mycological 
procedures and chromatogenic medium (Chromotogenic Candida, Liofichem/Bacteriology 
products, Italy ). To identify the species of the genus Candida and Saccharomyces cerevesiae  
the commercial test of assimilation AuxacolorTM (BioRad, France) and biochemical test 
FungitestTM (BioRad, France) were applied. For statistical analyses of collected, systematized 
and encrypted data, statistical calculator within the program Epi Info (Ver.6.04) and statistical 
package SPSS (16.0 for Windows) were used. 
Results: It was established that fungal genital infection was proved in 15,1% of patients. The 
dominant cause of CVV is C. albicans (75,1%) followed by C. glabrata (12,4%) and C. 
krusei (6,0%). Other non-albicans Candida species and Saccharomyces cerevesiae  were 
isolated from material of significant lower patients percent (Saccharomyces cerevesiae- 1,8%; 
C. tropicalis -1,8% , C. parapsilosis- 0,9%, C. kefyr- 0,9%, C. guilliermondi -0,5%). Fungal 
genital infection is more prevalent in women who are in  reproductive period, however 
statistical significant difference of  C. albicans and C. glabrata infections regarding the age of 
patients was proved. C. albicans is the species  (p=0,001) cause of CVV in prereproductive 
period and C. glabrata is the most common (p=0,005) in postreproductive period of women.    
Conclusion: Significant percent of women with genital mycosis caused by non-albicans 
species of genus Candida suggest that mycological analysis is necessary regarding the therapy 
choice, especially in chronic  form of infection. 






6. RESULTS 2011-13. FROM SMART IN SOUTH AND SOUTHEAST SERBIA 
 
Branislava Kocić1,2, S. Mladenović- Antić2, R. Veličković1,3, M. Dinić1,2, J.Petrović3, R. 
Mitić3 
1University of Niš Faculty of Medicine, Serbia 
2Public Health Institute Niš, Serbia 
3Clinical Center Niš, Serbia 
Introduction: SMART was initiated in 2002 and is an on-going worldwide surveillance study 
monitoring the in vitro susceptibility of intra-abdominal and urinary tract aerobic and 
facultatively anaerobic gram-negative bacilli. In September 2012 study had 217 active 
investigational centers. SMART was initiated in Serbia in 2011, with  2 sites - Clinical Center 
of Serbia and Clinical Center Nis. SMART is sponsored by Merck Sharp & Dohme Corp., a  
subsidiary of Merck & Co., Inc., Whitehouse Station, NJ, USA. Study Objectives: To 
monitor the in vitro susceptibility of clinical bacterial isolates to antimicrobials in intra-
abdominal and urinary tract infections worldwide. Also,to identify early changes in 
susceptibility patterns of community- or hospital-acquired organisms, including those that 
produce extended-spectrum β-lactamases (ESBLs) and other resistance mechanisms including 
carbapenem resistance. Study Methods: Isolates are identified to the species level and tested 
at each of the study sites using local laboratory methods. Every year study collect up to 100 
consecutive aerobic and facultative gram-negative bacilli from patients with intra-abdominal 
and 50 urinary tract² infections, including only unique initial isolates, with recording duration 
of hospitalization (<48 h or ≥48 h) at time of isolate recovery. A centralized database of 
SMART study findings is maintained by International Health Management Associates. 
Antimicrobials included in investigation were: Ampicillin/sulbactam, Piperacillin/tazobactam,  
Amikacin,  Ertapenem,  Imipenem/cilastatin,  Levofloxacin,  Ciprofloxacin,  Cefoxitin,  
Cefotaxime, Ceftazidime,  Ceftriaxone and Cefepime.  Results: The most frequently isolated 
microorganisms in the period 2011-2013 at the Clinical Center Niš were: Escherichia coli 
(44%), Klebsiella pneumoniae (15%), Proteus mirabilis( 11%) and  Pseudomonas aeruginosa 
(9%). The most common ESBL + isolates were Klebsiella pneumoniae (74%),  Proteus 
mirabilis (49 %) and Escherichia coli (19%), respectively. Increase in  number of ESBL + 
isolates in the examined period was noted in Escherichia coli and Klebsiella pneumoniae. 
Susceptibility to all of the test antimicrobials in Escherichia coli amounts to more than 80%, 
except for the ampicillin-sulbactam (52%), while in the carbapenem was 100%. In the three-
year investigation period recorded a decrease susceptibility to all tested drugs except 
carbapenems.  Susceptibility  of Klebsiella spp. is the lowest of all tested pathogens (around 
30% for all tested drugs except carbapenems). Sensitivity to imipenem was 90% and 61% to 
ertapenem.  Susceptibility of  intra-abdominal isolates is about 55% for all the tested drugs 
except levofloxacin and amikacin (80%), imipenem (100%) and  ertapenem ( 80%), while in 
the urinary isolates susceptibility were approximately 20% for all the tested drugs except 
amikacin (50%), imipenem (86%) and ertapenem ( 53%). Reduction of  sensitivity to all 
tested drugs is about 20% of the isolates from urine. The sensitivity of intra-abdominal 
isolates of Proteus mirabilis was about 35% for all tested drugs except piperacillin 
tazobactam (89%) and  ertapenem (100%).  Susceptibility to imipenem is 50%. Sensitivity in 
isolates from urine was  approximately 20% of all tested drugs except piperacillin tazobactam 
(86%), and  ertapenem (100%). Susceptibility to imipenem is 29%. The increase in resistance 
to all tested drugs except piperacillin- tazobactam and  ertapenem is about 40%. In 
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Pseudomonas aeruginosa  greatest sensitivity is noted to ceftazidime and piperacillin- 
tazobactam (78%). There was an increase in the sensitivity to ceftazidime and amikacin. 
Overall, the sensitivity of intra-abdominal isolates  was better than the sensitivity of the 
isolates obtained from urine, for all tested pathogens. Conclusion: Stady gives insight into the 
local and regional distribution of gram-negative pathogens and track prominent pathogens 
over time. Also, allows for local/worldwide analysis of susceptibility and identifies 
differences in community vs. hospital-acquired infections. That data may help identify the 





7. LISTERIA MONOCYTOGENES- IZOLATI DOBIJENI IZ KRVI I CEREBROSPINALNE 
TEČNOSTI BOLESNIKA HOSPITALIZOVANIH U KLINIČKOM CENTRU U NIŠU. 
7. LISTERIA MONOCYTOGENES ISOLATED FROM THE BLOOD AND 
CEREBROSPINAL FLUID OF PATIENTS HOSPITALIZED IN THE CLINICAL 
CENTER NIŠ  
 
Dinić Marina1,2, Mladenović-Antić S1, Kocić B1,2, Stanković-Đorđević D1,2, Bogdanović M1,2. 
1Public Health Institute Niš 
2Faculty of Medicine, University of Niš 
 
Listeria monocytogenes (L. monocytogenes) is the cause of infection in animals, and humans 
are infected after consuming contaminated food. The microorganism can be found in the soil 
and plants, but also in the stool of healthy humans. Listeriosis is a rare disease in humans, but 
when present, it may produce severe systemic events such as bacteriemia and meningitis. 
Pregnant women, newborns and immunodeficient persons are most commonly affected. 
The aim was to present the isolates of L. monocytogenes isolated from the material obtained 
from hospitalized patients, as well as their sensitivity to antibiotics. 
Material and methods: In the period from January 2012 to September 2014, in the laboratory 
for pioculture, Public Health Institute in Niš, we performed bacteriologic examination of 2880 
blood samples and 580 samples of cerebrospinal fluid (CSF) obtained from the patients of the 
Clinical Center Niš. L. monocytogenes was isolated utilizing standard methodology and 
identified by using the VITEK 2 system (bioMerieux, France)/ BBL Crystal GP (Becton 
Dickinson, USA). The susceptibility testing was performed using Etest strips (bioMerieux, 
France) and the test was read according to the EUCAST interpretive standards. 
Results: Out of the total number of examined blood samples and CSF, positive findings were 
obtained in 435 and 62 samples, respectively. L. monocytogenes was isolated from the 
material of five patients, out of which three adults, one child aged 4 months and one child 
aged 5 years. Ten isolates were obtained, out of which three from the blood and seven from 
the CSF. In three patients, L. monocytogenes was isolated only from the CSF, and in two both 
from the blood and CSF. All the isolates were sensitive to penicillin G, ampicillin, 
erythromycin, meropenem, and trimetoprim/sulfamethoxazole. 
Conclusion: Although L. monocytogenes belongs to rare causes of meningitis, a timely 
etiological diagnosis is required, especially in the cases in which empirical therapy does not 
contain the agents of choice for the treatment of infections caused by this microorganism. The 
susceptibility test demonstrates that the drug of choice is ampicillin, i.e. 
trimetoprim/sulfamethoxazole in those allergic to penicillin. 
Acknowledgments 
This work was supported by Ministry of Science and Technological Development of the 
Republic of Serbia, Project  No  31079. 
B. Session: MICROBIOLOGY TODAY   48. DPM 
43 
 
8.  NONTUBERCULOUS MYCOBACTERIA ISOLATED FROM RESPIRATORY 
SPECIMENS IN BELGRADE: A 4-YEAR RETROSPECTIVE STUDY 
 
Aleksandar Vitkovic1, Antic-Glavaski A.1, Tosic M.1, Arandjelovic I.2 
1Municipal Institute for Lung Disease and Tuberculosis, Belgrade 
2Institute for Microbiology and Immunology, School of Medicine, University of Belgrade 
Introduction: An increase in the isolation of nontuberculous mycobacteria (NTM) from 
clinical specimens has been noted worldwide.  
Objective: The aim of the study was to determine the frequency of isolation of NTM from 
respiratory specimens in Belgrade over a 4-year period, and to analyse the demographic 
parameters in patients whose specimens yielded NTM isolates.  
Material and methods: Retrospective analysis of laboratory records for the period June, 
2010 - June, 2014 was performed at the Laboratory for mycobacteria, Municipal Institute for 
Lung Disease and Tuberculosis, Belgrade.  
Results: Out of 2314 cultures of mycobacteria recovered from respiratory specimens over the 
study period, 359 (15.5%) were identified as NTM. Molecular identification by the GenoType 
CM assay (Hain Lifescience) was performed in 163 isolates. In total, nine species of NTM 
were recognized, while 36 isolates were identified as Mycobacterium sp. The most frequently 
isolated NTM species was M. xenopi (76/163; 46.6%). The 163 isolates originated from 97 
patients. Fifty (51.5%) patients were older than 65 years, while gender distribution was 40 
(41.2%) men and 57 (58.8%) women.  
Conclusion: According to the available data, the isolation rate of NTM in Belgrade is 
comparable to increased isolation rates of NTM noted in other surveys. The isolation of NTM 
was significantly associated with older age and female gender.   




9. REZISTENCIJA IZOLATA CAMPYLOBACTER JEJUNI I CAMPYLOBACTER COLI  
NA TESTIRANE ANTIBIOTIKE 
9. RESISTENCE OF CAMPYLOBACTER JEJUNI AND CAMPYLOBACTER COLI 
ISOLATES TO THE ANTIBIOTICS 
 
Ljiljana Ristić1, Branislava Kocić1,2, Tatjana Babić1, Biljana Miljković-Selimović1,2 
1Center for Microbiology, Public Health Institute Niš 
2Referent Laboratory for Campylobacter and Helicobacter, Public Health Institute, Niš  
3Department for Microbiology and Immunology, Faculty of Medicine University of Niš 
Introduction: Thermophilic Campylobacter spp. are leading cause of bacterial enterocolitis. 
Disease is usually milde and self-limiting. In some cases antimicrobial treatment is necessary 
with erythromyicin as drug of choice. Fluoroquinolonese were also efficient until recently. 
Aims: To determine the prevalence of resistant strains of thermophilic Campylobacter on our 
geographical locality. 
Materials and methods: Resistance to antibiotics was monitored in 255 strains of C. jejuni 
and C. coli isolated and identified over a period 2012-2014. in the NRL for Campylobacter 
and Helicobacter Public Health Institute in Niš. Sensitivity of the strains to antibiotics was 
examined by disk-diffusion method on blood agar enriched with 5% of sheep blood according 
to CLSI 2013 and CLSI 2006 criteria. 
Results: Out of 255 strains, 225 C. jejuni strains and 30 strains of C. coli were examined. All 
of the tested strains were resistant to cephalothin and sensitive to imipenem, except one 
isolate of C. coli, others were sensitive to chloramphenicol (99.60%). Of the total number of 
strains tested, resistance to erythromycin was registered in 5 isolates (1-C.jejuni; 4-
C.coli)(1.96%). The resistance to ciprofloxacin was determined in 192 isolates (76.8%), while 
resistance to nalidixic acid was 189 (74.11%). 
Conclusion: Since most of the strains were sensitive to erythromycin, gentamicin, 
tetracycline, chloramphenicol and imipenem, these antibiotics can be used in the therapy of 
diarrhea and severe extraintestinal cases of disease caused by thermophilic campylobacter. 
However, resistance to quinolones diminishes their application and urges necessities of 
antibiotic susceptibility testing. 
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10. BIOTIPIZACIJA SOJEVA CAMPYLOBACTER JEJUNI I CAMPYLOBACTER COLI 
IZOLOVANIH U SRBIJI  
10. BIOTYPING OF CAMPYLOBACTER JEJUNI AND CAMPYLOBACTER COLI 
STRAINS ISOLATED IN SERBIA 
 
1Miloš Ranđelović, 1Tatjana Milenković, 1,2Branislava Kocić, 1Tatjana Babić, 1Ljiljana Ristić, 
3Matthew Gilmour, 1,2Biljana Miljković Selimović 
1Public Health Institute, Center for microbiology, NRL for Campylobacter and Helicobacter, 
Niš, Serbia 
2School of Medicine, University in Niš, Serbia 
3National Laboratory for Enteric Pathogens, National Microbiology Laboratory, Canadian 
Science Centre for Human and Animal Health, Bacteriology and Enteric Diseases Program, 
Winnipeg, Canada 
Introduction:Campylobacter jejuni (C. jejuni) and Campylobacter coli (C. coli), one of the 
major causes of bacterial enterocolitis worldwide could be differentiated (typed) by several 
methods: biotypng, serotyping, and molecular methods for epidemiological and outbreak 
investigations. Biotyping scheme based on biochemical activity can subtype C. jejuni in three 
subtypes and C. coli in two subtypes. 
Aim: The aim of this work was to detect prevalence of some biotypes in investigated strains 
and other differential characteristics of strains in Serbia.  
Materail and methods: We investigated 61 strains of thermophilic campylobacters isolated 
in patients with enterocolitis from collection of National Reference Laboratories (NRL) for 
Campylobacter and Helicobacter in Serbia. Strains were previously isolated in selective 
campylobacter media in microaerophilic conditions at 42oC and presumably identified by 
colony morphology, Gram staining, oxidase, catalase tests and hippurrate hydrolysis. Final 
identification and characterization of investigated strains was done by a combination of a 
PCR-based RFLP test and biotyping tests: hippurate hydrolysis, rapid H2S, production and 
DNA hydrolysis tests.  
Results: The ratio of C. coli to C. jejuni strains was 18:43. This showed that C. coli were less 
common than C. jejuni in Serbia. Biotyping was performed on all 61 strains. Three biotypes 
were identified in C. jejuni strains; biotype I (17 isolates), biotype II (19 isolates) and biotype 
III (7 isolates). In C. coli strains, biotype I was represented by 13 strains, and biotype II by 5 
strain. 
Conclusion: In C. jejuni biotype II were predominant, while in C. coli strains, it was C. coli 
biotype I. 







11. ZNAČAJ BAKTERIJE BACILLUS CEREUS U ETIOLOGIJI ENTEROKOLITISA 
11. THE IMPORTANCE OF BACILLUS CEREUS IN THE ETHIOLOGY OF 
ENTEROCOLITIS 
 
Tatjana Milenković 1, Miloš Ranđelović.1, Tatjana Babić1, Branislava Kocić1,2, Predrag 
Stojanović1,2, Biljana Miljković- Selimović1,2 
1Public Health Institute, Niš, Serbia 
2Faculty of Medicine, University of Niš, Serbia 
Introduction: Bacillus cereusis (B. cereus) are Gram- positive, motile, endospore forming, 
aerobic or facultatively anaerobic bacteria. B. cereus is widely distributed in nature. This 
bacterium belongs to the genus Bacillus. It can cause diseases that can be manifested as 
diarrheic syndrome or emetic syndrome. 
Materials and methods: Examinations were performed in the Microbiology Center of Public 
Health Institute of Niš from November the 15th, 2011 to july, the 1st 2014. Stools were 
examined in patients who were suffering from enterocolitis. The stools were examined by the 
standard microbiological methods for the presence of the following bacteria: Salmonella, 
Shigella, Yersinia, Campylobacter, Aeromonas, Clostridium difficile and B. cereus. The 
examination of the production of the non-hemolytic enterotoxin (NHE) and the hemolysin BL 
(HBL) toxin was conducted by the immunochromatographic test (Merck, USA). 
Susceptibility testing to antibiotics was carried out using disk diffusion method and beta 
lactamase production by cefinase disk (bioMérieux, France). 
Results: 24734 samples of stool were examined (20676 ambulatory and 4058 clinical). 
Pathogenic bacteria were detected in 1426 samples (5.77%). The total number of positive 
isolates demonstrated the presence of Salmonella in 21.85%, Shigella were not detected, 
Yersinia in 5.52%, Campylobacter in 8.99%, Aeromonas in 0.33%, Clostridium difficile in 
53.67% and Bacillus cereus in 9.65%. Female persons were more sensitive to B. cereus 
infection (64.96%) and patients between 56 and 65 (19.66%) years of age. The presence of 
NHE and HBL toxins was examined in 49 samples. The presence of both toxins was detected 
in 48 ones, and just one toxin (NHE) in one examinee. Investigated strains were susceptible to 
ampicillin, co-amoxiclav and ciprofloxacin, but resistant to tetracycline and rifampicin. It was 
found that the strains produce cefinase. 
Conclusion: B. cereus cause enterocolitis more often in female persons and are more 
common in patients between 56 and 65 years of age. 
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12. QUALITY CONTROL OF MICROBIOLOGICAL TESTS  OF FOOD AND  
WATER BA INTER LABORATORY (PROFICIENCY TESTING SCHEMES) 
 
Delova Angela,  Nedelkova M.,Stefanovska S.,  Krsteva Kelepurovska E.,  Krsteva E. 
Public Health Centre – Bitola R.Macedonia 
 
Introduction: The laboratory for sanitary microbiology is included in the rank of accredited 
laboratories according to ISO/IEC 17025 Standard.  
Besides the application of the ISO Methods in the everyday routine testing, in accordance to 
the requirements of ISO 17025 Standard, each laboratory must provide internal and external 
control of the testing quality.  
Aim: One of the essential elements for conducting of external control of the quality of the 
results from the microbiological testing of food and water is the participation in Proficiency 
testing schemes (PT) that are organized by reference laboratories FEPAS (Food Examination 
Performance Assessment scheme) and LEAP (Laboratory Environmental Analysis 
Proficiency scheme). 
Material and methods: Identification and enumeration of the defined parameters is done in 
the dehydrated samples of food (beef and chicken, flour, powder milk, soft cheese) and water 
samples. 
Results: 
When analyzing the data, the results received with participation in the inter laboratory 
comparison testing’s, statistical methods are applied, including evaluation of the results 
according to the Z-value (a simplified method of Mandel h statistics). Z-value is calculated 
according to the following formula: Z = (x-X)/δ, where: x – result of individual laboratories, 
X – determined, received value in a reference laboratory δ – standard deviation  
Regardless of the number of laboratories, participants and the number of repeated tests, Z- 
values have the following interpretation: z < = 2 – satisfactory results, 2 < = z <=3 - doubtful, 
questionable results, 3 <= z – unsatisfactory results. 
The goal of each lab is to get acceptable results of the tests, i.e. z<= 2, indicating the 
reliability of the results.In our laboratory are obtained results that are in the permitted range 
z<= 2:   
coagulase positive staphylococci z –score 0,8; yeasts and molds -0,5; Enterobacteriaceae -
0,3;E.coli -0,5.(tests of food); Except in quantitative,we have participated  in qualitative PT -
scheme for detection Salmonella spp. and Listeria monocytogenes, where the results are based 
on the presence and absence of the requested bakteria.And these tests are assessed as 
satisfactory results..In the  samples of water were obtained the following results: for 
Escherichia coli z-score 0.5, Enterococcus-0,3i Pseudomonas aeruginosa -0,3. 
Conclusion: 
Based on the results from the interlaboratory tests (FEPAS and LEAP) derives that with the 
applied methods for testing water and food in our laboratory are obtained reliable results . 
This enables continuous improvement and development of new methods, and also checking 
the quality of work internationally. 





13. IS THE MPN METHOD BASED ON THE DEFINED SUBSTRATE 
TECHNOLOGY AN ADEQUATE SOLUTION TO THE QUANTIFICATION OF 
ENTEROCOCCI IN SURFACE WATERS?  
 
Raketić Svetlana, Šumanov V. 
Public Health Institute Čačak  
 
Introduction: Enterococci are valuable indicators for evaluating the level of fecal 
contamination of surface waters. The recently adopted Rulebook on Parameters Indicative of 
the Ecological and Chemical Status of Surface Waters  requires laboratories to quantify 
enterococci over a wide range of 40 to > 40000 when assigning surface water bodies to 
ecological status classes. MPN-based methods previously used cannot meet this requirement. 
Therefore, laboratories performing surface water testing must opt for other diagnostic 
procedures to satisfy the new requirements.  
Objective: To evaluate the potential use of the method based on the defined substrate 
technology (IDEXX Enterolert E/Quanti-Tray 2000) for determining enterococcal counts 
through comparison with the national standard MPN method published in NIP PP 1990, 
Drinking Water, Standard Hygiene Testing Methods. 
Material: During 27 June 2012 – 11 December 2012, a total of 20 samples of surface waters 
collected from the Moravica Region were analyzed. The samples were collected in 
accordance with the Guidance on Surface Water Sampling.   
Method: After homogenization, adequate dilutions of the samples were performed following 
the national method and the Enterolert manufacturer’s instructions. Then, the samples were 
analyzed using both methods. The enterococcal count obtained was used to assign the surface 
waters to ecological status classes, thus providing basis for comparison of the two methods.  
Results: The data analysis shows that in 18 out of 20 samples the enterocccal counts obtained 
by both methods suggest identical classification of the surface waters analyzed (classes 
matching). Classes did not match only in two samples (samples 1 and 10). 
Conclusion: - IDEXX Enterolert E/ Quanti Tray / 2000 results are definitive at 28 h.  
-Both sample preparation and testing are simple procedures that require minimum staff 
involvement. 
- The results of both methods based on the comparison of the estimated ecological status of 
surface waters are equivalent for a high percent of samples. 
 
The above findings suggest that MPN methods based on the defined substrate technology are 
a highly suitable solution to the enterococci quantification problem facing laboratories 
performing surface water testing. 
 
Keywords: Enterococci, surface waters, defined substrate technology  
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14. THE EFFECTS OF THE FLOW OF UNTREATED COMMUNAL WASTE 
WATER ON THE MICROBIOLOGICAL QUALITY OF THE RIVERS OF 
MORAVICA DISTRICT 
 
Raketić Svetlana, Šumanov V. 
Public Health Institute Čačak 
 
Introduction: Microbiological quality of rivers is marked by testing of the concentration 
(number/100ml) of bacteria which indicate fecal contamination. The presence of these 
microorganisms mostly suggests the possibility of  pathogenic microorganisms present in the 
water and therefore high risk of using such water for drinking, irrigation and recreation. 
Aim: To carry out microbiological testing of river water samples on the territory of Morava 
district both before and after the flow of untreated communal waste water. 
Material and method: In the period from 27/06/2012 – 11/12/2012, testing of 20 river water 
samples on the territory of Moravica district was carried out. The samples were tested in the 
laboratory using IDEXX Colilert and Enterolert tests. The calculation of MPN was done using 
tables, taking into account the sample dilution. 
Result: The number of total coliform bacteria before the flow of untreated communal waste 
water varied from 12450 to 460400, the number of E.coli from 80 to 244200, and the number 
of enterococci from 80 to 79452. 
The number of total coliform bacteria after the flow of untreated communal waste water 
varied from 14750 to >1209800, the number of E.coli from 6750 to >1209800, and the 
number of enterococci  from 430 to > 96784. 
Conclusion: Ecological status of rivers on the territory of Moravica district can be classified 
as bad or poor, even before the flow of untreated communal waste water. The flow of 
untreated communal waste water has multiple effects on deterioration in the values of 
microbiological parameters which are used in marking the ecological status. 
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1. QUARANTINE DISEASES TODAY 
 
Tiodorović Branislav 
University of Niš, Faculty of Medicine 
Public Health Institute Niš 
 
The world population is highly mobile.International travel and troop movements increase the 
risk of communicable disease transmission.Forced migration for war and famine, and 
voluntary immigration increase communicable disease risk. 
It is very important to distinguish between the isolation of quarantine. 
Definition: Isolation 
Separation and restricted movement of ill persons with contagious disease 
– Often in a hospital setting 
– Primarily individual level, may be applied to populations 
– Often voluntary, but may be mandatory 
– Fundamental, commonly used public health practice 
Definoitin: Quarantine 
Separation and restriction of movement of well persons presumed to have been exposed to 
contagion 
– often at home or residential facility 
– may be voluntary or mandatory  
 
In most countries in the world and in Serbia Quarantinable Diseases: Smallpox ,Plague ,Viral 
hemorrhagic fevers,Yellow fever, SARS. 
However, a number of states, and the United States added to this list and : Cholera , Infectious 
tuberculosis, Diphtheria, Novel influenza virus (pandemic potential). 
 
Certainly the most important groups of quarantine diseases are Viral hemorrhagic fever. 
Viral hemorrhagic fever (VHF) refers to a diverse group of viral pathogens that are 
characterized clinically by fever and a bleeding diathesis. Manifestations may include 
flushing of the face and chest, petechiae, mucosal and gastrointestinal bleeding, frank 
bleeding, malaise, edema, hypotension, myalgias, headache, vomiting, and diarrhea. In 
extreme cases, shock and death may occur because of circulatory instability due to increased 
vascular permeability and diffuse hemorrhage. 
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Several viral infections are responsible for causing VHF. These viruses are often transmitted 
by arthropods, especially mosquitoes. Sometimes the infection may be spread from person to 
person through direct contact with infected patients, their blood, or their secretions and 
excretions. Animal reservoirs are generally rodents, but domestic livestock, monkeys, and 
other primates may also serve as intermediate hosts. 
The distinct enveloped RNA viruses that cause most VHF cases are members of 4 families: 
Arenaviridae, Bunyaviridae, Filoviridae, and Flaviviridae. 
Lassa fever is caused by a single-stranded zoonotic RNA virus of the Arenaviridae family. 
First described in 1969, infection occurs in West Africa and is named after the town in 
Nigeria where the first cases were observed. The "multimammate rat" of the genus Mastomys 
is a common village rodent and is a host for the virus. The virus is spread to humans by direct 
contact with infectious rodent urine and droppings. Transmission can occur through cuts and 
sores, as well as by inhalation of infectious particles. Person-to-person transmission can occur 
through contact with infectious blood, tissue, secretions, and excretions, but not through 
casual contact such as skin to skin 
Crimean-Congo hemorrhagic fever (CCHF) is caused by the Nairovirus in the family 
Bunyaviridae. It was first characterized in the Crimea in 1944 and recognized in 1969 in the 
Congo. CCHF is found in Eastern Europe (particularly in the former Soviet Union), 
throughout the Mediterranean, in Northwestern China, Central Asia, Southern Europe, Africa, 
the Middle East, and India. The principal host vector is the Hyalomma tick. Cattle, goats, 
sheep, and hares serve as amplifying hosts for the virus. Transmission to humans occurs 
through contact with infected animal blood or infected ticks. Person-to-person transmission 
may occur, resulting in nosocomial outbreaks. 
Yellow fever is an anthroponotic infection (vector-borne person to person) caused by the 
yellow fever virus, a flavivirus. Infection occurs in tropical regions of Africa and in parts of 
Central and South America and is vectored by Aedes mosquitoes. Human infection occurs via 
mosquito bites after the mosquito has fed on infected monkeys. Urban yellow fever, however, 
is the most common cause of yellow fever outbreaks and epidemics. In such cases, 
mosquitoes live among humans in cities, towns, and villages and spread the virus among 
susceptible humans. The presence of infectious mosquitoes is facilitated by larval growth in 
discarded tires, flower pots, oil drums, and water-storage containers.Mortality ranges from 
15% to more than 50%. Vaccination against yellow fever is recommended before travel to the 
Amazon forest. For those who acquire clinical illness, there is a 3- to 6-day incubation period. 
Dengue fever (DF) is viral illness transmitted by mosquitoes. It is found in tropic and 
subtropic regions, including the Indonesian archipelago, northeastern Australia, South and 
Central America, Southeast Asia, and Sub-Saharan Africa. DF is caused by a flavivirus and 
has 4 described serotypes. Infection is transmitted to humans by mosquitoes. Most infections 
are self-limited and influenzal in nature. Other manifestations include dengue hemorrhagic 
fever (DHF) and dengue shock syndrome (DSS). 
Ebola virus hemorrhagic fever (HF) is named after a river in the Democratic Republic of the 
Congo (formerly Zaire) in Africa where it was first recognized in 1976 and has appeared 
sporadically since its initial recognition. The incubation period for Ebola HF ranges from 2 to 
21 days. Within a week, a raised rash, often hemorrhagic (bleeding), spreads over the body. 
Typically there is bleeding from the mucous membranes (eg, mouth, nose, eyes, and rectum). 
This image shows treatment of patients with Ebola HF during outbreak of the disease in 1995 
in Kikwit, Democratic Republic of the Congo, as well as an Ebola HF prevention poster used 
during the Kikwit outbreak. 
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Closely related to Ebola is Marburg HF virus. Marburg HF has been reported in Uganda, 
Zimbabwe, the Democratic Republic of the Congo, Kenya, and Angola. Cases of Marburg HF 
outside Africa are rare but have been reported in Europe. 
The 2014 West African Ebola Outbreak is so far the largest and deadliest recorded in history. 
The affected countries, Sierra Leone, Guinea, Liberia, and Nigeria, have been struggling to 
contain and to mitigate the outbreak. The ongoing rise in confirmed and suspected cases, 2615 
as of 20 August 2014, is considered to increase the risk of international dissemination, 
especially because the epidemic is now affecting cities with major commercial airports. 
 
Due to the increasing threat of bioterrorism, these highly infectious and potentially lethal 
viruses are of increasing concern. 
Good surveillance does not necessarily ensure the making of right decisions, but it reduces 




2. EPIDEMIOLOGICAL - DIAGNOSTIC ASPECTS OF INFECTIONS CAUSED BY 
CLOSTRIDIUM DIFFICILE 
 
Stojanovic Predrag  
University of Niš, Faculty of Medicine 
Public Health Institute Niš 
 
C. difficile is a typical representative of the genus Clostridium, which comprises a group of 
Gram-positive, moving, or aerotolerantnih anaerobic bacilli, ubiquitous in soil and in the 
intestinal tract of animals. Spore forming subterminalno rarely central. Spores are resistant to 
heat, drying and chemical agents that enables them to survive in adverse environmental 
conditions. After 48 h incubation the medium CCFA C. difficile colony-forming a yellow 
color, which are raised, with the circular thin filamentous edges, uneven surface size 2-4 mm 
(1). 
Diseases that are known to cause a disease associated with the presence of C. difficile (C. 
difficile-associated disease - CDAD). CDAD is normally occurs a few days after the receiving 
an antibiotic (1). Giving antibiotics causes a change in the normal relations of bacteria that 
inhabit the digestive tract allowing C. difficile to proliferate and colonize the lining of the 
intestinal tract. After colonization of toxigenic C. difficile strains capable of producing two 
exotoxins, enterotoxin (toxin A) and cytotoxin (toxin B), which can cause diarrhea and colitis. 
CDAD is clinically manifested by diarrhea, colitis, pseudomembranous colitis (PMC), 
fulminant colitis and toxic megacolon. CDAD may complicate ulcerative colitis or Crohn's 
disease. 
When 8-50% of patients with CDAD, after application of the therapy, which destroys the C. 
difficile can occur back (recurrent) form of CDAD. It is assumed that the basis of recurrent 
infections is sporulation of C. difficile during therapy, which after treatment discontinuation 
are subject to germination. When 15-20% of the patients is the recurrent form of the disease 
caused by the same strain that caused the primary infection (relapse). However, the use of 
serotyping, ribotyping PCR or restriction endonuclease analysis of chromosome number of 
researchers suggest that most of the recurrent CDAD caused by other types of strain (re-
infection) (2). 
The diagnosis of CDAD  
The microbiological diagnosis of CDAD primary cultivation takes place in appropriate 
nutrient media. Grown colonies with characteristic morphology, are identified based on 
antigenic structure and biochemical activity. Due to the rapid degradation of toxins and loss of 
cytotoxic activity is necessary to examine fresh stool samples. If this is impossible, then they 
should be stored at 4 ° C up to 48 h, frozen at -20 ° C or at best -70C (3). 
Clinical methods: The clinical manifestations of CDAD include diffuse abdominal pain, 
stool odor softer or liquid coexistence and fever. These symptoms are not specific and not 
essential for diagnosis. Leukocytosis dominated during CDAD but is also uncertain diagnostic 
sign. 
Endoscopy: pseudomembrane are the size of raisins, yellow and sometimes formed and 
raised plaques surrounded by inflamed mucosa. The appearance of pseudomembrane may be 
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sufficient in most cases for macroscopic diagnosis but recommended biopsy for 
histopathological diagnosis, especially in volcanic lesions (4). 
Fecal leukocytes and lactoferrin: results of various studies suggest that detection of fecal 
leukocytes in the preparation colored methyl-blue may be useful in distinguishing cases of 
noninflammatory diarrhea. More valid marker for the presence of leukocytes in a sample of 
faeces is fecal lactoferrin, which can be detected by latex agglutination (5). 
 
Detection of the products of C. difficile: 
Glutamate dehydrogenase: represents specific marker of C. difficile. By nature of the enzyme 
and is introduced as a commercial test in order to verify the genuineness of positivity latex 
immunoassay detecting toxin A. Today this test usually commercially produced along with 
test detecting the toxin A (6). 
Highly volatile fatty acids: C. difficile produced readily volatile fatty acids, and it isocaproic, 
isovaleric and para-cresol. Tests can also work directly from feces or culture. Toxins: can 
detect biological (cell cytotoxicity test) and immunological methods (latex agglutination or 
immunoassay). 
The test of cell citotoksik: observed that stool of patients with colitis caused by antibiotics 
damage cell culture and before the C. difficile is recognized as the cause of CDAD. For this 
reason, the test cell cytotoxicity recommended as ,, gold standard,, in the diagnosis of CDAD. 
The test is performed on a single layer of cells exposed to the impact of the filtrate chairs. 
After incubation, a microscope is required cytopathic effect (7). 
Latex agglutination toxin A: Compared to the cytotoxic assay, latex tests show a good 
negative predictive value but also a high rate of false pozitivninih reaction (8).  
Immunoassay: during the last thirty years have developed two types of immunoassays, classic 
with various embodiments, the membrane imunohromatografija which has not found wide 
application. 
 
Detection of gene sequences C. difficile: 
16sr RNA: primary objective detection 16srRNA genes to determine the presence of a 
microorganism in a stool sample (9). This process reveals toxigenic but netoksigene strains of 
C. difficile.  
The genes encoding the toxins: Using PCR method and the reproduction of part of the gene 
encoding the toxin A of the chair is described in 1993. Wherein the results are fully compliant 
with the test cell cytotoxicity. Detection of toxin B from stool PCR method is described in the 
same year (10). 
 
Typing: typing of isolates is of great importance in microbiological research and descriptive 
epidemiology. 
Knowledge acquired during their studies typification of C. difficile 
By using different methods typification of C. difficile during the last 15 years, we obtained 
data that contributed to the understanding of the epidemiology of this bacterial species. 
Probably the most comprehensive data come from a reference laboratory for anaerobes the 
 56 
 
Cardiff, where he keeps more than 2000 isolates obtained from stool of patients 58 British 
hospitals. Total has identified 54 different types of PCR ribonukleinskih when it comes 
isolates recumbent patients, but only 16 PCR ribonukleinskih types account for 90% of all 
samples and PCR RNA Type 1 is represented by 58%. The next most common strain, PCR 
RNA type 106, accounts for 7% of the isolates, and has expanded over the past few years in 
London and the South East of England in relation to its source - the central part of the United 
Kingdom. The research results indicate that the PCR type 1 endemic in almost all hospitals 
that follows the reference laboratory, and to be associated with acute and prolonged outbreaks 
of CDAD. PCR type 1 was responsible for the most famous outbreak of CDAD in the UK 
when it was infected 175 people, of which 17 died (11). Brazier's study (12) determined that 
the PCR type 1 corresponds Delme's serogroup G, and also this strain has caused infections in 
the United States. PCR type 1 is determined that corresponds to the strain of D1 described by 
Samore MH. with et al. (13). Samore has learned that this is the most commonly isolated 
strain from samples of natural environments, from hospital workers and patients from the 
hospital on the east coast of America. 
Delme's group of researchers reported that serogroup C usually causes outbreaks in Belgium 
(14). This serogroups corresponding PCR Tipu 12, which represents only 2.6% of all hospital 
isolates typed in England and Wales. A study conducted in 11 hospitals of France (15), 
suggesting that serogroup C, D, G and H are the most frequently isolated strains, with the 
prevalence of serogroup H (21%). Serogroup C is most commonly associated with diarrhea 
izazvnom antibiotics. The results of most studies show that a large number of cases of CDAD 
caused by the same strain of C. difficile. However, there are studies that are group CDAD 
cases caused by different strains. These sporadic cases suggest that it is not always about 
cross-infection and are most likely caused by strains introduced from outside the hospital 
environment (community). 
C. difficile serogroup F produces only toxin B, and the corresponding PCR Tipu 17 
Information typization strains of C. difficile in England and Wales show that in 10 British 
hospitals (16) detected toxin A negative / toxin B positive strains. They account for less than 
3% in relation to all standardized isolates. It is possible that these strains do not detect it in the 
diagnosis CDAD commonly used tests that detect only toxin A. 
Research conducted in England showed different representation PCR ribonukleinskih types of 
C. difficile, which are isolated from hospitalized patients compared to those cultured from 
patient samples were examined and treated in outpatient general practitioner. The study tests 
the isolates obtained from samples of people living in the community, usually was cultivated 
nontoxic PCR type 10 (15.9%). PCR RNA types 20:14 were present in 11.8% and 8.7%. PCR 
type 1 was represented by only 7.4%. The published results indicate that certain strains 
probably more rapidly in the very hospitals and hospital departments conditions themselves 
act as a selector for the presence of certain strains. 
 
The epidemiology of CDAD 
Previous studies do not provide direct evidence that C. difficile infection may be the origin of 
the animals (zoonoses), but there is evidence of large numbers of domestic, wild, farmer 
animal species that are reservoirs and carriers of this bacterial species (17). 
This bacterial species can be found in 80% of newborns, with no clinically significant events, 
which represents the transitory colonization or normal flora. The high rate of carriers persisted 
during the first 8 months of life until the establishment of the normal intestinal flora, and then 
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decreases and falls to 2-3% in adults. The rate of carrying among adults residing in hospitals 
is much higher (up to 21%) (18). 
The reservoir, source and transmission of C. Difficile 
Significant reservoir of C. difficile in hospitals, patients with asymptomatic carriers of the 
symptoms and patients with CDAD that contaminate the hospital environment spores and 
vegetative forms. Spores of C. difficile can be held for several months in hospital surfaces 
(floors, furniture, medical equipment, etc..), Which contributes to a slight spreading infection. 
Transmission of infection is feco-oral. Spores and vegetative forms but C. difficile is usually 
transmitted from contaminated surfaces and objects in patients over the dirty hands of medical 
personnel. Some studies indicate that it is possible and direct entry of C. difficile in the 
gastrointestinal tract of contaminated objects. Remove the patient from room to room or to 
another ward or hospital is also important in the transmission of the disease (19). 
 
Incidence and prevalence of CDAD 
The incidence of CDAD is different and ranges from 0.1 - 2%. This incidence are covered 
outpatient as well as patients with hospital infections, C. difficile (over 90% of cases are 
considered hospital infections). The results of individual studies indicate that the annual 
incidence of outpatient cases of CDAD 8 per 100,000 residents. Reports from the area of the 
United Kingdom suggest that the incidence of CDAD in patients on an outpatient basis 
increases of 1 case per 100,000 inhabitants during 1994 yr. to 22 during 2004.. It is interesting 
that only 37% of outpatients during the 90 days prior to the diagnosis of CDAD used 
antibiotics. Results of the study Hirschorn L. et al. (USA) (20) showed incidence of 7.7 cases 
per 100,000 population per year. 
 
Risk factors for the occurrence of CDAD 
According to data from the published studies 70 - 90% of diseases caused by C. difficile occur 
after the administration of antibiotics. The use of antibiotics in many cases has resulted in 
killing bacteria of the normal flora of the digestive tract. Antibiotics are prior to the CDAD 
usually administered in a combination of two or more. The combination of antibiotics or long-
lasting application increases the risk of disease (21).  
A large number of research points to the significant risk factors for nosocomial CDAD. A 
statistically significant difference in the study Raveh D. et al. (22) was observed in patients 
age (p <0.0001) (76 vs 66 years) stay in intensive care unit (p <0.05) in the number of 
leukocytes (p <0.001) , a higher level of urea nitrogen in blood (p <0.05), serum albumin less 
(p <0.01) and primnju diuretics and clindamycin (p <0.05). In studies Gareja K. et al. (23) 
indicates that patients with CDAD age from 50 to 80 years old (p = 0.016), and that the most 
significant risk factors significantly associated with the development of CDAD: age greater 
than 80 years (p = 0.001), presence of hemodialysis (p = 0.0227), a longer stay in hospital 
rooms and intensive care (p = 0.001). In addition to Al-eidan FA. et al. (24) there are also 
studies that indicate that women often reported diarrhea during hospitalization (54%: 46%), 
which explains the use of antibiotics in the treatment of urinary tract infections, but unlike 
them, there are a number of studies indicating that there are no statistically significant 
differences by sex patients with CDAD. 
The presence of severe underlying disease, according to results of a large number of research 
results in significant predisposing factor for the development of CDAD in hospitalized 
patients. In a study of Al-eidan FA. et al. All 87 patients hospitalized with CDAD had severe 
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underlying disease: pneumonia or other respiratory infections - 46%, 42% diabetes, ischemic 
heart disease - 34.5%, hypertension - 31%, chronic obstructive diseases of the respiratory tract 
17%, kidney 3.3% liver disease and 2.3%. In 21 patients (24.1%) indicated the presence of 
two or more diseases at the same time. 
Due to the high risk and likelihood of occurrence of CDAD in the elderly is not surprising the 
large number of studies that perceive risk factors for the occurrence of CDAD in people older 
than 60 years. Ackermann G. et al. (25) in their work pointed out that with the use of 
antibiotics presence of vascular, heart, kidney and lung disease in elderly hospitalized patients 
associated with the development of CDAD. Study Fraissea A. et al. (26) on a sample of 21 
cases of CDAD in the elderly (mean 85.9 years) also showed that all the patients had severe 
underlying disease, and as risk factors of developing CDAD were determined administration 
of antibiotics (penicillin, cephalosporin and fluoroquinolone), protein malnutrition, 
immunodeficiency, and trails in the column. The study Beaujean D. et al. (27) found that 
patients with CDAD hospitalized longer than those without CDAD (39: 17.8 days). CDAD 
usually occurs during fourteenth day of hospitalization. 
It is known that in cancer patients frequently occurring infections that require antibiotics and 
can not be reliably determine the importance of application of oncological therapy as risk 
factors for CDAD. Thus, the research Hornbucklea K. et al. (28) multivariate analysis are 
shown that previous hospitalization during the two months before the onset of CDAD, 
parenteral administration of vancomycin and low-level administration of cytostatics represent 
significant risk factors for the development of CDAD. The study Gifford A. et al. (29) 
identified the risk factors of developing CDAD in hospitalized cancer patients in age, lung 
cancer, antibiotics (cephalosporins), decrease in serum albumin and administration of 
interleukin-2. The study Blot E. et al. (30) have also studied the risk factors responsible for 
the occurrence of diarrhea and CDAD in cancer patients. As risk factors for the occurrence of 
diarrhea defined as age (p = 0.03) and the use of antibiotic therapy (p = 0.008). Targeted they 
were compared to patients with diarrhea and finding toksigenog C. difficile (n = 21) and 
patients with diarrhea and finding netoksigenog C. difficile as well as patients with diarrhea 
without finding C. diffic in stool (n = 59-21 = 38). Statistical analysis of these data revealed 
that the cytostatic chemotherapy and antibiotics are not a risk factor for the development of 
CDAD (p = 0.02). 
Risk factors for the occurrence of CDAD in children (31)  is the presence of severe 
underlying disease for which he was given an antibiotic and cytostatic chemotherapy, Crohn's 
disease, organ transplantation, immunodeficiency, and Hirschsprung's disease. It also suggests 
that premature birth, conditions that are accompanied by disruption in bowel habits and 
anatomical obstruction (stricture column) can influence the onset of CDAD. 
Prevention of CDAD 
The most successful have been shown to rationalization measures davnja antibiotics, training 
of medical staff, the use of disposable gloves, isolation of patients with CDAD in a separate 
room with a toilet, disinfection thermometer and use hipohlorata and aldehyde disinfection of 
hospital environment. Implementation of these measures led to a drop in the incidence of 
CDAD with 155 cases per year in the 67 rooms in intensive care hospital west coast of the 
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ORAL PRESENTATIONS  
 
1. CONFRONTING THE ANTI-VACCINISTS 
 
Radovanović Zoran  
Academy of Medical Sciences, Serbian Medical Society, Belgrade 
 
Objectives: 1. To assess the impact of local and regional anti-vaccination activities on the 
parental compliance to let their children vaccinated; 2. to suggest the means to neutralize 
adverse influence of anti-vaccinists (“anti-vaxxers”).  
Methods: Careful review of printed and electronic media. 
Results: Motives of people and groups opposing vaccination may be classified as follows: 1. 
personal traumatic experience (usually inability to accept true causes of their child’s 
handicap); 2. lucrative (crooks who promote their “mighty cures” instead of vaccines); 3. 
psychopathic (including uncritical self-promotion); 4. other (obsession with human rights, 
alternative medicine, religion, xenophobia, etc.). Anti-vaccinists’ influence is often 
proportional to the absurdity of their concocted data as ‘arguments’. Recently, they got 
regionally connected, better organized and much more aggressive, drawing media attention, 
distributing ready-made forms for refusing vaccination and circulating a petition for 
abandoning compulsory vaccination. As a result, the compliance is steadily decreasing.  
Conclusion: Parents should be confronted with consequences of refusing vaccination, and 
“anti-vaxxers” have to be made legally responsible for spreading false information. Both 
doctors and prosecutors must insist that parental right to refuse vaccination has no more 
weight than the interest of the child to remain healthy and the interest of the social 
environment. 
Key words: vaccination, immunization, anti-vaccinists, compliance 
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2.BINDING IMMUNIZATION OF CHILDREN IMMUNITY AS A WAY TO 
MAINTANCE OF COLLECTIVE IMMUNITY-PROS AND CONS 
 
Kon Predrag 
City Public Health Institute Belgrade 
 
The aim is to start an ethical debate on mandatory immunization, and highlight the 
importance of introducing additional recommended and optional immunizations.  
Materials and Methods: Literature available on the Internet, descriptive method. 
Results: In the countries of Europe, USA and Australia through history to the present day in a 
different way was attainable high immunization coverage. In a number of countries in Europe 
today do not apply the mandatory immunization, while still being implemented in the United 
States and Australia, with more frequent granting of exemptions, whether for religious 
reasons or conscientious objection. Contemporary ethical principles in public health and a 
discussion regarding immunization seek review stance on mandatory immunization for 
increasing the number of available vaccine to protect health. It is still legal protection of 
community health ahead of personal requests from individuals. New ethical questions are 
what to do in relation to parent who refuse to immunize their children or fail to immunize 
them, how to deal with the fact that immunization becomes an important item of the state 
budget in order to maintain the principle of justice in access to and availability of information 
about vaccination. Since the obligation is justified only in case of the failure of parents to 
vaccinate their child brings to a child at greater risk of contracting a serious illness, does that 
mean that all vaccines in the current program should be mandatory and to introduce new 
vaccines in the program? How and whether the state should compensate those who have 
suffered from immunization reaction? Legislation in the field of immunization in Serbia is 
very complex, because the vaccines are treated as drugs, and public procurement as a 
commodity, which requires compliance with more than 10 laws and more than 20 legal 
regulations. High activity of Anti Vaccine Movement in Serbia concludes this brief analysis 
of the contents of various websites available on the first ten pages of search engine "google" 
the word "vaccine" in August 2013. The high representation of websites that misinform the 
public and the information offered on these sites are not in line with WHO recommendations. 
Conclusion: It is necessary to implement immunization against all diseases for which there 
are vaccines that are under the Law on Medicines registered in Serbia and introduce them in 
the Law on the protection of the population against infectious diseases. In addition to 
mandatory immunization, in this law should be defined the recommended and optional 
immunizations and how to implement ethical, and then a public hearing. It is necessary for the 
formation of an advisory body for immunization in Serbia which would be carried out regular 
professional and ethical debate. All views of this body should actively communicate over 
public health transferred to the public, and by the new communication strategy needs to come 
up to social networks. 
Keywords: Immunization, Vaccination, Compulsory, Ethics 
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3. KNOWLEDGE AND ATTITUDES OF PRESCHOOL CHILDREN PARENTS 
ABOUT VACCINES AND DISEASES PREVENTED BY VACCINES 
 
Veličković Zoran1, Rančić Nataša1, Spasić Mihajlo2 
1Faculty of Medicine, Niš 
2Public Health Institute Niš  
Introduction: Vaccination is the most effective measure of primary prevention against 
infectious diseases that are most common in preschool children. 
 
The aim of this study was to analyze the knowledge and attitudes of parents of preschool 
children about diseases prevented by vaccines and vaccines. Materials and Methods: The 
study was conducted as a cross sectional study on a randomly selected representative sample. 
The sample consisted of parents of children aged 1-6 years from nine kindergartens in the city 
of Nis. The survey was conducted in 2011. An anonymous survey was administrated among 
parents. 
Results: Of the 1,000 distributed surveys  772 were completed, response rate was 77.2%. 
From the total number 523 (67.7%) knew to specify at least one infectious disease against 
which their child has been vaccinated. 502 (96%) of parents know that vaccination is 
compulsory by law. Only 14 (2.6%) believed that it is better that the child's immunization 
decide for itself. 718 (94.6%) of parents think that vaccines are important for the health of 
their children and it is better to get the vaccine than to get sick. 632 (82.3%) of parents felt 
that pediatricians are most qualified to speak about vaccines. 450 (58.4%) think that the main 
reason why parents is do not bring children to vaccination is the fear, 211 (27.4%) ignorance, 
and 64 (8.3%) lack of information. 634 (83.1%) said that vaccines are not harmful to health. 
Most of the parents (90.1%) will be informed about vaccines from the press, on television and 
radio. 254 (34.1%) purchased the vaccine, as recommended by the pediatrician. 122 (15.8%) 
of parents said they would not allow their child to receive some of the vaccines. 
Conclusion: Parents have confidence in vaccines that are applied for a long as in health care 
workers. It is essential that health care professionals increase communication with parents 
about vaccines by introducing special call-centers or through official websites of medical 
institutions, e-mails. 




4. ESCHERICHIA COLI O104:H4 OUTBREAK IN GERMANY —CLARIFICATION 
OF THE ORIGIN EPIDEMIC 
 
Radosavljević Vladan  
Military Medical Headquarters, Department of Preventive Medicine, Ministry of Defense  
Objectives: In 2011, Germany was hit by one of its largest outbreaks of acute gastroenteritis 
and haemolytic uraemic syndrome caused by a new emerging enterohaemorrhagic 
Escherichia coli O104:H4 strain. The German Haemolytic Uraemic 
Syndrome/Enterohaemorrhagic E. coli (GHUSEC) outbreak had unusual microbiological, 
infectiological and epidemiological features and its origin is still only partially solved. The 
aim of this article is to contribute to the clarification of the origin of the epidemic.  
Materials and Methods: To retrospectively assess whether the GHUSEC outbreak was 
natural, accidental or a deliberate one, we analysed it according to three published scoring and 
differentiation models. Data for application of these models were obtained by literature 
review in the database Medline for the period 2011–13.  
Results: The analysis of the unusual GHUSEC outbreak shows that the present official 
assumption of its natural origin is questionable and pointed out to a probability that the 
pathogen could have also been introduced accidentally or intentionally in the food chain.  
Conclusion: The possibility of an accidental or deliberate epidemic should not be discarded. 
Further epidemiological, microbiological and forensic analyses are needed to clarify the 
GHUSEC outbreak. 
 
Key words: Escherichia coli O104:H4, outbreak, Enterohaemorrhagic E. coli, origin of the 
epidemic, Haemolytic Uraemic Syndrome 
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5. OUTBREAKS OF HEPATITIS A IN SERBIAN ARMED FORCES, 1991-2010 
 
Mladenović Jovan, Čekanac R., Lazić S., Mladenović Z.  
Institute of Epidemiology, Military Medical Academy, Belgrade 
 
Introduction/Aim: Hepatitis A has a long history as a militarily important disease. Epidemics 
of hepatitis A have threatened many wartime operations, particularly in highly endemic areas 
and during unstable field conditions. Risk factors for hepatitis A outbreaks in military units 
are crowded living conditions, substandard personal and unit hygiene practices under field 
conditions, mass food processing facilities and frequent movement of personnel among units 
and throughout various geographic locations. 
The purpose of the current report was to summarize and characterize hepatitis A outbreaks in 
the Serbian Armed Forces (SAF) from 1991 to 2010. 
 
Method: This study was a retrospective analysis of epidemiological reports, gathered by the 
Institute of epidemiology Military Medical Academy, representing all reported outbreaks of 
Hepatitis A in the SAF between 1991 and 2010. 
 
Results: Total of 22 outbreaks was reported during study period. The greatest numbers (4 
outbreaks) occurred in 1994 and 1999 but the largest, with biggest number of cases, were 
recorded in 1991 (two outbreaks with total of 111 cases). Total number of cases was 268. 
Number of cases per outbreak ranged from 3 to 100 and average number was 12. Most 
outbreaks (68.2%) had less than 10 cases. Attack rates in outbreaks ranged from 1.1% to 
71.4% with mean attack rate of 16.0%. Outbreaks last from 1 to 99 days (average duration of 
outbreak was 50.8). Majority of outbreaks occurred during late summer and autumn, with 
maximum in October (4 outbreaks). Most frequent mode of transmission in outbreaks was 
contact (40.9%), then food (22.7%), unidentified (22.7%) and water (13.6%). Largest 
percentage of outbreaks (50%) occurred on territory of Kosovo and Metohia.  
 
Conclusion: There is significant risk of outbreaks of hepatitis A among members of the 
military especially during the war, humanitarian disasters or engaging in multinational 
peacekeeping operations, therefore compulsory vaccination against Hepatitis A should be 
introduced for all military personnel. 
 




6. HOSPITAL INFECTIONS IN CLINICAL CENTER NIS IN THE PERIOD 2008-
2013 
 
Janićijević Ivana1, Tiodorović B.1, 2, Veličković Z.1, 2 
1Public Health Institute Niš  
2Faculty of Medicine Niš 
 
Introduction: Hospital infection is the one that occurred in the hospital and became evident 
48 hours after admission of the patient to the hospital and later on, or if it is found associated 
with surgical intervention and manifested after 30 days after the intervention, if not impants 
have not been installed, resp, or one year if imlantant has been installed. 
Goals: To review the frequency of occurrence of hospital infections at Clinical Center Nis, 
the localization of the most frequent causes as well as their resistance in the period of 2008-
2013. 
Material and Methods: The descriptive method. As a source of data, the application of 
hospital infections and annual reports PHI Nis and protocols Center for Microbiology PHI 
Nis. 
Results: In the period from 2008 to 2013, 899 hospital infections have been reported. The 
greatest number of hospital infections have been reported by surgical clinics (general surgery, 
vascular and neurosurgery), while a small number of applications were from general internal 
areas. The most common localization of hospital infections are surgical site infections 
(47,7%), followed by following infection of the respiratory system (13.7%) and infections of 
the digestive system (10.6%). Infections of the eye, nose and throat, as well as cardio vascular 
system were not registered. 
The causes of hospital infections have not been significantly changed except that they are 
becoming more and more resistant, so they are now the most common MRSA, ESBL strains 
of Klebsiella, E. coli, and Acinetobacter. Outbreake of Clostridium difficile is the most 
common cause of hospital infections. In the observed period there were 9 hospitalized 
outbreaks. There have not been recorded any deaths. 
Conclusion: Over the years the number of hospital infections is growing.Infections of  
surgical site were the most common, although there is an increasing number of infections of 
the digestive tract where the cause of Clostridium difficile, which is a big hospital problem.  
MRSA and ESBL strains are the most common causes of surgical site infections and 
respiratory system. As a consequence the number of days of hospitalization is lenghtened and 
therefore the possibility for the maintenance and expansion of hospital infections. There is a 
smaller range of medicines to treat the growing resistance of pathogens.  
Keywords: hospital infections, hospital infections cause, resistance, nosocomial outbreaks 
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7. EPIDEMIOLOGICAL CHARACTERISTICS OF INFECTIOUS DISEASE 
MORTALITY IN THE TERRITORY OF NISAVA AND TOPLICA DISTRICTS 
 
Kostić Marina1, Veličković Zoran 1,2 
 
1Public Health Institute Niš  
2Faculty of Medicine Niš  
 
The aim of this paper is to show the trend and epidemiological characteristics of mortality 
from infectious diseases in the territory Nisava and Toplica region in the period from 2004 to 
2013.  
As materials were used: the report – unsubscribe of  communicable diseases from Nisava and 
Toplica district from 2004 to 2013 and annual reports PHI Niš. A descriptive epidemiological 
method was used. Rates are non-standardized and are calculated per 100,000 inhabitants. 
Results in the observed period there have been 630 cases of infectious disease with fatal 
outcome. Reported cases belong to all groups of infectious diseases. In the first place are 
respiratory infectious diseases with 51.59%. Mortality trend is on the rise and is y = 17.27 + 
8,31x and R2 = 0.64. The average annual mortality rate was 12.71% ooo, and lethality 0.48%. 
The highest mortality rate is 2013. (22.31% ooo) and the lowest 2004 to 1.00% ooo. Lethality 
is the biggest of 2012 (0.91%) and the lowest in 2004. (0.06%). Pneumonia viralis non 
specificata is in the first place with 27.14% of the total mortality from infectious diseases, 
while septicemia is in the second place with 26.19%. Municipality of Razanj has the highest 
average annual mortality rate (17.11% ooo), followed by municipalities Aleksinac (17.04% 
ooo) and Niš (13.72% ooo), and the municipality Sokobanja has the smallest (47.36% ooo). 
Males had more fatal outcomes (365 265) and a higher mortality rate (152.83% ooo: 108.03% 
ooo) compared to the female gender. In both sexes, the highest mortality rate was in the age 
group of 60 years and over. In March has been registred the highest number of patients - 
10,63%. 
Conclusion: The territory of Nisava and Toplica districts experienced growth in mortality 
from infectious diseases. The most vulnerable population are the older-aged males. The 
emergence of new infectious diseases, as well as the uncontrolled use of antibiotics leads to 
the emergence of bacterial resistance to the medicines and the occurrence of complications, 
may contribute to a further increase in mortality from infectious diseases.  






1. OUTBREAKS OF SALMONELLOSIS IN THE POPULATION OF BELGRADE 
FOR THE 1994-2013 PERIOD 
 
Maris Slavica1, Maksimović J.2, Uzelac-Škorić A.1, Begović-Lazarević I.1, Begović-
Vuksanović B1 
1Public Health Institute of Belgrade  
2University of Belgrade, Faculty of Medicine, Institute of Epidemiology 
 
Introduction. Salmonellosis is an important global public health  problem causing significant 
morbidity. The aim of this study was to analyze outbreaks of salmonellosis in the population 
of Belgrade for the period 1994-2013.  
Method. The study applied a descriptive epidemiological study. The analysis outbreaks of 
salmonellosis were used data from the annual reports on the work of the prevention, 
combating and elimination of infectious diseases and the results of epidemiological and 
laboratory investigation. 
Results. During the period covered in the Belgrade area were registered 273 outbreaks of 
salmonellosis with a total of 4425 affected individuals. The largest number of outbreaks (249) 
took place in the outpatient environment where affected total 4026 persons (91%) and 24 
outbreaks (399 patients) in the hospital environment. Two-thirds of all registered outbreaks 
are family epidemics (63.37%). The most common mode of transmission in outbreaks of 
salmonellosis was through food (94.50%). The average duration of outbreaks was 6 days. The 
most common cause of outbreaks of salmonellosis were S. enteritidis (89.09%). 
Conclusion. In order to reduce the number of recorded outbreaks of salmonellosis it is 
necessary to improve control over all facilities for the preparation and distribution of food. 
 
Keywords: salmonellosis, outbreaks, S. enteritidis 
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2. EPIDEMIOLOGICAL CHARACTERISTICS OF TB IN MONTENEGRO IN THE 
2004-2013 PERIOD  
 
Rakočević Božidarka¹, Bojović O.², Medenica S.¹, Vujošević D.¹, Mugoša B.¹ 
1Public Health Institute, Podgorica, Crna Gora 
2Special Hospital for Lung Diseases „dr Jovan Bulajić“, Brezovik, Nikšić, Crna Gora 
 
Introduction: Tuberculosis continues to be  a major public health problem in both developed 
and developing countries as one-third of the world´s population is infected with 
Mycobacterium tuberculosis.  
Aim: To describe the epidemiology of tuberculosis in Montenegro between 2004 and 2013 
and identify more susceptible populations. 
Materials and methods: Data source were the National TB Registry and the Statistical 
Office of Montenegro-Cencus of Population. In the analysis of the data we used crude 
incidence rates and descriptive statistics. 
Results: The highest TB incidence rate was in 2006 - 27,5/100 000 while the lowest was in 
2012.-17,2/100 000. During the observing period 61% of the cases were among men.  The 
highest average incidence rate was recorded among the age group of over 64 and it was 
42,6/100 000. In ten-year period  extrapulmonary tuberculosis constitutes up to 12-14% of all 
cases. During the observing period 4 persons with HIV/TB were registered.  
Conclusions: In the last ten years there has been stagnation in sudden onset of tuberculosis in 
Montenegro. Despite the decrese in incidence rate in  Montenegro, there are still many 
challenges in the control of TB, as early detection of cases, diagnostic and successful 
treatment.  
Key words: TB, epidemiology, burden, incidence 
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3. EPIDEMIOLOGICAL ASPECTS OF COLLECTIVE CONSUMPTION IN KICEVO 
REGION WITHIN 2006-2012 
 
Kerimi N.,Eftimijadoska F. 
State Sanitary and Health Inspectorate-Kicevo,  
Public Health Center - Bitola, Hygiene Kicevo-Republic of Macedonia 
 
Objective: To assess the security risk of collective consumption in Kicevo to provide 
preventive measures proposed to reduce the risk of infectious diseases transmitted by food. 
Materials and methods: Used statistical information data epidemiological inspections 
carried out in facilities for collective consumption,control of microbiological purity,control 
of hygienic quality of food that is prepared according to Regulation Food Safety and food 
safety criteria for microbiological Fig.R.M. no.78/2008.Retrospective statistical method 
used to work,and results will be presented tabular and graphic. 
Results: Performed a number of epidemiological inspections facilities for insights into 
collective consumption(190),examined 407 samples of food for bacteriological 
analysis,2108 samples of drinking water from the city water supply and all corresponding 
regulations.Of the 345 bacterial swabs bacteria isolated 8(2%),while in the period 2001-
2005y.out of 294 had a greater number of defective samples 40(14%),total 361 meals tested 
were bacteriological defective 3%.The number of ill of  alimentary toxicinfections goes 
from 36 in 1996y., 201 in 2000y. to 1 in 2012y. 
Conclusion: The examined period of 2006-2012y. situation improved in general 
satisfies.The percentage of defective bacterial smears decreased from 14% to 2%,and food 
from 3% to 0%.It’s necessary to respect the principles of the HACCP system.Alimentary 
toxicinfections are decreasing in Kicevo. 
Keywords: Еpidemiological inspections, collective food,alimentary toxic infections. 
 
C. Session: ACTUAL PUBLIC HEALTH PROBLEMS OF COMMUNICABLE DISEASES  48. DPM 
71 
 
4. WHAT ARE THE MOST SIGNIFICANT FACTORS THAT CONTRIBUTED TO 
HIV/AIDS BECOMING A GLOBAL PROBLEM? 
 
Radivojević Bisenija1, Andrejević Vesna2  
1Health Center Kragujevac  
2Public Health Institute Kragujevac  
 
Objectives:  
HIV/AIDS is not just a health problem, but also a development problem. By spreading fast 
mostly to young people and working-age adults, HIV/AIDS affects the economy, society, 
family and schooling in a country, weakening the country as a whole.  
Materials and methods:  
In our work w’ll try to give an answer to the following question (using the available data) why 
HIV/AIDS becoming a most important global health problem? 
 
Results:  
HIV-1 is transmitted in body fluids. The most important factors that contribute to the 
epidemic of HIV infection are: Low socio-economic status, lack of realistic estimates of the 
size of vulnerable groups, insufficient coverage of key preventive activities populations. 
Conclusion: Today, with modern medical advances, AIDS doesn’t have to be a death 
sentence. To people who living in the developed world with adequate resources and access, 
HIV has more often become a chronic illness that can be managed for years. But in Africa, the 
World Health Organization estimates that only 28% of those in need of treatment are getting 
it.  International efforts have produced results, but still have a long way to go.  




5. THE EPIDEMIC OF TULAREMIA IN VILLAGE VRAPCHISHTE- 
MUNICIPALITY GOSTIVAR 
 
Ognjanoski Vojislav ¹, Jovanoska D.¹, Ognjanoska K.², Ristoska K.³ 
1Public health institution Center for Public Health Tetovo - Regional unit Gostivar  
2Private health institution Dr Katerina Gostivar  
3Private health institution Sistina nefro plus one Gostivar  
 
Purpose: The purpose of this work is to show the occurrence of the disease tularemia, which 
for the first time appeared in epidemic form, not only in the village Vrapchishte, but and in 
the region in Gostivar, with special emphasis on the reasons for the occurrence of this 
zoonotic diseases and measures to prevent and combating this epidemic. 
Materials and Methods: There were used individual applications for infectious diseases, 
epidemiological surveys of patients, the analysis of biological materials, patterns of water, 
reports, newsletters and information created within the epidemiological department in 
Gostivar. 
Results: Since the beginning of the epidemic until its end, were interviewed 40 ill persons 
with symptoms suspicious for tularemia. The same number (40) of serums samples were 
tested for the disease. The positive result of tularemia showed 20 patients. The largest part of 
the 19 patients or 90% were from the village Vrapchishte, one or 5% of the village Zubovce 
one or 5 % of the village of Galate. In this epidemic were 11 ill men and 9 ill women. The 
greatest part were the age of 40-49 (7 patients), followed by persons 20-29 years of age (4 
patients), and three children ages 10-19 and a child of 3 years. 
Conclusion: This epidemic is the second time registered in the Republic of Macedonia (the 
first recorded epidemic was in the year 1995 with 31 ill). Although we were unable to confirm 
the source of infection, with great certainty, we believe that these were the squirrels, which 
we found in the tank with water from the local water supply to all three villages, and the water 
was a way of spreading this infectious disease. 
 
Keywords: tularemia, squirrels, water 
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6. EPIDEMIOLOGICAL CHARACTERISTICS OF THE SALMONELLOSIS 
AMONG THE FOODBORNE DISEASES IN MONTENEGRO IN THE 2004-2013 
PERIOD  
 
Medenica Sanja1, Rakočević B.1, Lakićević N.2, Vujošević D. 1, Stanišić M. 1, Mugoša B. 1 
1Public Health Institute Montenegro  
2Clinical Centre Montenegro  
 
Introduction: Salmonellosis is acute, bacterial, intestinal infection with short incubation 
period, clinical presentation of the gastroenteritis and general intoxication. 
Aim: Research epidemiological characteristics of the Salmonellosis among the foodborne 
diseases in Montenegro in 2004-2013. 
Materials and method: Data source were reporting cards for communicable diseases and 
epidemiological questionnaires and Census of Population- Statistical Office of Montenegro. 
In the analysis of the data we used crude incidence rates and descriptive statistics. 
Results: In observing period 22,931 cases of foodborne diseases were registered (average 
incidence was 369.84/100,000), and 3,177 registered cases of Salmonellosis (Incidence of 
51.24/100,000) or 13.85%. Higher average Salmonellosis incidence rate was recorded in 
Pljevlja (160.46/100,000), Budva (144.14/100,000), Kotor (62.82/100,000). Of all registered 
cases 67.5% were among preschool and school age group. The most common serotype is 
Salmonella Enteritidis - 85%. 
Conclusion: Number of Salmonellosis cases is probably higher than number of registered 
cases, considering the great number of cases of acute gastroenterocolitis. Higher incidence in 
named municipalities is explained with higher frequency of people and higher temperatures in 
summer months. The highest number of registered cases among the youngest is explained 
with sensitivity of these age groups and more frequent visits to doctors.  




7. INTESTINAL INFECTIOUS DISEASES IN SERBIAN AREAS OF KOSOVO AND 
METOHIJA 
 
Milić Marija1, Parlić M.1., Stevanović J.1, Kostić M.1, Samardžić V.1, Vukadinović Z.2, 
Novaković D.2, Antonijević S.2  
1Medical Faculty of Priština, Kosovska Mitrovica  
2Public Health Institute, Priština, Kosovska Mitrovica 
 
Objective: The main objective of this paper is to identify the most important epidemiological 
characteristics of intestinal infectious diseases in the Serbian areas of Kosovo and Metohija.  
Materials and methods: In this research we used epidemiological study design (cross-
sectional). As a material for the understanding of the size of the problem of intestinal 
infectious diseases and inference we used data from the monthly and annual reports on the 
movement of infectious diseases of the Public Health Pristina in Kosovska Mitrovica. The 
study covered the period from 2004 to 2013. year.  
Results: In the observed period the Serbian areas of Kosovo and Metohija was a total of 6238 
patients with intestinal infectious diseases, with an average incidence 398.35 / 100 000.  For 
the same period  was recorded 21 outbreaks with a total of 327 patients. Analyzing the disease 
from the group of intestinal infectious diseases, which are most frequent, enterocolitis acuta 
ranks first with registered 4987 (80%) patients. Statistically significant intestinal infectious 
diseases were more prevalent in males (chi-square 14.973, p = 0.005). Disease showed a 
seasonal character and connection with the summer months, except that VHA was more 
common during the fall and winter.  
Conclusion: Intestinal infectious diseases in the Serbian areas of Kosovo and Metohija are the 
actual health problem and needs to work on strengthening preventive measures. 
 
Keywords: intestinal infectious diseases, Kosovo and Metohija, enterocolitis acuta 
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8. EPIDEMIOLOGICAL CHARACTERISTICS OF BRUCELLOSIS IN THE 
REGION OF PRILEP FOR THE PERIOD 1986-2013 
 
Kuzevski Goran, Stanimirovik T, Ingilizov G. 
Public Healthcare Institution, Public Health Centre, Prilep, Republic of Macedonia 
 
Objective: Review of epidemiological characteristics of brucellosis in the region of Prilep for 
the period 1986-2013. 
Materials and methods: Data from reports on the movement of contagious disorders, 
registration cards and surveys conducted with diseased persons have been used. This is a 
retrospective study in which both descriptive and analytical working methods have been 
applied. 
Results: The first case of person infected with brucellosis in the region of Prilep was 
registered in 1986. By the end of 2013, 1023 infected persons were registered. Average 
annual morbidity rate is 37.3 in every 100 000. Brucellosis has shown a declining tendency 
since 2000. Morbidity rate of the rural population is higher that the one of the urban (92:18). 
By way of direct contact were infected 55.3%. Analysis conducted in different age groups 
revealed that people aged 50-59 most commonly become infected (morbidity rate 52.4/100 
000). The greatest part of infected persons is registered in June (15.7%).  
Conclusion: Brucellosis has been present in the region of Prilep since 1986. There has been a 
declining tendency for the last 10 years.  Brucellosis is an occupational disorder.  
Transmission by way of contact is a dominant one. People aged 50-59 are most commonly 
become infected.      
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1. OSTEOPOROSIS IN RHEUMATIC DISEASES: EPIDMIOLOGY, PREVETION 
AND TREATMENT  
 
Matucci Cerinic Marco1, Blagojević J 1,2 
1Department of Rheumatology, University of Florence, Italy 
2Oncology and Clinical Medicine, University of Siena, Italy 
 
Introduction 
Osteoporosis (OP) is one of the major causes of morbidity in rheumatic diseases, besides 
cardiovascular and neoplastic pathologies.  It complicates either inflammatory rheumatic 
diseases and connective tissue diseases.In these pathologies OP is principally related to the 
release of the inflammatory mediators that up regulate bone resorption and down-regulate 
bone formation.Moreover, important risk factors associated with OP in rheumatic diseases are 
the glucocorticoid therapy and reduced physical activity. 
Epidemiology 
Inflammatory arthropathies 
Rheumatoid arthritis (RA): 
OPis major extra-articular complication of long-standing RA. Anti-citrullinated peptide 
positivity as well as higher levels of interleukin-6 is associated with decreased bone mineral 
density (BMD) and polymorphisms in the vitamin D receptor in RA patients may predispose 
to OP (1).OP is more frequent in RA patients than in the healthy population, with about 
double rate (2).In patients with longstanding RA the occurrence of OP ranges from 19% to 
32% in the spine and from 7% to 26% in the hip (2,3,4).Moreover, patients affected by RA 
have a 1.5 fold higher risk of osteoporotic fractures compared to healthy controls (5). 
 
Ankylosing spondilytis(AS) and Psoriatic arthritis (PA): 
Low bone mineral density (BMD) and bone loss have been well documented in the spine and 
hipsof patients with AS (6).Low BMD has been found in the early stages of the disease, 
whereasin long-standing  AS the presence of structural bone lesions, such as syndesmophytes 
and periosteal bone formation, may be responsible for alterations in bone density scan (DXA) 
measurements (7). In patients with long-standing AS, the prevalence of vertebral fractures 
ranges between 1% and 19% (8,9). In patients affected both by AS and OP, the prevalence of 
vertebral fractures ranges between 29.6% and 33.3% (9). 
 




Data on prevalence of OP in PA are contrasting. Some studies showed lower BMD levels in 
patientsaffected by PA compared to healthy controls (10) and  BMD values of lumbar spine 
and total femur  showed an inverse correlation with the duration of arthritis (11). These results 
were not confirmed by other studies that have notfound a reduction in the bone mass in 
patients affected by PA (12,13), showing also no correlation between duration of the disease 
and BMD (14).  
 
Connective tissue diseases 
Systemic lupus erythematosus(SLE): 
Low BMD and a high prevalence of vertebral and peripheral fractures have been reportedin 
patients affected by SLE.The prevalence of OP in SLE ranges from 1.4 to 68%, while the 
prevalence ofsymptomatic fractures since lupus diagnosis ranges from 6 to 12.5%(15).This 
wide range is probably  due to the differences between different study populations, regarding  
disease activity, ethnicity, age, sex, size and treatment. 
Besides the chronic inflammation, other risk factors for OP in SLE are represented by: 
glucocorticoid treatment, hypovitaminosis D, reduced physical activity due tojoint and 
muscular involvement. Patients with SLE have high prevalence of hypovitaminosis D as a 
result of reduced sun exposure due to photosensitivity, renal insufficiency and the use of 
medications such as anticonvulsants, antimalarials and the calcineurin inhibitors, which alter 
the metabolism of vitamin D or downregulate the functions of the vitamin D receptor. 
Moreover, these patients are at higher risk for falls, due to neurological and musculoskeletal 
involvement and visual defects, and are consequently exposed to higher fracture risk. 
 
Systemic sclerosis (SSc) and Polymiositis/Dermatomyositis (PM/DM): 
Numerous  studies reported a high prevalence of OP in SSc withBMD values similar to or 
even lower than those of patients with RA (16,17). Arecent casecontrol study showed a higher 
prevalence of OP and vertebral fractures in postmenopausal women with SSc compared to the 
control group (18). Risk factors for OP in SSc are represented by: intestinal malabsorption, 
reduced physical activity, low body mass index, renal impairment and vitamin D deficiency.   
An increased risk of OP in adult PM/DM patients has been reported recently (19), and it is 
probably related to glucocorticoid treatment and low physical activity due to the muscular 
impairment.  
 
Increased prevalence of OP has been described in other rheumatic diseases as polymyalgia 
rheumatic and giant cell arteritis (20)and ANCA (anti-neutrophil  cytoplasmic antibodies)-
associated  vasculitis (21).  
 
Prevention and treatment 
The prevention of OP in rheumatic diseases should be initiallyperformedby: 
- optimal disease control in order to avoid the release of inflammatory mediators and 
cytokines that promote OP 
- minimization of use of glucocorticoids, using also steroid sparing agents (eg. Methotrexate 
and other immunosuppressants) 
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-  adequate supplementation of calcium and vitamin D 
-  physical activity and adequate exercise  
- good nutrition and maintenance of normal body weight  
- avoidance of smoking and alcohol 
 
The timing of the pharmacological anti-osteoporotic intervention should be based on the 
individual absolute risk of fracture. The World Health Organization developed the FRAX® 
computer- based fracture risk-assessment tool (http://www.shef.ac.uk/FRAX) to calculate a 
10-year probability of hip fracture or a major osteoporotic fracture,  starting from clinical risk 
factors with or without BMD testing .It considers the following  variables: age, sex, weight, 
height, history  of fractures, parental history of hip fractures, current smoking, consume of 
alcohol ≥ 3 units/day, use of glucocorticoids, presence of rheumatoid arthritis, secondary 
osteoporosis and femoral neck BMD. 
 
Italian experience: DeFRA algorithm 
Although the FRAX tool represents a major step forward in the management of OP, it has 
some limitations. This led the Italian Society of Osteoporosis Mineral Metabolism and 
Skeletal Diseases (SIOMMMS) to develop a new tool (DeFRA; https://defra-osteoporosi.it) 
based on the data published for the development  of FRAX and yielding almost 
superimposable results (22). 
DeFRA (FRAX derivate) is the algorithm used currently by Italian rheumatologists and its 
gives the possibility to register data of each patient.  It takes in consideration the same clinical 
risk factors used by Frax, but  with a possibility to detail some of them. FRAX permits to give 
two answers on use of steroids. 
DeFRA defines better the chronical use of steroids; it gives the possibility to specify if the 
daily dose of glucocorticoids is superior or inferior than 5 mg of prednisone equivalent. As 
regards the personal  history of fractures, DeFRA permits to insert if there is one or more than 
one fracture, while FRAX gives the possibility to wright yes or no. Eventually, FRAX defines 
only the presence or absence of current cigarette smoking as a risk factor for OP, while 
DeFRA  gives the possibility to  diversify if the daily quantity of cigarette is superior or 
inferior than 10. These improvements of FRAX algorithm may allow to estimate better the 
influence of  the osteoporotic risk factors on risk of fractures, according to their intensity.  
 
Treatment of OP in rheumatic disease follows the general principles of osteoporotic therapy 
used  in other settings.Management of glucocorticoid-induced osteoporosis (GIO)  is one of 
the major clinical challengesin rheumatic diseases, due to a widespread use of steroids. A 
treatment with 10 mg/d of prednisone or equivalent for more than 3 months leads to a 7-fold 
increase in hip fractures and a 17-fold increase in vertebral fractures (23).For this reason, the 
attention of a section on prevention and treatment of OP will be focused on GIO.  
As regards the prevention of GIO, when a patient starts a glucocorticoid treatment which is 
intended to last at least 3 months, adequate prevention measures against fractures need to be 
adopted.The same applies to patients already on glucocorticoids.Thresholds for cost-
effectiveness have been developed on the basis of economic assumptions that are country-
specific.   




The most recent recommendations from the AmericanCollege of Rheumatology (ACR) are 
stratified by glucocorticoid dose and fracture risk based on FRAX calculations (24). They 
divided patients at risk of OP in those at low (FRAX 10-year risk of a major fracture <10%), 
medium  (FRAX 10-year risk of major fracture   10-20%) and high risk (FRAX > 20%). 
Postmenopausal women and men aged 50 and older at low-risk should be treated if their 
steroid doseis ≥7.5 mg/day and steroid use lasts or is expected to last more than 3 
months.Medium-risk patients should be treated in case of prolonged steroid therapy (> 3 
months) at dosage  <7.5 mg, while high-risk patients should be treated for any duration and 
dose of glucocorticoids.The FRAX tool is currently not applicable to premenopausal women 
or men younger than age 40 years. 
As regards premenopausal women and men younger than 50, the decision is based on 
previous fractures. For patients without previous fractures, no recommendation was 
formulated, due to a limited data on this subset of patients. In man < 50 years or in 
premenopausal women with no childbearing potential who have had a fracture, treatment is 
indicated if the patient has received glucocorticoids at any dose for longer than 3 months, or if 
the steroid dose is≥ 5 mg/day for 1 to 3 months.In premenopausal women with childbearing 
potential the potential fetal toxicity of bisphosphonates should be consider, recommending to 
avoid the use of zolendronate due to its long half-life. 
A joint Guideline Working Group of the International Osteoporosis Foundation (IOF) and the 
European Calcified Tissue Society (ECTS) has recently published a framework for the 
development of national 
guidelines for the management of GIO (25). In postmenopausal women and men aged ≥50 
years exposed to ≥3 months of oral glucocorticoids it recommends to consider the treatment 
in case of previous fracture, age > 70 or steroid dose≥7.5 mg/day. Otherwise, a decision 
should be made by assessing risk with adjusted FRAX (with or without BMD testing). 
Intervention thresholds based on FRAX will also depend on the country. In premenopausal 
women and men  aged <50 years exposed to ≥3 months of oral steroids, treatment should be 
considered in patients with prior fracture. Treatment decisions in individuals with no prior 
fracture should be based on clinicaljudgment.  
Besides calcium and vitamin D supplementation, bisphosphonates are considered first-line 
options for GIO (24). Alendronate, risedronate, and zoledronic acid are recommended by the 
guidelines, as showed to reduce the risk of vertebral fractures(26).An alternative GIO 
treatment is teriparatide,a recombinant human parathyroid hormone, that showed to increase  
spinal BMD faster and to a greater extent than alendronateand also to  reduce vertebral 
fractures (27). Teriparatide represents a rationalapproach to GIO, because it contrasts some 
fundamental effects of glucocorticoids on bone, as anincrease in osteoblast and osteocyte 
apoptosis and the decrease in the number of osteoblasts. Another potential treatment option is 
denosumab, a humanized monoclonal antibody to RANKL, approved for the fracture 
prevention in postmenopausal OP, but not yet for GIO. It showed some promising results  in 
patients withRAreceiving glucocorticoid treatment  ad dosage lower than 15 mg/day 
ofprednison (28). Denosumabmay be considered for glucocorticoid-treated patients with 








OP is one of the major complications of rheumatic diseases. Treatment with 
glucocorticoidsrepresent one of the main osteoporotic risk factors in these patients, besides 
chronic inflammation, vitamin D deficiency and reduced mobility. 
Treatment and prevention of OP should be based on national and international guidelines, but 
has to be personalized, taking into accountpotential side effects and cost-effectiveness. 
Decisional algorithms, as FRAX or Italian version DeFRA, should be used in everyday 
clinical practice. Recommendations for prevention and treatment of OP in premenopausal 
women and young men should be implemented.  
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3. INCIDENCE TREND OF MALIGNANT DISEASES IN THE MALE POPULATION 
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Mirko Ilić1, Petrović B1,2 
1University of Niš, Faculty of Medicine Niš 
1Public Health Institute Niš 
 
Introduction: Malignant diseases are a very important public health problem.  
Objective: To review the basic epidemiological features of male patients with malignant 
neoplasms in the city of Nis in the 1986-2010 period 
Materials and methods: we used the official data of the Public Health Institute in Niš 
computer database CanReg 4 conducted at the Center for Disease Control and Prevention. A 
descriptive epidemiological method was utilized.  
Results: In the period from 1986 to 2010 in the city of Nis there were 12253 new registered 
cases of men with malignant diseases. This number ranged from 203 (1994) to 818 (2004). 
According to the number of patients, the lowest incidence rate was registered in 1994 (less 
than 200/100000 of men), and highest in 2004 (close to 700 per 100,000 population). The 
trend of incidence rate was rising for about 16 new cases per 100 000 inhabitants. Statistically 
significant upward trend was observed in men in the age group of 50-54, 55-59, 65-69 and 70-
74 years. Malignant lung tumors among men in the city of Nis in the period have expressed an 
increasing trend of about 3 patients per 100,000 people and a share of 20% in comparison to 
other malignant tumors.  
Conclusion: Reducing the incidence of malignant neoplasms should be a priority in 
addressing this problem and should reduce the burden on our society, the mass disease. 




4. INCIDENCE TREND OF MALIGNANT DISEASES IN THE FEMALE 
POPULATION IN THE CITY OF NIŠ 
 
Kocić Biljana1,2, Rančić N.1,2 
1University of Niš, Faculty of Medicine Niš 
2Public Health Institute Niš 
 
Introduction: There were 14.1 million new cancer cases in 2012 worldwide. The overall age 
standardized cancer incidence rate is almost 25% higher in men than in women. Female rates 
are ranging from 103 per 100,000 in South-Central Asia to 295 per 100,000 in Northern 
America. In Central Serbia, female crude incidence rate was 469.7, while standardized 
incidence rate was 259.2, in 2011. Objectives: The aim of the study was to assess incidence 
trends of the malignant diseases among female population in the City of Niš, in the period 
1986-2010. Materials and methods: Data used for analyses were provided by the Cancer 
Registry of the Public Health Institute, Niš. Trends of the crude incidence rates (per 100,000) 
were calculated. Results: In the study period, a total of 12510 new cases of malignant diseases 
in females were registered. The highest incidence rate was registered in 2004 (645.2), while 
the lowest rate was found in 1986 (220.0). There was an increasing tendency of linear trend of 
malignant diseases incidence rates (y=12.885x+225.84, R2=0.634). During the entire period 
of observation, a increasing tendency of linear trend of incidence rates was registered among 
all age groups: 0-4 (y=0.4824x+11.061), 5-9 (y=0.0052x+9.7544), 10-14 (y=0.445x+3.1643), 
15-19 (y=0.1412x+12.783), 20-24 (y=0.6399x+19.417), 25-29 (1.2547x+20.308), 30-34 
(1.9469x+75.003), 35-39 (y=3.0966x+132.68), 40-44 (y=6.869x+199.64), 45-49 
(y=5.3237x+349.92), 50-54 (y=16.537x+362.44), 55-59 (y=18.707x+515.69), 60-64 (y= 
7.4891x+790.14), 65-69 (y=22.032x+739.63), 70-74 (31.559x+847.25), and 75+ 
(y=16.465x+1049.2). The leading cancer sites in females were: breast (26%), cervix uteri 
(9%), corpus uteri (8%), cutis (8%), pulmo (5%), ovarium (5%), colon (4%), rectum (4%), 
ventriculus (3%), and hepar (3%). An increasing tendency of linear trend of incidence was 
observed for the breast (y=3.3906x+56.22), cervix (y=0.3514x+29.455), cutis except 
melanoma (y=1.8344x+7.1895), corpus uteri (y=1.7255x-4.0656), pulmo 
(y=0.9485x+6.6912), ovarium (y=0.3521x+14.337), colon (y=0.5965x+9.6905), rectum 
(y=0.614x+9.3576), and ventriculus (y=0.2165x+9.9488). Conclusion: Registration of 
unfavorable incidence trends of malignant diseases among female population in the City of 
Niš, during 25 years, indicate failure in primary and secondary prevention in the past. It is 
thus of vital importance to provide much intensive and comprehensive activities for primary 
and secondary prevention. 
 





1. SHORTCOMINGS IN BLADDER CANCER ETIOLOGY RESEARCH AND A 
MODEL FOR ITS PREVENTION 
 
Radosavljević Vladan 
Military Medical Headquarters, Department of Preventive Medicine, Ministry of Defense, 
Belgrade, Serbia 
 
Objectives: Bladder cancer (BC) is the most expensive cancer to treat with incidence and 
mortality not decreased during last three decades. Numerous uncertainties are still 
surrounding its etiology. Low-cost BC screening test that would be applicable for early 
detection in asymptomatic persons, noninvasive and with satisfactory sensitivity and 
specificity should be priority. 
Materials and Methods: Critical issues in BC etiology research we classified as entrances, 
toxicity and metabolism, amounts, and duration of exposure to carcinogens in the bladder. 
Based on the proven risk factors for BC, we presented a simple scoring system as part of a 
new BC screening method. 
Results: The heterogeneous results of studies on BC etiology are largely due to a lack of 
research into the compounds (and their mutual interactions) present in the urinary bladder and 
the daily dynamics of exposure to exogenous risk factors. We have calculated a score for BC 
screening which is an integral component of a new, four-level system of BC prevention. 
Conclusion: Interactions of carcinogens and their daily dynamics deserve more attention in 
further clarifying BC etiology. New attempts in BC screening should be focused on urine 
content analyses (carcinogens, antioxidants, vitamins, minerals). We propose a score for BC 
preevaluation and recruitment for screening and a new model of BC prevention. 
Key words: Bladder cancer, etiology, risk factors, prevention, models. 




2. LUNG DISEASES INFECTION AND RISK OF LUNG CANCER  
 
Pavlovska I1, Orovcanec N.1, Tausanova B.1, Zafirova B.1, Isjanovska R.1 Stefanovska-Velic 
V.1 
1Institute of Epidemiology and Biostatistics with Medical Informatics 
Medical Faculty, Skopje, Republic of Macedonia 
 
The aim of the study was to determine the existence of the eventual causal associations 
among the previous lung disease (PLD) and development and distribution of the lung cancer 
(LC). Material and Methods:The research was conducted as a case-control study. A total of 
324 microscopically confirmed cases with LC, and the same number of frequency-matched 
controls (control group-CG) were analyzed using unconditional logistic regression, which 
provides results in the form of crude odds ratio. The odds ratios and their 95% confidence 
intervals (CI) were computed. Results:PLD was registered in 46% of LC patients. Chronic 
bronchitis was found in 38.9% of examined subjects and in 18.5% of CG. Chest x-ray 
findings of tuberculosis were present in 7.1% of patients and in 4.6% of CG. The risk was 
significantly increased in LC subjects with PLD compared to those who did not have a history 
of any lung disease (OR=2.83;95%CI 2.01-3.96). There was almost three-fold risk for the 
development of the LC in patients who have had chronic bronchitis (95%CI,1.96-4.01). 
Conclusion:Each third diseased patient had a history of chronic bronchitis. Due to the 
established causative relation between cicatrix lung changes and onset of cancer, a 
strengthened health control of these subjects is imposed as an urgent need. 
 
Key words: lung cancer, previous lung disease, tuberculosis, chronic bronchitis. 
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3. EPIDEMIOLOGICAL CHARACTERISTICS OF MALIGNANT DISEASES IN 
THE REPUBLIC OF MACEDONIA 
 
Stoilova Snežana1, Popova-Ramova E.1 
1High Medical School, Bitola, Republic of Macedonia 
 
 The aim of this paper is to show an increasing trend of malignant neoplasms in the Republic 
of Macedonia, as well as review of morbidity and mortality from these diseases. Materials and 
methods. We used a descriptive method of working on a database for the movement of 
malignant neoplasms in the Republic of Macedonia obtained from the registers of 
malignancies, as well as applications for non-infectious diseases of the Public Health Institute 
- Skopje. The data relating to the period of 2010/2012 years. Results. Malignant neoplasms 
are the second to the mortality of the population in the Republic of Macedonia to the 
representation of 18.3% in the overall number of deceased persons. In 2012, in the Republic 
of Macedonia mortality from malignant neoplasms diagnosed in 3689 persons with a 
mortality rate of 179.0 per 100,000 population. Noted an increased mortality of 13.9% 
compared to 2003 when they registered 3238 people died at a rate of 158.8 per 100,000 
population. In relation to gender higher mortality rate is recorded in males, and they were 
represented with 60.6% and women 39.4%. In relation to the localization of the most frequent 
malignant neoplasm of bronchus and lung cancer with the highest mortality rate of 31.6% ooo 
in 2003 and an increase of the same to 38.9 deaths per 100,000 population in 2012.  
 
Key words: malignant neoplasms, The Republic of Macedonia. 






1. MALIGNANT NEOPLASMS IN PROBISTIP 2007-2013 
 
Stojanovski Zoran 
P.H.O Center for public health-Stip r.u. Probistip R.Macedonia 
 
Objective of the work: To show the situation with the malignant neoplasms in  Probistip for 
the period of 2007-13y. A comparation is made with the situation in R.Macedonia. The 
morbidity is in scale 1:100000. 
Method of the work: Individual applications for non-communicable diseases were used from 
P.H.O. as also data from I.P.H.-Skopje department of social medicine. An analytically-
descriptive method was used.  
Results: In the given period in Probistip there are total of 211 registered cases with an 
average MB-199/100000 which is lower than in R.Macedonia. There more women diagnosed 
than men 57%-43%. unlike from  R.Macedonia where more men got ill. The highest MB 
found is in the age group over 70y. with MB 4719/100000 as in R.M. Both in R.M. and in 
Probishtip the most common primary is localized in the breast with average 
MB(706:737)/100000 while in men in R.M. the bronchus and lung (Mb.76.8/100000) and in 
Probishtip is the colon (48.5/100000).  
Conclusions: Probishtip has lower morbidity than Macedonia, women got ill more often and 
the most common primary localization in women is the breast, and the colon in men.  




2. ROLE OF GEOGRAPHIC INFORMATION SYSTEM IN CANCER RESEARCH 
 
Rakić Uroš, Jelić M. 
Public Health Institute of Serbia “Dr Milan Jovanović Batut”, Belgrade, Serbia 
 
Objective: Fighting cancer requires knowledge about the origin, the risk of exposure, and the 
consequences of variations in the risk of disease among the population. For fight against  
cancer  are needed tools  as  a geographic information systems that enable the establishment 
of a relationship between exposure to environmental factors and health at the individual, local, 
regional and, global level.  
 
Materials and Methods:.Geographic Information Systems (GIS) and other spatial analytical 
methods allow estimation of the spatial distribution of disease and risk factors. GIS creates a 
series of "stacked layer" of geo-referenced data (determined by latitude and longitude) that are 
associated with descriptive information or attributes. GIS has the ability to integrate spatial 
and temporal data. Application of GIS in cancer research includes the spatial analysis of 
cancer incidence, mortality, survival, and / or prevalence in the local population. GIS can 
monitor patterns of cancer and their changes over time and space. 
 
Results: Thethematic maps shows the locationsthat are used forcancerscreeningin the 
Republic ofSerbia. 
 
Conclusion: GISservesas a means of monitoring, planning and evaluation strategies for 
cancer control, as well as for prevention and intervention in the community, especially those 
who are economically disadvantaged. 
 
Keywords:cancer research, cancer screening, geographic information system, mapping 
  




3. BREAST CANCER IN RASINA DISTRICT AND CHALLENGES IN 
IMPLEMENTING THE NATIONAL SCREENING PROGRAMME  
 
Avramović Mirjana1, Živković S.2, Vuksanović D.1, Jovanović N.3, Petronijević E.3 
 
1Public Health Institute Kruševac 
2Public Health Institute of Serbia "Dr Milan Jovanović Batut" 
3General Hospital Kruševac  
Introduction: Every year in Rasinski district about 138 women are diagnosed with breast 
cancer. The National screening program in 2014, it was discovered eight cases of breast 
cancer.  
Objective: Consideration of the epidemiological features of breast cancer, and the ability to 
reduce the mortality by including women in the screening program.  
Materials and Methods: The descriptive epidemiological method. The database CR4 for 
Rasinski county and databases for the dead.  
Results: In the ten year period 2002-2011 breast cancer with 27.6% participated in the 
morbidity of cancer in women. The average incidence rate of breast cancer, which amounted 
to 58.9 / 100000 was the first height. The incidence showed a tendency to decrease -2,0321x 
+ y = 73.407; as well as the mortality rate is decreased to a lesser extent -0,4073x + y = 22,34. 
In 2011 the incidence rate of breast cancer Rasinski district was below the average for Central 
Serbia.  
Conclusion: We expect that during the implementation of the National screening programs 
for breast cancer, first increase the incidence of breast cancer in general. Is expected to 
decrease mortality and prolonging survival of newly diagnosed cases of breast cancer.  





4. ORGANIZED SCREENING OF CERVICAL CANCER IN THE REPUBLIC OF 
SERBIA  
 
Milošević B., Naumović T., Jovanović V.  
 
The aim of this study is to present, analyze and evaluate the most important process and 
outcome indicators from the organized cervical cancer (CC) screening program. The period 
analyzed in this study was December 2012 (beginning of the CC screening program) until 
June 2014. 
Methods: In the Republic of Serbia, until June 2014, organized cervical cancer screening 
program was implemented in 15 municipalities-15 Primary Health Centers (PHC), in 10 
administrative districts. Monthly reports from regional PHC and Institutes of Public Health 
were used as a source of data for this analysis. 
Results: The number of invited women was 151 148. Coverage by invitations was 61.3%. 
Coverage by Pap test was 35.8%. Attendance rate (%) was 58.5%. Positive findings (Pap 
finding-III, IV and V group) were found in 5639 (6.4%) women.  
Conclusion: In the future, more effort should be made to increase the coverage and attendance 
rate of women through CC screening promotion and education.  
 
Keywords: organized screening, cervical cancer, coverage calls, response, coverage 
  




5. EPIDEMIOLOGICAL CHARACTERISTICS OF COLON CANCER IN 
BRANICEVO AND DANUBE DISTRICT IN THE PERIOD 2003-2012 
Vera Jokovic Kostic  Nikolic G.    Stankovic N. 
Department of Public Health in Pozarevac  
Objectives: The aim is studying the participation of malignant tumors of the colon in total 
development of malignant diseases, and epidemiological features of the territory in Branicevo 
and Danubian district.  Materials and Methods: A descriptive epidemiological method was 
used. The study included data from the applications of persons suffering from malignant 
disease and other publications were being processed.  Results: Due to the unavailability of 
data for 2012, data for nine year period ending with 2011 were being processed. The total of 
1637 patients with average incidence of 45.55 was registered. The lowest incidence was 
recorded in 2008 in Danubian district 34.24 per 100 000 inhabitants, and the highest in 2007 
in the same district 57.79 per 100 000 inhabitants. Although it can be registered in younger 
age groups, the disease is most common in patients over 50 years. The disease is slightly more 
frequent in men than women.  Conclusion: In the world the expansion of malignancy 
correlates with increasing of population. In Serbia, the population are decreasing, but it is not 
being registered the decline in the number of patients with cancer. Colon cancer is the second 
most common malignancy (after lung cancer in men, and after breast cancer in women).  
 
Key words: colon cancer, the incidence rate, Branicevo and Danubian district. 
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6. EARLY DETECTION OF BREAST CANCER IN SERBIA 
Kravić Klaudia, Lazić Lj. 
Public Health Institute of Serbia "Dr Milan Jovanović Batut"  
Objective: Comparison of model of the National programme for early detection of breast 
cancer in the Republic of Serbia with the models of organized breast cancer screening in 
Croatia, Slovenia, France, UK and Finland.  
Materials and methods The data used in this comparative analysis is based ontheRegulation 
of National programme for early detection of breast cancer in Serbia, data collected through 
Cancer Screening Office of Public Health Institute of Serbia, andfrom organized breast cancer 
screening programs of above mentioned countries.  
Results: Screening cycle, target population, as well as inviting women to screening is similar 
in most of the analyzed countries. Mammography is used as a screening test and the 
interpretation of the findings is done twice, by two independent radiologists in respect to 
European guidelines for quality assurance in screening.  
Conclusion: Given the similarity of organized screening program for breast cancer in Serbia 
and countries whose programs are compared, reduction of breast cancer mortality in Serbia 
might beexpected in the next several years.  
Key words: breast cancer, incidence, mortality, early detection, organized screening 




7. MENTAL HEALTH PROBLEMS IN THE ADULT POPULATION OF 
NORTHERN KOSOVSKA MITROVICA 
Milošević Jovana1, Mirković M1, Đurić S1, Ilić D1,Milošević N2 
1Department of Preventive Medicine, School of Medicine in Pristina with temporary 
headquarters in Kosovska Mitrovica, Serbia  
2Department of Neurology and Psychiatry, Faculty of Medicine in Pristina with temporary 
headquarters in Kosovska Mitrovica, Serbia 
 
Cilj rada: je da se utvrdi učestalost poremećaja mentalnog zdravlja (PMZ) i njihov uticaj na 
socijalne odnose (SO) odraslih stanovnika severne Kosovske Mitrovice. 
Metod rada: Studijom preseka obuhvaćena je populacija odraslih stanovnika severnog dela 
K. Mitrovice.Za prikupljanje podataka o socijalno-ekonomskim i demografskim 
karakteristikama, PMZ i SO korišćen je upitnik koji je korišćen u Ispitivanju zdravlja 
Republike Srbije u 2006. godini. Statistička analiza uključila je metode deskriptivne 
statistike i hi-kvadrat test, sa nivoom značajnosti od 0,05. 
Rezultati: Istraživanjem je obuhvaćena 161 osoba ženskog i 167 osoba muškog pola. 
Najučestaliji PMZ bio je osećaj nervoze i zabrinutosti, koga je prijavilo 72,8% ispitanika. 
Kod 60,7% ispitanih PMZ imali su uticaj na SO. Najveći broj ispitanih (35,1%) se izjasnio 
za neznatan uticaj, umereno jak i veoma jak uticaj prijavilo je 19,5%, odnosno 5,2% 
ispitanih, dok je kod 0,9% uticaj PMZ na SO bio izuzetno jak. Uticaj PMZ na SO bio je 
statistički značajno (r<0,05) učestaliji kod osoba starijih od 65 godina (83,3%), udovaca 
(90,9%), ispitanika nižeg nivoa obrazovanja (83,3%) i osoba koje svoje materijalno i 
zdravstveno stanje opisuju kao loše (100%).    
Zaključak: Problemi sa mentalnim zdravljem predstavljaju učestalu pojavu među odraslim 
stanovnicima severnog dela K.Mitrovice. Našom studijom utvrđen je i značajan uticaj ovih 
problema na SO, posebno u populaciji starijih osoba, udovaca, osoba nižeg nivoa 
obrazovanja i onih koje svoje materijalno i zdravstveno stanje opisuju kao loše.  




8. ANXIETY IN PATIENTS WITH CARDIOVASCULAR DISEASES 
 
Jović Jelena1, Krstić Ristić M.2, Ristović K.3, Nikolić B.4, Ilić D.1, Marković M.5,Ćorac A.1 
1School of Medicine, University of Prishtina-Kosovska Mitrovica, Department of Preventive 
Medicine, Kosovska Mitrovica, Serbia 
2Primary Health Care Center Aleksinac, Serbia 
3Public Health Institute of Užice, Užice, Serbia  
4The Ministry of Defense, center for education end science, MMA, Belgrade 
5Department of cardiology hospital Užice  
 
Objectives: Anxiety is a common psychological problem with prevalence between 3.0- 7.3% 
in the general adult population. The relation between heart diseases and anxiety is 
bidirectional. The aim of our study was determination of anxiety prevalence in the population 
of patients suffering from cardiovascular diseases (angina pectoris (AP), infarct myocardial 
(IM), arrhythmia absolute).  
Materials and methods:Cross sectional study was carried out on the sample of 83 patients 
(40 women and 43 men). A socio-demographics questionnaire and Beck Anxiety Inventory 
were used. 
Results:There were 21.7% examinees with no anxiety symptoms; the rating in the group with 
mild anxiety was 28.9%, moderate anxiety 15.75%, while even 32.5% of the examinees were 
in the group with severe anxiety.In the group with the highest level of anxiety the score was in 
24.3% of examinees suffering from AP, 28.6% of patients suffering from arrhythmia absolute 
and 43.8% of patients who got over IM.The scores in the anxiety scale differed in sex in all of 
the diseases.  
Conclusion: Our results show that anxiety has higher prevalence in the population of patients 
suffering from coronary heart disease. Anxiety is associated with an increased risk of sudden 
cardiac death. When diagnosed, treated and followed in time, anxiety symptoms, coronary 
heart diseases and a better understanding of their interrelatedness can certainly bring to a 
more effective treatment and to amelioration of life quality of these patients. 
Key words: anxiety, cardiovascular diseases, Beck Anxiety Inventory 
  




9. FACTORS ASSOCIATED WITH DEPRESSION IN PATIENTS WITH DIABETES 
MELLITUS TYPE 2 
 
Šabanović Admir1, Grgurević A.2 
1Health Center Bijelo Polje  
2Institute of Epidemiology, University of Belgrade 
 
Background: The aim of the survey was to assess the prevalence ofthe depression in patients 
with type 2 diabetes mellitus (T2DM), and the identification of risk factors associated with 
thedepression.  
Materials and methods: A cross-sectional survey was carried out among the patients with 
T2DM at General Hospital in BijeloPolje. Sample of 70 patients participated in the survey. 
Patient Health Questionnaire 9  (PHQ – 9) is used for the assessment of the presence and 
theintesity of the depression. The data related to social and demographic characteristic, body – 
mass index, physical activity, comorbidity, duration of the disease and complications were 
obtained by questionnaire made for the survey.  
Results:Depression was associated withthe duration of the disease more than 5 years (p 
<0,001),physical inactivity (p <0,005), presence of diabetic polyneuropathy (p <0,014), 
presence of cataract (p <0,021). Statistically significant variables according to logistic 
regression analysis were theduration of the disease more than 5 years (OR= 7,27; 95% CI= 
2,37 - 22,84), andthe presence of cataract (OR= 4,84; 95% CI= 1,11 - 20,99).  
Conclusion: In our survey we found that risk factors for depressive disorders among patients 
with T2DM are theduration of the disease and the presence of cataract. This suggests that the 
control of the above-mentioned risk factors, the risk for the occurrence of depression could be 
decreased. 






10. SOME RISK FACTORS ASSOCIATED WITH CORONARY ARTERIAL 
DISEASE FOUND IN CASES OF FEMALE PATIENTS DURING MENOPAUSE 
 
Taushanova Biljana1, Petrovska N2, Orovcanec N.2, Zafirova Ivanovska B, Pavlovska I, 
Isjanovska R. 
1Primary School “Vuk Karadzic”, Kumanovo, Macedonia 
2Institute of epidemiology and biostatistics, Faculty of Medicine, University “Sts. Cyril and 
Methodius”, Skopje, Macedonia 
 
Introduction: Coronary/ischemic heart disease is acute or chronic disease of the heart muscle 
that occurs due to anatomical or functional changes of the coronary arteries and their 
branches. The flow of blood is threatened via atherosclerosis walls of arterial blood vessels or 
narrowing of the lumen that occasionally is caused by vasospasm.  
 
Materials and methods: Case-control study was performed on 200 respondents (female 
patients older than 45 years in menopause) and on the base of presence/absences of the 
diagnosis of coronary arterial disease they were divided into 2 groups: patients who have 
coronary disease and control group.  
Results: From 200 respondents, 93 (46.5%) had high blood pressure, 85 (42.5%) were with 
normal blood pressure, while only 22 (11.0%) had low blood pressure.  
Out of 93 respondents with high blood pressure, 68 (73.1%) belong to the experimental 
group, while 25 (26.9%) belong to the control group. In the group of 85 respondents with 
normal blood pressure, 25 (29.4%) belong to the experimental group, while 60 (70.6%) 
belong to the control group/p<0.05. From 200 respondents, 61 (30.5%) had elevated levels of 
blood sugar, while 139 (69.5%) had normal levels of blood sugar. From 61 women that had 
elevated levels of sugar in the blood, 38 (62.3%) belong to the experimental group (Odds 
Ratio=2,052) From 200 respondents, 119 (59.5%) had a BMI above normal, 77 (38.5%) 
normal, 4 (2.0%) below normal. From 119 with a BMI above normal, 68 (57.1%) belong to 
the experimental group. From 200 respondents, 124 (62.0%) constructively deal with stressful 
situations, 5 (2.5%) with neutral position, while 71 (35.5%) show destructive behaviour 
during stressful situations. From 71 that destructively cope with stressful situations, 51 
(71.8%) belong to the experimental group, while 20 (28.2%) belong to the control group 
(p<0.05). Conclusion:The survey showed that risk factors (blood pressure, glucose, BMI, 
stress) play an important role in the occurrence of coronary arterial disease, particularly 
destructive pessimism and stress affects coronary arterial heart disease in women, while those 
that constructively deal with stressful situation and optimism have protective role in heart 
health. 
 
Key words: Coronary artery disease, menopause, risk factors 




11. CHRONIC DISEASES AMONG ADULT RESIDENTS OF NORTHERN 
KOSOVSKA MITROVICA 
Mirković Momčilo1, Đurić S.1, Milošević J., Ilić D.1 
1School of Medicine, University in Pristina – Kosovska Mitrovica, Department for prevention 
medicine, Kosovska Mitrovica, Serbia 
 
Objective. To determine the frequency of the most common chronic disease among residents 
of northern Kosovska Mitrovica and the significance of the differences for the most prevalent 
diseases in relation to demographic and socio-economic characteristics. 
Method. The study was conducted as a cross-sectional study of a representative sample of the 
adult inhabitants in northern Kosovska Mitrovica in the 2012. As a research instrument was 
used a questionnaire that was used in a Health Survey in Republic of Serbia in 2006. Were 
surveyed 328 adult respondents. Statistical analysis included descriptive statistics and chi-
square test, with a significance level of 0.05. 
Results. The most common chronic diseases among residents of northern Kosovska 
Mitrovica are hypertension, back pain, rheumatic diseases of joints, increased blood fats and 
heart insufficiency. As the most common disease, high blood pressure is significantly more 
frequent in the elderly person (chi-square=60.352; df=2; p=<0.001), widowers (chi-
square=53.885; df=3; p=<0.001), who has with many children (chi-square=26.685; df=5; 
p=<0.001) and with less education (chi-square=24.360; df=4; p=<0.001). 
Conclusion. Determination of the most common diseases among the population as well as 
those groups that suffer from them is very important for the planning and implementation of 




12. INCIDENCE RATE OF DIABETES MELLITUS IN TOPLICA DISTRICT IN 
THE 2006-2012 PERIOD 
 
Deljanin Zorana1,2, Ilić Mirko2, Rančić Nataša1,2, Miladinović Bojana1 
1University of Niš, Faculty of Medicine Niš 
2Public Health Institute Niš 
 
Diabetes mellitus (DM) is one of the most common chronic disease and a major public health 
problem. The WHO (World Health Organization - WHO) and the International Diabetes 
Federation (International Diabetes Federation - IDF) estimates that 2011th, the worldwide 
suffer from DM 366 million people, and that the number of patients to the 2030th increase to 
552 million. The study was designed to examine the basic epidemiological characteristics of 
DM (in rates) population Toplica District of DM type 1 and type 2 by sex and age, in the 
period since 2006. to 2010th. Data on all patients and analysis were performed using data from 
the population register of DM Toplica District. Incidence rates were calculated per 100 000 
population.  
In the period from 2006 to 2010th in Toplica District, a total of 31 registered people newly 
diagnosed with type 1 DM (21 men and 10 women) and 1035 of type 2 DM (451 men and 584 
women). Average annual non-standardized rate for men with DM type 1 was 17.1, 6.2 for 
women, while men with DM type 2 was 174.3, and 260.9 for women.The incidence rate was 
1.2 times higher among women with type 2 DM In terms of age, patients with type 1 DM, the 
maximum average incidence rate was registered in the age group 0-4 years (17.20). In type 2 
DM, the maximum average incidence rate was registered in the age group 55-59 years 
(659.6). In general, with increasing age and incidence rates, so that the lowest incidence rates 
observed in younger children. 
Although the highest incidence rates recorded in developed countries, the largest increase in 
the number of cases expected in developing countries, where one of our country. Therefore, 
the time to take appropriate preventive measures to prevent the increase in the incidence and 
mortality of DM 
 
Keywords: diabetes mellitus, incidence, prevention  




13. CHRONIC KIDNEY DISEASE – PUBLIC HEALTH PROBLEM IN REPUBLIC 
OF MACEDONIA 
 
Zdravkovska Milka1, Ejub Gjulsha2,Popovska Katja3, Taleski Vaso1, Markovski Velo1, 
Jovevska Svetlana1  
1Faculty of Medical Sciences, Goce Delcev, 2University of Stip, Republic of Macedonia; 
PHCI “D-r Gjulsha” 
3Institute for microbiology and parazitology,UKIM Skopje R.Macedonija; 
 
Main goal: The goal of the study is to determine the distribution and to test the significance 
of differences between patients with chronic kidney disease who are treated with ambulatory 
and hospital haemodialysis in Institute of Nephrology – Struga  in agreement with the gender, 
age, place of living (city/village), nationality, marital status, level of education, social status, 
primary disease, duration of the primary disease, duration of the haemodialysis treatment; To 
evaluate the patients’ satisfaction of the way of communication with the health care 
personnel, the information about their health condition and further treatment provided by the 
doctors, as well as retention of the right of equal treatment while providing health care. 
Materials and methods: The research was conducted in the Institute of Nephrology – Struga, 
in the period from 01 November to 01 December 2011. In the study were included and 
analyzed a total of 80 patients who were on haemodialysis in the institute in the test period, in 
which the patients were divided in two test groups: (N1) – Patients on chronic haemodialysis 
program (CHP) which receive ambulatory dialysis 2 to 3 times a week, that mainly live in the 
Ohrid – Struga region and (N2) – patients on CHP which do dialysis in a hospital, because the 
lack of space in the Centre for haemodialysis in or near the place of living. Because of that 
they are obligated on hospitalization in the Institute for Nephrology in Struga. 
Results: According to the patients’ gender, the occurrence was almost equal in men and 
women (p = 0,8473). The examinees, whose haemodialysis was performed ambulant (N1), 
were approximately 56,8 ± 11,5 years old, while the patients who were done a hospital 
treatment (N2) were 60,3 ± 15 years old – the differences were not significant (p = 0,2386). 
According to the nationality, between the examinees from both groups, there is a significant 
difference (p = 0,0354). Bad social status was confirmed by 18 (45%) patients that were 
treated ambulatory and 17 (42,5%) patients who were treated in a hospital. In both groups, in 
most of the cases (35% of N1 and 40% of N2), as a primary disease which led to CKD 
stadium 5 was noted chronic glomerulonephritis. According to the age of the patients during 
the diagnostic procedure of the primary disease there is no significant difference between the 
patients of the both groups         (p = 0,0652). From the total of 80 examinees included in the 
study, 50 (62,5%) consider that they have an equal treatment as the other patients on 
haemodialysis in the country. 
Concluson: In our country, as well as the rest of the world, patients with CKD treated with 
haemodialysis are considered as a major public-health problem which should be solved 
systematically, in advantage of the patients. The country and the health institutions should 
find a way and resources for improving the conditions for treatment of these patients with 
which they will enjoy all rights that they deserve according to the Law for protection of 
patients’ rights. 
 




14.  PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN SERBIAN 
PEDIATRICS - PRAXIS AND PERSPECTIVES 
 
Bojko Bjelaković  
Clinic of Pediatrics, Clinical Center, Nis, Serbia; Medical faculty, University of Nis 
Primary prevention is the preferred method to lower cardiovascular risk and the resulting 
social and medical problems. In spite of the fact that numerous pediatric associations 
recognize the importance of prevention, developing major priorities, strategies  and strong 
recommendations, the real life of public health practice is far from preferred. 
Although many significant advances in terms of life savings are potentially affordable we are 
among the top-notched countries of cardiovascular morbidity and mortality. On the other hand 
evidence is also accumulating that coronary heart disease begins in childhood and progresses 
throughout life. Besides, a number of children have unrecognized but treatable primary 
myocardial or electrical heart disease. Often we neglect myocardial storage disease with much 
more optimistic prognosis nowadays 
The absence of political will or interest, diverse and alienated medical and social care 
institutions are some of the issues to be addressed in the future. 
A lot of initiatives have to be taken by medical workers and representatives to improve our 
medical system. 
  




15. PREVENTION OF OSTEOPOROSIS IN DIFFERENT AGE GROUPS 
(ADOLESCENTS, TEENAGERS, ADULTS, MENOPAUSAL WOMEN, 
POSTMENOPAUSAL WOMEN AND OLD PEOPLE) 
Elizabeta Popova Ramova, Snezana Stoilova,  
High Medical School Bitola, University St.ClementOhridski Bitola, R.Macedonia 
Prevention of osteoporosis is activity of Who in next decade 2011-2020. It is consisting of: 
early detection of risk patients, healthy nutrition  and life style, physical activity and 
insolation. It is investigating in next age groups: adolescent, tanagers, adults, menopausal 
women, postmenopausal women and old people, by same parameters but in different range of 
standard measurements. The aim of our research was in those age groups to assessment of 
nutrition, life habits, insolation and physical activity. Material and method: The data was 
collected on population of 1490 in South west region of Macedonia in elementary school, 
middle school, adults in different work groups and old people associations and home care 
units. Results: calcium supplementation and healthy nutrition is increasing by increase of age, 
Tabaco intake is characteristic for age of 22-65 and it is 19%, sport activity is the highest in 
age 10-21, and it is 29% in age 10-50 years, relative physical activity have 40%, no one 
indicate by age have fall prevention exercises and phythotherapyintake. DEXA have made 
24% from risk groups by age, and only 13% of them intake antireorptive therapy. Discussion: 
in age 10-14 years physical activity of 4 hours weekly and calcium intake by food is 
necessary for building good bone mass. The level of recreate gymnastic (walking, dance, 
palates) and good health life habits are necessary for good bone mass in adults.  Prevention of 
osteoporosis in old people age 65 and more can prevent complications from it, fractures and 
pain, and bone mass resorption can stop only with medicaments. Conclusion: Our population 
have good son insolation and must use that for Vit.D, activation, with education and 
promotion of healthy life style we can increase preventive activities for bone mass bulding 
and stop bonne resorption. 
Key words: prevention of osteoporosis, nutrition, physical activity. 
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Medical Centre Gadžin Han 
 
Introduction: Gestoses are pathological phenomena that occur with pregnant women as an 
effect of disharmony between the mother’s body and the baby in development. The 
appearance of edema, proteinuria and hypertension /EPH/ results in eclampsia – the most 
severe form of gestoses, which can cause death of the pregnant woman and her baby. AIM: 
The aim of this paper is to present the regular monitoring of pregnant women with 
hypertension /AP/ in our Medical Care Centre in order to prevent eclampsia as the most 
severe form of EPHgestoses that threaten the lives of both the mother and the baby. 
METHOD:In our research we used the medical records of the Department for pregnant 
women in Medical Care Centre “Gadzin Han”within the period from 2000 to 2012, as well as 
the discharge records from the Gynecology and Obstetrics Clinic in Nis.RESULTS: The 
highest number of pregnant women (19) with AP is in the age group from 21 – 30 years old. 
Regarding the parity, 22 pregnant women were primipara. The values of the blood pressure 
with 19 of them were mostly 150/100. Three deliveries were with VE, seven with SC, but we 
didn’t have any lethal outcomes. One newly born baby had 1300 gr body weight, while four 
of them had 2600 gr. CONCLUSION: Medical care for pregnant women along with an 
adequate treatment and hygienic-dietary regime is an important factor in the prevention of 
eclampsia. In this way the rate of prenatal mortality, premature births and birth of 
underweight babies is significantly reduced.   
  














1. DIAGNOSIS AND MONITORING OF PROTEIN-ENERGY MALNUTRITION IN 
PERITONEAL DIALYSIS PATIENTS 
 
Slavica Radjen1,2, Stankovic-Popovic V3 
1Institute of Hygiene, Military Medical Academy, Belgrade, Serbia  
2Medical Faculty of Military Medical Academy University of Defence in Belgrade, Serbia 
3Clinical department of Nephrology and Metabolic Disease with the Center for Dialysis,  
Zvezdara University Medical Center, Belgrade, Serbia 
Protein-energy malnutrition (PEM) is common complication in peritoneal dialysis (PD) 
patients and contributes to morbidity and mortality. PEM results from a decreased energy or 
protein intake as compared to actual needs. There are several factors that can contribute to the 
development of malnutrition that are relatively specific to peritoneal dialysis: losses of protein 
and amino acids into the peritoneal dialysate; dialysate in the abdomen impart a feeling of 
fullness that decrease the appetite; hyperglycemia, which can be induced by the absorption of 
glucose from the dialysate, may suppress appetite. 
There is not a single measurement which can be used to determine the presence of PEM. 
Therefore, malnutrition should be diagnosed by a number of assessment tools including 
dietary assessment, anthropometry, subjective global assessment and some biochemical 
examinations that correlate with nutritional status. 
In order to prevent malnutrition, periodic assessment of nutritional status should be part of the 
routine care of dialysis patients to permit early recognition and the institution of appropriate 
therapy. The nutritional status of the patient should be reassessed every 3–6 months and the 
dietary regimen should be modified according to changes in patient preferences and clinical 
status. Early identification of malnutrition and optimal use of diet, the dialysis dose, and 
perhaps supplements will lead to an improvement in nutritional status and patient outcome. 
Key words: malnutrition, chronic kidney disease, peritoneal dialysis. 
 
Protein-energy malnutrition is common complication in PD patients which contributes to 
morbidity and mortality and affects their survival and quality of life. In PD patients the 
prevalence of PEM varies, according to the considered nutritional parameters, from 18% to 
56%  
PEM results from a decreased food intake as compared to actual needs. Multiple factors can 
affect nutritional status of dialysis patients: restrictive regimens, inadequate dialysis, frequent 
hospitalization, multiple medications, comorbidities, uncontrolled anaemia, uremic toxins, 
gastroparesis, exocrine pancreatic insufficiency and reduced mucosal enzyme activities, 
altered plasma amino acids and neurotransmitters synthesis, inflammatory cytokines, 
depression, low social status, solitude and an inability to prepare meals. 
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There are several factors that can contribute to the development of malnutrition that are 
relatively specific to PD such as losses of protein and amino acids into the peritoneal 
dialysate, dialysate in the abdomen impart a feeling of fullness that decrease the appetite, 
early satiety or feelings of fullness, suppression of appetite due to the abdominal distension, 
suppression of appetite induced by the absorption of glucose from the dialysate, impairment 
in gastric emptying due to the instillation of dialysate. 
There is no single measurement which can be used to determine the presence of malnutrition 
Thus, malnutrition should be diagnosed by a number of assessment tools including history 
and physical examination, dietary assessment, anthropometry, subjective global assessment 
and some biochemical examinations that correlate with nutritional status. 
 
History and physical examination  
The history and physical examination can often provide important data which can direct to the 
patient who might be malnourished. These include symptoms such as nausea, vomiting, 
anorexia, weight loss or gain, and presence of concomitant problems that can affect nutrition, 
such as alcoholism, diabetes mellitus, and gastrointestinal disease. Besides, it is necessary to 
pay attention to some psychosocial issues such as access and affordability of food, and ability 
to prepare meals. Signs or symptoms of depression should also be identified, since clinical 
depression often results in decreasing caloric intake. 
 
Dietary assessment 
An accurate assessment of the patient's food intake is an important component of the 
nutritional assessment. 24-hour dietary recall covers short period of time and may not 
represent a typical food intake. A food diary include longer period of time (include dialysis 
and nondialysis days). It is very useful, especially if the patient weighs the portions of food. 
 
Anthropometry  
Anthropometric measurements provide a rapid, easily performed noninvasive method for 
evaluating body composition. It is best if serial measurements are carried out by the same 
observer. If this isn't feasible, it somewhat limits its usefulness. PD patients often have PEM 
with a reduction of both fat mass and lean body mass. Therefore, assessment of body weight, 
subcutaneous fat mass and muscle mass are important part of routine nutritional assessment.  
Body weight is the simplest and most effective indicator of energy intake and it should be 
measured regularly. Unplanned weight loss should always be investigated. An unplanned 
weight loss greater than 10% occurring over 3 months or less has a negative prognostic value. 
Of course, in a PD patient, edema may be responsible for an increase in body weight. Body 
mass index (BMI) is also important and easy to determine, although BMI is more useful for 
the assessment of obesity than of malnutrition. 
Body fat is estimated by measuring skin fold thickness at four sites, while mid-arm 
circumference and mid-arm muscle circumference can provide an estimate of the muscle 
mass. 
Hand-grip strength is a cheap and simple method that agrees reasonably well with other 
measures of nutritional status and predict outcome in PD patients. Thus it may be 
recommended for routine follow-up of PD patients. 
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While anthropometry has the advantage of being simple and quick to carry out, there are less 
precise than DEXA. There is good correlation between those techniques and that each could 
be readily used in stable dialysis patients. DEXA is fairly expensive and not always readily 
available. DEXA should be reserved for selected patients. BIA is not recommended for 
routine assessment of nutritional status. Thus, at present, anthropometry is the only method 
that can be readily performed in most units. 
 
Biochemical parameters 
Measurement of several circulating proteins has been used to assess nutritional status in PD 
patients. There are, however, potential limitations to their use in this setting due to changes in 
protein distribution or metabolism by renal failure or comorbid conditions. Because of that, 
interpretation of the values obtained should be undertaken with caution. 
The plasma albumin concentration correlates well with body protein stores. Since albumin has 
a long half-life and hepatic synthetic reserve is very large, hypoalbuminemia is a relatively 
late manifestation of malnutrition. Several studies have demonstrated a negative correlation 
between the plasma albumin concentration and mortality in PD. The increase in mortality 
with hypoalbuminemia appears to occur even at near normal albumin levels. CANUSA study 
has shown that each 10 g/L increase in the plasma albumin concentration decreased the 
relative risk of death by 6% in PD patients. 
However, serum albumin also reflects several non-nutritional factors which are frequently 
present in PD patients, including infection, inflammation, hydration status, peritoneal and 
urinary albumin losses, and acidaemia. Thus hypoalbuminaemia in PD patient may not always 
result from PEM and albumin alone is not a clinically useful measure for PEM. The serum 
albumin concentration should be measured monthly. 
Prealbumin has a shorter half-life than albumin, has a close relationship with nutritional status 
and is a good predictor of clinical outcome, but it is a negative acute phase protein as well as 
albumin. 
Low transferrin levels have been described in dialysis patients and have been ascribed to 
malnutrition. However, plasma transferrin values are frequently reduced in renal failure 
independent of malnutrition, perhaps due to fluctuations in iron stores. 
Protein Equivalent of Total Nitrogen Appearance (PNA) is a valid and useful measure of net 
protein degradation and protein intake in PD patients. There are some limitations to its use. In 
the clinical stable patients it can be used to estimate protein intake. In the catabolic patient 
PNA will exceed, while, in anabolic patients PNA will underestimate actual protein intake. 
When the protein intake is less than 1 g/kg/d PNA may overestimate dietary protein intake. In 
obese, malnourished, and edematous patients, normalizing PNA to body weight can be 
misleading. 
The serum total cholesterol concentration is reduced in malnourished patients. It is less 
sensitive nutritional marker, but is cheap and easily available. 
 
Subjective global assessment 
Subjective global assessment (SGA) is a useful valid clinical instrument for assessing the 
nutritional status of PD patients. It is inexpensive and it can be performed rapidly. It gives a 
global score of protein-energy nutritional status. The SGA is based on history and physical 
examination. It focuses on gastrointestinal symptoms (anorexia, nausea, vomiting, diarrhoea), 
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weight loss in the preceding 6 months, and visual assessment of subcutaneous tissue and 
muscle mass. Scores are subjectively rated on a four-point or seven point scale. The use of the 
seven point scale is recommended because of its greater sensitivity and its use in large 
epidemiological studies such as the CANUSA study. SGA has a high predictive value for 
mortality, but one potential problem with SGA is its subjective natures, which may reduce its 
reproducibility. The European Best Practices Guidelines also suggest that monitoring include 
a subjective global assessment. 
 
Monitoring 
Nutritional status of the patient should be assessed at the start of PD and reassessed every 3–6 
months. Unstable and malnourished patients may require monitoring at shorter intervals. 
Some parameters such as albumin should be evaluated monthly. 
 
Conclusion: 
Malnutrition is higly prevalent among PD patients. In order to prevent malnutrition, periodic 
assessment of nutritional status should be part of the routine care of dialysis patients to permit 
early recognition and the institution of appropriate therapy. The routine assessment of 
nutritional status involves evaluation of dietary intake, anthropometry, laboratory and clinical 
examinations. The nutritional status of the patient should be reassessed every 3–6 months and 
the dietary regimen should be modified according to changes in patient preferences and 
clinical status. Early identification of malnutrition and optimal use of diet, the dialysis dose, 
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2. EXCESSIVE SALT INTAKE- HUMAN HEALTH RISK 
 
Milka Popovic1,2 
1 Medical faculty, University of Novi Sad 
2 Public Health Institute of Vojvodina, Novi Sad, Serbia 
 
Noncommunicable diseases (NCDs) are the leading cause of death globally, causing 
preventable death of more people each year than all other causes combined (1). The major 
NCDs currently account for approximately 60% of all deaths and 43% of disease burden 
globally. Cardiovascular disease (CVD) itself accounted for 30% of all deaths. Hypertension 
is considered a major risk for CVD, especially heart attack and stroke (2).Excess body weight 
(body mass index > 25 kg/m2), excessive consumption of energy, saturated fats, trans fats, 
sugar and salt, as well as low consumption of vegetables, fruits and whole grains are leading 
dietary risk factors for NCDs (3). Among them, excessive dietary salt intake, greater than 
5 g/day, is major risk factor for hypertension, positively correlated with mean blood pressure 
in a population (4) and causes more deaths than any other dietary risk factor (5). Also, there is 
evidence substantiated relation between salt intake and incidence of CVD, especially heart 
attack and stroke (6). High salt intake is recognized as risk factor for end stage of renal failure 
(7), it is in a positive association with stomach cancer (8) and osteoporosis (9).  
Salt intakes across the world’s populations vary, in wide range of values, greatly exceeding 
physiological needs (10). Most adult populations have mean sodium intakes between 9 and 
12 g/day, although in some population’s average salt intake exceeded 20 g/person/day. In 
most countries over 75-80% of salt consumed comes from processed and ready-to-eat foods. 
In Japan and China, as opposed to, 75% of salt consumed comes from cooking from high 
sodium products (10).  
Population based modest reduction of salt intake is followed by the statistically significant 
reduction of the mean blood pressure, prevalence of hypertension, morbidity and mortality 
rate of CVD and all causes of death (11). The recognized problem and beneficial outcome of 
salt intake reduction within population motivated national health authorities worldwide to 
implement programs on salt intake reduction (12). The World Health Organization (WHO) 
recommends reducing salt intake in the general population as a cost-effective strategy. 
Measures in this direction are considered a “best-buy” approach to preventing NCDs (13).  
 
A prevalence of hypertension in the Republic of Serbia (RS), blood pressure ≥140 mmHg and 
diastolic blood pressure ≥90 mmHg, among adults aged 18 year and more is 46.5%. In the RS 
cardiovascular diseases are leading cause of death. They participate with 55.2% in the total 
death cases (14). National salt intake survey in Republic of Serbia (RS) is yet to be done. 
Results of the pilot survey on salt intake conducted in Novi Sad in 2011-2012, showed that 
the average salt intake in a sample of adult population of the city of Novi Sad, aged 18-65 
years, using the internationally recognized 24 h urinary sodium excretion method was 12,12 
g/d. Nearly all of the subjects exceeded the World Health Organization population salt intake 
goal of 5 g a day, and none of them consumed the amount of salt recommended in non-
pharmacological treatment of hypertension (15). Another studiesperformed in Novi Sad 
showed that salt content in meals in public kindergartens, elementary schools, boarding 
schools and student restaurants were high (16, 17) and that the salt content in ready-to-eat food 
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retailed in Novi Sad have high hidden salt content and that could be considered as an 
important contributor to relatively high salt consumption of its citizens (18). 
 
Results of these studies urges national health authorities to implement National Program on 
Cardiovascular Diseases Prevention, Treatment and Control in the RS up to 2020 year, which 
recognized the importance of salt control intake and food products salt labeling (19).  
In several Member States in the WHO European Region, salt reduction strategiesarethe 
priority in NCDs prevention programmes. European Food and Nutrition Action Plan (2015–
2020) points to the impact of integrated salt reduction programmes. The primary objective is 
to take a stepwise approach to reducing sodium content across food product categories and 
market segments, with a view to adaptation of consumer taste preferences over time. Their 
success depends on monitoring, stakeholder engagement and establishment of benchmarks 
and targets, with sophisticated population awareness initiatives (3).  
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Fatty acid as food ingredients through different physiological mechanisms regulating 
cholesterol metabolism and lipoprotein concentrations in the blood and affect the other 
cardiometabolic risk factors such as blood pressure, hemostasis, glycoregulation and body 
weight. Dietary habits in our population were energy-dense diet, high in saturated fat and 
sugar with imbalance intake of polyunsaturated fats which may be important in pathogenesis 
of many lifestyle-related diseases.Furthermore, a large intake of fat in the diet, but also 
inadequate profile of the fatty acids in serum and erythrocytes can affect the progression of 
obesity and insulin resistance.These findings suggest the usefulness of measurements fatty 
acid status in supplementation-intervention and nutrition-epidemiological studies in 
relationship between diet intake/status and disease/health outcome. Fatty acid status in 
patients with different clinical metabolic condition, but also in our healthy population, 
indicate the necessity of nutrition care program and the use appropriate diet with adequate 
saturated/monounsaturated/ω-6/ω-3 ratio. Date acquired knowledge on the effects of the 
metabolism of the individual fatty acids, as well as their interactions with other nutrients, gene 
expression, and the biomarkers of their status in the main risk factors for occurrence 
cardiometabolicsyndrome, particularly in obesity, dyslipidemia, insulin resistance and 
diabetes, show the importance of the fatty acids intake in the prevention and treatment of 
cardiometabolic syndrome. 
Key words: biomarker, diet, cardiometabolic syndrome, supplementation, fatty acids  
 
Introduction 
The concept of cardiometabolic risk factors is a cluster of conventional cardiovascular risk 
factors and metabolic syndrome factors including central obesity, hypertension, insulin 
resistance, dyslipidemia, and inflammatory responses. In recent years, there has been 
increased focus on the role of diet, especially dietary fats acids in the etiology and 
development of cardimetabolic syndrome [1,2]. The metabolic effects of individual dietary 
fats may also be modified by the overall fatty acid composition of the diet. Dietary fat is a 
mixture of fatty acids (FA), with saturated (SFA), trans-unsaturated (TFA), monounsaturated 
(MUFA) and polyunsaturated (PUFA) as the main components. It have been recently reported 
that saturated fat intake greater than 10% of total caloric value represented a double risk for 
cardiometabolic syndrome diagnosis [2,3]. This association is mostly attributed to saturated 
palmitic acid due to the fact that excessive intake of palmitic acid increases the visceral 
adipose tissue in greater proportion than other fat types. Although, dietary recommendations 
have focused on restricting SFA consumption to reduce cardiovascular disease (CVD) risk, 
evidence from prospective studies has not supported a strong link between total SFA fats 
intake and CVD events [3]. In the large multiethnic cohort, a higher intake of dairy SFA, 
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which was the greatest contributor to total SFA consumption, was inversely associated with 
lower CVD risk [4]. Also, there was observed no significant associations of plant or butter 
SFA intake with CVD risk. In contrast, a higher intake of meat SFA was associated with 
higher CVD risk. Primary prevention studies have clearly demonstrated benefits of high-dose 
long chain ω-3 PUFA supplements on metabolic risk factors. It was recently reviewed that 
reductions in the ω-6 to ω-3 PUFA ratio in the diet may lower the incidence of many chronic 
diseases that involve inflammatory processes [2,5,6]. Thus, the specific ω-6/ω-3 PUFA ratio 
in the diet is of particular interest for maintaining overall health and current dietary guidelines 
generally put more emphasis on the quality of fat.   
Dietary sources  
One of the most abundant SFA in many common foods (dairy, meat, palm and coconut oil) is 
palmitic acid. The amount of palmitic acid is the highest in palm oil (around 50%), but 
significant amounts of palmitic acid (25-26%) can also be found in butter, chicken fat, lard, 
beef and lamb fat, as well as in cocoa butter [1,3]. Even olive oil, which is one of basic 
components of the healthy Mediterranean diet, contains around 16% of palmitic acid [1,2]. 
Furthermore, palmitic acid is present in human milk with 20-25% of total fats. Overall, 
palmitic acid and stearic acid (18:0) are the most common dietary SFA and therefore they are 
also the major SFA in human plasma and tissues. Their concentration in serum/plasma 
phospholipids and cholesterol esters reflect dietary high fat intake. Commonly present 
MUFAs in the diet is oleic acid, which is found mostly in olive (56-84%) and rapeseed oil [1]. 
Linolenic acid (LA, precursor of ω-6) is present in significant amounts in many vegetable 
oils, including corn, sunflower, grape seed and soybean oils, and in products made from these 
oils, such as margarines. Alfa-linolenic acid (ALA, precursor of ω-3) is found in green plant 
tissues, in some common vegetable oils, including soybean and rapeseed oils, in some nuts 
and in particular in linseeds and linseed oil. Arachidonic acid (20:4, ω-6) is mostly present in 
meats and its intake is estimated at 50 to 500mg/day [1]. The richest sources of 
eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), are oily fish (tuna, salmon, 
mackerel, herring, and sardine). One oily fish meal can provide between 1.5 and 3.5g 
EPA+DHA. Consumption of 1g fish oil capsule per day can provide about 300mg of these 
fatty acids. According to habitual dietary information in Serbia, on small sample size, low fat 
consumers have an intake of 10.4, 11.2, and 5.4% of daily energy intake (% E) and high fat 
consumers around 13.4, 14.5 and 5.9 % E from SFA, MUFA and PUFA, respectively [7] 
Dietary fatty acids and lipids  
In general, SFA and TFA increase while MUFA and ω-6 PUFA decrease low-density 
lipoprotein (LDL) cholesterol [8,9]. Dietary ω-3 PUFA are more potent in reducing 
triglycerides, partly through improved lipoprotein lipase activity [1,2,8], but have a limited 
effect on LDL and high-density lipoprotein (HDL-C) cholesterol concentrations. However, 
supplementation with PUFA among individuals with relatively high TFA intake may have 
limited benefits on lipid profiles [9]. According to several publications, substituting SFA with 
unsaturated fats convincingly decreased concentrations of serum/plasma total and LDL-
cholesterol in randomized control studies (RCTs) [2,9]. For these reasons, recommendation 
by the WHO/FAO experts for SFA (butter, cream, full-fat dairy products) intake is limited to 
less than 10% of daily energy needs [10]. Thus consumption of PUFA or MUFA in place of 
SFA leads to lowering of serum/plasma total cholesterol, LDL-cholesterol, and ApoB, slight 
lowering (for PUFA) of HDL-cholesterol and ApoA1, little effect on triglycerides and 
lowering of the total cholesterol/ HDL-cholesterol. Meta-analysis of 72 randomized control 
trials reported a serum triglyceride reduction of 25–30 % at a dosage of 3–4g/day of 
EPA+DHA [1,2]. The most abundant SFA in milk fat is palmitic acid, which make up about 
 116 
 
36% of total fats and 44-51% of the total SFA in milk fat [3,4]. For this reason, milk and dairy 
products are usually considered unhealthy, especially for people with dyslipidemia. In spite of 
this fact, it has been well established that milk fat raises serum HDL-cholesterol, helping to 
maintain a good HDL-cholesterol/total cholesterol ratio that is inversely related to CVD [3,4]. 
Furthermore, palmitic and stearic acids in milk fat occupy the sn-2 position of triglycerides, 
which is typically the position of unsaturated fatty acids in plant oils [3].  
Cardioprotective effects of dietary fats  
The cardioprotective effects of ω-3 PUFA, especially ALA, EPA, and DHA, have been 
defined by epidemiological, human, animal, and cell culture studies [1,2,5]. Some studies 
attribute the cardioprotective properties of ω-6 PUFA to LDL-cholesterol lowering properties 
while others contradict these conclusions mostly due to the potent pro-inflammatory effects of 
specific eicosanoids derived from AA [2,6]. Hence there is no clear evidence that ω-6 fatty 
acids elevate markers of inflammation. LA has been shown to enhance the clearance and 
down regulate the production of LDL-cholesterol and to have a protective role on the 
cholesterolemic effects of SFA at intakes 5% E. In recent years there has been growing 
interest in the potential for plant-derived ω-3 PUFAs to mimic the effects of long chain ω-3 in 
mediating CVD risk. Beneficial effects of ALA on thrombosis and arterial compliance have 
been shown at intakes between 2 to 5 E% but this is greatly in excess of estimated habitual 
intakes (approximately 0.6% E) [1,2,5]. High intakes (2.3% E) have also been shown to have 
negative effects on CVD risk: reducing HDL-cholesterol and raising the LDL /HDL-
cholesterol ratio. Decreasing dietary ω-6/ω-3 PUFA ratio to approximately 3:1 in older 
individuals by increasing the intake of EPA and DHA, lowers fasting and postprandial plasma 
triglycerides concentrations, but also decreased the proportion of small dense LDL while the 
proportion of HDL2 increased. Overall, these findings indicate that in the context of a total 
PUFA intake of 6% E, decreasing the ratio by increasing the intake of EPA and DHA to 
approximately 1–1.5g/day resulted in potentially beneficial effects with regard to 
cardiovascular risk [2,5].  
In the National Heart, Lung and Blood Institute Family Heart Study high intakes of ALA or 
LA were both associated with low risk of CVD in a cross-sectional study. The Health 
Professionals Follow-up Study also showed that intakes of LA were inversely associated with 
CHD risk in men and the Nurses’ Health Study showed the same association in women 
[1,2,6]. In addition, a systematic review of primary and secondary prevention trials where 
SFA were replaced by PUFA showed a reduction in coronary events with a non-significant 
trend for a reduction in all-cause mortality [3]. An increasing body of evidence suggests that 
n–3 PUFA supplementation may improve defects in insulin signaling and prevent alterations 
in glucose homeostasis and further development of diabetes type 2 [5]. These effects are 
possibly mediated through the PPARs, which are up-regulated by long-chain PUFA and in 
turn are related to the gene expression involved in lipid oxidation and synthesis. Other 
pleiotropic effects of ω–3 PUFAs may contribute to decreased condition of the metabolic 
syndrome, such as modulation of inflammation, platelet activation, endothelial function and 
blood pressure. A meta-analysis of 60 controlled trials reported that replacement of 
carbohydrates with PUFAs (largely ω-6) had a beneficial effect on the total cholesterol/HDL-
cholesterol ratio, and on the LDL-cholesterol concentration [1,2]. Replacing SFA by ω-6 
PUFA also led to a substantial reduction in the total cholesterol and LDL-cholesterol, a 
reduction of the total cholesterol/HDL-cholesterol ratio and thus may reduce the risk of 
coronary heart disease (CHD) [8,10]. Meta-analysis found a dose-response hypotensive effect 
of 5.6g ω-3 PUFAs on, systolic and diastolic blood pressure, which was reduced by 3.4 and 
2.0 mmHg respectively in hypertensive patients [1,2,5]. Dietary fats may modulate blood 
pressure through different mechanisms. Possible mechanisms include modulation of the 
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biosynthesis of eicosanoids: hydroxyl eicosatetraenoates or epoxy eicosatrienoates [2,5]. 
PUFA ω-6 and ω-3 are converted to prostaglandins, which reduce blood pressure by affecting 
arterial vasodilation, electrolyte balance, and renal release of renin or pressure hormones. 
Dietary fatty acid intake and status as cardiometabolic risk factor 
Central to the etiology of cardiometabolic syndrome is an interrelated triad comprising 
inflammation, obesity (particularly abdominal), and aberrations in fatty acid metabolism 
[1,2,5]. Dietary SFA are of particular scientific interest because of their association with 
CVD. However, meta-analyses of cohort studies with self-reported SFA intakes are not 
associated with CHD, stroke, or CVD [3,4]. Although, high fat intake and serum fatty acid 
profile may influence the progression of obesity and insulin sensitivity [1,2,11]. Insulin 
resistance is markedly affected by the amount and composition of dietary fats [2,12]. Amount 
is particularly important, since excessive intake of total fat (> 37% of daily energy intake) 
independently on the fatty acid composition in diet, may worse insulin resistance [2]. 
Although underlining mechanism is still unclear, it likely includes interference with binding 
of insulin to its receptors and accumulation of triglycerides in skeletal muscle [5]. For 
instance, ∆9 desaturase-1 (palmitooleic/palmitic acid) is valuable marker of dietary saturated 
fat intake [3], but has also been established as an independent predictor of directly measured 
insulin sensitivity [5]. Further, high SFA proportion in serum phospholipids can predict the 
development of cardiometabolic syndrome [12].  
The proportion of fatty acids in serum and erythrocyte phospholipids, an important 
determinant of both health and disease, depends on the dietary intake and endogenous 
metabolism controlled by genetic polymorphisms. Thirteen studies have been reviewed and it 
was found that serum EPA and DHA was significantly lower in the cases of CHD than in the 
controls as predicted [1,2]. Thus increasing the intake EPA and DHA by 1.2 or 3g/day 
lowered the erythrocyte content of ω-6 highly unsaturated fatty acids by 26, 39 and 48%, 
respectively [2,5]. It follows that increasing the intake of ω-3 (competition with ω-6) is a 
more effective way of lowering tissue AA content than decreasing the intake of ω-6 fatty 
acids. Fatty acid composition in serum lipids reflects dietary fat intake for 6 to 8 weeks and 
metabolic processes [12]. High proportions of palmitic, palmitoleic (16:1), and dihomo-γ-
linoleic (20:3,ω-6) acids and a low proportion of LAin serum/plasma lipids predicts 
cardiometabolic syndrome, type 2 diabetes, myocardial infarction and stroke  [12,13]. 
Patients with hyperlipidemia in our population have low levels of ω-6 and ω-3 PUFA and 
higher levels of SFA in serum and erythrocyte phospholipids compared to healthy subjects 




Table 1. Fatty acid status in Serbian population with cardiometabolic risk 2,4,11,14,15 
Fatty acid  Cardiometabolic risk patients Healthy subjects 
 Hyperlipidemic 
patients 
(serum)            
(Er) 
Obesity women 








(serum)               
(Er) 
Palmitic 
acid   
30.3±5.9      
25.6±4.2  
22.5±1.7          
22.7±1.2 
30.0±2.7  26.5±2.4         
22.4±2.6 
SFA  48.6±9.4      
44.7±1.1 
40.7±1.7          
41.8±2.9 
47.17±1.5 42.6±3.1         41.1±4.8 
MUFA 12.1±1.9      
18.2±2.3 
16.6±0.8          
17.4±1.5 11.1±2.3 
12.2±1.7         
17.5±2.7 
PUFA 42.0±1.7      
41.1±2.4 
42.7±1.9          
40.7±3.6 43.0±3.8 
45.4±2.9         
43.3±2.4 
n-6 37.6±10.1    
31.1±7.1 
35.0±2.4          
35.0±3.4 
39.5±3.4 40.8±2.9         
36.6±2.4 
n-3 3.4±1.1         
5.4±2.2 
7.6±1.7            
5.7±1.2 
3.5±1.0 4.6±1.4           
6.9±1.3 
n-6/n-3  11.7±4.6       
5.8±2.1 
4.8±1.4            
6.4±1.37 




In the Serbian population with type 2 diabetes who also had abnormal lipid levels, the ω-6 and 
ω-3 PUFA in plasma were lower, while the ω-6/ω-3 ratio was higher when compared to 
healthy subjects [15]. EPA, DHA and total ω-3 PUFAs in the erythrocyte phospholipids in 
these patients were also low. ω-6/ω-3 ratio was 11.7, 11.2, 8.8 in type 2 diabetic patients, 
hyperlipidemic patients and healthy subject, respectively. Suboptimal levels of ω-3 PUFA in 
erythrocytes have been found in obese subjects, as well as a lower proportion of EPA, DHA 
and total ω-3 PUFA, and a significantly higher ω-6/ω-3 ratio in insulin-resistant (IR) [11]. 
Palmitic acid and total SFA are higher with now significant difference in MUFA proportion in 
serum phospholipids in patients with diabetes type 2 and hyperlipidemic patients compared to 
healthy subject. Obesity patients with normal glucose tolerance (NGT) have higher levels of 
MUFA in erythrocyte (Er) compared to IR obesity patients [11]. Serum phospholipids fatty 
acid profile is suitable biomarker of dietary fatty acid intake. Nevertheless, the fatty acid 
composition in serum lipids can be used not only as a biomarker of fat quality intake, but also 
as an indicator of disease risk. In spite of pathologies, diet could markedly change the fatty 
acid profiles in patients; however, the ω-6/ω-3 ratio in healthy subjects in the Serbian 
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population was also very high above 11 to 12 suggesting the importance of changing dietary 
habits in Serbia.  
Conclusion 
Associations of SFA with health may depend on food specific fatty acids or other nutrient 
constituents in foods that contain SFA, in addition to SFA. Date acquired knowledge on the 
effects of the metabolism of the individual fatty acids, as well as their interactions with other 
nutrients, gene expression, and the biomarkers of their status in the main risk factors for 
occurrence cardiometabolic syndrome, particularly in obesity, dyslipidemia, insulin resistance 
and diabetes, show the importance of the fatty acids intake in the prevention and treatment of 
cardiometabolic syndrome. Fatty acid status in patients with different clinical metabolic 
condition related to cardiovascular risk and may be a useful functional marker and disease 
indicator; indicate the necessity of nutrition care program and the use appropriate diet with 
adequate saturated/monounsaturated/ω-6/ω-3 dietary fatty acid ratio. 
This study was supported by the Project III 41030 financed by the Ministry of Science of the 
Republic of Serbia 
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1. THE INFLUENCE OF QUALITY EDUCATION IN FOOD SAFETY 
 
Mag. Mateja Čebular 
Institute of Food Safety and Environmental  Health, Slovenia 
 
Introduction: In order to ensure the food safety, it is necessary to deal with all aspects of 
practices which may have an impact on food safety in the entire food chain. Education in food 
safety is carried out for that purpose.  
Objective: To present the results on the impact of education in food safety in food companies 
Method: Survey and questionnaire has been carried out in one hundred of food production 
companies which have passed the education in food safety. Proportional system of sample 
units was chosen as follows: 8 companies for food production, 24 shops, 57 companies of 
public nutrition, 5 distribution companies, and 6 butcheries. 
Results: The results of the individual items of food safety show that relevant sanitary 
technical equipment was improved (+ 19.5%), the  HACCP system is better (46,52%) 
increases the level of hygiene and health status is monitored better (+ 61,65).  
The level of good hygiene practices of employees in dealing with food and control of pests 
and hygiene of plant is increased (34.2%). An increasing number of operators decide for 
laboratory analysis and control of conformity of foodstuffs (+ 9.11%),. 
Conclusion: The results of the analysis show that education and training in food safety has a 
major impact on organizations that have contact with food.  
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1. IN VITRO ANTIBACTERIAL ACTIVITY OF METHANOLIC EXTRACTS FROM 
SALVIA VERBENACA L.  
 
Kostić Milica1, Miladinović B.1, Mihajilov-Krstev T.2, Zlatković B.2, Pavlović D.1, 
Milutinović M.1, Kitić D.1 
1Faculty of Medicine, University of Niš 
2 Faculty of Science and Mathematics, University of Niš  
 
Objectives: Plant species of the family Lamiaceae are the sources of natural preservatives and 
antioxidants which have been long used as the constituents of foodstuffs and medical 
products. Salvia verbenaca L. is an aromatic plant traditionally used as a flavouring and spice. 
The objective of the study was to determine antibacterial activity of methanolic extracts of the 
above-ground parts of S. verbenaca collected in Niš.  
Material and methods: Herbal material was extracted with absolute and 80% methanol by 
both maceration and ultrasonic method, respectively. Determination of minimum inhibitory 
and bactericidal concentration (MIC and MBC) was carried out by micro-well dilution 
method against laboratory control strains obtained from the American Type Culture 
Collection: Bacillus cereus, Listeria monocytogenes, Staphylococcus aureus, Escherichia 
coli, Pseudomonas aeruginosa and Salmonella enteritidis.  
Results: All extracts exerted inhibitory effects on every tested bacterium in the range 
MIC=12-100 mg/mL. It is particularly important to emphasize the high inhibitory activity 
against P. aeruginosa, which is a nosocomial, opportunistic pathogen and the most usual 
cause of food spoiling in refrigerators. The extract prepared with 80% methanol by ultrasonic 
method gave best results for this strain (MIC/MBC=12/12 mg/mL).  
Conclusion: Further research should be conducted to confirm non-toxicity and safety of the 
extracts. 
Key words: Salvia verbenaca, methanolic extracts, antibacterial activity 
Acknowledgement: The research was financially supported by the Ministry of Education, 
Science and Technological Development of the Republic of Serbia (Grant No III 41018).  
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2. MICROBIOLOGICAL CRITERIA AND FOOD SAFETY IN THE REPUBLIC OF 
SERBIA- THE CURRENT SITUATION  
 
Dr Svetlana Raketić, Dr V. Šumanov 
The Public Health Institute Čačak 
The Ministry of Agriculture of the Republic of Serbia adopted the Law on Food Safety in 
2009, the Rulebook on  “Microbiological Criteria” in 2010 and  а Guide to the Application of 
Microbiological Criteria containing additional recommended process hygiene criteria in June 
2011.  
After several years of implementation of these regulations, the following questions have 
arisen: What results have been achieved? Are there any professional dilemmas? and, in 
particular, Has the application of new microbiological criteria contributed to achieving the 
main goal of the Law on Food Safety – ensuring a high level of human health protection? 
The main issues regarding the application of microbiological criteria are as follows: 
1. a complete lack of microbiological criteria for particular food categories  
2. incomplete microbiological criteria for particular food categories 
3. inappropriate limits set for certain microbiological criteria 
4. inadequate methods for certain microbiological criteria 
5. an undefined number of units constituting a sample for small FBOs 
This has resulted in a complete lack of harmonised microbiological process hygiene criteria 
for major food categories. The situation has received different interpretations by FBOs, 
authorities and analysts, starting from an explanation that the lack of defined criteria suggests 
that no testing is required through to testing different criteria, with different limits for the 
same categories of food established, resulting in the absence of any traceability and food-
related microbiological risk management. 
With the current problem of undefined state-level authority over food control within the 
distribution system, it is clear that food safety (in terms of the presence of serious 
microbiological risks that are not under either FBO or state control) is highly threatened. 
The process hygiene criteria recommended in the Ministry of Agriculture Guide need to be 
revised as soon as possible in order to correct the above mentioned deficiencies and improve 
microbiological control of food products and, hence, reduce the risk of epidemics and ensure 
the maintenance and promotion of public health.    





3. QUALITY CONTROL OF MICROBIOLOGICAL TESTS OF FOOD AND WATER 
BY INTER LABORATORY COMPARISONS (PROFICIENCY TESTING SCHEMES) 
Angela Delova, M. Nedelkova, S. Stefanovska, E. Krsteva Kelepurovska,  E. krsteva 
Public Health Centre – Bitola R.Macedonia 
Introduction: The laboratory for sanitary microbiology is included in the rank of accredited 
laboratories according to ISO/IEC 17025 Standard.  
Besides the application of the ISO Methods in the everyday routine testing, in accordance to 
the requirements of ISO 17025 Standard, each laboratory must provide internal and external 
control of the testing quality.  
Aim: One of the essential elements for conducting of external control of the quality of the 
results from the microbiological testing of food and water is the participation in Proficiency 
testing schemes (PT) that are organized by reference laboratories FEPAS (Food Examination 
Performance Assessment scheme) and LEAP (Laboratory Environmental Analysis 
Proficiency scheme). 
Material and methods: Identification and enumeration of the defined parameters is done in 
the dehydrated samples of food (beef and chicken, flour, powder milk, soft cheese) and water 
samples. 
Results: When analyzing the data, the results received with participation in the inter 
laboratory comparison testing’s, statistical methods are applied, including evaluation of the 
results according to the Z-value (a simplified method of Mandel h statistics). Z-value is 
calculated according to the following formula:  
Z = (x-X)/δ, where: x – result of individual laboratories, X – determined, received value in a 
reference laboratory δ – standard deviation.                            
Regardless of the number of laboratories, participants and the number of repeated tests, Z- 
values have the following interpretation: z < = 2 – satisfactory results, 2 < = z <=3 - doubtful, 
questionable results, 3 <= z – unsatisfactory results. 
The goal of each lab is to get acceptable results of the tests, i.e. z<= 2, indicating the 
reliability of the results.In our laboratory are obtained results that are in the permitted range 
z<= 2:   
coagulase positive staphylococci z –score 0,8; yeasts and molds -0,5; Enterobacteriaceae -
0,3;E.coli -0,5.(tests of food); Except in quantitative,we have participated  in qualitative PT -
scheme for detection Salmonella spp. and Listeria monocytogenes, where the results are based 
on the presence and absence of the requested bakteria.And these tests are assessed as 
satisfactory results..In the  samples of water were obtained the following results: for 
Escherichia coli z-score 0.5, Enterococcus-0,3i Pseudomonas aeruginosa -0,3. 
Conclusion:Based on the results from the interlaboratory tests (FEPAS and LEAP) derives 
that with the applied methods for testing water and food in our laboratory are obtained reliable 
results . This enables continuous improvement and development of new methods, and also 
checking the quality of work internationally. 
Key words: Proficiency testing shemes, LEAP,FEPAS 
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1. CONTAMINATION OF INDOOR AIR RELATED TO FUNGI AND MOULD 
 
Radakovic SS1, Marjanovic M2, Ristanovic E1  
1Medical Faculty of the MMA, University of Defence, Belgrade, Serbia 
2Galenika, Belgrade, Serbia 
Acknowledgements: This paper is realized under the research project MNTR 42008/2011-
2014, supported by Ministry of Science and Technological Development, Republic of Serbia 
Interest in indoor air quality first emerged in USA in the 1970, when “Sick Building 
Syndrome” was first described. Biological pollutants may originate from human activity, 
building materials and carpets; they may also penetrate from outdoor environments. One of 
the common indoor air pollutants are fungi and mould. Their presence in indoor air is result of 
transportation from outside environment via building materials, carpets, furniture, wallpapers, 
etc. Ventilation and air-conditioning systems are another common ways of penetrating of 
fungi into the buildings. The rate of further growth, spreading and multiplication depends 
exclusively on moisture content in indoor air, regardless the type of surface. The natural food 
source for fungi vary from plant, animal and human particles in house dust, to fragments of 
construction materials such as floor and wall textile coverings, furniture, residua of cooking 
traces, food storage, paper materials. Fungi may be extremely harmful for human health, but 
may also destruct the building itself, particularly the wooden parts, such as roofs, timbers, and 
other materials. Some fungi species produce strong allergens, which initiate immune reaction 
type I (IgE mediated). For example, the indoor contamination with Alternaria, Penicillium, 
Aspergillus and Cladosporium spp., is related to asthma and other allergic respiratory 
diseases. Some of these species, such as Penicillium and Aspergillus can also induce type III 
allergy (IgG mediated), while at high concentrations, may also initiate combined type III and 
IV reaction manifested as hypersensitivity pneumonitis. Major fungal allergens are isolated 
and identified (such as Cla h I from Cladosporum herbarum, Alt a I and Alt a II from 
Alternaria alternata and Asp f I and Asp f III from Aspergillus fumigatus). The harmful effect 
of mycotoxins is manifested by interference with RNA synthesis leading to DNA damage. 
Fungi mycotoxins have strong genotoxic, cancerogenic, and immunotoxic potential. The 
cancerogenic effects of aflatoxin (mycotoxin produced by Aspergillus flavus and Aspergillus 
parasiticus) are well known. The most important mycotoxins related to indoor air 
contamination are trichotechens, generated by fungi Stachybotrys chartarum (macrocyclic 
trichotechens, trichodermin, sterigmatocystin and satratoxin G). Several fungi also produce 
volatile organic compounds as the result of their metabolic processes, but their effects on 
human health are yet to be investigated. Considering the difficulties in assessment of 
biological pollutants in indoor air, this problem is more pronounced.  
Key words: air pollutants, mycotoxins, fungi, mould, environments  
Interest in indoor air quality emerged in USA in the 1970, when „Sick Building Syndrome” 
was first described (1). During those years, due to energy crisis, the building environments 
substantially changed – namely, the ventilation, air-conditioning, and other energy-demanding 
maintenance processes were sparingly used, particularly in public office buildings. Many 
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office workers reported headache, mucous membrane irritation, and difficulty concentrating 
during working hours. All symptoms disappeared at home. Understanding of risk factors 
underlying this epidemic led to improvement of legislation regarding ventilation rates and 
maintenance, so the number of complaints decreased in the 1990s.  
Indoor air pollution is present in virtually each and every indoor space. Biological pollutants 
may originate from human activity, building materials and carpets; they may also penetrate 
from outdoor environments by forced ventilation, diffusion or infiltration. The influence of 
the pollution on human health may vary, depends on age, health condition, and individual 
predisposition.  
Historically, moulds were the very first recognized and recorded contaminants in indoor 
environment. World Health Organization (WHO) Regional Office for Europe, in 2006 
prepared Guidelines for indoor air quality (2), according to previously formulated postulate 
The right to healthy indoor air. The importance of this problem is emphasized by the fact that 
people, particularly vulnerable populations such as children, pregnant women, elderly, ill and 
disabled, spend a substantial amount of time indoors.  
According to conclusions of WHO working group (2), there are no specific microorganisms 
that can be specifically associated with indoor air pollution; rather they represent common 
allergens and other pathogens. Considering the variety of microorganisms and their 
characteristics, it is virtually impossible to quantify their concentrations in a form of tolerable 
levels of exposure.  
Building dampness and mould are present even in high-income countries. The dampness and 
mould are traditionally related to overcrowded accommodations without adequate heating, 
ventilation and insulation. Climatic changes such as global warming with more frequent 
occurrence of storms and heavy rains lead to gradual increase in sea level. Together with 
more frequent floods, it results in increase in percentage of buildings affected by dampness 
and mould. Increased indoor dampness provides optimal conditions for increased growth of 
biological agents, such as fungi.  
The presence of fungi in indoor air is result of transportation from outside environment via 
building materials, carpets, furniture, wallpapers, etc. Ventilation and air-conditioning 
systems are another common ways of penetrating of fungi into the buildings. The rate of 
further growth, spreading and multiplication depends exclusively on moisture content in 
indoor air, regardless the type of surface. Even the primary colonizers, or xerophilic fungi, 
which may grow on less moisture surfaces, require relative humidity in excess of 50%. 
Secondary colonizers require more humidity in their substrates, while tertiary colonizers, or 
hydrophilic, need sheer water content in liquid phase for their germination and mycelia 
growth (3); hence, they are present only in buildings with severe condensation problems. The 
natural food source for fungi vary from plant, animal and human particles in house dust, to 
fragments of construction materials such as floor and wall textile coverings, furniture, residua 
of cooking traces, food storage, paper materials. Since these materials are in ample in every 
building, and considering that optimal temperature for fungi growth ranges from 10-35 ºC, the 
only limiting factor for development of fungi and mould contamination is dampness. Fungi 
may be extremely harmful for human health, but may also destruct the building itself, 
particularly the wooden parts, such as roofs, timbers, and other materials.  
Some fungi species produce strong allergens, which initiate immune reaction type I (IgE 
mediated). For example, the indoor contamination with Alternaria, Penicillium, Aspergillus 
and Cladosporium spp., is related to asthma and other allergic respiratory diseases. Some of 
these species, such as Penicillium and Aspergillus can also induce type III allergy (IgG 
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mediated), while at high concentrations, may also initiate combined type III and IV reaction 
manifested as hypersensitivity pneumonitis. Major fungal allergens are isolated and identified 
(such as Cla h I from Cladosporum herbarum, Alt a I and Alt a II from Alternaria alternata 
and Asp f I and Asp f III from Aspergillus fumigatus). Most of them are glycopeptide 
enzymes, produced during germination and released through spores and hyphae, i.e. live 
particles (4).  
Nevertheless, even dead particles carry substantial health risk, because they may contain 
possibly harmful (1→3)-β-D-glucans with the potential to impair respiratory functioning (5), 
and mycotoxins. The harmful effect of mycotoxins is manifested by interference with RNA 
synthesis leading to DNA damage. Sometimes this toxicity is beneficial – e.g. penicillin, a 
strong bactericidic antibiotic, is a mycotoxin produced by fungi Penicillium. But, in general, 
fungi mycotoxins have strong genotoxic, cancerogenic, and immunotoxic potential. The 
cancerogenic effects of aflatoxin (mycotoxin produced by Aspergillus flavus and Aspergillus 
parasiticus) are well known. The most important mycotoxins related to indoor air 
contamination are trichotechens, generated by fungi Stachybotrys chartarum (macrocyclic 
trichotechens, trichodermin, sterigmatocystin and satratoxin G) (6).  
Several fungi also produce volatile organic compounds as the result of their metabolic 
processes, but their effects on human health are yet to be investigated.  
The assessment of fungi contamination in indoor air is very difficult. In study conducted by 
Pietarinen et al., culture methods identify only few of species that were recognized and 
quantify by quantitative PCR (7). Penicillium, Aspergillus and Streptomyces were 
predominantly indentified by both methods. But, culture method successfully indentified 
Aspergillus fumigates only in samples containing the amount of total viable fungi more than 
106 cfu/g. Likewise, culture method was able to detect Stachybotrys chartarum only in 
samples with very high level of fungi contamination, contrary to qPCR method. These results 
are in agreement with another Finnish study which confirmed the highest prevalence of 
Penicillium/Aspergillus species in house dust, with more precise results obtained by qPCR 
method (8). Same authors indicated that concentrations of fungi differ significantly between 
seasons with the highest concentrations of Aspergillus detected in winter (more that 10000 
cells/mg of dust). 
There are major problems in detection, identification and quantification of fungi in indoor 
environments. A study conducted in Finland indicated that culture method failed to detect 
Aspergillus fumigates, while qPCR in same samples detected the average of 2,21 x 103 cells/g. 
The average concentrations of Penicillium spp. and Aspergillus spp. were significantly lower 
when detected by culture method than qPCR (9,01 x 103 cfu/g vs. 1,96 x 105 cells/g and 1,35 x 
104 cfu/g vs. 5,44 x 106 cells/g, respectively) (9). 
 
Epidemiological, clinical and toxicological evidence suggest that microbiological 
contamination of indoor air may be related to numerous diseases and health conditions. Damp 
and humid environment are obligatory factors for growth, development and multiplication of 
microbes, hence, the main public health goal should be targeting these problems. Considering 
the variety of microorganisms, possible synergistic effects, the fact that the most endangered 
populations are children, women, elderly (who spent relatively substantial time indoors), 
disadvantages of determination techniques and lack of evidence-based risk assessment, it 
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Improvement of the coherency of different noise reduction actions requires changes in the 
overall approach to noise problem involving a new strategy to improve the accuracy and 
standardization of data.  
The structure of new future noise policy has to be based on the Directive on the Assessment 
and Management of Environmental Noise, 2002/43/EC. The Directive defines the three key 
elements: assessment of  environmental noise through strategic noise mapping, 
implementation of action plans to reduce noise where necessary and information for the 
public about noise levels and its effects. The Directive defines the common noise indicators 
and methods for strategic noise mapping as well as the deadline for the Directive 
implementation. 
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Abstract  
Metal health involves emotional stability, and healthy emotional relationships with other 
people. Prevention and mental health care, most often defined as a common application of 
psychological, medical and social measures aimed at elimination of harmful factors of human 
life. Working in health care brings with it a number of factors that their presence may 
adversely affect the mental health of employees. Specific health problems caused by risk 
factors in the workplace related to the occurrence of stress, burnout, anxiety, irritability and 
depression. Improving mental hygiene in health care workers is rank very important to 
preserve their mental health. Promotion of mental health care requires a multidisciplinary 
approach through the implementation of specific methods and programs that aim to allow 
healthcare workers to make the best possible overcome stress factors in work environment 
and raising awareness of the need for the improvement and maintenance of their mental 
health.  
Keywords: mental hygiene, mental health, health care workers. 
Healthcare is consistently ranked as among the most stressful fields to work in perhaps due to 
a combination of the difficulty of the work itself, budget cuts, a high turnover of employees, 
and staff shortages. Health care occupations have long been known to be highly stressful and 
associated with higher rates of psychological distress than many other occupations.  
Health care workers in the health care sector is particularly subjected to such mental health 
risks (1). 
Mental hygiene is the branch of psychiatry that deals with the science and practice of 
maintaining and restoring mental health, and of preventing mental disorder through education, 
early treatment, and public health measures. 
According to the WHO (2), mental health can be conceptualized as ‘a state of well-being in 
which the individual: realizes his or her own abilities, can cope with the normal stresses of 
life, can work productively and fruitfully and is able to make a contribution to his or her 
community. 
Pychosocial risk factors have a greatinfluence on employees’ physical and mental  
health.These risks depend of the way work is designed, organised and managed. 
The specific health problems caused by these risk factors may include: stress, burnout, 
anxiety, irritability i depression 
 
The National Institute for Occupational Safety and Health (3) defines occupational stress as 
“the harmful physical and emotional responses that occur when the requirements of the job do 
not match the ca-pabilities, resources, or needs of the worker.” 
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Causes of stress can be: internal (arising from within the individual) and external (arising 
from the external events and demands).The effects of stress can 
be:physical,psychological,behavioural and cognitive. 
The following workplace factors (job stressors) can result in stress: work overload, lack of 
task control, role ambiguity, poor interpersonal relations, unfair management 
practices,financial factors,conflict between work and family roles and responsibilities, lack of 
opportunity for growth or promotion, lack of management    commitment to core values, 
conflicting communi-cation styles, etc.(4). 
The causes of work related stress can be many and varied, but can be broadly classified into 3 
groups:stress from doing the job(caused for example by monotonous work, too much work or 
insufficient time),stress from work relationships (due for example to poor teamwork, complex 
hierarchies of authority, working in isolation or bullying and harassment) and stress from 
working conditions (due for example to shift work, dealing with life - threatening injuries, 
illnesses and patient deaths or the threat of violence and aggression) (5). 
 
Two important definitions of burnout are (6):  
• "A state of physical, emotional, and mental exhaustion caused by long term 
involvement in emotionally demanding situations." – Ayala Pines and Elliot Aronson.  
• "A state of fatigue or frustration brought about by devotion to a cause, way of life, or 
relationship that failed to produce the expected reward." – Herbert J. Freudenberger. 
Copenhagen Burnout Inventory assesses burnout status using three dimensions: personal 
burnout, work-related burnout and client-related burnout.  
Burnout has many causes. They fall into the main categories relating to job structure, lifestyle 
features, and individual personality characteristics. Classic symptoms include the following: 
depleted physical energy, emotional exhaustion, lowered immunity to illness, less investment 
in interpersonal relationships, increasingly pessimistic outlook, increased absenteeism and 
inefficiency at work. Specific symptoms of burnout include: having a negative and critical 
attitude at work,dreading going into work, and wanting to leave once you're there,having low 
energy, and little interest at work,having trouble sleeping,being absent from work a lot,having 
feelings of emptiness,experiencing physical complaints such as headaches, illness, or 
backache,being irritated easily by team members or clients,having thoughts that your work 
doesn't have meaning or make a difference,pulling away emotionally from your colleagues or 
clients,feeling that your work and contribution goes unrecognized,blaming others for your 
mistakes,thinking of quitting work, or changing roles (7,8,9). 
Stress is often relatively short-term, and it is often caused by a feeling that work is out of 
control. However, once the situation changes, stress often lessens or disappears entirely. 
Burnout often takes place over a longer period. Burnout can cause a variety of health 
problems including sleeplessness, physical ailments and sicknesses, depression, and even 
substance abuse. 
According to Pollett (10), mental health promotion is ‘the process of enhancing protective 
factors that contribute to good mental health’.   
Organisational level interventions include: improving quantity of work, to optimise 
intellectual requirements, to reduce time pressure, improving the use and development of 
skills, to enhance control over work, to increase participation in decisions, improving social 
support among colleagues, and between colleagues and superiors, introdusting flexible 
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working hours, to provide childcare services at work, to allow study leave and career breaks, 
to enable employees to plan and implement rotas based on work rota autonomy (11). 
The most commonly implemented organizational interventions in health care settings 
includeteam processes,  multidisciplinary health care teams and  multicomponent 
interventions.   
Team processor worker participatory methods give workers opportunities to participate in 
decisions and actions affecting their jobs. Workers receive clear information about their tasks 
and role in the department. Team based approaches to redesign patient care delivery systems 
or to provide care, have been successful in improving job satisfaction and reducing turnover, 
absenteeism, and job stress (12). 
Multidisciplinary health care teams (e.g., composed of doctors, nurses, managers, 
pharmacists, psychologists, etc.) have become increasingly common in acute, long-term, and 
primary care settings. Teams can accomplish the following: allow services to be delivered 
efficiently, without  sacrificing quality, save time, promote innovation by exchanging ideas, 
etc. (13,14). 
Multicomponent interventionsare broad-based and may include risk assessment,  intervention 
techniques, and  education. 
Work-related stress in healthcare systems is a major challenge to the health of those who work 
in those systems, to the healthiness of their organisations and to the effectiveness of the 
healthcare that they deliver. The development of the action plan, based on the evidence from 
the risk assessment, involves deciding on: what is being targeted, how and by whom, who else 
needs to be involved, what the time schedule will be, what resources will be required and how 
the action plan will be evaluated (15). 
Mindfulness-based stress reduction program consists of a training to improve communication 
skills, learn how to deal with stress reactions, self-compassion; training to improve practical 
skills to reduce stress, and to improve relation and functioning with patients. 
Conclusion  
Maintaining good mental health is crucial to living a long and healthy life. A multidisciplinary 
treatment approach, group care, and case management are common features of mental health 
treatment settings only rarely used at health care workes. Mental health interventions aimed at 
preventing and combating burnout need to be directed at the organizational, as well as the 
individual, and the societal level.  
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Abstract 
Serbia has excellent geographical, geological and meteorological conditions for development 
of balenoclimatology – mineral waters, gases and peloids, as well as the appropriate climate. 
These natural medicinal factors can be applied both in the therapy (balneotherapy) and the 
prevention of diseases (balneoprevention). 
The scientific community for the most part focuses on the researches in the efficiency of 
balneotherapy while balneoprevention is considered a relatively new approach in balneology.  
The purpose of this paper is to present a historical review of the development of 
balneoclimatology as a part of  the public health, from the ancient times till present days.  
Key words: Balneoclimatology, history, public health 
 
Introduction 
 Balneology is a medical discipline that deals with the action of natural physical and chemical 
factors of the environment on the human organism and the possibility of using them for 
medical purposes. Deals with the action of balneological factors and possibility of using them 
for medical purpose mineral waters with varyng  degrees of mineralization, temperature and 
radioctivity, peloids of organic or inorganic orgin havig suitable chemical composition and 
physico chemical properties and therapeutic gases of varyng composition, including ones 
having adequate amounts of radioactive emanations (radon). Human bioclimatology treats the 
relationship between the human organism and the climate and the direct effect of weather 
conditions on health and the sickness (1).   
Balneoclimatology is not completely recognized as an independent specialist branch of 
medicine at the international level by  the European Union of Medical Specialists -UEMS. In 
some countries it is recognized as a branch of physical medicine (Poland, Slovakia, and 
Romania), while in the UK, the Netherlands, Sweden, and Denmark there are no similar 
medical specialties. In many countries (Germany, Austria, Poland, Hungary, France, Japan, 
and others), it is known as Health Resort Medicine, Balneology, Medical Hydrology) (2). 
According to the currently applicable  “Regulations on specializations” from 2003, this 
subspecialization can be completed by all medical specialists  (with the exception of social 
medicine specialist). 
This situation indicates that this scientific branch is in the need of a holistic and 
multidisciplinary approach.   
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History of balneoclimatology 
The ancient Egyptians, Sumerians, Babylonians, and Aztecs, like the Greeks and Romans of 
centuries ago, used water both for religious rituals and for medical purposes. Starting with 
Homer, bathing has been used for hygienic purposes, while  Asclepiades (124 BCE) 
recommends the use of water (bathing and drinking) in the treatment and also in the 
prevention of diseases. 
In his  Corpus Hippocraticum (part De aere, aquis et locisto), Hippocrates (460–370 BC) was 
one of the first to point out to the influence of the living environment on one’s health.. He 
deduced that the diseases occur as a result of the imbalance of fluids in the organism, and that 
in order to prevent and treat a disease, apart from the recommended water cures (drinking 
water and bathing), one should also use walking and massages. The baths were often 
combined with sports and education (3).  
In the Mesopotamia, in 2500 B.C., clay was used for medicinal purposes, while in the ancient 
Egipt, anti-inflammatory and antiseptic properties of clay were well known and frequently 
used.    
The ancient Greeks applied the treatment termed “Heliosis”, during which they would expose 
themselves to the sunlight on the terraces of their houses for purposes of treatment and 
general improvement of health. In 525 BCE Herodotus associated the strength of the skull to 
sunlight exposure claiming that skulls of the Persians were more sensitive to hits than those of 
the Egyptians who cut their hair short and exposed their heads to sunlight (4). 
Following the example of the Greeks, the Romans opened numerous thermae  with a capacity 
for thousands of people, where  very hot waters were used    for renewing their appetites and 
thirst. Spas were used not only for the recovery of the injured but also for the relaxation of 
healthy soldiers. Apart from bathing they also applied exercises, socializing, relaxation, 
worship and medical treatment. With the fall of the Roman Empire in 476 A.D, and the 
advent of Christianity the culture of bathing gradually disappeared.   
In the 13th century, under the influence of the Moors, Europe opens first public baths, but 
during the renaissance they were closed due to occurrence of syphilis, plague, and leprosy, 
and also as places of gathering of political and religious dissidents. The currently used word 
“spa” may be derived from the Walloon word “espa” which means   fountain, or from the 
name of the Belgian town Spa (in the 14th century) boasting a thermal spring.  
During the 16th century several Italian doctors discovered forgotten medical texts from the 
ancient times leading to the recognition of value of balneology.  Medicinal waters have been 
studied at that time and efforts have been made to determine their effects on health.  In 1571, 
Bacci published De thermis, in which he taught the art of the baths from Galen and the 
Aristotelians. Minardo published in 1594 a compendium on the two baths in Verona. The first 
bath was used for drinking and bathing, the second was used by bathers with skin conditions, 
for bathing of animals, and for washing off therapeutic mud. The treatments consisted of 
drinking cures, bathing, purging, and application of mud. This new culture of bathing spread 
from Italy to the rest of Europe.    Hotels and lodgings next to the springs of mineral water 
started to abound both  across Europe and in the North America. Every larger spa had its own 
theater, casino and promenades next to the buildings dedicated to bathing and resting. Spas 
became gathering points for the elite but also for artists: painters, writers and composers (3).    
At the beginning of 20th century, women generally and especially if belonging to higher social 
classes were encouraged to avoid exposure to sunlight.  Nevertheless, two facts will soon 
change this situation. Sunbathing becomes cosmetically popular and  Niels Finsen uses 
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ultraviolet rays  (UV)  to treat tuberculosis and receives the Nobel prize (1903) for his work. 
Subsequently, heliotherapy gains international popularity. In Switzerland, dr A. Rollier opens 
a clinic for treatment of tuberculosis and rickets, and also promotes heliotherapy as a good 
prevention for theses diseases.   Medical handbooks of the time describe more than two 
hundred conditions where UV light has beneficial therapeutic effects and heliotherapy 
becomes a part of the public health. This lasts until 1930 when the correlation between skin 
cancer and extreme exposure to sunlight was made public   and proved in the experimental 
studies (4).  
Today the importance of heliotherapy for the creation of the vitamin D is well known, which 
is important for the prevention of rickets and promotion of health of the bones as well as for 
the prevention of autoimmune diseases, cancers and cardiovascular diseases (5).   
From what is previously said it evident that throughout the major part of the history 
balneoclimatology was considered to be of public health importance.   
 
Balneoclimatology today 
Today, when in the majority of cities in Serbia people doubt the quality of the tap water and 
buy bottled mineral water, the intake of this water can have a beneficial effect on the activity 
of the gastrointestinal system, ionic balance of the organism, and excretion. Consequently, 
balneological factors have today public health significance.   The researches in 
balneoprevention should be therefore focused towards two directions (6). 
Primarily, preventive aspects of balneotherapy  can be investigated mainly with 
(interventional or experimental) epidemiological methods (i.e. the analysis of the 
consumption of mineral waters in population). 
Secondly, balneoprevention should also involve toxicity studies on chemical  substances 
found in  mineral waters and muds (peloids),  with mutagenic, carcinogenic or other specific 
toxic components, either of mainly geochemical origin or as a secondary contamination (i.e. 
pesticides).  
All these researches are a part of balenoclimatology and involve specialists of preventive 
medicine, which points out to the necessity of a holistic and multidisciplinary approach to this 
branch of medicine.    
 
Conclusion 
Balneoclimatology had a significant role throughout human history in the preservation and 
improvement of health of the population in general, more often greater than balneotherapy 
itself.  Further researches should be directed to the potential of natural factors for prevention 
of diseases, as well as to the research of the safety of their application from the aspect of the 
possibility of toxic and microbiological contamination.   
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Emergencies in the water supply are regulated by national law. The reasons for emergency 
were blurring sources with or without a breakdown of the parts of the water supply as a result 
of flooding and enormous amounts of rainfall.  
The aim of the study was to review emergency water supply in the territory Nisava and 
Toplica region through the work of field and laboratory teams IPH Nis worked part-time 
intensive monitoring of drinking water which results are presented in this paper.  
A total of 1081 samples of drinking water from municipal water supply, from 19.4. to 
23.5.2014.godine. Numbers of samples per municipality are distributed over time. Supplying 
the population with water through mobile tankers and attempts improvised stationary water 
tanks of the Red Cross of Serbia were strictly controlled and supported made mandatory 
procedures especially for filling hydrants, disinfection of means of transport and circulation of 
water.  
It is not enough just the implementation of the legal framework of the action plan for dealing 
with emergencies, but the real application of a known field. Only then it is possible in a short 
period of time to ensure a safe water supply and to maintain the health of the population. 
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Hands and instruments, as well as cellular telephones, used by healthcare workers and patients 
could play an important role in the spread of the hospital infections. 
Objectives: The aim of this study was to investigate bacterial contamination of the mobile 
phones of the healthcare workers in hospitals, in order to find possible preventive measures 
and to draw the attention of healthcare workers to this topic.  
Materials and methods: The study was carried out collecting swab samples from mobile 
phones of attending healthcare staffs from different departments of Clinical Center, Nis. Each 
participant was asked to fill up questionnaire regarding patterns of usage. Samples from the 
mobile phones of healthcare workers (n=210) and from the mobile phones of non-healthcare 
workers (n=70) were collected without intimation. The bacteria determined by using standard 
microbiological procedures. 
Results: Hygiene practice of healthcare workers about using mobile phones were not 
satisfactory. Microbial analysis revealed 71,4% investigated mobile phones contaminated by 
different type of bacteria, and 16.7% of them grew bacteria known to cause nosocomial 
infections.  
Conclusion: Our results confirmed that the mobile phones of healthcare workers may become 
reservoir of microorganism for nosocomial infections and developing preventive strategies is 
of great importance.  
 








1. ANTIOXIDATIVE ACTIVITY, TOTAL ANTHOCYANINS, POLYPHENOLS AND 
TANNINS CONTENT OF BLACK CURRANT (Ribes nigrum L.) VARIETY OMETA 
 
Bojana Miladinović1, Stojanović D1, Kostić M1, Milutinović M1, Branković S1, Pavlovic D1, 
Kitić D1 
1Faculty of Medicine, University of Niš, Serbia  
 
Objectives: Black currants are berries with the high contents of anthocyanins, flavonoid and 
ascorbic acid. These constituents are known to take part in both, antioxidative and biological 
activity and ameliorate and prevent diseases such as chronical noncommunicable diseases. 
The aim of this research was to determine the contents of total anthocyanins, polyphenols and 
tannins and to see how they would correlate to the antioxidative activity of black currants 
variety Ometa.   
Materials and Methods: The juices used for the experiment, were made from the fresh, 
undamaged samples of berries, collected during 2008, 2009 and 2010. The total amount of 
anthocyanins was determined according to European Pharmacopeia 6.0. and expressed as 
cyanidine-3-glucoside chloride. The total phenolic and tannins contents were determined 
using Folin-Ciocalteu method by Hagerman. The antioxidant capacity was evaluated using 
two complementary in vitro tests - DPPH system and β-caroten/linoleic acid model.  
Results: The highest total anthocyanins content were found in Ometa 2008 (0.2%). The best 
inhibition of lipid peroxidation in β-carotene-linoleic acid emulsion was observed in Ometa 
2009 (0.08 mg/ml). Statistically significant differences were found between years in all tested 
parameters. 
Conclusion: Ometa variety stands out due to the largest number of beneficial characteristics. 
Therefore all the presented facts may contribute greatly in related further research. 
Acknowledgements: This research was supported by the Ministry of Education, Science and 
Technological Development of the Republic of Serbia (Grant no. III 46013). 
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2. RESEARCH: HOW WELL CONSUMERS UNDERSTAND NUTRITIVE AND 
HEALTH CLAIMS ON FOOD PRODUCTS  
 
Danica Zarić1, Rakin M.2, Stamenković-Đoković M.3, Bulatović M.2 Krunić T2. 
1Institution: IHIS –Nutricionizam, Belgrade  
2Institution: Faculty of Technology and Metallurgy, University of Belgrade  
3Institution: IHIS- Science and Technology Park, Belgrade  
 
Objectives: Diseases of modern man are increasingly associated with the manner and quality 
of food consumption. The first contact with food the consumers realize through labels on the 
products, they provide basic information about the quality, quantity and composition of the 
food product. The aim of this study was to determine how the information provided by the 
declaration of foodstuffs is understandable to the average consumer, how much of it do they 
believe and how much the nutritional information is a criterion for the selection of a particular 
product.  
Materials and methods: The study was conducted on 500 respondents who filled out a 
provided form. Filling out the form was either directly or on the website of the Association of 
Serbian consumers (www.apos.org.rs) in May and June 2014. The form had four personal 
questions about the respondents (gender, education, age and whether they have allergies), 5 
questions about consumer habits (frequency of buying and reading the declarations, if they 
believe the information on the label and if so, which information) and 12 questions which 
would clearly show whether consumers understand the information in the declaration. Of 
these 12 questions, respondents were offered the correct answer, 2-3 incorrect answers and the 
answer - I do not know. 
Results: The structure of the respondent group: Females 58.3%, of which 37.4% were in the 
age group 36-55, and 33.5% in the age group 26-35. University graduates 55.8% and high 
school graduates 31.1%. Of all respondents 69.3% sometimes read the declaration, while 
41.3% go shopping 3-5 times a week. Problems with allergies had only 9.2% of 
respondents. Asked how allergens are declared only 6.3% knew the answer, while the 
nutritional claim “with a small amount of fat” only 14.2% of them understood. The difference 
between nutritional claim “rich in fiber” and “source of fiber” knew only 29.5% of 
respondents. How trans fatty acids should be declared knew up to 49.6% and what exactly are 
probiotics 64.6% of respondents answered correctly. The accurate health claim for potassium 
knew 47.4% of respondents. 
Conclusion: It is necessary to educate consumers, since the total of correct answers was only 
38.3%; incorrect answers 25.1% and even 36.6% of the responses were “I do not know”. The 
educating is needed to be done by: manufacturers, responsible ministries, research institutions 
and consumer protection associations. The results show that consumers do not understand the 
basic nutritional information. Manufacturers who have products with quality ingredients need 
to use marketing campaigns to explain the effect of these ingredients on human 
health. Nutritional information and the entire food label must become the basis for selecting 
food products, so as to improve existing eating habits and maintain and improve the overall 
health of the nation. 




3. SO2 AIR CONCENTRATION IN THE LIGHT OF THE USING NEW TYPES OF 
DIESEL FUEL 
 
Danijela Ilić1,Ćorac A1, Jović J1, Mirković M1, Milošecić J1, Bukumirić Z.2  
1Department of Preventive Medicine - Faculty of Medicine Pristina-Kosovska Mitrovica 
2Institute for Medical Statistics and Informatics-Faculty of Medicine Belgrade 
 
Introduction: The main sources of SO2 in the air are the combustion of fossil fuels, 
containing sulfur, and coal and oil. Sulfur dioxide is presented in the exhaust of motor 
vehicles, especially diesel engines. Use of new types of diesel fuel with lower sulfur content 
and more modern vehicles with lower emissions of pollution resulted in the decrease of 
concentration of SO2 in the air . 
Objectives: To evaluate the effect of the use of new types of diesel fuel with a concentration 
of SO2 in the air. 
Methods: Data on consumption of different types of diesel fuel (compared to the period of the 
adoption of the Regulation on conditions of import of motor vehicles for the area of Kosovo 
and Metohija) were obtained from the relevant services. In the period since 2009. to 2013., the 
immission of SO2 was monitored at locations - Kosovska Mitrovica and Zvecan. Sulfur 
dioxide concentration was determined by spectrophotometry - pararosanylin method (TSMF). 
Statistical hypotheses were tested at statistical significance level of 0.05 
Results: The implementation of the Regulation has caused an increase to more modern types 
of diesel fuel. Median value concentration of the SO2 in the area of research was 9.16 µg/m3. 
The lowest measured concentration of SO2 was 0.02 µg/m3. and the highest 95.81 µg/m3. 
Median values of  the concentration SO2 before the implementation of the Regulation (2009.) 
was 12.58 µg/m3 (range, 4.36 to 67.2) and after the implementation 2010-2013. was 8.36 
µg/m3 (range, 0.02 to 95.81), which is a statistically significant difference (p <0.001). 
Conclusion: The use of new types of fuels with reduced sulfur content led to the decrease in 
the concentration of SO2 in the air. 
 
Keywords: diesel fuel, air, sulfur dioxide. 
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4. MONITORING NUTRITIONAL QUALITY OF MEALS IN PRESCHOOL 
CHILDREN FROM 4-6 YEARS IN KINDERGARDEN IN KICEVO R.M. FOR THE 
2001-2013 PERIOD 
 
Fani Jakamozi – Eftimijadoska 
Public Health Center – Bitola- Kicevo, R.Macedonia 
 
Purpose: To evaluate the biological value and presence of salt in the diets of  pre-school 
children,to assess the sanitary condition and propose corrective measures. 
Materials and Methods: Statistical data is made from the examinations of biological energy-
consumptive values of the analytical method in the period 2001-2013y. in accordance with the 
recommendations of the W.H.O in  2004y. 
Data from tests for hygienic laboratory are made according to the Regulations for Food Safety 
and Food Security by microbiological criteria,Fig.Journal R.M.br.78/2008.It’s used 
retrospective statistical method of operation. Results:Of the 100 analyzed daily meals in 
average energy value,carbohydrates,vit.B2 and C are satisfying.Proteins and Vit.A share of 
surplus,vitamins B1,PP,B6 and minerals are with a deficit.Daily amounts of salt not 
exceeding 2grams.After groups groceries shortage occurs in the meat,vegetables and fruit but 
milk is in surplus.Of 86 bacteriological swabs only 1(1%)does not match. 
Conclusion: Nutritional quality of meals for children do not correspond to the large daily 
variations and has no differens compared with the period 2001-2005y.The quantity of 
salt,milk and diversity of vegetables,fit the regulations and the amount of the vegetables,fruits 
and  meat are deficient. It is the addition of larger quantities of meat,vegetables and fruit to be 
balanced meal to reduce the risk of diseases. 
 






5.TRACKING BIOLOGICAL VALUE OF HOSPITAL FOOD IN GENERAL 
HOSPITAL 
 KICEVO R.M FOR THE 2001-2013 PERIOD  
 
Fani Jakamozi – Eftimijadoska 
Public Health Center – Bitola- Kicevo, R.Macedonia 
  
Aim: To assess the biological value of food to patients, quality of meals, the risk of food 
safety and to suggest possible remedial measures. 
Materials and Methods: Statistical data is made from the examinations of biological energy-
consumptive values of the analytical method in the period 2001-2013y. in accordance with the 
recommendations of the W.H.O in  2004y. 
Data from tests for hygienic laboratory are made according to the Regulations for Food Safety 
and Food Security by microbiological criteria,Fig.Journal R.M.br.78/2008.It’s used 
retrospective statistical method of operation.  
Results: Оf the 140 analyzed daily meals in average energy value is 2161kkal and vit.B2 are 
within the recommended value.Deficit occurs 20%carbohydrates,28%iron,55% in vit.C. 
Surplus is 14% protein,28% fat and 17% calcium.After the groups groceries prevalent enough 
milk and milk products and meat,while major deficit vegetables(45%) and fruit (77%).Daily 
amounts of salt not exceeding 3grams.Examined samples of drinking water are all 
correct.Bacteriological failure to swabs is reduced from 18 % to 9 %. 
Conclusion: Sanitary-higienical condition in the period 2009-2013y. is much improved 
biological floor value of the food is with great variation and almost has no different compared 
to previous period  2001-2005y.It is recommended correction of the menu to improve the 
entry minerals and protective substances. 
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6. SIGNIFICANCE OF CONTINUOUS MONITORING OF WATER SUPPLY FOR 
THE HEALTH OF POPULATION IN ZAJECAR AND BOR DISTRICT 
 
D. Gotović 
Public Health Institute “TIMOK“ Zaječar 
 
Abstract 
 The aim of work is to indicate the importance of continuous monitoring of water supply in 
order to prevent the occurrence of diseases caused by the use of unhygienic drinking water. 
In this study I will present the results of the city`s water supply from year 2011th to 2013th. A 
total sample is 3658 in Bor district and 3504 in Zaječar district. Sampling was done by the 
authorized person at the exactly prescribed methodology. 
The analysis of physical and chemical parameters indicated that the highest percentage of 
irregularity is for turbidity and consumption of KMnO4  in Majdanpek with 46,17%. 
Percentage of microbiological irregularity of water is much lower because of chlorinated 
water in city`s water supply.  
Conclusion: Water supply should be controlled and continuously monitored, not only city`s 
water supply but also rural water supply, in order to react preventively and protect health of 
population. 





7. CONTINUOUS MONITORING OF DEVELOPMENT WATER AND HEALTH 
SAFETY OF DRINKING WATER IN THE NEWLY ESTABLISHED 
MUNICIPALITIES IN KICEVO R.MACEDONIA IN THE PERIOD 1996-2013 YEAR 
 
F. Jakamozi-Eftimijadoska, V.Trajkovski, T.Konjanovski, N.Kerimi 
Public Health Center Bitola-Kicevo, State Sanitary and Health Inspectorate-Kicevo, 
R.Macedonia 
 
Objective: The aim of this paper is to give a realistic assessment of the development of water 
supply in Kicevo municipalities by type of facilities,and recommend appropriate preventive 
measures to prevent pollution of drinking water. 
Materials and methods: Water supply will be shown through statistical-data information 
from local government to municipalities,laboratory analysis of hygienic quality of drinking 
water between 1996-2013y.(According to the Standard Methods of Regulation for water 
safety OJ RM 46/2008),epidemiological report on the movement of intestinal infectious 
diseases.Applied is a descriptive epidemiological and statistical method to work. 
Results: From 56.734 population in Kicevo and the villages in 1996y.29.261(52%) residents 
are supplied with water from the city water,hygienic aspect is correct.The remaining 48% 
rural population (76 villages) received drinking water from 34(45%)local water supply and 
42(55%)other types water supply facilities.Between 2001-2005y.from other water supply 
facilities received drinking water 14(20%)and from 2006-2013y.are supplying only 8 villages 
and 5% of the total population. 
Conclusion: That the mass construction of water supply from 2001 to 2013y.improve the 
quality of drinking water,which certainly reflects on the morbidity of intestinal infectious 
diseases and the trend decline.Necessary to continue to meet our educational services to the 
population and taking all preventive sanitary-hygienic and anti-epidemic measures. 
 
Key words: Development of water supply in Kicevo,prevention 
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8. STUDENTS' AWARENESS OF THE LINK BETWEEN SALT INTAKE AND 
HEALTH 
 
Jovičić-Bata J1, Grujičić M2, Novaković B1 
1Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia 
2Department of General Education Subjects, Faculty of Medicine, University of Novi Sad, 
Novi Sad, Serbia 
 
Objectives: The objective of this research was to assess the awareness of the link between 
high salt intake and health among students from University of Novi Sad. 
Materials and methods: The research was carried out in a convenient sample of 1082 
students (mean age 20.9±1.9 years, 38.9% males) at the University of Novi Sad, Serbia. 
Students' awareness of the link between salt intake and health was assessed by a 
questionnaire. 
Results: Majority of the respondents (92.9%) were aware that high salt intake poses a health 
risk. This percentage was higher among females than among males (95.0% vs. 89.5%, 
p=0.001). Health problems associated with high salt intake were hypertension (82.9%) and 
heart problems (64.3%), followed by stroke (35.0%) and obesity (31.7%). Only 3.8% of 
students recognized stomach cancer as a salt-related health issue. Levels of awareness of 
specific salt-related health problems was consistently higher among female respondents 
(p<0.001). 
Conclusion: Awareness of the link between salt intake and health was high, but substantial 
knowledge gaps exist about specific salt-related health problems that need to be addressed in 
future students' education programs. 
 






9. URINARY COTININE AS A BIOMARKER OF EXPOSURE TO 
ENVIRONMENTAL TOBACCO SMOKE 
 
Ljiljana Stosic1, S. Milutinovic1 
1Public Health Institute Nis 
 
Measuring of specific smoke constituents or their metabolites in physiological liquids can 
give more precisely data about exposure to ETS. Although several parameters have been 
explored, urinary cotinine detection is the most frequent. Cotinine, a metabolite of alkaloid 
nicotine - the major component of tobacco smoke has a much half/life than nicotine and this is 
considered a  more useful marker in assessing tobacco use.  
The aim of this paper was to established  the relationship between parent-reported estimates 
of children,s exposure to ETS at home and children,s  urinary cotinine levels.  
The study sample consisted of 1074 children aged 7 to 11 years from Nis. Children are chosen 
because their lungs are more susceptible to harmful effects from air pollutants, they aren,t 
smokers and they aren,t professional exposed. From the total sample of children, two groups 
of 15 are made: children with respiratory symptoms and respiratory diseases exposed to 
environmental tobacco smoke and children with respiratory symptoms and respiratory 
diseases non exposed to environmental tobacco smoke. Cotinine was examined in urine of 
children. Samples morning,s urine were collected  from children and in the same day those 
have been read. «Rapid Signal COT Cassete», immunochromatographic test is used.  
A total of 30 urine samples were analyzed: 6(20%) were positive with cotinine concentrations 
of more than 200ng/mL. Statistical significance of difference is established by Fischer test of 
exactly probability. 
Results of cotinine detection in urine also have showed that urinary cotinine levels were 
significantly higher in the exposed group than the non exposed group 
Key words: schoolchildren, urine cotinine, ETS 
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10. RESEARCH ON FOODS AND SUPPLEMENTS: USE OF NUTRITION AND 
HEALTH CLAIMS 
 
Stamenković-Đoković Marijana.1, Rakin M.2, Zarić D.3, Bulatović M.2 Krunić T2. 
1IHIS- Science and Technology Park Zemun, Belgrade  
2Institution: Faculty of Technology and Metallurgy, University of Belgrade  
3Institution: Institution: IHIS –Nutricionizam, Belgrade  
 
Objectives: On food and supplements there are nutrition and health claims, the wording is not 
in line with EU food legislation (EU Regulation 1927/2006 and Directive 432/2012), nor with 
the SRB legislation. In Serbia, the book of regulations on nutrition and health claims is still in 
the defining phase. Formulation of statements, which on the products are false and usually 
incorrect, can be misleading for consumers. This paper presents a study conducted on 2504 
products, which are divided into nine groups: oils and margarines; bread and pastry; breakfast 
cereals; sweet confectionery, savory confectionery; non-alcoholic beverages, supplements, 
dairy products and dietary products.  
Materials and methods: The research - filling in forms (list of ingredients, nutrition and 
health claims, nutrition charts) for each product taken from shelves of two hypermarkets in 
June-September 2013 in Belgrade and statistically analyzing the data.  
Results: Of all products only on 23% of them there were nutrition claims, of that on 91% of 
them the claims were correctly used and on 9% they were incorrect. Most of the nutrition 
claims were found on supplements, up to 68%, and the least on the bread group 11%. The 
most accurate nutrition claims used, 97%, were on the non-alcoholic beverages group, and the 
worst on the bread group (up to 99.8% incorrect claims). 
Health claims were located on only 8% of the products, of which 30% were correctly 
used. Most of the health claims were on the supplements, as much as 25%, and the least on 
the savory confectionery group (2%). The most correct health claims used, as much as 56%, 
were on the sweet confectionery group, and the least correct were on the bread group (100% 
with incorrect claims). 
Conclusion: It is necessary to educate the producers, because on 42% of the products correct 
nutrition claims were found and the as much as 27% of correct health claims. It is also 
necessary to educate consumers, in order for them to identify false and incorrect claims. Food 
legislation (designated Ministry) should as soon as possible issue a book of regulations 
concerning nutrition and health claims. 
 





11. WHEN LOW DOSE IS TOO HIGH - EMERGING CONTAMINANTS IN 
ENVIRONMENT AND HEALTH 
 
Nataša Milić1, M.Milanović1, S. Goločorbin-Kon1, N. Milošević1, M. Vojinović-Miloradov2 
1University of Novi Sad, Faculty of Medicine 
2University of Novi Sad, Faculty of Technical Sciences 
 
Emerging substances (EmS) are newly recognized pollutants widely used as pharmaceuticals, 
endocrine modulating compounds, biological metabolites, personal care and household 
products, agricultural chemicals, flame retardants, plasticizers, etc.  
Although EmS have been detected at ppb, ppt and lower concentrations in wastewater, surface 
water and ultimately in drinking water, constant input into the environment makes EmS the 
pseudo-persistent pollutants even if their half-life is short. EmS have received great attention 
among the scientists and the public due to the possible negative effects of occurred low doses 
on human health and environment in general. The registered growing resistance of the vast 
bacteria groups, potential mutagenic, carcinogenic and toxic effects of EmS as well as adverse 
reproductive and developmental consequences of hormonally active EmS at low doses affect 
powerfully on the state of the environment and on the human health. 
Based on the new evidences that EmS low doses have adverse effects on wildlife and 
moreover on human health, the traditional thinking in toxicology is not adequate to conclude 
consequences of present concentration levels of hormonally active EmS.  
Acknowledgements: This research has been financially supported by the Ministry of 
Education, Science and Technological Development, Republic of Serbia (III46009) and 
NATO Science for Peace Programme (ESP.EAP.SFPP 984087).  
 




E. Session: HYGIENE   48. DPM 
151 
 
12. CONTROL OF WATER SUPPLY IN TERMS OF PROHIBITING THE USE OF 
POTABLE WATER FROM CENTRAL DISTRIBUTION NETWORK OF THE CITY 
OF UZICE 
 
Olivera Janjić, Prosić V. 
Public Health Institute Uzice 
 
Process of water treatment in water system plant  ‘Petar Antonjevic’ did not provide healthy 
and safe drinking water to population of Uzice in the period of December  2013 to February 
2014 as well as in the period of July and August 2014. The presence of biological indicators is 
the cause of the deterioration of water quality. To reduce the risk to public health a number of 
preventive activities was conducted. 
In accordance with legislation, in Public Health Institute Uzice physico-chemical and 
bacteriological water quality  testing of water that was used in the sanitary-hygienic purposes, 
drinking water from cisterns and water from alternative sources  was carried out. Sampling 
and treatment of samples was done by standard SRPS ISO 5667-1 and standard SRPS ISO 
5667-2. There was bacteriological malfunction in 5.28% of the samples. Determination of 
total content of  microcystin and microcystin LR (parameters of the indication) in 33 samples 
of drinking water from the distribution network showed their absence. Sanitary-hygienic 
monitoring of tanks for drinking water, indicates difficulties in maintaining bacteriological 
correctness in summer. It was found that most of the alternative sources (public fountains, 
springs, wells) are outside the control of water quality. A large part of those wells whose 
water is  controlled  does not meet the criteria of hygienic safety. In order to improve the 
quality of water supply it is necessary to implement a monitoring system for alternative water 
sources, to develop the care and regular maintenance of facilities and to develop a program to 
educate the population. During the period of difficult water supply there was no deterioration 
of the epidemiological situation and increase the number of diseases that are a result of using 
water for drinking. 
 





13. NUTRITIONAL STATUS OF CHILDREN AGED 15 YEARS IN TOPLICA 
DISTRICT 
 
Suzana Milutinović1, Lj. Stošić1, Lj. Tadić2 
1Public Health Institute Niš 
2Internal Department of Military Hospital Niš 
Objectives: Obesity prevention is an international public health priority and there is growing 
evidence of the impact of overweight and obesity in children and adolescents on short-term 
and long-term functioning, health and well being. The aim of this study was to determine the 
anthropometric and nutritional status among children in Toplica district. 
Materials and methods: The cross sectional study encompassed 775 children (409 boys and 
366 girls) aged 15 years and it was conducted between 2003-2004. The body mass index 
(BMI) were calculated using the anthropometric measurements (body heights and body 
weights) measured by trained physicians or nurses.  
Results: Overweight (BMI, 85th to 95th percentile) was observed in 10,02% of boys, and in 
9,84% of girls, compared with 5,13-5,19% of obese children (BMI, >95th percentile). On the 
basic of standard deviation (SD) score, the prevalence of the overall overweight (SD score, 2 
to 3 for BMI) among the examined children was 3,42% in boys and 1,91% in girls. The 
prevalence of the SD score >3 for BMI was 1,96% in boys and 3,28% in girls. 
Conclusion: Anthropometric assessment still takes on great importance in the nutritional 
diagnosis of children. The effective and sustainable prevention of obesity among children and 
adolescents is possible and is a must in tuday's societies.  
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14. SMOKING AND HEALTH 
 
Viktorija Đorđevic 
Public Health Institute Nis 
 
Introduction :Smoking is one of the most common and the most infamous of harmful factors 
that lead to a large number of consequences in terms of occurrence of various diseases and 
conditions.  
The World Health Organization ranked the smoking addiction, which makes the image all the 
more worrying because with nicotine, smokers also breathe about 4,000 other chemicals in 
cigarette smoke. Many of them are chemically active and cause profound and detrimental 
effects in the body.  
Methods :Review of the literature available on research databases. 
Results : World Health Organization estimates that 1.2 billion people worldwide use tobacco, 
of which 84% of smokers live in developing countries. According to the same source, tobacco 
causes death, with 6 million people a year, with the expectation that this figure to double in 
the next 20 years. If the growth in the number of smokers present rate, the number of smokers 
will be from today's 1.2 billion to climb to 1.7 billion by 2025. Every 6.5 seconds one person 
dies as a result of smoking. 
Conclusion:Smoking leads to nicotine addiction, which is the least dangerous among 
addictions, but knowing all the risks to health which leads, not at all harmless. Because of 
pleasure which provides smoking cigarettes are much smaller than the hazards and risks that 
entails.  
Quit smoking has long-term beneficial effect on the health of the individual. Smokers who 
have stopped smoking before they become 35 years of age have the same length of life as 
non-smokers. 






15. VEGETABLE OILS AS A GOOD SOURCE OF VITAMIN E 
 
Zorica Basić1, S. Ražić1  
1Institute of Hygiene, Military Medical academy,, Belgrade, Serbia 
 
Objectives: Vegetable oils are characterised with high vitamin E content. [1]  Depending on 
way of production and usage, that content can be preserved or diminished. On our market 
exists more and more versatile offer of vegetable oils with declared tocopherols content. By 
appropriate usage of this foodstuff, it is possible, to the significant extent, to satisfy vitamin E 
daily needs. [2]   
The aim of this work was to determine tocopherols content in esculent vegetable sunflower 
and olive oils from our market before and after their thermal treatment, by using HPLC 
method.  
Materials and methods: Esculent vegetable oils from retail, of various origin and way of 
production (14 sunflower and 4 olive oils, total of 16) were analysed before and after thermal 
treatment for 20 min. For an accurate and reliable determination of vitamin E content in 
foodstuffs of complex composition it is necessary to perform multiple sample purification, 
while for a determination in vegetable oil a liquid/liquid extraction is recommended after 
alkaline hydrolysis. [3] An n-hexan extraction was applied, extract vaporization and 
reconstitution in methanol using membrane filtration. Separation was performed by using RP-
HPLC method with fluorescent detector with changeable wavelengths.  
Results: A sunflower oil tocopherols content varies between 265,6 do 920,7 mg/kg. All 
samples except one fullfil declaration requirement. A difference in vitamin E content in olive 
oil is also significant and varies between 194,7 do 454,1 mg/kg. A thermal treatment applied 
diminishes the tocopherols content 41,7% in sunflower oil and 27,8% in olive oil on average. 
Conclusion: Tocopherols  content determined in oils before thermal treatment corresponded 
to the declared content, with significant differences depending on origin and declared way of 
production. Thermal sample treatment affected significantly reduction of vitamin E content. 
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16. INPORTANCE OF QALITY CONTROL OF MILK AND OTHER MILK 
PRODUCTS (2010-2014) 
 
Biljana Đorđević, D.Nikolić, N. Mladenović 
Public Health Institute Nis 
 
Introducing new Food Law, Public health institutes do not systematically control food. 
In period 2010 - august 2014.  734 samples from group of milk and milk products .Total 
number of defective samples was 53 (7.1%). Results were interpreted  by Regulations for 
milk and milk product and starter cultures and Regulations for declaration. 
From 310 samples of cheeses 6.5% (20) was defective. Defectiveness, caused with lower fat 
and/or lower dry matter was occurred in 50.0% of samples, 10.0% samples contained more fat 
then it was declared and 15.0% of samples were not  properly declared.  
The remaining samples (424) from group milk and milk products were defective in 8.3% (35 
samples) of which, 48.6% were with lower fat content, 22.9% with lower dry matter without 
fat (or proteins), 8.6%  samples contained more fat then it was declared and 17.1% of 
defective samples was not properly declared. 
Such results represents less quality, changed biological value, with intention to yield the 
cheapest product or applied poor technology. Poor declaration indicates lack of information or 
unawareness of new Regulations for milk and milk product and starter cultures introduced 
from 2010.  
In order to protect consumers it is recommended further systematic control of producers. 





17. DETERMINATION OF TOTAL LEAD IN MAKEUP PRODUCTS 
 
Jelena Videnović, S. Veličković 
Public Health Institute Nis 
 
Introduction: Lead is natural environment element and all of us on a daily basis is exposed to 
small amounts of lead in food, water and air. 
Accumulation of lead in the body can be the cause of phenomena such as lower IQ, 
behavioral and growth problems, vision and kidney damage, reproductive disorders, high 
blood pressure .... 
Slight traces of lead due in make up products (lipstick, lip gloss ...) throughout the production 
process from ingredients such as dyes and pigments. 
Goal: Determination of total lead in make up products from market by  random selection and 
evaluation of potential intake of lead as a toxic element by these products. 
Results: Sample preparation was performed by microwave digestion and determination of 
lead using GFAAS. 
The lead content in the ten analyzed samples ranged from 0.39 mg / kg to 6.39 mg / kg. 
Conclusion: Although the lead content in these products is high, it is believed that there is no 
security risk because of locally application, limited absorption and low ingestion of makeup 
products.  
We can’t talk about safe exposure to this toxic metal that has a cumulative effect in the body. 
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18. LEVELS OF COMMUNAL NOISE IN NIGHT INTERVAL IN SUTOMORE 
DURING SUMMER SEASON MONTHS 
 
Borko Bajic1, Mladenka Vujoševic1 
1Public Health Institute, Podgorica 
 
Introduction: Adequate sleep is a necessary prerequisite for the normal functioning of the 
human organism. Communal noise as a stressor can exert various adverse health effects, 
especially on the quality and duration of sleep. 
Objective: To determine the level of night noise pollution in the residential area of coastal 
local community Sutomore during the summer season months. 
Material and methodology: The levels of noise pollution were measured within the 
reference interval for the night. Measurement were carried out in the period from 20.07-
18.08.2013, in a measuring intervals of 15 minutes. A total of 35 measurements was 
performed according to the standard methodology and relevant legislation. 
Results: The dominant source of noise pollution are the hospitality facilities (restaurants, 
clubs, etc.), emitting too loud music. In all measurement intervals noise levels enormously 
exceeds the levels stipulated by law. 
Conclusion: In order to reduce noise levels in the residential area of Sutomore, it is necessary 
to take protective measures. This measures can be organized through increased surveillance of 
the communal police, banning of limiting the use of electro-acoustic devices, financial 
penalties and other measures in order to allow adequate rest and sleep for residents and 
tourists. 





19. SALT CONTENT IN PREPARED FOOD FROM RESTAURANTS AND THE 
RISK OF NCDS 
 
Djordjevic Z1, Joksimovic I1, Delević V1, Bajic B1 
1Public Health Institute, Podgorica 
Introduction: Excessive salt intake from food is directly related to the occurrence of 
Noncommunicable diseases (NCDs), which are the leading cause of mortality worldwide. 
According to literature, the highest salt intake from food,  75 % of total intake originates from 
the so-called hidden sources – food we don’t prepare at home.  About 15% of the salt we are 
adding ourselves, while only 5% of salt intake comes from natural sources. 
Objective: To determine salt intake based on the average restaurant meal in Montenegro. 
Material and methodology: Salt content is analyzed in prepared dishes sampled from 
restaurants within the Health and Sanitary Inspection Programme. Mohr Volumetric Method 
was used to determine the salt content in food. 
Results: The analysis included 94 samples divided into 9 groups. The lowest average salt 
content was detected in salads, while the highest was detected in meat and pasta dishes. 
Taking into account the food samples and daily intake, it can be estimated that the average 
lunch in restaurants contains more than 9g of salt. 
Conclusion: To reduce daily salt intake in accordance with WHO recommendations, it is 
necessary to establish better cooperation with food business operators in order to provide food 
with low or decreased salt content. In order to achieve a reduction in morbidity and mortality 
from NCDs, it is necessary to conduct training at all levels, and to provide consumers with 
choice in decision making. 
Key words: salt content, Noncommunicable diseases, daily intake, prepared dishes. 
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20. DETERMINATION OF HEAVY METALS IN PM 10 
 
Biljana Ljubenović, B. Petrović 
Public Health Institute Nis 
 
The atmosphere is releasing millions of tons of various pollutants, gases, vapors, particles 
from diferent sources (households, power and industrial plants, metallurgy, transport), and 
they emit a large amount of various air pollutants. Suspended particles are a complex mixture 
of organic and inorganic substances whose composition depends on the source of emissions, 
and the length of survival in the air depends on the size, shape and density of particles. 
According to the Regulation on the conditions and requirements for monitoring air quality 
(Official Gazette of RS No. 11 / 2010.75 / 2010 and 63/13) the level of air pollution is 
monitored by measuring the concentration of suspended particulate matter (PM 10 and PM 
2.5), and further analysis suspended particles PM10 heavy metals lead, arsenic, cadmium and 
nickel. Sampling procedure includes the preparation, retrieval, storage, transport to the 
laboratory, where it is the physical and chemical testing of samples. Results of measuring the 
concentration of pollutants are compared with the prescribed limit, tolerance and target values
. The measurements were carried out with twenty-four hour sampling of ten days a month, 
from January 2013 to December 2013, the measuring spot Public Health Institute Nis, and 
determined the concentrations of PM10, lead, arsenic, cadmium and nickel.  
The threshold value for the sampling of 24 h for PM10 fraction of suspended particulate 
matter is 50 mg / m 3, while the tolerance value for the same parameter of 75 mg / m3. For the 
same period the fairness and tolerance for lead at 1 mg / m3. And if the first three months 
2013 concentration fractions PM10, crossed the border and in three cases and tolerant values, 
concentrations of heavy metals remained far below the threshold and tolerance values. 






21. SANITARY-HYGIENIC CONDITIONS IN THE CATERING FACILITIES IN 
THE ZLATIBOR DISTRICT  
 
Violeta Prošić, Janjić O. 
Public Health Institute Užice 
 
The monitoring of sanitary- hygienic conditions in the catering facilities is of great 
significance since it allows definition and improvement of the activities which refer to 
maintaining sanitary and hygienic conditions in these objects for the sake of achieving high 
level of consumers' health and interest protection. 
Objective: Determination of potential contamination sources based on the sanitary and 
hygienic parameters' analysis, based on which the professional help with the correction of 
sanitary-hygienic conditions  in these object will be provided. 
Material and Methodology: The research included the sanitary-hygienic conditions  of 
kitchen block by the local inspection method, as well as the sanitary and hygienic condition of 
the kitchen block by the swab analysis of the dishes, utensils, work surfaces and hands of staff 
who manipulates food during preparation for the catering facility Zlatibor District in the 
period  2011. to 2013. The tests were performed using standard bacteriological methods and 
the accuracy score was performed on the basis of existing legislation. 
Results: In this period  2621 swab samples of the dishes, utensils, work surfaces and 1040 
swab samples hands of staff employed were analyzed in the kitchen block of the catering 
facilities. 98 swab samples (3,74%) of dishes, utensils, work surfaces  and 47 (4,52%)  swab 
samples hands of staff employed the kitchen block does not satisfy the standards provided by 
the applicable legislation. 
Conclusion: The regular monthly controls and advices have given a positive improvement in 
the sanitary-hygienic conditions Zlatibor District catering facilities. 
Keywords: catering facilities, Zlatibor District 
 
  
E. Session: HYGIENE   48. DPM 
161 
 
22. THE DISORDER OF UZICE WATER SUPPLY SYSTEM IN THE PERIOD OF 
DECEMBER 2013-AUGUST 2014 
 
Violeta Prošić, Janjić O. 
Public Health Institute Uzice 
 
The disorder of Uzice water supply system has occurred due to appearance of cyanobacteria  
at both the source and the water supply system, which can have an adverse effect on health of 
drinking water consumers'. 
The aim of this paper was to present the results of biological raw water research and modified 
drinking water in the period of December 2013 – August 2014.  
Material and methodology: In this period, sampling of 90 raw water samples and 637 
treated water samples took  place for the sake of biological analysis. Sampling and treatment 
of samples was done according to the standards ISO 5667-1 and ISO 5667-2. In all water 
samples was performed identification and quantification of the number of cyanobacteria cells, 
according to method SRPS EN 15204:2008 Water quality - The manual for Phytoplankton 
count using invert microscopy, such as determination of total microcystine content and the  
LR microcystine in the 34st drinking water sample from the distributive network.  Januray 
2014. at the Insitution of Berlin, the microcystine analysis took place and there was no 
evidence of thy presence in the drinking water. 
The results of biological research has shown that the water supplied to consumers by the 
water supply systen of Užice contains Planktothrix rubscens, but not cyanotoxins. 
The conclusion is that the monitoring of cyanobacteria cells in the water supply systems in 
the distribution network , such as introducing new water processing technologies is necessary 
due to potential health risk. 





23. PREVALENCE OF PSEUDOMONAS AERUGINOSA IN WATER FOR 
SWIMMING AND RECREATION  AND INDOOR AND OUTDOOR SWIMMING 
POOLS 
 
Avramović Dušan, Jovanović Dara, Mladenović Slaviša, Ristanović-Ponjavić Ivana 
 
City Public Health Institute Belgrade 
 
Objectives: To determine the frequency of p.aeruginosa positive finding in water samples of 
swimming pools on the territory of Belgrade.  
Materials and methods: Our study included 3837 samples of water from public and hotel 
pools analyzed in the laboratory of GZZJZ during period January 2009 to December 2013. 
Parameters included are pool type (indoor/outdoor), water temperature (0C) and free residual 
chlorine concentration (RCl2-mg/l) measured at site, and bacteriological p.aeruginosa positive 
finding. 
Results: We have registered 165(4.30%) P.aeruginosa positive samples, of which 64(5.96%) 
in outdoor pool water samples (n=1080) and 101(3.66%) in indoor pools water samples 
(n=2757). In P.a. negative samples from indoor pools average water temperature was 
T=27,50C(MEDIAN 27,30C) and average concentration of RCl2-=0.44mg/l(MEDIAN  
0.50mg/l). In P.a. positive samples from indoor pools average water temperature was 
T=28,90C(MEDIAN 28,30C) and average concentration of RCl2-=0.30mg/l(MEDIAN 
0.30mg/l). In P.a. negative samples from outdoor pools average water temperature was 
T=25,20C(MEDIAN 25,60C) and average concentration of RCl2-=0.42mg/l(MEDIAN 
0.40mg/l). In P.a. positive samples from outdoor pools average water temperature was 
T=25,20C(MEDIAN 26,20C) and average concentration of RCl2-=0.42mg/l(MEDIAN 
0.40mg/l).  
Conclusion: P.aeruginosa positive finding in swimming water is more frequently registered 
in outdoor pools, as well as in indoor pools with higher water temperature and lower free 
residual chlorine concentration. 
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24. DIETECTIS SUPPLEMENT IN MALE INFERTILITY COMPLEMENTARY 
TREATMENT 
 
Marin Bašić 1,M.Krstić 1,Mitić D. 2, J.Popović2 
1Gynecology-Obstetrics Clinic, In-vitro fertilization Department, Nis 
2Faculty of Medicine, Nis 
 
Infertility represents the lack of pregnancy after a year of unprotected sexual intercourses. The 
spread of male infertility, according to some authors, varies from 25% to 40% out of entirely 
registered infertility. Male infertility has many causes which can be divided into testicular, 
pre-testicular and post-testicular. The number and variety of the causes which lead to the 
decrease or lack of male fertilizing potential demand different treatment approaches. The 
easiest forms of therapy are the ones which include supplemented diet, and the most radical 
ones are from the domain of surgery. Scientific literature describes the following as the most 
commonly used: vitamin-mineral preparations, fruits and extracts of particular plants and 
essential amino-acids where there is a wide spread of registered levels of their success. The 
goal of our work is to determine to which extent the dietetic supplements are suitable for 
male infertility treatment. In methodology, we applied semen analysis of men who have been 
registered with the decreased fertilization potential according to the strict Kruger’s criteria, at 
the beginning of the therapy and 3 months afterwards. The work comprised 100 
systematically chosen examinees and the changes of their parameters were followed: the 
number of spermatozoids in 1 ml of ejaculation, changes in the spermatozoids progressive 
movement (active and slow movement) as well as the changes in the percentage of 
morphologically normal spermatozoids. The patients were recommended, besides taking 
Proksid, to quit smoking, increase physical activity and use various available supplements. 
Results:with regard to the number of spermatozoids in 1 ml. of ejaculation, it is determined 
that their value is considerably increased from the moment before taking supplements 
p < 0.001 (X¯1 = 44.78, SD1 = 40.28) and after taking the supplements (X¯2 = 58.73, 
SD2 = 46.75), t (99) = -5.265, p < 0.001. The T-test of the samples estimated the influence of 
the supplements on the percentage of progresivelly mobile spermatozoids in the examinees' 
ejacualtion. Statisticly significant value increase is determinedfrom the moment before taking 
supplements p < 0.001 (X¯1 = 42.13, SD1 = 27.84) to the moment after taking the supplements 
(X¯2 = 56.49, SD2 = 25.88), t (99) = -6.587, p < 0.001. Statistically significant increase in the 
percentage of actively mobile spermatozoids is determined form the moment before taking 
supplements on the level p < 0.001 (X¯1 = 12.53, SD1 = 14.04) to the moment after the 
supplement therapy (X¯2 = 21.55, SD2 = 18.03), t (99) = -7.297, p < 0.001. Also, we 
determined the statistically significant increase in the value of slowly mobile spermatozoids 
(B mobility) from the moment before taking the supplements on the level p < 0.05 (X
¯ 1 = 29.70, SD1 = 20.07) to the moment after the supplement therapy (X¯2 = 34.90, 
SD2 = 17.29), t (99) = -2.584, p = 0.011. Also, the T-test of the paired samples estimated the 
influence on the normal spermatozid forms percentage in the examinees' ejaculations. 
Stiatistically significant value increase is determined form the moment before taking 
suppolements on the level p < 0.001 (X¯1 = 9.84, SD1 = 6.64) to the moment after supplement 
therapy (X¯2 = 12.53, SD2 = 6.40), t (99) = -7.123, p < 0.001. 
Conclusion:Besides the fact thatour studies determined the high level of positive correlation 
between taking supplements and semen quality improvement, we recommend that the 
examination should be continued with the more subtle methods in this field in order to 
complete the knowledge, application and to improve the efficiency of dietetic supplements in 
male infertility treatment. 
 
Key words: dietetic supplements, male  
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25. MICROBIOLOGICAL INDICATORS OF WATER POLLUTION BY 
MUNICIPAL SOLID WASTE LANDFILL 
 
Aleksandar Ćorac1, Barać N.2, V.Minić3, Barać M.4, Bukumirović Z.5,D.Ilić1, J.Jović1, 
Milićević S.6 
1Department of Preventive Medicine - Faculty of Medicine Pristina-Kosovska Mitrovica 
2Innovation Center, Faculty of Technology&Metallurgy, University of Belgrade, Serbia 
3Public Health Institute, Kosovska Mitrovica,Serbia 
4Department of Technology & Metallurgy, Faculty of Technical Sciences University of 
Pristina, Kosovska Mitrovica, Serbia 
5
 Institute for Medical Statistics and Informatics-Faculty of Medicine Belgrade 
6Clinic ”Dr Miroslav Zotovic”-Belgrade, Serbia 
 
The research was conducted within the project TR 37016 of Ministry of Education, Science 
and Technological Development of Republic of Serbia 
Introduction. Inadequate and unplanned municipal solid waste (MSW) landfills pose a huge 
problem and long-lasting risk for the environment and humans as well. Inadequate positioning 
and organization of MSW landfills could be a source of additional problems for 
environmental pollution. These problems are specially expressed when the landfills exercise 
direct influence on the groundwater pollution. 
Objectives. Determination of bacteriological pollution disposition from solid waste landfills 
into the environment. 
Materials and Methods. Water sampling was carried out in the surrounding of the MSW 
landfill in which it achieves direct contact between landfill content and groundwaters. Taking 
into account position of the MSW landfill, surface water, groundwater as well as landfill's 
wastewater were analyzed. Samples were analyzed at microbiological laboratory of the Public 
Health Institute in Kosovska Mitrovica. 
Results. Total number of bacteria per ml in surface water sample – before landfill was 800, 
first piezometer – before landill – was 60 000. In landfill wastewater sample we found 160 
000 (with the presence of Pseudomonas aeruginosa) while in second piezometer – after 
landfill and surface water also after landfill we found same number of 100 000. 
Conclusions. MSW landfills represent the large source of groundwater bacterial 
contamination. Structure of groundwater and surface water pollution influenced by landfill 
had a significant changes, both in their number and in content. 
Keywords: Municipal Landfills, Bacterial Contamination, Water. 
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26. PARTICIPATION IN LGC PT SCHEME- METALS IN WASTE WATER AQ 3506 
Biljana Ljubenović,J.Videnović, I.Kamenović, S.Veličković 
Public Health Institute Nis 
 
Metals are cations that are best suited for research and analysis. Purchase of the first atomic-
absorption-spectrophotometer (AAS), 1988, Laboratory for Sanitary Chemistry, Public Health 
Institute, Niš, was included in the first five laboratories which were able to be next to the 
analysis of metals in food, water, air pollution and general purpose , conducts scientific 
research, as a logical sequence of training and testing of daily work followed the different 
interlaboratory comparisons both local and global character.  
Today, interlaboratory comparisons are mandatory requirement that each laboratory must 
meet in order to have the authority to operate. 2014, we participated in Aquacheck PT Schema 
AQ3506, the matrix waste water. The subject of the analysis are ten metals in different 
concentration ranges.  
Results for the nine metals were within the permissible values as follows: As, Cr, Cu, Fe, Pb, 
Mn, Hg, Ni and Zn. Z-score for Cd, was outside acceptability range.  





27. LEAD CONTENT IN PERSONAL CARE PRODUCTS AND BODY AND FACE 
COSMETICS 
Konstansa Lazarević1,2, Ljubenović B.2, Videnović J.2, Bogdanović D.1,2 
1State University of Novi Pazar 
2Public Health Institute Niš 
 
The purpose of this paper is to determine lead concentration in personal care products and  
body and face cosmetics (group A and B), an  to interpret the results in accordance with the 
Regulations on conditions concerning health and safety of personal care products and 
cosmetics that can be put on the market. 
The accredited laboratory for sanitary chemistry (ISO 17025) of the Public Health Institute 
Nis, in the period from June 2008 to June 2009, using atomic spectrophotometry method, 
determined the content of lead in 131 personal care products and body and face cosmetics 
(group A and B).   
The lead content for  mouth and dental care products was (n=7) from 0.2-1.30 mg/kg, for 
products for beatification and coloring of lips (n=16) from <0.02-1.32 mg/kg, for products for 
beautification and coloring of eyes (n=9) from 0.11-5.1 mg/kg, for skin care and protection 
products (n=57) <0.02-1.32 mg/kg, for face and body coloring  n=9)- 0.002-2.68 mg/kg and 
for deodorants (n=33)  <0.02-1.32 mg/kg. 
The Regulations stipulates the maximum lead concentrations that can be released from mouth 
and dental care products (10 mg/kg), products for beatification and coloring of lips (20mg/kg) 
and products for beautification and coloring of eyes and other product that stay on skin for 
longer  period up to 30 mg/kg. 
The levels of lead  in all analyzed samples  were significantly  lower than those  stipulated by 
the Regulations, and there is no health risk  for lead exposure  by means of personal care 
products and body and face cosmetics.  
Key words: lead, personal care products, face and body cosmetics 
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28. MATHEMATICAL MODELS FOR DETERMINING THE ZONE OF AIR 
POLLUTION AND DISTRIBUTION OF BLOOD LEAD LEVELS  
Ćorac Aleksandar1,  Barać Nemanja2,  Milićević Saša3 i Bukumirić Zoran4   
1Department of Preventive Medicine, Faculty of Medicine, University of Priština - Kosovska 
Mitrovica, Serbia 
2Innovation Center, Faculty of Technology & Metallurgy, University of Belgrade, Belgrade, 
Serbia 
3Clinic "Dr Miroslav Zotović" – Belgrade, Serbia 
4Institute of Medical Statistics and Informatics, Faculty of Medicine, University of Belgrade, 
Serbia 
The research was conducted within the project TR 37016 of Ministry of Education, Science 
and Technological Development of Republic of Serbia 
Introduction. In the areas where air pollution by heavy metals is present, distribution of 
pollution is usually not uniform. Mathematical models could provide an significant assistance 
in quality and speed of obtaining results of distribution of air pollution. 
Objective. Determining the trends of capillary blood lead levels (cBLL) among workers in the 
zones with different levels of air pollution, established by a mathematical model of 
distribution. 
Materials and Methods. Using a mathematical model provided in the WRPLOT ViewTM 
7.0.0. software, we determined air-pollution spreading of the town of Leposavić. In two 
groups, we sort the 35 subjects. According to the mathematical model, the first subjects group 
was their work activities performed in the zone of contamination, while the second subjects 
group their activities was performed outside of the zone of contamination. In both groups we 
found that certain cBLL. 
Results. The mean cBLL value of all subjects was 15,1 ± 14,6 µg/dl. The mean cBLL value of 
workers from the second group was 5,9 ± 4,7 µg/dl, while in workers of the first group it was 
23,4 ± 15.6 µg/dl, which is statistically significant difference (p<0,001). Workers of the first 
group had significantly higher vBLL values. 
Conclusions. cBLL values of workers employed in zones with higher levels of air pollution, 
defined by a mathematical model, were higher. The level of lead in biological material 
follows environment pollution levels, previously defined by mathematical model. 





29. CHRONIC EXPOSURE TO CADMIUM  IN METAL INDUSTRY 
Vesna Lazarević1, Ivan Krstić2 
1Military Hospital Niš, Centre for Preventive Medical Care  
2Faculty of Occupational Safety, University of Niš, 
Objectives: Chronic poisoning professionally can occur after long-term exposure to cadmium 
by inhalation or orally, which has the task to study its toxic effects. Given that exposure to 
low levels of cadmium in biological materials is an important indicator of the toxicological 
risk, performed the statistical analysis of the association of age and length of service and 
cadmium concentrations.  
Materials and methods: The applied analytical method type of retrospective epidemiological 
cohort study covering the period of ten years. We used data from the annual reports of social 
services and medical statistics, data from medical records and the specific primary health care 
professional is employed and the Institute for Health Workers and the Public Health Institute 
in Nis. Using atomic absorption spectrometry, the analysis of the concentration of cadmium in 
biological material. Statistical analysis and presentation of the results was performed software 
packages Excel, Matlab, SPSS19.0.   
Results: The level of cadmium in blood and urine of exposed groups during the study period 
was positively correlated with age (r=0,722, p<0,01 i r=0,656, p<0,01, respectively). 
Determined by the high positive correlation between the concentration of cadmium in blood 
and urine and the exposed length of service in exposed subjects during the time of study, 
(r=0,806, p<0,01 i r=0,705, p<0,01, respectively).  
Conclusion: These data confirm the association between occupational exposure to cadmium 
as well as the age and length of service exposed and pointing to a response to the effects of 
harmful effects. A retrospective cohort epidemiological study showed that the systematic 
effects of cadmium exposure results in an increase of its concentration in biological material, 
confirming the hypothesis of high toxicological risk. 
Key words: cadmium, chronic exposure, toxicological risk. 
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1. PERFORMANCE EVALUATION OF REGIONAL HEALTH CARE SYSTEMS: 
AN ITALIAN EXPERIENCE 
 
Antonio de Belvis, Battisti A, Burgio A, Murianni L, Tanzariello M, Bucci S, Ricciardi W, 
Višnjić A 
The National Observatory on Health Status in the Italian Regions (Osservatorio Nazionale 
sulla Salute nelle Regioni Italiane), Rome, Italy 
 
Abstract 
This paper aims to develop a performance evaluation tool, that allows to analyse some 
dimensions of National Health Service performance. The considered dimensions are: 
Efficiency, Appropriateness, Effectiveness, Patient centeredness, satisfaction and 
accessibility.  
As performance is a challenging issue in terms of theoretical construct and measurement, a 
total of 26 indicators, as a proxy of the performance dimensions chosen, have been selected, 
using a Delphi approach, from 103 indicators taken from the Italian New Healthcare 
Information System (NSIS). For each dimension, composite indicators have been calculated, 
as synthesis of single indicators, by geometrical mean. These composite indicators allow us to 
make Regional rankings, for each dimension, and produce evaluations on the trade-off 
between some of the different dimensions considered. 
The analysis, carried out within the Italian Regionally based National Health Service, pointed 
out the gap between the Northern and the Southern Regions, although some interesting 
exceptions are evident. Even more interesting is the comparison between efficiency and each 
of the other analysed dimensions. It highlights that the pressure on efficiency has often 
undesirable consequences on outcome, both in terms of health outcomes and appropriateness, 
accessibility and satisfaction. 
 




Over the past decade, health care expenditure has risen in all developed countries, questioning 
the economic sustainability of health systems, especially, those on public financing. The 
decision makers should find a way to ensure a health system that optimizes the use of 
resources and provides universal coverage [1, 2]. 
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Italy’s health care system has experienced important transformation during the last thirty 
years. Since 1978, Italy’s health care system is a regionally based National Health Service 
that provides universal coverage free of charge at the point of service throughout the country. 
The system is organized at three levels. The definition of the essential level of care, resource 
allocation, and policy and planning frameworks are the responsibility of the national 
government through the Ministry of Health. The central government retains responsibility for 
other functions as approving the National Health Plan, allocating funding and defining clinical 
and accreditation guidelines.  
The regional level is responsible for ensuring the delivery of a benefit package through – the 
local level - a network of population-based health management organizations (Local Health 
Trusts) and public and private accredited hospitals [3].  
The period 1997–2001 witnessed a series of radical and innovative changes in state 
institutions and health care regulation. The 2001 constitutional reform (the so-called Reform 
of the Chapter V of the National Constitution) substantially strengthened the evolving system 
of ‘fiscal federalism’. Now the organisation of health care falls into the remit of the Regions 
and autonomous provinces, which are liable for any deficit incurred.  
Central government also has a constitutional obligation to guarantee access to health care in 
each of the regions, to reduce health inequalities and to ensure that the health system operates 
efficiently and transparently, with an increasingly important role played by the Government-
Regions Committee through agreements known as “Health Pacts” (Patti per la Salute), which 
are adopted every three years. 
However, these arrangements are not fully implemented; a detailed list of services guaranteed 
by the National Health Service has never been defined in important areas such as hospital care 
and regional health expenditures have not always been controlled. In addition, in the 2001–
2010 period, regions generated over 38 billion Euros of cumulative deficit, approximately 
4.2% of the total expenditure over the period. This deficit has been highly concentrated in the 
Lazio, Campania and Sicily - in the Central-Southern Italy - which together account for 69% 
of the total cumulative deficit [4]. Thus, in Italy, the growing interest in performance 
evaluation is due not only to the economic sustainability of the system, but also to the effects 
of political and organizational changes, fiscal federalism and changes in standard cost 
observed over the past 20 years. 
In the meantime, financial deficits among Regions increased. As a significant reduction of 
indicators of quality, continuity and outcomes of the health care has not been found, short (a) 
and long (b) term impact effects on health were reported: a) raise of mental health related 
problems, measured in terms of number of suicides, depression and substance misuse lower 
access to preventive services, decreasing in healthy habits; b) almost two hundred deaths a 
year due to the increase of unemployment rate [4, 5].  
Therefore, it is necessary to implement new technical tools to support politicians, public 
administrators and citizens in the evaluations of the correspondence between the health care 
needs in each Region and how they are able to combine fairness and efficiency. 
Methods 
In order to perform an extensive literature review, we first updated a research aimed at 
defining the most frequent dimensions to evaluate the performance of national healthcare 
systems [6].  
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The dimensions of the performance are composed by many sub-dimensions or components 
(for example, appropriateness include clinical and organizational appropriateness [6, 7]) and 
all of the dimensions represent "hidden dimensions", theoretical constructs that cannot be 
measured directly.  
The performance dimensions, defined according to the literature review, were matched with 
the available indicators from a database, consisting of a list of 103 indicators of the Italian 
New Healthcare Information System (NSIS). 
To: a) select indicators referred to the performance dimensions chosen, according to validity, 
responsiveness, interpretability, feasibility and reliability at regional level; and b) identify and 
compare the different methods to yield composite indicators useful to describe and evaluate 
the healthcare performance among the 21 Italian Regions and Autonomous Provinces [8, 9], 
we applied the Delphi technique, as a structured process using a series of questionnaires or 
‘rounds’ to gather information, held until group consensus is reached.  
In addition, we searched to identify synthesis methods to build up composite indicators useful 
to evaluate healthcare systems performance. The working group was composed of 3 health 
economists, 5 public health doctors and 1 statisticians. The synthesis of the indicators has 
been performed by using geometric means of standardised indicators (z-score). This technique 
is likely to guarantee better than others the composition of indicators referred to not 
replaceable components. Every indicator has the same weight in the construction of the 




We defined the main dimensions of performance, as follows: 
- Effectiveness/improvement of health outcomes: it is the capability of services - produced 
by NHS and dispensed to the population – to lead to the expected health results. Efficacy, as 
a dimension of performance, is related to those health outcomes strictly attributable to the 
health system activity [9]. It includes the dimensions of effectiveness, safety, and 
competence; 
- Appropriateness: it is defined as the assessment of medical acts in relation to costs, 
resources available and desirable results. Appropriateness should be clinical or 
organizational. Clinical appropriateness consists of the assessment of specific interventions 
to evaluate whether the expected benefits exceed adverse effects. The size of the 
performance evaluated is whether health care delivered is adequate to clinical needs, 
compared to current scientific knowledge. Organizational appropriateness is related to the 
setting in which care is provided, furthermore to the operational efficiency. The size of the 
performance evaluated is the appropriateness of the setting, and setting is a proxy measure 
of the resources used to provide care [10]. 
- Patient centeredness: This is achieved when health care establishes “a partnership 
among practitioners, patients, and their families (when appropriate) to ensure that decisions 
respect patients' wants, needs, and preferences and that patients have the education and 
support they need to make decisions and participate in their own care” [11]. It shows how 
systems respond to people’s expectations with regard to how they are treated. Satisfaction 
evaluation tries to capture the level of satisfaction or dissatisfaction of citizens toward the 
health care system [12]. In a universal shaped health care system accessibility can be 
defined as the ease to access the guaranteed health services for those who need them. 
Access can be physical, financial or psychological and requires that services are available a 
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priori [13]. Accessibility evaluation allows us to evaluate the ability of the system to 
organize properly the offer of services, with regard to the ability of users to obtain treatment 
at the right place and at the right time, independently of income level and geographical 
location, in sufficient quantity and at a reasonable cost. 
- Efficiency: it is defined as the ability of healthcare systems or organizations to maximize 
outcome for a given level of inputs, or alternately, to minimize input for a given amount of 
outcome [14, 15]. It is divided into allocative efficiency (microeconomic and 
macroeconomic) and technical efficiency, which refers to the physical relation between 
resources (capital and labour) and health outcome [16]. 
After the Delphi approach, the complete list of indicators was defined as follows: 
Effectiveness 
- Life expectancy at  birth – Male  
- Life expectancy at birth – Female 
- Infant mortality rates (Deaths per 1 000 live births) – Male 
- Infant mortality rates (Deaths per 1 000 live births) – Female 
- Influenza vaccination coverage (per 100 residents) 
- Rates of hospital discharges potentially avoidable for Chronic Obstructive Pulmonary 
Disease (COPD) and for heart failure without cardiac procedures (per 10,000 
residents) 
- Rate of hospital discharges potentially avoidable for long-term complications of 
diabetes mellitus (per 10,000 residents) 
- Life expectancy without limitations at 65 – Male 
- Life expectancy without limitations at 65 – Female 
- Standardized rate of avoidable mortality for health services (0-74 years per 100,000 
residents) 
Appropriateness 
- Proportion of patients with a hip fracture who have underwent surgery within 2 days 
- Percentage of cesarean  
- Proportion of birth occurred in hospitals performing more than 500 births per year 
- (Territorial) Consumption of antibiotic drugs (DDD/1,000 inhabitants die) at the 
expense of the NHS 
- Percentage of laparoscopic cholecystectomy on the total of the cholecystectomy 
- Percentage of transurethral prostatectomyon total prostatectomies 
- Rate of hospitalization for hysterectomy (per 10,000 residents women) 
- Hospitalization rate under the ordinary scheme for DRG inappropriate (per 1,000 
residents) 
Patient centeredness  
- Attractiveness Index hospital (immigration and emigration) 
- Percentage of the private expenditure on the total health care expenditure 
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- Percentage of people very or fairly satisfied of the medical care received during the 
last hospitalization 
- Percentage of people very or fairly satisfied of the nursing care received during the 
last hospitalization 
- Percentage of people very or fairly satisfied of the food received during the last 
hospitalization 
- Percentage of people very or fairly satisfied of the toilets used during the last 
hospitalization 
- Rate of eligible elderly in integrated homecare assistance (for 10,000 elderly residents) 
 
Efficiency  
- Results per capita (sum of the costs, revenues and balances of regional mobility) 
The results of performance evaluation highlight a gap between North and South, although 
with some interesting exceptions [4, 17]. The most virtuous and efficient Regions are those of 
the North and of the Centre of Italy, but with some exceptions. The best in the management of 
budgets are Valle d’Aosta, the autonomous province of Bolzano, Emilia-Romagna, Umbria 
and Abruzzo. On the other end of the spectrum Liguria, Lazio, Marche and Piemonte are 
characterized by low or middle-low efficiency levels. 
The Regions with the highest levels of appropriateness are predominantly those of the North, 
Valle d’Aosta, Veneto, Friuli-Venezia-Giulia, Liguria and Marche. Emilia-Romagna, Umbria 
and Lazio present a middle-low appropriateness level. The last of the ranking are the Regions 
in the South.  
The most effective Regions are Piemonte, Valle d’Aosta, the autonomous province of Trento, 
Liguria and Toscana. The other Regions in the Centre and in the North and Basilicata show a 
middle-high effectiveness level. At the end of the ranking the Regions of the South and the 
Autonomous Province of Bolzano, Lombardia and Friuli Venezia Giulia can be found. 
The Regions with the highest level of satisfaction and accessibility are the Autonomous 
province of Bolzano, Veneto, Friuli-Venezia-Giulia, Emilia-Romagna and Marche. Sicilia, 
Calabria, Puglia, Campania and Umbria are at the lowest part of the ranking. Sardegna reveals 
a middle-high satisfaction and accessibility level. Piemonte, Valle d’Aosta and Toscana show 
middle-low accessibility and satisfaction level. 
Even more interesting is the comparison between efficiency and each of the other analysed 
dimensions. It shows that the pressure on efficiency has often undesirable consequences on 
outcome, both in terms of health outcomes and appropriateness, accessibility and satisfaction. 
Figure 1 shows the comparison between efficiency and effectiveness.  
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Figure 1: Comparison between efficiency and effectiveness
The autonomous Province of Bolzano and Abruzzo reveal on one hand positive budget, on the 
other hand low or middle-low effective level: it’s the example of a good expenditure 
management versus poor results in terms of health. On the other side Regions, like Liguria 
and Basilicata with a low efficient level, show middle
example of excellence: it’s able to combine high efficiency and effective levels. Calabria and 
Sardegna show negative results both on the efficiency and effectiveness sides.
The comparison between the dimensions efficiency and satisfaction and 
2) is interesting too. It highlights Umbria as the most virtuous on the side of health care 
spending, but it provides a low level of accessibility and satisfaction. Instead Marche, Liguria, 
Molise and Sardegna disclose low or middle
side of accessibility and satisfaction.
Figure 2: Comparison between efficiency and accessibility and patient satisfaction
The comparison between efficiency and appropriateness (
Regions show contrasting levels of efficiency and appropriateness: Liguria, Marche and 
Piemonte reveal middle-low level of efficiency and middle
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middle-low appropriateness level. The other Regions stand on diagonal, that’s to say there’s 
concordance between the two dimensions. These results fit with the assumption that 
efficiency and (organizational) appropriateness can be strictly related:
should promote a good expenditure control. It should be the same referring to clinic 
appropriateness, if it’s able to avoid the lengthening of care paths because of ineffective 
interventions. 
Figure 3: Comparison between efficiency a
Discussion 
We implemented a performance evaluation tool, suitable for the Italian healthcare regional 
context, so to apply a composite indicator for each dimension of performance.
Since 2001, a series of radical and innovative changes i
regulation have been taking place in Italy: political devolution of health care powers to the 
regions is creating the need for a new regulatory framework that radically transforms the 
institutional rules of governance a
perform a new control role [4]. 
Though the guiding values of the reform process are subordinated, financial responsibility of 
all levels of government, fairness and the correspondence between stand
financing of guaranteed essential levels of care (the so
Assistenza) and main functions, the 19 Italian Regions and 2 Autonomous Provinces have 
exercised their autonomy very differently, with the Northern Reg
in establishing effective structures of health care delivery, management and monitoring, if 
compared with the Southern Regions. 
Less successful results come from other Regions, mainly but not only in the South, where 
centres with high standards of care, often spontaneously started and developed, are exceptions 
in a regional environment where poor vision, mismanagement and in some cases corruption 
have seriously affected the capacity of these Regions to offer a complete and approp
of care to their citizens [17]. 
Regional variation in health care reflects differences of contextual, political, economic and 
cultural, factors as well as differences between the Regional health systems. In fact, in the last 
years, the North-South territorial gaps is witnessed, in terms of socio
availability, access and satisfaction with good healthcare, self
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citizens and their vulnerabilities, thus recording a fall where levels were lowest, due to the 
economic crisis [18, 19].  
A recent survey showed that in 14 of the 21 Regions and Autonomous Provinces, the system 
is performing fairly well and is well perceived by citizens. Six Regions, however, are on the 
verge of financial and service breakdown [4]. 
The choice to use composites indicators and the selection of singles indicators was made 
taking into account national and international experiences and other caveats: 
- There is no performance definition shared by all experts 
- Health care system performance is affected by many circumstances 
- Circumstances to be monitored are heterogeneous and interrelates [20] and there is no 
single indicator able to evaluate health care system performance, composites indicators 
should overtake these limits  
- There are many methods for the construction of composite indicator, those can be based 
on different techniques of analysis [21] that are valid from the statistical point of view, but 
at the same time affected by conceptual limits that require choices not lacking of negative 
implications. 
The methodology used for the calculation of the composite indicator has affected the selection 
process, especially concerning the components “not replaceable”, that is the component for 
which is not allowed a compensation (for example, regarding the dimension effectiveness is 
not possible to assume that a low rate of child mortality could compensate a high number of 
avoidable hospitalisations, and vice versa). 
Given these facts, the indicators used to measure each dimension do not pretend to be 
exhaustive with respect to the many aspects that health care performance evaluation involves. 
Thus, the evaluation of the performance, that it fallows, must be read exclusively taking into 
account the dimensions considered, it is not the absolute or global performance and it is the 
more accurate the more the indicators are linked to the evaluated dimension. The provided 
dataset, given from the Italian NSIS, is dated 2008. Thus, we are not confident it would 
significantly measure the impacts of the economic crisis in the above mentioned dimensions. 
The study does not pretend to be exhaustive in the measurement of the performance, because 
it investigates only some dimensions of the performance. Therefore the results of this analysis 
should be read with reference to the components considered and recalling the arbitrariness in 
the choice of the dimensions measured and in the approximation used for measuring. 
Conclusions  
At national as well regional level, health systems are complex bodies with several  dimensions 
that make it very difficult to summarize performance, especially through a single measure. By 
combining separate performance indicators into a single index or measure, ranking or 
comparing the performance of different systems by providing a bigger picture and offering a 
more rounded view of performance, composite indicators aim to offer a comprehensive 
performance assessment [19].  
Our study demonstrated that performance of health systems is hardly evaluable and hard to 
assess, at least in highly regionalized health systems (even within the same health system, 
wide differences have been highlighted). In Italy, according to the considered dimensions, the 
typical North-South trend has been revealed. A trade-off effect resulted, so far, between the 
dimensions of performance, underlining the unbalance that can be caused by different 
sensitivities of the regional governments on economic efficiency theme rather than fairness.  
Some arising questions need to be clarified:  
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- Is it useful to use conceptual framework to measure health systems performance, both 
overall and specific and to which extent these are applicable on different contexts? 
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Abstract 
Health status presents the results of measuring the health of an individual or a group or 
population using health indicators. Health care is oriented towards the promotion and 
preservation of health; therefore, it is necessary to monitor and analyze the health of the 
population as a basis for setting priorities, planning and selection of appropriate measures and 
activities in the provision of health care. Reasons for the measurement of health status: 
• Monitoring of health status of the population and taking action for improvement, 
analysis of the difference in time 
• The study of changes in morbidity and timely response to lessening morbidity 
• Analysis of the distribution of health resources and activities for their identification; 
• Management of health projects and programs 
Health status indicators: 
• Life expectancy 
• Morbidity 
• Standardized mortality rates;  
• Incidence and prevalence of chronic mass diseases. 
• Registers of vital events in the population (birth certificate, death certificate) 
• Routine health statistics. 
The health care system in the Republic of Serbia, organized and run it three institutions: the 
Ministry of Health of the Republic of Serbia, National Health Insurance Fund of Serbia and 
the Public Health Institute of Serbia "Dr Milan Jovanovic Batut". Public Health Institute of 
Serbia "Dr Milan Jovanovic - Batut" together with a network of institutes of Public Health in 
Serbia, collecting data about the health of citizens and the work of health institutions, 
analyzes the collected data on the health status and suggest measures for improving the health 
status of the citizens of Serbia , accompanied by the adoption and implementation of plans of 
health institutions in Serbia,  monitor staffing situation in the health care and education of 
their movement, coordinated development and functioning health information system.  




The health status is the results of measuring the health of individuals or population with the 
help of health indicators. Health care is oriented towards improving and maintaining the 
health, it is therefore necessary to monitor and analyze the health of the population as a basis 
for prioritizing, planning and selection of the necessary measures and activities in the 
provision of health care. 
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The health status of the population is not only a collection of assessment of health status of 
individuals, but the overall picture of the state of health and disease, and other problems 
related to population health in the community. Changes resulting transition trends in social, 
economic, and cultural environment affected the change of the concept of health and healthy 
living. 
Development of methodology to measure health status 
PHASE  I until the end of World War I 
• It is characterized by the massive death from infectious diseases 
• Register mortality 
STAGE II until the end of World War II  
• Improvement of sanitary environment  
• successful outcome of immunization  
• Occurrence of numerous acute diseases  
• Register morbidity 
STAGE III until the end of the eighties  
• It is characterized by AGING POPULATION  
• Increased number of patients suffering from chronic not infectious diseases  
• Increases the number of days of disability and disablement  
• SCALE OF HEALTH 
 
STAGE IV 
• Accelerated way of life , a number of factors  
• Indicators of quality of life are registered  
The definition of health in the spirit of the historic " absence of disease and decrepitude WHO 
" is far behind us , completely psychophysical health is increasingly conditioned by their own 
individual concerns and factors within society. Health is increasingly represents a dynamic 
health, social and economic category , variable under the influence of various factors in the 
society. Health and health care are not solved exclusively within the health system and can 
not be viewed in isolation from the social, economic, political and cultural indicators that 
significantly affect the health of the population. 
Reasons for the measurement of health status: 
1. Monitoring health status of the population and taking actions for improvement, analysis of 
the  difference in time; 
2. Second study of changes in morbidity and timely response in reducing morbidity;  
3. Analysis of the distribution of health resources and activities in their equalization;  
4. Managing health programs and projects. 
Most of the health care system today is characterized by an increase in the number of sectors 
that deal with health issues and complex relationships between them. The level of 
expectations of the health system and the needs of the population daily increases, there is less 
financial resources and rapid development of technology and education. It is evident that the 
aging population, the intensification of the "forgotten " and the presence of new diseases. 
The basic function of public health is to assess the health status of the population and the 
health care organization with the goal of improving the health sector and the community. 
Assessment of health status is based on monitoring and analysis of the determinants of health, 
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leading causes of mortality and morbidity of the population. Results of research on the 
lifestyle and habits of the population are the basis for the organization of an efficient health 
care system oriented to health promotion and disease prevention. 
The objectives of the assessment of the health status of the population are:  
1. Registration of the most important health problems;  
2. Evaluation and monitoring changes in health status;  
3. Analysis of differences between individual groups of population and territories with the 
aim of reducing inequalities;  
4. Implementation of measures to improve the health status of population;  
5. Improving the model of financing and health management. 
Indicators of health  
1. Life expectancy;  
2. Morbidity;  
3. Infant mortality, perinatal mortality;  
4. Standardized mortality rates;  
5. The incidence and prevalence of chronic mass diseases.  
6. The registers of vital events in the population (birth certificate, death certificate);  
7. Routine health statistics.  
 
In the City of Nis we have 19,1% older than 65. The mean age of the population was 43.1 
years, the aging index is 141.2. 
The birth rate is 8.6 ‰, the general fertility rate, 38.7 ‰, the mean age of mothers at elivery 
29 years, born in marriage was 75.6% of children, the rate of nupciality was 4.2 ‰, the rate of 
divorceiality 1,3 ‰, divorce rate/ 1000 marriages 303 ‰ (one third), low birth weight 8.2% of 
newborns. 
Overall mortality rate was 15.0 ‰, the natural increase was 6.3 ‰, life expectancy from 2010 
to 2012. year. M = 72.5 and F = 77.3 years, the infant mortality rate was 8.6 ‰, the rate of 
early neonatal mortality rate was 3.7 ‰, the perinatal mortality rate of infants was 11.6 ‰, 
the rate of mortality was 8.0 ‰, the mortality rate of children under 5 years was 3.7 ‰. 
In the structure of causes of death and cardiovascular disease continues to lead with 49.7%, 
with 21.7% of tumors, insufficiently defined conditions R00-R99 with 7%. 
The health care system in the Republic of Serbia, organized and run it three institutions: the 
Ministry of Health of the Republic of Serbia, National Health Insurance Fund of Serbia and 
the Public Health Institute of Serbia "Dr Milan Jovanovic Batut". 
The Ministry of Health is responsible for the overall organization and operating health system 
in and the preservation and improvement of public health, responsible for the operation of 
health insurance, regulated health policies, determines standards for work of ealth services, 
regulating quality control mechanisms and controls, organizes and monitors the work of the 
inspection services in the field of health care and total oversees and promotes the work of 
health institutions in Serbia. 
Republic Health Insurance Fund of Serbia raises funds for health insurance that citizens pay 
from salaries and fund the provision of health care. Negotiate and finance the work of health 
institutions in Serbia purchasing plans of health facilities and controls the fulfillment of 
contractual obligations. Financing of health care institutions is based on the current situation 
and the available resources of the Fund. Absolutely funded health care provision in the health 
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care plan from the network, except institutes for public health and health facilities that provide 
rehabilitation services. 
Public Health Institute of Serbia "Dr Milan Jovanovic - Batut" together with a network of 
institutes of Public Health in Serbia, collecting data about the health of citizens and the work 
of health institutions, analyzes the collected data on the health status and suggest measures for 
improving the health status of the citizens of Serbia, accompanied by the adoption and 
implementation of plans of health institutions in Serbia, monitor staffing situation in the 
health care and education of their movement, coordinated development of health information 
system. Performs other healthcare services in the field of social medicine, hygiene, 
epidemiology and microbiology. 
Health care is organized and operates through primary, secondary, and tertiary health care 
through health care at all three levels. 
At the primary level of health care provided by health centers, pharmacies and institutes. 
Serbia has organized 158 health centers, 35 pharmacies and 16 institutes. Insured health 
insurance fund users used services at the primary level only with health card. Insured Fund for 
health insurance usually included in the health care system right in the home health, and with 
the guidance of his chosen doctor moving towards health institutions of secondary and tertiary 
health care. Within the framework of activities of the Public Health Institute in Nis organized 
12 community health centers. 
Health care at the primary level include: 
1) protection and promotion of health, prevention and early detection, treatment, rehabilitation 
of sick and injured;  
2) preventive health care to the population groups exposed to increased risk of disease and 
other residents, in accordance with a special program of preventive health care;  
3) health education and counseling for health improvement;  
4) The prevention, early detection and control of malignant disease;  
5) the prevention, detection and treatment of diseases of the mouth and teeth;  
6) home care visits, treatment and rehabilitation at home;  
7) Prevention and early detection of disease, health care and rehabilitation for persons placed 
in institutions for social welfare;  
8) emergency medical care and ambulance transport;  
9) pharmaceutical health care;  
10) Rehabilitation of children and youth with disabilities in physical and mental development;  
11) mental health;  
12) palliative care; 
At the secondary level in the Republic of Serbia, it is organized the 77 hospitals, 40 general 
and 37 special. Patients are referred to the hospital when their health problems beyond the 
competence of medical doctors of primary health care home health conditions or need an 
expert opinion of a higher level of health care. At this level of health care is organized in the 




Health care at the secondary level involves specialized consulting business. In relation to 
health activity at the primary level include more complex measures and procedures for the 
detection of diseases and injuries as well as treatment and rehabilitation of sick and injured 
with the use of appropriate equipment and personnel as prescribed by the Ministry of Health. 
Hospital health activities include the diagnosis, treatment and rehabilitation, health care and 
accommodation in hospitals, and pharmaceutical services in a hospital pharmacy. 
When exhausted all treatment options in general or special hospital patient is referred to the 
highest level of care at the tertiary level. Refers to the clinical centers in our country which 
has 4 (Belgrade, Nis, Novi Sad and Kragujevac) or one of the clinics (6) or institute (16) and 
KBC (4). At this level of care patient arrives with instructions chosen physician, based on the 
advice of medical doctors in general and special hospitals. 
Health care at the tertiary level includes the provision of the most complex forms of health 
care and specialist-consultative and hospital health activities with the use of sophisticated 
equipment and more specialized medical doctors. This level of care is organized in places 
where there is a college of health professions. So that in these institutions carry out scientific 
research and educational activities. In the area of activity of the Public Health Institute in Niš 
has two tertiary health institutions. 
For more levels of health care in the Nisava and Toplica administrative district organized by 
the Public Health Institute, Department of Forensic Medicine and the Institute for Blood 
Transfusion 
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3. WRITING AND PRESENTING SCIENTIFIC PAPERS 
 
Miodrag Stojanović, Zorica Antić, Dijana Stojanović 
Public Health Institute Niš, Serbia 
 
Objectives: The aim is to inform scientists and health professionals with the basic elements 
of writing and presenting scientific papers. 
Materials and methods: Defining the rules of correct citation and academic writing is 
determined on the basis of the APA and the Vancouver Convention, in order to reach the 
necessary level of academic writing. 
Results: In accordance to the Vancouver Convention parts of the manuscript are: Title page; 
Abstract with Key words; Text; Acknowledgements (to the authors’ desire), References, and 
Enclosures. The text of the articles includes: Introduction, Methods, Results, and Discussion. 
Results should be presented in logical sequence in the text, tables and illustrations. Emphasize 
or summarize only important observations. Discussion is to emphasize the new and significant 
aspects of the study and the conclusions that result from them. Relate the observations to 
other relevant studies. Long articles may need subheadings within some sections to clarify 
their content. 
Conclusion: Writing a scientific paper is the most common way of communicating the results 
of research to other scientists and to health professionals. It goes without saying that authors 
should at all times have in mind objectivity, clarity and honesty in reporting their research. 
The format for writing a scientific paper for publication in biomedical journals has been 
standardized to provide a systematic and organized way to present the data. 
 
Key words: Writing, presenting, scientific papers 
 
 
The standard of academic writing and correct citation have long been accepted in the world , 
while with us still meet with texts that are written out of the rules, which is difficult to follow 
and that are understandable only to the authors and the inner circle of insiders. 
The basics of international standards writing tied to 1928. when a group of publishers met in 
Madison Bently (USA), made a report and published 7 pages entitled Psihologycal Bulletin, 
which is now known journal of the American Psychological Association (APA). The 
document was revised in 1952, then 1974, then 1983 and 1984, and the last version of the 436 
page was published in 2007. 
In late 20th century APA standards and Vancouver convention, have become a major 
documents within which they move instructions to authors of most magazines and publishing 
houses. 
Scientific work is a written and publicized report from original research that contributes to 
knowledge and understanding of a problem , and that can be checked and repeated by any 
competent researchers. Published papers represent a stimulus for further research and their 
number is an indicator of creative productivity of researchers. 
Types of scientific papers are: Original scientific papers, review articles, letters to the editor, 
preliminary reports, theses and presentations at conferences. Original scientific papers are the 
 186 
 
most important publications and the primary source of scientific information and a carrier of 
new ideas and knowledge. 
 
Preparation of manuscript 
Parts of the manuscript are: Title page; Abstract with Key words;Text; Acknowledgements (to 
the authors’ desire), References, Enclosures. 
1. Title page 
a) The title should be concise but informative, while subheadings 
should be avoided; 
b) Full names of the authors have to be signed with exact names and places of department(s) 
and institution(s) ofaffiliation where the studies were performed, city and the state for 
anyauthors, clearly marked by standard footnote signs; 
 
2. Abstract and key words 
The second page should carry a structured abstract (250-300 words for original articles and 
meta-analyses) with the title of the article. In short, clear sentences the authors should write 
the Background/Aim, major procedures–Methods (choice of subjects or laboratory animals; 
methods for observation and analysis), the obtained findings – Results (concrete data and their 
statistical significance), and the Conclusion. It 
should emphasize new and important aspects of the study or observations. A structured 
abstract for case reports (up to 250 words) should contain subtitles Introduction, Case report, 
Conclusion). Below the abstract Key words should provide 3–10 key words or short phrases 
that indicate the topic of the article. 
 
3. Text 
The text of the articles includes: Introduction, Methods, Results, and Discussion.  
Introduction. The introduction should tell the reader why the research was started, and make 
clear what question the research was designed to answer. Research is not a fishing expedition. 
It is designed with a specific question in mindAfter the introductory notes, the aim of the 
article should be stated in brief (the reasons for the study or observation), only significant data 
from the literature, but not extensive, detailed consideratuion of the subject, nor data or 
conclusions from the work being reported. 
Methods. Replicability of results is the heart of science. The methods section should provide a 
detailed exposition of the research design. A reader of the methods section should be able to 
repeat the study and to validate the findings. A methods section less than two double-spaced 
pages is probably inadequate.The selection of study or experimental subjects (patients or 
experimental animals, including controls) should be clearly described. The methods, 
apparatus (manufacturer's name and address in parentheses), and procedures should be 
identified in sufficient detail to allow other workers to reproduce the results. Also, give 
references to established methods, including statistical methods. Identify precisely all drugs 
and chemicals used, with generic name(s), dose(s), and route(s) of administration. State the 
approval of the Ethnics Committee for the tests in humans and animals. 
 
F. Session: SOCIAL MEDICINE   48. DPM 
187 
 
Results. The objective of the research should be kept in mind. Results that do not relate to the 
research objective should not be mentioned. Sufficient detail should be given to allow  
other scientists to assess the validity and accuracy of the results. Statistics should not take 
over the paper, but statistical analysis of the results should be adequately described. Results 
should be presented in a logical sequence in the text, tables, and illustrations. Tables and 
graphs are often extremely helpful in summarizing large amounts of data. Authors should not 
repeat in the text the numerical data contained in figures and tables. should be presented in 
logical sequence in the text, tables and illustrations. Emphasize or summarize only important 
observations. 
Discussion is to emphasize the new and significant aspects of the study and the conclusions 
that result from them. Relate the observations to other relevant studies. Link the conclusions 
with the goals of the study, but avoid unqualified statements and conclusions not completely 
supported by your data. Good papers have a targeted discussion, to keep it focused. The 
discussion should preferably be structured to include the following six components (Docherty 
and Smith, 1999):  
• statement of principal findings  
• strengths and weaknesses of the study  
• strengths and weaknesses in relation to other studies  
• meaning of the study, possible mechanisms and implications for clinicians and  
policymakers  
• unanswered questions and future research  
• conclusion. 
 
References. References should be superscripted and numerated consecutively in the order of 
their first mentioning within the text. All the authors should be listed, but if there are more 
than 6 authors, give the first 6 followed by et al. Do not use abstracts, secondary publications, 
oral communications, unpublished papers, official and classified documents. References to 
papers accepted but not yet published should be cited as ”in press“. Information from 
manuscripts not yet accepted should be cited as ”unpublished data“. Data from the Internet are 
cited with the date of citation. 
 
Tables and Illustrations. Each table should be typed on a separate sheet, numbered in the 
order of their first citation in the text in the upper right corner and supplied with a brief title 
each. Explanatory notes are printed under a table. Each table should be mentioned in the text. 
Any forms of graphic enclosures are considered to bi figures and should be submitted as 
additional databases in the System of Assistent. Letters, numbers, and symbols should be 
clear and uniform, of sufficient size that when reduced for publication, each item will still be 
legible. Each figure should have a label on its back indicating the number of the figure, 
author's name, and top of the figure (Figure 1, Figure 2 and so on). If a figure has been 






Citation of references 
The reference section is an important part of a scientific paper. The number of references 
should be restricted to those that have a direct bearing on the work described. Except for 
review articles, it is rarely necessary to have more than 40 references in the longest paper 
(Halsey, 1998). Different standard formats for citing references are used in different scientific 
disciplines. In biomedical sciences, there are two major styles for citing the references: the 
Harvard system and the Vancouver system. 
 
Steps in the process of writing a paper 
The process of writing a scientific paper should start before doing the research, continue 
during the research, and be completed after the research results have been described, analysed 
and interpreted.  
Before the research 
• Search the literature and keep a record of the references. 
• Prepare dummy tables for results. 
During the research 
• Record the results. 
• Update the literature. 
After completion of the research  
• Use a systematic approach, building the paper step by step. Do not try to do the  
whole thing at once. 
• The discussion is the part that requires most careful thought and interpretation. 
• Begin with the easiest section. Deal with individual sections one at a time. 
• Decide on the journal to which the article will be submitted and study its format  
requirements. 
• Write the rough draft: Once you start, write as fast as you can. Do not worry about  
style.  
• Put the paper aside for several days or weeks and then re-read it. 
• Give a version of the paper to a colleague or colleagues to review it. 
 
After successfully performed research and written work by all applicable criteria remains 
another, perhaps the most difficult step. This step is the selection of magazines, sending and 
accepting work for publication. Acceptance of paper and printing is actually a crown work 
and proof that hard work was not in vain. 
 
Charles Darwin said, "A scientist’s life would be a happy one if he had only to observe and 
never to write.” 
 
 





1. Lester JD, Lester JD, Jr. Writing research papers: a complete guide, 10th edition. New 
York, Longman, 2002. 
2. H. Leisma, Modeling the Relevance of Sentences. Detecting Domain Specificity and 
Semantic Relatedness from Scientific Texts, M.Sc. thesis, School of Computing, University 
of Eastern Finland, 2011 
3. T. Turunen, Introduction to Scientific Writing Assistant (SWAN) - Tool for valuating the 
Quality of Scientific Manuscripts, M.Sc. thesis, School of omputing, University of Eastern 
Finland, 2013 
4. Pearce N. Style: What is it and does it matter? In: Hall GM, ed. How to write a paper, 2nd 
edition. London, BMJ Books, 1998: 116–121. 
5. Pipkin FB. How a thesis or dissertation is assessed or examined. In: O’Brien PMS, Pipkin 
FB, eds. Introduction to research methodology for specialists and trainees. London, Royal 
College of Obstetricians and Gynaecologists Press, 1999: 248–253. 
6. Skelton JR, Edwards SJL. The function of the discussion section in academic medical 
writing. British Medical Journal, 2000, 320: 1269–1270. 
7. Strunk W Jr. The elements of style. 4th edition. New York, Longman, 2000. 
8. Wildsmith JAW. How to write a case report. In: Hall GM, ed. How to write a paper. 2nd 
edition. London, BMJ Books, 1998: 70–76. 
9. Ambrose, H. W., III. and K. P. Ambrose. 1995. A handbook of biological investigation. 






4. SETTING THE MAIN CRITERIA TO PLAN CARE PATHWAYS 
 
Aleksandar Višnjić 
Public Health Institute Niš, Serbia 
 
Abstract 
Objectives: A care pathway is a complex intervention for the mutual decision making and 
organisation of care processes for a well-defined group of patients during a well-defined 
period. Care pathways provide better health care and reduce unnecessary variations in 
practice. It is a relatively new clinical process improvement tool that has been gaining 
popularity across various healthcare institutions worldwide. A care pathway defines the 
optimal care process, sequencing and timing of interventions by healthcare professionals for a 
particular diagnosis or procedure. The objective of the study was to to find out whether there 
is universal care pathway pattern for health care facilities and to derive key characteristics of 
care pathways. 
Materials and methods: Our investigation was done in UCSC, Rome, Italy, from March to 
April 2014. Our search strategy was finding proper information on Pubmed and Embase, for 
which we used the following terms: "care pathway", "critical pathway", "clinical pathway" or 
"integrated care pathway". We also searched the reference lists of relevant articles. To 
approach the best analyses, the DELPHI method was used. 
Results: We focused on 32 existing articles about care pathways developed by individual 
hospitals for specific diseases. Care paths were developed through collaborative efforts of 
physicians, nurses, pharmacists, and others to improve the quality and value of patient care. 
They were designed to minimize delays and resource utilization and to maximize quality of 
care. Care pathways were also used as a tool to implement local and national guidelines into 
everyday practice. But, national health systems are different from each other, and healthcare 
institutions within the same system have their own individual characteristics. When selecting 
an appropriate topic to develop a care pathway, the criteria like common condition or high-
risk condition was mostly taken into account. They became a documented sequence of clinical 
interventions that help a patient progressively move through a clinical experience to a desired 
outcome. 
Conclusions: There is no universal form of care pathway that could be consistently applied in 
all health facilities. It is necessary for each institution in accordance with their needs to 
develop its own care pathways, because they are specific. Physicians and practitioners have to 
be the key players in any pathway development and implementation. There is a real danger 
when critical pathways are brought in from external sources on the basis of administrative 
attempts to reduce costs. 
Main messages: Physicians have to be the key players in any pathway development and 
implementation. It is essential to design and implement care pathways into organisational 










Many synonyms exist for the term ICPs (Integrated Care Pathways) including: Clinical 
Pathways, Critical Pathways, Multidisciplinary pathways of care, Pathways of Care, Care 
Maps, Collaborative Care Pathways, Critical or Clinical Paths. 
Critical Path and Process Mapping methodology was used in industry, particularly in the filed 
of engineering from as early as the 1950s. In the 1980’s, clinicians in the USA began to 
develop the pathway tool within Managed Care; they were redefining the delivery of care and 
attempting to identify measurable outcomes. They were focusing on the patient rather than the 
system, but needed to demonstrate efficient processes in order to fulfill the requirements of 
the insurance industry. Developed and used initially for the purpose of cost containment, in 
the UK in the late 1980s, the emphasis has been to use clinical pathways as a quality tool. 
They were developed in response to the initial Diagnostic Research Group based prospective 
reimbursement system of the early 1980’s at the New England Medical Center by Karen 
Zander and Kathleen Bower, among others. In the early 1990’s the NHS in the U.K. funded a 
patient focused initiative to support organizational change. This resulted in the investigation 
and development of concepts such as pathways. 
Clinical Pathways as introduced in the early 1990s in the UK and the USA were being 
increasingly used throughout the developed world. Clinical or Critical Pathways are 
structured, multidisplinary plans of care designed to support the implementation of clinical 
guidelines and protocols. They are designed to support clinical management, clinical and non-
clinical resource management, clinical audit and also financial management. They provide 
detailed guidance for each stage in the management of a patient (treatments, interventions 
etc.) with a specific condition over a given time period, and include progress and outcomes 
details.  
Clinical Pathways aim to improve, in particular, the continuity and coordination of care across 
different disciplines and sectors.  
Care Pathways can be viewed as algorithms in as much as they offer a flow chart format of 
the decisions to be made and the care to be provided for a given patient or patient group for a 
given condition in a step-wise sequence. A clinical pathway is a tool used in achieving 
coordinated care and desired outcomes within an anticipated time frame by utilizing the 
appropriate resources available. It is a blueprint that guides the clinician in the provision of 
care. ICPs are preconceived patient care algorithms, or paths, that are intended to reduce 
variability and cost, increase efficiency, and ultimately improve patient care. Pathways 
provide patient focused care with benefits to the patient, family and members of the multi-
disciplinary team. They allow for the continuous evaluation and improvement of clinical 
practice and help to stimulate research. Their use represents a new approach to patient care, 
fulfilling many of the demands of clinical practice. 
Critical pathways as care plans that detail the essential steps in patient care with a view to 
describing the expected progress of the patient have four main components:  
• a timeline 
• the categories of care or activities and their interventions 
• intermediate and long term outcome criteria and  
• the variance record (to allow deviations to be documented and analysed).  
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Critical paths are developed through collaborative efforts of physicians, nurses, pharmacists, 
and others to improve the quality and value of patient care. They are designed to minimize 
delays and resource utilization and to maximize quality of care. Clinical Pathways differ from 
practice guidelines, protocols and algorithms as they are utilised by a multidisciplinary team 
and have a focus on the quality and coordination of care. The approach and objectives of 
clinical pathways are consistent with those of total quality management (TQM) and clinical 
continuous quality improvement (CQI). 
A clinical pathway is a method for the patient-care management of a well-defined group of 
patients during a well-defined period of time. A clinical pathway explicitly states the goals 
and key elements of care based on Evidence Based Medicine (EBM) guidelines, best practice 
and patient expectations by facilitating the communication, coordinating roles and sequencing 
the activities of the multidisciplinary care team, patients and their relatives; by documenting, 
monitoring and evaluating variances; and by providing the necessary resources and outcomes. 
The aim of a clinical pathway is to improve the quality of care, reduce risks, increase patient 
satisfaction and increase the efficiency in the use of resources. 
 
The European Pathway Association (EPA) defines a care pathway as “a complex intervention 
for the mutual decision making and organization of care processes for a well-defined group of 
patients during a well-defined period”. 
It is important that physicians and practitioners be key players in any pathway development 
and implementation. There is a real danger when critical pathways are brought in from 
external sources and implemented on the basis of administrative attempts to reduce costs. 
The real impact of critical pathways and appropriateness protocols is their use as tools for 
collection of information. Pathways can serve as a screening test for inefficient care. The 
danger is that a pathway with too many critical areas under review will be too sensitive, 
resulting in the review of a large number of marginally appropriate cases. Review of critical 
pathway data should be focused on the highest-impact areas in terms of either cost, quality of 
care, or preferably, both. 
But the first issue is that critical pathways address processes in the “ideal” patient and in some 
cases do not address issues in the majority of patients who enter the path. Identification of 
appropriate patients to enter the pathway is an important issue in implementation. In general, 
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critical pathways are more applicable to patients with uncomplicated illnesses who are 
undergoing procedures or surgery. 
Integrated Clinical Pathway development: 
1. Select a Topic 
Topic selection in general should concentrate on high-volume, high-cost diagnoses and 
procedures. 
2. Select a Team 
It is important to develop a multidisciplinary team for critical pathway development. Active 
physician participation and leadership is crucial to the development and implementation of the 
pathway. 
3. Evaluate the Current Process of Care 
Data are key to understanding current variation. Scan a map of processes. Providing a 
framework for collecting data on the care process. 
4. Evaluate Medical Evidence and External Practices (Evidence-Based Medicine) 
After key rate-limiting steps have been identified, the critical pathway team must evaluate the 
literature to identify evidence of best practices. 
5. Determine the Critical Pathway Format 
The format of the pathway may vary widely. Important features include a task-time matrix in 
which specific tasks are specified along a timeline. There is a spectrum of pathways that range 
from a form that takes the place of the medical record to a simple checklist. A reduction in 
charting that may occur with more complicated pathways is a benefit.  However, if the 
pathway format is too difficult to follow, it will not be used. 
6. Document and Analyze Variance (Evaluation) 
Variances are patient outcomes or staff actions that do not meet the expectation of the 
pathway. In general, variance in clinical pathways is a result of the omission of an action or 
the performance of an action at an inappropriate (often late) time period. Because the critical 
pathway is a series of time-associated actions, this analysis of variance can be overwhelmed 
by multiple data points. Another approach is for the pathway team to concentrate on a few 
critical items in the pathway that have been identified in advance, such as extubation time 
after cardiac surgery or length of stay in the intensive care unit. 
7. Pathway implementation 
Critical pathway implementation can be a challenge, and if not handled well, it can generate 
major obstacles. Factors critical in implementation include education of all staff members 
who will be involved in any component of the pathway. This is particularly true of non 
participants in 
pathway development. Concerns and misconceptions about the pathway should be addressed. 
One obvious concern would be repercussions of failure to follow the clinical pathway. 
A synergy appears to develop when pathways and algorithms are used together. 
Clinical pathways are multidisciplinary plans (or blueprint for a plan of care) of best clinical 
practice for specified groups of patients with a particular diagnosis that aid in the coordination 
and delivery of high quality care. They are a documented sequence of clinical interventions 
that help a patient with a specific condition or diagnosis move, progressively through a 
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clinical experience to a desired outcome. Predominantly, they are management tools and 
clinical audit tool that are based on clinical information developed in other guidelines or 
parameters. They are specific to the institution using them. 
Recognized benefits of ICPs are: 
• Support the introduction of evidence-based medicine and use of clinical guidelines 
• Support clinical effectiveness, risk management and clinical audit 
• Improve multidisciplinary communication, teamwork and care planning 
• Can support continuity and coordination of care across different clinical disciplines 
and sectors 
• Provide explicit and well-defined standards for care 
• Help reduce variations in patient care (by promoting standardisation) 
• Help improve clinical outcomes and improve and even reduce patient documentation 
• Support training and optimise the management of resources 
• Can help ensure quality of care and provide a means of continuous quality 
improvement 
• Support the implementation of continuous clinical audit in clinical practice  
• Support the use of guidelines in clinical practice 
• Help empower patients, manage clinical risk and improve communications between 
different care sectors 
• Disseminate accepted standards of care and provide a baseline for future initiatives 
• Not prescriptive: don't override clinical judgement 
• Expected to help reduce risk and costs by shortening hospital stays. 
Potential problems and barriers to the introduction of ICPs are: 
• May appear to discourage personalised care 
• Risk increasing litigation 
• Don't respond well to unexpected changes in a patient's condition 
• Suit standard conditions better than unusual or unpredictable ones 
• Require commitment from staff and establishment of an adequate organisational 
structure 
• Problems of introduction of new technology 
• May take time to be accepted in the workplace 
• Need to ensure variance and outcomes are properly recorded, audited and acted upon. 
Anyway, issues for discussion which still remain in everyday practice are the differences 
between clinical protocols/ guidelines and care pathways. 
An integrated critical or clinical pathway defines the optimal care process, sequencing and 
timing of interventions by healthcare professionals for a particular diagnosis or procedure. 
That is why it is essential to design and implement care pathways into organisational strategy 
which will provide its improvement and also to be used as a tool to implement local and 
national guidelines into everyday practice. But, national health systems are different from 
each other, and healthcare institutions within the same system have their own individual 
characteristics. When selecting an appropriate topic to develop a care pathway, the criteria 
like common condition or high-risk condition is mostly taken into account. They become a 
documented sequence of clinical interventions that help a patient progressively move through 
a clinical experience to a desired outcome. 
There is no universal form of care pathway that could be consistently applied in all health 
facilities. It is necessary for each institution in accordance with their needs to develop its own 
care pathways, because they are specific. Physicians and practitioners have to be the key 
players in any pathway development and implementation. There is a real danger when critical 
pathways are brought in from external sources on the basis of administrative attempts to 
reduce costs. 
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5. EMBEDDING RESEARCH INTO HEALTH CARE SYSTEM: EXPERIENCE 
FROM ENGLAND, UK 
 
Boban Savelyich 
National Health Service, Great Britain 
 
Abstract 
Research plays a key role in developing public health policy and practice. According to the 
World Health Organisation’s last year report, universal health coverage, with full access to 
high-quality services for health promotion, prevention, treatment, rehabilitation, palliation and 
financial risk protection, cannot be achieved without evidence from research. Preventive 
medicine too, as a field of public health, can only be effective if informed by research and 
evidence. 
In this presentation, the aim was to describe some experiences of embedding research into 
health care from the UK National Health Service (NHS), and in particular such practice across 
England. As this is one of the largest single healthcare systems in the world, it should offer a 
unique insight on relevant practical health research policy initiatives. 
The objectives were first to present some facts related to the NHS and health research, then to 
describe some barriers encountered in embedding such research into daily practice and finally 
to mention some of the UK government policies that directly or indirectly address health care 
research. In particular, the attention way paid to two pieces of the UK health care legislation 
(Health and Social Care Act, 2012 and Care Act, 2014) and their attributed impact on the 
research by presenting some data on current participant recruitment in the NHS. 
 
Benefits of research: public health and preventive medicine 
 
Research plays a key role in developing public health policy and practice. According to the 
World Health Organisation’s last year report, titled “Research for Universal Health 
Coverage”, universal health coverage, with full access to high-quality services for health 
promotion, prevention, treatment, rehabilitation, palliation and financial risk protection, 
cannot be achieved without evidence from research. 
One of the key messages from the report was that research for universal health coverage 
requires national and international backing. Embedding research into health care systems was 
recommended, principally through developing national research agendas, raising funds, 
strengthening research capacity, and making appropriate and effective use of research 
findings. 
Preventive medicine too, as a field of public health, can only be effective if informed by 
research and evidence. For example, findings from studies on the health effects of high salt 
intake have led to a reduction in the salt content of processed foods; and research has guided 
the introduction of new immunisation programmes, such as the meningitis C vaccine that has 
been extremely successful in controlling the disease. Research is also critical to evaluate 
whether public health policies and practice are effective. Studies have shown that the number 
of hospital admissions for heart attacks has reduced since the introduction of the ban on 
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smoking in public places. In this presentation, I aim to describe some experiences of 
embedding research into health care from the UK National Health Service (NHS), and in 
particular such practice across England. As this is one of the largest single healthcare systems 
in the world, it should offer a unique insight on relevant ractical health research policy 
initiatives. 
My objectives are to first present some facts related to the NHS and health research, then 
describe some barriers encountered in embedding such research into daily practice and finally 
mention some of the UK government policies that directly or indirectly address health care 
research. In particular, I will draw your attention to two pieces of the UK health care 
legislation (Health and Social Care Act, 2012 and Care Act, 2014) and their attributed impact 




The health care system in the UK has workforce that includes 1.3 million NHS employees in 
England, 1.5 million community services employees and 5 million community carers. There is 
an estimate that UK employs 25% of all those who work in the medical biotechnology sector 
in Europe.  
The NHS is an ecosystem split between commissioners and providers. It also places an 
emphasis on GPs and clinicians to influence commissioning decisions in response to their 
patients’ needs. There are 250 secondary care Trusts, and primary care is delivered by 20,000 
GPs across 8,000 practices. Since its inception in 1948, envisaged as the service “free for all 
at the point of care” the NHS has enjoyed a 4% increase in expenditure in real terms year on 
year, although these finances have been frozen since 2011. Currently, the commissioners have 
been allocated £65 billion to spend on healthcare. Previously, research in the NHS suffered 
through the diversion of money intended for research and infrastructure support into direct 
patient care. NHS  managers are subject to intense pressures to deliver immediate healthcare 
targets, and understandably afford a low priority to research. As a result, the NHS was often 
perceived by the academic and commercial community to be a challenging and inconsistent 
research partner. 
 
Drivers for embedding research into UK health care system 
 
Consistent with the global health strategy, the current UK government, particularly in 
England, has now committed themselves to have research at a core of the healthcare system. 
The public overwhelmingly believe the NHS should support research into new treatments – 
93% believe their local NHS should be encouraged or required  to support research (Ipsos 
MORI, 2011. Public support for research in the NHS. AMRC: London). The NHS have 
responded to this by stating in their constitution that it is committed “… to innovation and to 
the promotion and conduct of research to improve the current and future health and care o f 
the population”. The UK government has also recognised that investing in research in the 
NHS and in public health is vital to improve all aspects of patient care, including prevention, 
diagnosis and treatment, and ultimately patient outcomes. There is evidence that research has 
facilitated the introduction of new innovations and approaches which ultimately saved the 
NHS money. In 2009-10, public funders invested almost £3 billion in health research in the 
UK, with over £1 billion coming from medical research charities. A vibrant research 
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environment in the NHS brought broader societal benefits including employment and 
investment from the pharmaceutical industry as it made the UK a more attractive location for 
research. For example, there is data showing that a £1 increase in government or charity 
spending on medical research could lead to an increase in private research spending from the 
pharmaceutical industry of between £2.20 and £5.10.  
Specific national health research strategies adopted so far are the Strategy for UK life 
Sciences (2011) aiming to facilitate increased collaborations between industry, the NHS and 
academia and Innovation Health and Wealth, accelerating adoption and diffusion in the NHS 
(2012). 
In relation to research structures, the UK government created back in 2006 the National 
Institute for health Research (NIHR).This is a principal national institution for driving 
research into healthcare setting, acting as central research facilitation, training and 
commissioning organisation. It has also established a number of Clinical Research Networks 
principally intended to facilitate implementation of clinical research into NHS. The NIHR has 
ringfenced budget, currently around £1 billion.  
More recently, in 2013 the government established Academic Health Science Networks 
(AHSN). Their main aim is to improve patient outcomes and generate economic benefits for 
the UK by promoting and encouraging the adoption of innovation in healthcare. There are 
currently 15 such networks across England, and It is estimated that their funding will be in the 
region of £2 per head of population served. With a population averaging 3m people, a typical 
AHSN might have expected roughly £6m per AHSN per year.  
Some barriers identified to successful embodiment of research into health 
system 
-Time taken to navigate complex research approval processes. An analysis from Cancer 
Research UK showed that after its funding for a study has been agreed, it has taken an 
average of 621 days to recruit the first patient (N=25 studies, period November 2006 to July 
2007) 
-Changes to organisational structures and culture are required to support research. This needs 
the engagement of staff at all levels. Leadership and high-level recognition of the value of 
research are 
particularly important. 
-Healthcare commissioners appear not to have sufficient support to establish, coordinate and 
develop expertise that allows them to engage meaningfully with research. 
-There is little evidence that patient and public engagement is integrated 
‘at all levels of the health and wellbeing system’ including research as a core component of 
that system. Involving patients and the public in research helps deliver high quality, more 
relevant research.  
-There are no viable safe and secure systems and governance arrangements that enable 
researchers sufficiently to access both anonymous and identifiable patient information for 
important research, while protecting patients and researchers. 
-There is need for a workforce and leadership trained to demand,understand and utilise 
research and innovation to improve patient care. 
-The practice of the adoption and spread of new innovations within the NHS is often very 
slow and sometimes even the best of them fail to achieve widespread use. 
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An intervention to towards effective health research: Legislation 
In addressing some of the barriers to embedding research into health care, the British 
Government has brought about for the first time in the history of health legislation a new Act 
that directly referred to the duty of ensuring research is used and promoted across the health 
care system. This is also 
one of rare examples of such legislation worldwide. This Act is known as Health and Social 
Care Act 2012 (HSCA). Collateral to enactment of the Act, the NHS England has started a 
public consultation on the health research strategy. This consultation is currently on-going, 
but there have been few themes that form bases for such strategy. These are: 
-Identifying and prioritising commissioning health services research topics and coordinating 
this work with the Department of Health, NIHR, Health Research Authority, research 
charities, industry and other stakeholders. 
-To develop the evidence base in relation to models of commissioning to ensure the approach 
to commissioning services is based on best research evidence and effectiveness. 
-To increase capacity amongst NHS England and commissioning staff to undertake research, 
and to utilise the outcomes of research, thereby increasing the quality of care and treatment. 
-To ensure the inclusion of patients in setting priorities for research and participation in the 
design, delivery, and dissemination of research. 
-To promote the ideal that every patient coming into the NHS is offered an opportunity to take 
part in research. 
-To increase the availability of information on current and completed 
research and research outcomes to the public. 
-To maximise the benefits from research through innovation, income, knowledge 
improvement and impact. 
Another recent legislation to influence health research is the Care Act 2014. Some of the 
relevant provisions were establishing the Health Research Authority (HRA) as statutory non-
departmental public body, with a remit to protect the interests of people in health and social 
care research. This act enables the HRA to lead in standardisation and implementation of 
effective research governance and ethics procedures for obtaining approvals to implement 
health research in the NHS. In addition, HRA ensures publishing research summaries and 
Research Ethics Committee opinions, promoting trial registration (desirable for all studies, 
and mandatory for clinical trials) and work towards mandatory publication of research 
results/data. There is a consensus in the UK research community that the current health care 
legislation was one of the most effective intervening variables contributing to driving and 
maintaining effective patient recruitment into research studies across England. The following 
data provided by the NIHR on patient recruitment into research studies in the NHS for 
2013/14 goes towards backing up this claim: 
_ For the first time, 100% of NHS Trusts recruited into research` studies 
_ There were 604,216 participants recruited into clinical studies, which is 21% above target; 
_ Over 77% of studies obtained research implementation permission at all sites within 40 
calendar days (around 3% short of declared target) 
_ There were an increased proportion of commercial contract studies in the NHS, with the 
recruitment above target by 22%. 
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_ Performance on the delivery of commercial contract studies to time and target has reached 
73%, which is a 25% increase on performance compared to 2012/13. 
(Comparison figures for the performance before year 2012, i.e. pre-legislation, in the 
appendix) 
 
Conclusions & Implications for preventive medicine 
 
In conclusion, a demonstrated high level commitment from policy makers, particularly if 
backed up in a form of enacted legislation, can significantly contribute to efficient and 
effective embodiment of research into the health system. Some other specific policy-level and 
practical recommendations 
coming out form the UK experiences are: 
o Provision of details of how the commitments to promote research and innovation will be 
delivered in practice  
o Development of mechanisms to deliver research locally 
o Establishment of streamlined and robust regulation and governance of health research 
o Integration of meaningful patient and public involvement in research 
o Enablement of the safe and secure use of patient data for research 
o Development of the health research workforce 
o Support for innovation in the health system 
These recommendations are fully consistent with the WHO measures outlined in the 
“Research for Universal Health Coverage” report. They will also have implications for 
preventive medicine practice, as it is expected there will be more opportunities to establish a 
good research-evidence base for variety of preventive programmes. 
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1. SETTING THE QUALITY INDICATORS FOR DIABETES CARE IN PRIMARY 
HEALTH CARE 
 
Vojvodic Katarina, Pocuca V, Marotic V.  
Public Health Institute, Belgrade, Belgrade, Serbia 
 
Objectives: This study was aimed to analyse  quality indicators in diabetes health care and to 
explore problems that occurred during the indicators collection.  
Materials and methods: We used data collected in 16 primary health centres in Belgrade 
from 2010 to 2013. To identify the patients we used ICD-10 codes E10-E14. Two process 
indicators were collected: the percentage of patient with measured level of HbA1c (once a 
year) and the percentage of patient that have been referral to ophthalmologist for yearly 
fundus examination.  
Results: Only one third of patient received opserved testing (25,9% in 2011, 34,4% in 2012 
and 32,6% in 2013 for ophthalmology testing;  31,9% in 2011, 29,9% in 2012 and 32,9% in 
2013  for laboratory testing).The percentage vary among health centres (from 3% to 100%). 
We identify problemes. Health centres didn’t have the same information system with ability 
to extract needed reports. Some used data collected in paper. Doctors spent more time on 
administration, they missed to note patients.  
Conclusion: Quality of care for patients with diabetes is insufficient. Electronic informational 
systems should be improved to support monitoring of quality indicators. Medical 
professionals should be informed about importance of valid and complete data collecting.  
 





2. SYSTEMATIC ASSESSMENT OF MODELING STUDIES FOR INFORMING 
HEALTH CARE DECISION MAKING  IN SERBIAN HEALTHCARE SYSTEM 
 
Vladica Veličković MD1, Slađana Jović1, Aleksandar Višnjić 1,2, Olivera Radulović1,2, 
Čedomir Šargić 1,2 
 
1 University of Niš Faculty of Medicine, Serbia  
 
2 Public Health Institute Niš, Serbia 
 
Objectives: The objective of our study was to identify and analyze published full economic 
evaluations using decision-analytic models for various health interventions in Serbian 
healthcare system and make recommendations for the development of future models. 
Materials and methods:  We performed a systematic literature search in electronic databases 
(MEDLINE, ScienceDirect, Cochrane Database and NHS EED) to identify published studies 
in Serbian healthcare system using mathematical models. Required inclusion criteria were: 
clearly defined study population in relation to relevant clinical and patient-relevant health 
outcomes over a defined time horizon. Standardized forms for data extraction, description of 
study design, methodological framework, data sources for each model and quality assessment 
of studies were used.  
Results: Six studies were included in the qualitative synthesis. Modeling approaches included 
decision trees, Markov cohort models and state-transition microsimulation models. Most 
models applied a lifetime horizon. All models identify and analyze in our assessment did not 
report on formal model validation.  
Conclusions: Lack of sufficiently validation, by new recommendation, is a “fatal flaw” and 
results of such studies should not be trusted for informing health care decision making. There 
are no single modeling study appropriate for Informing health care decision making  in 
Serbian healthcare system according to  new recommendation.  
 
Keywords: Modeling Studies, Economic Evaluations, Decision Making, Systematic 
Assessment, Health Technology Assessment. 
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3. INTEGRATED HEALTH INFORMATION SYSTEM (IHIS) AS A BASIS FOR 
THE DEVELOPMENT OF HEALTH STRATEGY 
 
Kunovska Mimoza, Eftimijadoska F. 
Center for Public Health-Bitola, R.Makedonija  
 
Objectives:To describe the role of modern information technology in the development of 
local and national health strategies and experiences of the CPH-Bitola in the integration of a 
local information system with an national information system(2010-2014). 
Material and methods: Health information systems development is looking for the 
knowledge of all the levels and structure of the health system. In the period 2010-2012, the 
Ministry of Health began IHIS project, was made the necessary legal framework and 
established a medical network in public health. 
Results:In 2013 started implementation of the electronic health card (as a separate project of 
HIF) and “MY TERM” system for the electronic generation of instruction in all public health 
network. The integration of local information system with IHIS implied the possibility of 
horizontal and vertical application of HIS in managing resources at local and national level. 
IHIS benefits: accurate information about used recourses and delivered services. Key issues 
are: simplification of the low level interface, data validity and paper documentation, the bi-
directional interfaces with the laboratory. 
Conclusion: Development of IHIS and access to correct information at all health care levels 
is essential in resources management. Exploiting this information will result in timely 
response of the health system in the prevention and treatment. 
 





4. PSYCHOSOCIAL RISK FACTORS IN CLINICAL-HOSPITAL HEALTH 
ACTIVITIES  
 
D. Nikolic, S. Jovic,  D. Bogdanovic 
Public Health Institute Nis 
 
The aim of the work: Consideration of goal-psycho-social hazards or risk factors in clinical-
hospital health activities that may produce poor mental and physical consequences.  
Methodology of the work: Sectional study, conducted the study in which they used two 
standardized questionnaires:  
1. COPSOQ - Questionnaire for the assessment of psychosocial factors in the work 
environment (National Centre for the Working Environment (NRCWE), Copenhagen, 
Denmark)  
2. WAI - Questionnaire for the assessment of the Work Ability Index (Work Ability Index, 
National Institutes of Health and Safety at Work, Finland)  
Included a total of 800 participants (400 physicians and 400 nurses) Clinical Center in Nis; 
100 respondents (50 physicians and 50 nurses) of the General Hospital in Aleksinac and 50 
patients (25 physicians and 25 nurses) Special hospital for nonspecific pulmonary diseases in 
Soko Banja.  
Results: Of the basic characteristics of respondents, use of medications and lifestyles, 
multivariate regression analysis as the most important factors associated with the increase in 
the value of the IRS allocated: living in a household with parents that is associated with an 
increase in the value of the IRS to 0.433 (0.088 to 0.778, p = 0.014) , the use of painkillers 
rarely or never to 0.419 (0.196 to 0.641, p <0.001), and use of tranquilizers rarely or never to 
0.279 (0.014 to 0.544, p = 0.039). The most important factors associated with the decline in 
the value of the IRS were: age 50 to 59 years, which is associated with impairment of IRS to 
0.503 (0.270 to 0.737, p <0.001), age 60 and older to 0.925 (0.456 to 1.394, p <0.001), daily 
intake of painkillers to 0.947 (0.407 to 1.488, p = 0.001), use of tranquilizers one or more 
times per week to 0.627 (0.127 to 1.127, p = 0.014), daily intake of medication for insomnia 
for 0.939 (0.208 to 1.671, p = 0.012) and passive leisure activities, or less than 2 hours per 
week to 0.469 (0.242 to 0.696, p <0.001). Regression model containing the above 9 factors 
and constant regression explains 16.3% of variability values IRS (coefficient of determination 
R2 = 0.163).  
The characteristics of jobs and scores COPSOQ questionnaire on domains, multivariate 
regression analysis as the most important factors that influence the value of the IRS allocated 
internship at the current workplace and scores: quantitative requirements, meaning work, 
obligations in the workplace, trust in leadership, health and samoprocenjenog stress.  
Features that indicate the existence of violence and harassment in the workplace, multivariate 
regression analysis as the most important factors that influence the value of the IRS allocated 
to threats of violence by the subordinates and exposure to physical abuse by managers. These 
factors are associated with significant impairment of IRS and exposure to threats of violence 
by the subordinates of 0.944 (0.094 to 1.793, p = 0.029), and exposure to physical violence by 
the Head of 1.102 (0.046 to 2.158, p = 0.041). Regression model containing these two factors 
and constant regression explains only 1.1% of the variability of the value of IRS (R2 = 0.011). 
Of all the diseases and injuries multivariate regression analysis as the most important factors 
that influence the value of the IRS allocated: a leg injury / foot ishialgiju, disease of the 
lumbar spine, mild mental disorder, illness or injury to the eyes, high blood pressure and 
goiter and other thyroid diseases .  
All three indicators of mental ability multivariate regression analysis confirmed its intent to be 
significant factors affecting the value of the IRS. These factors are associated with an increase 
in the value of the IRS, including: enjoying the daily activities of 0.330 (0.215 to 0.445, p 
<0.001), the activity and bustle of 0.146 (0.011 to 0.281, p = 0.034), and the fulfillment of the 
F. Session: SOCIAL MEDICINE   48. DPM 
205 
 
hope of the future for the 0,219 (0.121 to 0.317, p <0.001). Regression model containing these 
factors and constant regression explains 11.3% of variability values IRS (R2 = 0.113).  
When in a regression model as independent variables included all factors in multivariate 
analyzes by blocks singled out as significant, the final model as the most important analyzed 
factors associated with the values IRS confirms age from 50 to 59 years, age 60 and over, 
taking painkillers every day, or passive leisure activities less than 2 hours per week, scores of 
quantitative demands, obligations at work, meaning work, samoprocenjenog health and stress, 
as well as the enjoyment of daily activities. Age 50 to 59 years is associated with a decline in 
the value of the IRS to 0.441 (0.224 to 0.657, p <0.001), and age 60 and older in 0,841 (0.408 
to 1.274, p <0.001). Daily use of analgesics is associated with impairment of IRS 0.843 
(0.372 to 1.315, p <0.001), and physical activity consisting of passive entertainment or 
activities that are less than 2 hours per week to 0.285 (0.073 to 0.496, p = 0.009). Enjoying 
the daily activities associated with the increase in the value of the IRS to 0.152 (0.046 to 
0.257, p = 0.005). Any increase in the value of the scores of the following domains 1 was 
associated with a significant increase in the value of the IRS as follows: the meanings of work 
to 0.144 (0.078 to 0.210, p <0.001), the obligation to work for 0.068 (0.005 to 0.130, p = 
0.035) and samoprocenjenog health of 0.369 (0.266 to 0.473, p <0.001). Any increase in the 
value of the scores of the following domains 1 was associated with a significant decline in the 
value of the IRS as follows: quantitative requirements for 0.125 (0.056 to 0.194, p <0.001), 
and the stress of 0.082 (0.020 to 0.145, p = 0.010). Regression model containing these factors 
and constant regression explains 27.6% of variability values IRS (R2 = 0.276).  
Conclusion: Solving the problems of psychosocial factors in the workplace is a continuous 
process that requires firstly their familiarity. The practical significance of the study lies in 
interventions organizational character, which will be based on the research results, and 
motivating teams, manager of the health system to continuously monitor their establishments 
psychosocial factors in the workplace and work on their improvement, which would 
contribute to a better quality of life and increase the index working capacity of employees. 




5. MORBIDITY OF CARDIOVASCULAR DISEASE IN NIS AND TOPLICA 
COUNTY IN OCCUPATIONAL HEALTH SERVICES FROM 2000 TO 2012. 
 
Ristić Saša 1, Nikolić D.1 i Marjanović S.1 
Public Health Institute, Niš 
 
Introduction: General and specific morbidity are medical-statistical indicators of the health 
status of the population (disease of) a certain area in a certain period of time stated in the rates 
of morbidity. The morbidity of heart disease and blood vessels indicates their frequency in the 
territory Nis and Toplica County in the period from 2000 to 2012. 
Aim: Based on the monitored years to establish a growing tendency in the disease group I00-
I99 ICD X morbidity in general medicine.  
Method: The study of morbidity in Nis and Toplica County from 2000 to 2012 and in the 
interval of every three years under routine medical statistics. 
Results: The rates of morbidity in Nis and Toplica County with occupational health services 
in general show a downward looking character that is particularly pronounced in Toplica. 
Such a decline was evident in both districts during the period from 2003 to 2006. Beginning 
in 2003, the rates of morbidity in diseases of the heart and blood vessels Nis County show a 
moderate decline, and as far as Toplica County Shire decline in mortality rates has a 
decreasing trend from 2000 to 2009 in the current year has been an increase and then returned 
decreasing character. Nis County had an increase from 2000 to 2003 and then was constantly 
moderate decline in overall morbidity of diseases of the heart and blood vessels. 
Conclusion: It is to maintain a high level of preventive examinations of the economically 
active population, considering the prevalence of cardiovascular disease in recent years among 
the younger population. Emphasize the importance of healthy lifestyles and to isolate all the 
risk factors and their impact on the health of the economically active population from which 
the greater potential coverage. 
 
Key words: Cardiovascular diseases, occupational medicine, Nis and Toplica County 
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6. USER SATISFACTION IN PRIMARY HEALTH CARE HEALTH OF CHILDREN 
IN NIS AND TOPLICA DISTRICTS IN 2013. YEAR. 
 
Marjanović Stanko 1, Milošević Z.1, 2, Marković R.1, Nikolić D.1 Ristić S.1  
1
 Public Health Institute, Nis 
2 Faculty of Medicine, Nis  
 
Introduction: Quality of care is evaluated in relation to the relevant indicators of quality of 
medical institutions. According to the Regulations on the verification of the quality of work of 
health institutions, health workers and associates internal quality checks are carried out on the 
basis of an annual program for monitoring the quality of work based on a survey of users. 
Aim: The objective of the survey was to determine the degree of satisfaction with services 
provided in health facilities. The results of research are the basis for the planning of activities 
for the improvement of the quality of work in the future. 
Methods: Patient satisfaction was conducted according to the methodology of the Ministry of 
Health of the Republic of Serbia, the questionnaires adopted and applied research in recent 
years. Respondents completed the questionnaires voluntarily and anonymously in order to 
implement the survey. 
Results: Overall satisfaction of respondents in healthcare services for children in 2013, in 
terms of overall satisfaction with health care in this service, shows a high percentage share of 
77.9% of users who were in the survey identified themselves as satisfied and very satisfied, 
also recorded a slight percentage decrease compared to the previous year when the overall 
satisfaction of the respondents in the services for the health care of children was 79.9%. 
Responses of other users are 20.1%, of which 5.4% were dissatisfied and very dissatisfied 
with health care services in the health care of children, while 16.7% of users gave a neutral 
response and formulated as neither satisfied nor dissatisfied. 
Conclusion: It is an important fact in the health care of children not only a harmonious family 
environment, but also the work of doctors pediatricians, educators, psychologists, speech 
therapists and teachers themselves in the detection and elimination of potential health 
problems of the child in this developmental period. 
 





7. THE IMPACT OF SATISFACTION FACTORS ON OVERALL EMPLOYEE 
SATISFACTION IN HEALTH CARE INSTITUTIONS IN NIŠAVA AND TOPLICA 
DISTRICTS 
 
Roberta Marković1, Zoran Milošević1,2, Aleksandra Ignjatović 1,2, Stanko Marjanović1, Nikola 
Tiodorović1 
1
 Public Health Institute, Nis 
2 Faculty of Medicine, Nis  
 
Introduction: Levels of needed quality in health care changes by time and assessment of 
quality of work in health facilities is dynamic process. The product of health system and its 
employees is health service whose quality is related to satisfaction and motivation of people 
working in health system. Satisfaction of the employee can be measured and can be assessed 
through the influence of different aspects of satisfaction: motivation, communication, 
organization, work conditions. 
The objective of this study was to assess and compare satisfaction with different aspects of 
work as well its influence on complete satisfaction, among different categories of employees 
in health facilities on primary, secondary and tertiary level of health care in Nisava and 
Toplica districts. 
Materials and methods: The study was conducted as one day study in 15 health facilities on 
primary level, 2 public hospitals and 27 clinics of Clinical Centre of Nis, using anonymous 
questionnaire.  3.892 emploees took part in this study, 2.227 from primary and 1.665 from 
secondary and tertiary level. 
Results: Employees’ satisfaction is presented through different factors of satisfaction: 
motivation, communication, organizational, structural. All employees on primary level are 
more satisfied with the majority of aspects of job comparing with employees on secondary 
and tertiary level of health care. Administrative staff is in general more satisfied with all 
aspects of job comparing with other categories of employees. All employees on secondary 
and tertiary level are more physically and psychically exhausted than employees on primary 
level of health care. Health staff on secondary and tertiary level is the most psychically 
exhausted. 
Conclusion: There is difference in satisfaction with different aspects of job at different 
categories of employees, and on different levels of health, in health facilities on Nisava and 
Toplica districts. Employees in health facilities on primary level of health are in general more 
satisfied than employees on secondary and tertiary level of health. Different factors of 
satisfaction influence commplete satisfaction. 
 
Key words: factors of satisfaction, employees, health facilities 
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8. AGE AND SEX DISTRIBUTION OF EMPLOYEES IN HEALTH INSTITUTIONS 
IN THE CITY OF NIS FROM 2003 TO 2013 
 
Mariola Stojanović1, Aleksandra Ignjatović1,2, Miodrag Stojanović1,2 
1Public Health Institute, Niš 
2Faculty of Medicine, Niš 
 
Introduction: Good strategy for the health system development, among other things, requires 
the planning of staff, employed in the health care system. For good planning it is necessary to 
know the structure of employees ranging from the missing branches of specialization to the 
age and sex structure of the existing staff.  
The aim of the Study: Trend of employees movements in health facilities in Nis in the period 
1985.-2013.; review of age and sex structure, as well some medical doctor’s specializations in 
the period 2003-2013. 
Source of data: Annual report on employees in health facilities in the period 1985.-2013 
Results: In the end of 2013. There were 6575 employees in health facilities in Nis. In the 
group of health stuff there were 1359 (20.7%) (64 medical doctors +125 medical doctors on 
specialization +1170 specialists), dentists (151 2.3%), pharmacists (120 1.8%), nurses on 
different levels (420-6.3%; 2616 - 39.3%; 26 0.4%). In the group of nonmedical stuff were: 
co-workers (chemists 17 and other co-workers 101), nonmedical stuff 1765 (26.8%): 
administrative 1137 (135 VSS, 85 VS, 474 SS, 443 NS) and technical stuff 628. Medical 
doctors are one fifth of the stuff (17%-22%), nonmedical stuff has the trend of degrees, but 
not under 26%. Number of pharmacists and higher level nurses has the trend of increase, and 
biggest decrease has number of dentists. Dentists are the oldest among all health workers. 
Pharmacists and nurses on lower level are the youngest group of health workers, then nurses 
with the higher level of education. Age structure of some medical doctors is very unfavorable. 
Only the number of specialist of urgent medicine has the trend of increase, but from 2004, 
there are no younger than 35, and only 2 are younger than 45. Only 1 pathologists and 
gynecologist are younger than 35, and only 4 radiologists are younger than 45. There are no 
specialists younger from 35: for internal medicine from 2011, pediatricians from 2005., 
radiologists from 2005., anesthesiologists from 2008., ophthalmologists from 2009. 
Conclusion: The worst situation is at pediatricians and radiologists were 80% are older than 
45. Age structure of medical doctors is extremely unfavorable. 






9. HOSPITAL HEALTH CARE IN SOUTH BAČKA DISTRICT SINCE YEAR 2003 
TO 2012  
 
Stevančević Nikola1, Jovanović-Mijatović Vesna2, Kvrgić Svetlana2 
1
 Institute for Health Protection of Children and Youth of Vojvodina, Novi Sad, Serbia  
2University of Novi Sad. Faculty of Medicine Novi Sad. Public Health Institute of Vojvodina, 
Novi Sad, Serbia 
 
Hospital health care on secondary and tertiary levels in South Bačka District has been 
provided by 7 healthcare facilities, during the period 2003 to 2012. The aim of this study was 
to analyze changes in functioning and utilization of stationary health care, and also in hospital 
beds capacity and workforce provision on District level, during the period of 10 years. This 
study was obtained using routine health statistics data collected by Public Health Institute of 
Vojvodina, national publications regarding health statistics in Serbia, and also international 
publications (WHO, OECD). The results showed that acute hospital bed capacity (4,71 on 
1.000 inhabitants) is higher than legal acts require (3,30/1.000 inhabitants). Medical doctors 
provision is higher than Republic and Province averages, but at the same time lower than in 
other university centers in the country. During the observed decade, there was registered 
increase in: number of hospital days from 730.487 to 744.328 (+1,9%), number of 
hospitalizations for 21% (88.588 in 2012th), hospitalization rate from 12299,7 (per 100.000 
inhabitants) in 2003th to 14400,1 in 2012th. At the same time, average length of stay shorted 
from initial 9,9 to 8,4 days, and bed occupancy grows up to 70,4% in 2012th (+1,3%), which 
means that stationary health care utilization on District level follows contemporary trends in 
this area.  
 
Key words: hospital health care, South Bačka district, hospital beds and workforce provision, 
health care utilization 
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10. ANALYSIS OF THE SATISFACTION OF SUPPORT AND POSSIBLE 
HEALTH WORKERS TO WORK IN USED SOMEONE THE KNOWLEDGE AND 
SKILLS 
 
Tamara Rangelov 1, Bulatovic K.1, Nikolić D.1, Ristić S.1 
Public Health Institute, Niš 
 
Introduction: Employee satisfaction is an integral part of quality in health care. Quality of 
health care depends on the manner in which the employees perform their work, which is, 
directly associated with their behavior, commitment, experience, and devotion. Basically 
everything is their motivation for work and quality work, as well as their satisfaction with the 
work they are doing. Their functioning within the health institution is not just tasks, but also 
achieve the standards of performance. 
Materials and Methods: This study included 4,582 health and non-health workers employed 
in health care in Nisava and Toplica districts.  
Results and discussion: The fact that (25.7%) of respondents are dissatisfied and very 
dissatisfied with the possibility of professional development, self-defeating in the field of 
vocational training, faster, higher quality and more innovative approach to business. The most 
dissatisfied with the medical staff to be voted (22.5%). When it comes to the possibility of the 
job using their knowledge and skills (16.8%) of these dissatisfied (24.6%) neither satisfied nor 
dissatisfied, and (44.7%) are satisfied and very satisfied, administrative workers very satisfied 
(64.6%) were satisfied and very satisfied, and .health workers (58.5%). 
Conclusion: Employee satisfaction in health care is of particular attention because it has been 
associated with providing quality health care, patient satisfaction, and satisfaction with the 
outcome of treatment of professional development is of particular importance in view of the 
ever increasing levels of professional competence of employees by attending various training 
as internal and of External and continuous. This level of satisfaction with professional 
development is of paramount importance, given that for years have been conducting various 
activities in order to advance the knowledge and professionalism of health workers and 
associates. 
 







11. ANALYSIS OF RELATIONSHIP SATISFACTION BY SOCIAL 
COMMUNICATION AND CLOSE COOPERATION EMPLOYEES IN HEALTH 
CARE FACILITIES IN NISAVA AND TOPLICA DISTRICTS IN 2013. 
 
Katarina Bulatović 1, Rangelov T.1, Nikolić D.1 i Ristić S.1 
Public Health Institute, Niš 
 
Abstract  
Introduction: Employee satisfaction is an integral part of quality in health care. Quality of 
health care depends on the manner in which the employees perform their work, which is, 
directly associated with their behavior, commitment, experience, and devotion. Basically 
everything is their motivation for work and quality work, as well as their satisfaction with the 
work they are doing. Their functioning within the health institution is not just tasks, but also 
to communicate with colleagues, which greatly affects the quality of work. 
Materials and Methods: This study included 4,582 health and non-health workers employed 
in health care in Nisava and Toplica districts. 
Results and discussion: When it comes to interpersonal relationships, 48.5% of employees to 
identify themselves as satisfied and very satisfied, somewhat more than one-quarter, 23.4% 
were dissatisfied and very dissatisfied, while 28.0% "neither satisfied nor dissatisfied." Health 
care workers are most satisfied (49.0%), while the distribution disgruntled by all categories of 
employees is very similar. Direct collaboration with fellow employees are generally satisfied 
(64.5%) administrative workers (47.7%), health workers (48.5%), and health care assistants 
(40.1%) and technical workers (43.2 %). 
Conclusion: This level of satisfaction with the direct cooperation with colleagues is of 
paramount importance, given that for years has been conducting various activities in order to 
promote teamwork, improve cooperation between health workers and associates. The fact that 
three thirds of employees to identify themselves as satisfied and very satisfied with the direct 
cooperation with colleagues is encouraging in terms of quality of work, quality of health 
services and the final effect. 
 
Keywords: job satisfaction, quality of health care, health care institutions,  
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12. PATIENT SATISFACTION AS AN INDICATOR OF THE QUALITY OF 
HEALTH CARE IN CHILDREN HEALTH CARE SERVICES IN PRIMARY 
HEALTH CARE CENTERS IN NISAVA DISTRICT 
 
Marija Andjelkovic Apostolovic1, Ignjatovic A.2,3, Stojanovic M.2,3, Milosevic Z.2,3, 
Apostolovic B.1 
1University of Niš, Faculty of Medicine 
2University of Niš, Faculty of Medicine, Department of Medical Statistics 
3Insitute of Public Health Niš  
 
Abstract 
Introduction: The quality of health care is considered a priority in the context of well-being 
of a patient as an individual, the population and the potential of one country. It is a dynamic 
process because levels of required quality change over time. The aim is to increase the 
effectiveness and efficiency while ensuring a certain level of equity in the provision of health 
services. 
The Aim: The aim of this study is to assess the level of patient satisfaction with health care 
provided in Children Health Care Services in Primary Health Care Centers in Nisava districts. 
Materials and Methods: A cross sectional study of children health care was conducted in 10 
Primary Health Centers in Nisava region in 2013. 1,043 out of 1,150 patients took the 
questionnaire to fill out, and 992 questionnaires were completed and returned (response rate 
95.10%). The study used an anonymous survey defined by the Republic Committee for 
Quality, the Ministry of Health of the Republic of Serbia. 
Results and discussion: In relation to the total satisfaction, 79.5% of patients declared as 
satisfied or very satisfied. The highest percentage of patients (77.9%) had selected their 
pediatricians and this study confirms that the awareness of the existence of selected 
pediatricians is greater than in previous years. 
Conclusion: More than three quarters of surveyed patients declared as satisfied or very 
satisfied with the work of the Department of Pediatrics in Health care centers in Nisava 
region. The awareness of the existence of selected pediatricians is far greater than in previous 
years and all the surveyed patients have a selected pediatrician (the greater percentage has 
selected their pediatrician themselves).  
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Abstract 
Echinococcosis (hydatid disease, HD; cystic echinococcosis, CE) is a global parasitic disease, 
the incidence and prevalence of which have been markedly reduced in recent decades. 
Although it is an ancient disease, it is regretfully still a current public health problem in many 
countries worldwide, even in the regions where the implementation of disease surveillance 
and control has been successful. The highest prevalence of CE has been observed in the 
countries with moderate climates. Geographical distribution of CE is variable throughout 
Serbia, and the territory of Niš municipality is a region with high seroincidence and 
seroprevalence of this parasitic disease. Numerous methods of molecular biology have made 
possible the genotyping and identification of Echinococcus spp. strains, which may contribute 
to a deeper insight into the epidemiological scenarios in individual regions. The most 
common strain in the world, associated with human CE, is the sheep strain (G1). There are 
numerous direct and indirect, and invasive and non-invasive methods in the diagnosis of CE. 
Imaging methods are suitable for the purposes of screening and detection of new cases of the 
disease, while the tests for detection of specific serum antibodies are suitable for 
serodiagnosis of CE. 
Key words: hydatid disease, epidemiology, serodiagnosis 
Introduction 
Echinococcosis is a zoonotic infection caused by the adult form or larva of the cestode that 
belongs to the Echinococcus genus of the family Taeniidae. It is a public health issue 
throughout the world, in spite of the measures of prevention and infection control. There are 
four morphologically and biologically different strains relevant for public health: 
Echinococcus grаnulosus (E. grаnulosus) (Batsch, 1786), the cause of cystic echinococcosis 
(CE); E. multiloculаris (Leuckart, 1863), the cause of аlveolаr echinococcosis (AE); E. 
oligаrthrus (Diesing, 1863); and E. vogeli (Rausch and Bernstein, 1972), the cause of 
polycystic echinococcosis (PE). In some small mammals (E. shiquicus) in the Tibetan Plateau 
and in African lions (E. felidis), new parasitic strains have been identified, with an 
insufficiently understood zoonotic potential (1). In recent years, numerous molecular 
techniques have become available, enabling the identification of certain Echinococcus spp. 
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strains, which may contribute to a deeper insight into the epidemiological scenarios in 
particular regions (2, 3, 4, 5). 
Cystic echinococcosis and AC are geographically widely distributed; they can cause fatal 
disease in humans and, in addition to the medical aspects, they present a huge economic 
problem (1, 2, 4). 
Life cycle of the parasites involves two hosts. The adult cestode inhabits the small bowel of 
carnivores (the final host) and produces eggs containing infectious oncospheres. The eggs 
and/or proglottids are excreted via feces. After an oral intake of eggs/proglottids, 
metacestodes (larva stage) develop in the intermediate (secondary) host. An adult metacestode 
produces numerous protoscolexes which may develop into adult cestode if there is an intake 
by the appropriate primary host (1, 2, 3). 
Cestode eggs contain the embryo, hexacanth, able to survive from six months to a year in the 
external environment. Echinococcal (hydatid) cysts represent the larval forms which develop 
in the secondary host (most commonly sheep, cattle, goats, horse, pig, and rarely men) (6). 
Humans are random (aberrant), secondary host to the larval stage of E. grаnulosus (dog 
tapeworm) which causes the disease termed echinococcosis, hydatid disease (HD), or cystic 
echinococcosis (CE). Cysts may form in various tissues after the ingestion of E. granulosis 
eggs. This form of echinococcosis is termed primary CE. Secondary CE (mostly localized in 
the abdominal cavity) is the result of spontaneous or trauma-induced cyst rupture and release 
of protoscolexes and/or small cysts that can grow into large cysts. On the average, 40-80% of 
patients with primary CE have single organ involvement and a solitary cyst (2, 3). In men, 
cysts are commonly localized in the liver (60%), lungs (about 20%), and rarely in the spleen, 
brain, and bones (4, 5, 6). 
When a men, as a secondary host, ingests the eggs, the hexacanth embryo casts away its 
membrane and actively penetrates the mucosa and bowel wall till it enters the lumen of a 
blood or lymph vessel. It reaches the liver via bloodstream, where it commonly stays for 
longer and transforms into a hydatidigenic cyst. The transformation progresses slowly, about 
1 cm in diameter in several months (about 5 months). The cyst stays alive for years. The cases 
of 10 to 20 years old cysts have been reported. The embryo, if it does not stay in the liver, can 
reach the lungs. If it passes the lung barrier, reaching systemic circulation, it is able to 
colonize any organ or tissue (1-6). 
The initial phase of primary infection is always asymptomatic. Small, well incapsulated, non-
progressive or calcified cysts usually do not cause complaints and patients continue living 
without any clinical manifestation of CE for years or for life (3). Disease development 
depends on the number, size and degree of development of the cyst(s) (being active or 
inactive ones), compression of the adjacent tissues and structures, and defence mechanisms of 
the host. The degree of growth of these cysts may vary depending on the involved organ and 
also on the region in the world the infected person is from (7, 8, 9). Ultrasound studies in the 
South America have demonstrated that the average cyst diameter in persons with 
asymptomatic echinococcosis is smaller (4 cm on the average) than in those with manifest, 
symptomatic disease (about 10 cm) (9). Clinical manifestations of echinococcosis can become 
evident after a very variable incubation period, from several months to several years (9, 10, 
11). 
Alveolar echinococcosis (AE) is a parasitic infection caused by E. multilocularis strain in the 
metacestode phase, which resembles an infiltrative and destructive tumor with a potential to 
induce serious, highly fatal disease (1-3). After the ingestion of E. multilocularis eggs, 
metacestodes develop almost exclusively in the liver. The size of these lesions in the liver is 
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very variable, from a small focus of several millimeters, to large infiltration zones from 15 to 
20 cm in diameter. Primary extrahepatic sites of E. multilocularis metacestode are extremely 
rare. From the liver, metacestodes spread via lymph or blood vessels to adjacent or distant 
organs, forming the infiltrations or metastases there (1-3). It has been believed for long that E. 
multilocularis metacestodes maintain an unlimited proliferative capacity till the patient death. 
However, under the influence of host defence mechanisms, metacestodes may become 
calcified and die. Spontaneous healing of AE is therefore possible, but the frequency of such 
an outcome is not known (3). 
In one third of the affected, clinical manifestations of AE are not specific enough (fatigue, 
loss of weight, hepatomegaly, abnormal values of routine laboratory parameters usually 
occur) and in two thirds cholestatic jaundice and/or epigastric pain may be encountered (3). 
The diagnosis of AE is based on the similar criteria and findings as in CE (patient history, 
clinical findings, morphological liver findings detected by imaging techniques, 
immunodiagnostic tests) (1-3). 
Epidemiology of human echinococcosis 
Worldwide incidence of human echinococcosis is between 1 and 200 per 100.000 inhabitants 
(1-4). Cystic echinococcosis in animals and humans prevails in the countries with the 
moderate climate, and in the south of South America, in the Mediterranean, southern and 
central parts of the ex-Soviet Union, in central Asia, China, Australia, parts of Africa, but it is 
also present in the regions with colder climates. In North America, from arctic Alaska 
approximately to the northern border of the United States, two natural cycles involve the wolf 
and wild reindeer and wolf and elk (moose) (1-4). The prevalence of human CE is highest in 
those involved in sheep farming (2). The diagnose of echinococcosis in the USA is most 
common in immigrant populations from the countries where the disease is endemic. 
Sporadically, autochthonous transmission has been reported in Alaska, California, Utah, 
Arisona, New Mexico (1, 2, 3). CE occurs in all age groups, even in those below one year of 
age and those over 75, and in both genders. In certain regions endemic for echinococcosis, 
most hospitalized cases belong to the age group from 21 to 40 years, but the highest disease 
rate is reported in younger persons aged 6 to 20 years (3). The distribution of patient 
occupation may vary from country to country, depending on the epidemiological and 
socioeconomic circumstances (2). 
In Europe, the incidence of echinococcosis ranges from 1 to 8 per 100.000 inhabitants, except 
for the countries of northern and central Europe and the Carribean, where echinococcosis is 
sporadical and/or is not reported at all. In Iceland and Greenland there is no echinococcosis, 
and New Zealand, Tasmania, southern Cyprus are „provisionally free“ of the infection (2, 3, 
14, 15, 16). Geographical characteristics of island countries have contributed to the control 
and suppression programs to be markedly more successful compared to other areas (1-3). 
The infection with E. granulosis is endemic and/or hyperendemic in most countries in the 
region. A study undertaken in six regions in Italy has shown a wide variability of infection 
rates in sheep (11-87%) (3). In Sardinia, the highest prevalence of echinococcosis in dogs and 
sheep was reported, while the yearly prevalence of human CE was 8.0 per 100.000 in 1990. 
The average incidence in the whole country for the period 1980-1984 was 1.92 per 100.000 
inhabitants, ranging from 0.46 to 10.1, depending on the region (3). 
In recent years, echinococcosis as an endemic/hyperendemic infection has been documented 
in many of the Balkan countries (the territory of former Yugoslavia, Romania, Bulgaria, 
Greece) (3, 16, 17). Due to a worse socioeconomic situation and cessation of control 
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programs for echinococcosis in Bulgaria, the rates of this parasitic disease are on the rise 
again in both animal and human populations. In the period from 1971 to 1995, in dogs and 
sheep, the rates of incidence of echinococcosis per year rose, as well as the average yearly 
number of surgical interventions (both new and repeated ones) for human CE throughout the 
country (from 176 to 291) (3). In 1995, the average incidence rate by the districts ranged from 
1.9 to 15.8 per 100.000, being highly endemic especially in southern parts of Bulgaria (3, 17). 
In the period 2001-2010, incidence rates ranged from 3.88 to 9.27 per 100.000 (18). In 
contrast to Bulgaria, Hungary is the country with lowest yearly incidence of echinococcosis 
(0.05-0.13). After a long period in which there were no information about echinococcosis in 
Albania, some recent data have shown extremely high values of the infection incidence (5.27 
cases per 100.000) (18). The study by Calma et al. detected a yearly incidence rate of 
echinococcosis of 3.8 cases per 100.000 in western Romania in the period 2004-2010 (19). In 
Greece, the prevalence of CE in domestic animals ranged very widely (from 82% to 56.6% in 
cattle; 80% and 100% in sheep; 24% and 15.4% in goats; and 5% and 9.3% in pigs) from the 
middle 1980s to middle 1990s. The proportion of human CE in surgical cases dramatically 
rose, from 12.9 per 100.000 inhabitants in 1984 to 29% in 1999 (16). In Greece, after a 
veterinary surveillance undertaken near the end of the 20th century, the prevalence of 
echinococcosis in cattle was reduced (i.e. there were no reports of HD in cattle) (16), while a 
recent study in central Greece revealed the incidence rate of 39.3% in sheep (20). In humans, 
the total incidence rate has been on the rise in recent years (being even as high as 12.7 per 
100.000 inhabitants); some recent studies have documented a significant drop of incidence 
rates (0.122 per 100.000 inhabitants), which does not agree with a large number of cases of 
human CE diagnosed yearly in surgery departments (and almost half of the affected are 
surgically managed) (4).  
In the territory of former Yugoslavia, echinococcosis was the leading infectious parasitosis. 
More recent data for the period 2001-2010 demonstrated the following values of incidence of 
echinococcosis: Former Yugoslav Republic of Macedonia, 0.3-1.89; Bosnia and 
Herzegowina, 0.32-1.06; Croatia, 0.23-0.81 and Slovenia 0.005-0.4 (18). 
Geographical distribution of CE is diverse in Serbia. The cummulative incidence of reported 
cases in the period 2001-2010 ranged from 0.46 per 100.000 in the central part of the country, 
to 39.0 cases per 100.000 in the south of Serbia. In the territory of Belgrade, the cummulative 
incidence was low (1.3 cases per 100.000 inhabitants in the period). The results of the 
analysis by Bobić et al. demonstrated that women were more commonly infected compared to 
men, especially those over 40 years of age, while the affected individuals most commonly 
inhabited rural regions (21). 
In the territory of the Niš municipality, in the period 1988-2000, the seroincidence of 
echinococcosis was significantly high, ranging from 2.02 to 10.86 per 100.000 inhabitants 
(22). The results of the last study showed that the Niš municipality was an area with 
exceptionally high seroincidence and seroprevalence rates of echinococcosis (23). The 
cummulative seroincidence of SE was 10.79 per 100.000 in the period 1988-2010. In the 
period 1988-1998, the seroprevalence of CE was 25.4%, and the introduction of new 
serological tests elevated the percentage of prevalence to 33.0% (23). 
Based on the data of the laboratory for immunodiagnosis of parasitic and fungal infections in 
the Center of Microbiology in Niš, the cummulative incidence rate of echinococcosis in the 
last three years (2011-2013) was 19.01 per 100.000 inhabitants, with average yearly disease 
rate of 6.33. In the analyzed period, the values of incidence rates ranged as follows: 5.89 in 
2011; 7.76 in 2012; and 5.35 per 100.000 inhabitants in 2013. In the analyzed period, the 
seroprevalence values were markedly lower (14.5%), ranging from 12% to 20%. In the 
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serological diagnosis of echinococcosis, in addition to the primary tests to detect specific IgG 
antibodies against E. grаnulosus in the patient sera, a secondary, confirmatory immunoblot 
test (Western Blot, WB) was utilized, enabling the confirmation and differentiation of E. 
grаnulosus/E. multilocularis strains, leading to a reduction of prevalence of echinococcosis in 
the territory of Niš municipality in the observed period.  
Methods of molecular biology have made possible the genotyping of E. grаnulosus and 
identification of 10 genotypes (G1-10): G1 and G2 sheep strains; G3 and G5 bovid strains; G4 
a horse strain; G6 a camelid strain; G7 a pig strain and G8 in wolves, dogs, mooses and elks 
in the northern parts of North America and Euroasia, the so called cervid or northern sylvatic 
genotype (a cervid strain). G9 genotype has been described in pigs in Poland, and G10 in elks 
in Eurasia. The sheep strain (G1) is the most common genotype worldwide and most 
commonly associated with human infection (3-5). In Serbia, by way of genotyping, the 
presence of E. granulosus sensu stricto G1 and E. canadensis G7 has been confirmed in 
humans (24).  
Variable geographical distribution of E. granulosus genotypes exists in different hosts, with 
some major public health implications. A shorter maturation period of adult parasite forms in 
the gut of the dog indicates that the interval of administration of antiparasitic agents to 
infected animals has to be shortened in the regions with G2, G5, and G6 genotypes (3-5). 
A widely present practice of feeding dogs with sheep entrails in households facilitates the 
transmission of sheep genotypes and increases the risk of human infection (1-3). The dogs 
infected with E. granulosus excrete the eggs via feces, and humans can be infected via 
contact, especially children in their play with dogs. Eggs accumulate around the anus of an 
infected dog, and can be also found on the hips and paws. Indirect transmission of eggs, via 
contaminated water, uncooked food, flies and arthropodes, as the consequence of poor 
mnagement of waste materials and lack of analyses in wild animals, can also lead to human 
infection (1-3). 
Alveolar echinococcosis is present in the northern hemisphere, with endemic regions being 
central Europe, northern and central Eurasia, parts of North America, and certain regions of 
northern Africa (Tunisia) (3). 
The first case of human AE was reported in Germany in 1852 (2, 3). In central Europe, till the 
end of the 1980s, endemic regions were reported in four countries (Austria, France, Germany, 
Switzerland). More recent data indicate that the geographical distribution of AE extends to 
another 12 countries (2, 3). A new focus of AE was identified in 1999 on the Svalbard islands 
in Norway (3). In central European countries, the prevalence of E. multilocularis in red foxes 
varies from <1% to >60%. There are signs of an increase in risk factors for this parasitic 
disease (an increased prevalence of the parasite in foxes, growth of population of foxes and 
their progressive expansion to urban areas after reduced incidence of rabies as the result of 
successful per os vaccination) (2, 3). In Serbia, the first case of E. multilocularis in the 
European beaver has been recently reported (25). 
In the Mediterranean region, human cases of AE have been reported in Turkey and Iran. E. 
multilocularis is endemic in large portions of the Russian Federation and neighbouring 
countries. In the People’s Republic of China, E. multilocularis is mainly distributed in the 
western and central parts of the country. In Japan, E. multilocularis is endemic in Hokkaido, 
while in North America it is present in the Alaskan and Canadian northern barren grounds 
(tundra), in the south of the northern central region of the USA, including the parts of three 
Canadian provinces, and also in thirteen other states of the USA. Most human cases of AE 
G. Session: CURRENT PARASITOSIS   48. DPM 
219 
 
have been reported in the northern zone, and only two cases in the northern central USA (1-
4). 
At the time of diagnosis, the patients with AE are mostly older adults of both genders. In 
Europe, the age of AE cases ranges from 10 to 89 years, peaking in the age group 50-70 years 
(3). 
E. vogeli and E. oligarthrus, the causes of human PE, are endemic in Central and South 
America. To date, at least 96 human cases of PE have been diagnosed in the area from 
Nicaragua in the north, to Chile, Argentina and Uruguay in the south (3). 
Immunodiagnosis of human echinococcosis 
In most cases, the diagnosis of echinococcosis can be made by the detection of characteristic 
structures and size of Echinococcus spp. cyst(s) using different imaging techniques, primarily 
by ultrasound (US) (1-5). The technique is suitable for screening purposes and detection of 
new cases of echinococcosis. Portable US machines have been used in recent years, since they 
can be easily transported and used in verious environments (3, 26). Nowadays, there are 
numerous direct and indirect methods, both invasive and non-invasive, and it is very 
important to select the simplest and cheapest methods, with as few as possible adverse effects, 
being most efficient at the same time. A group of experts for echinococcosis has presented 
some general recommendations for the diagnosis of this parasitic disease (3). 
Immunodiagnostic methods intended to detect specific antibodies to Echinococcus spp. 
antigens in the serum make possible the diagnosis of echinococcosis in patients observed 
and/or differential diagnosis in cases with unspecific findings yielded by the imaging 
techniques. The results of immunodiagnostic methods also make possible the epidemiological 
surveillance of echinococcosis, being of utmost importance in the prevention and control of 
the disease. 
In clinical practice, tests to detect specific antibodies in the serum have special significance in 
immunodiagnosis of echinococcosis. However, in some patients with echinococcosis, in spite 
of high values of sensitivity of the above tests, false negative results can be encountered. A 
low titer of antibodies and/or their absence can occur if echinococcus cysts are anatomically 
situated in the brain or eye, as well as in calcified echinococcal cysts, regardless of the 
anatomical site. Antibody response can be weak in some population groups and in infants. In 
contrast, false positive results can occur in patients with some other helminthic infections (3, 
5).  
Out of serological tests to detect echinococcal antibodies in the serum of patients suspected to 
have CE, primary and secondary tests are recommended (3, 5). The usage of several primary 
tests (the enzyme-linked immunosorbent assay for detecting of IgG, IgG-ELISA; the indirect 
hemagglutination antibody test, IHAT; latex agglutination test, LAT are commonly used in 
laboratories and less frequently, immunofluorescence antibody test, IFAT;  
immunoelectrophoresis, IEP and some other tests) can increase the method sensitivity. 
Positive serology obtained by a primary test should be confirmed using a secondary 
serological test (2, 3). 
Many laboratories use at least two different primary tests for routine diagnosis of CE, since 
the results of serological tests depend on a multitude of factors (test quality, training of the 
personnel, organ involvement, number of hydatid cysts, individual patient reactivity, and so 
on) with a possible impact on test sensitivity. Regretfully, there is no standard, highly 
sensitive and specific serological test to detect antibodies in human CE cases (3, 5). 
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In recent years, several secondary test systems have been used in specialized laboratories 
(double diffusion method, identification of IgG subclass, immunoblotting, indicating the 
reactivity of serum antibodies with subunits of E. granulosus antigens). These tests are less 
sensitive but more specific than primary test systems (1-3). 
The tests of IgG antibodies against E. granulosus antigens are less important in the 
assessment of treatment results (surgery and/or chemotherapy), in contrast to IgG subclass 
analysis, which is superior in demonstrating the qualitative changes of parameters in the 
serum (3). 
Early diagnosis of AE is considered to be a precondition for an effective treatment of the 
affected people (101). Population screening for AE in the endemic regions of Japan and 
Europe have clearly shown that early diagnosis can reduce both morbidity and mortality, as 
well as treatment related costs. AE diagnosis is based on the findings and criteria similar to 
those in CE. Serological tests intended to detect serum antibodies are more reliable in AE 
diagnosis than in CE diagnosis. In immunodiagnosis of human AE, out of the primary ones, 
two types of tests to detect antibodies (IgG) are used. The first, type A tests are highly 
sensitive and specific, and use purified E. multilocularis antigens (Em2-antigen, the Em18-
antigen, the Emalkaline phosphatase-antigen, the C-antigen) or the recombinant antigens II/3-
10 and Em10. The second, type B tests are less sensitive and specific and use raw E. 
granulosus or E. multilocularis antigens. In everyday practice, type A tests should be 
preferred as primary tests because of diagnostic sensitivity ranging from 90% to 100% (1-5). 
Similar to the immunodiagnosis of CE, secondary tests (an enzyme immune test with E. 
multilocularis protoscolex-antigen, IgG4 determination in ELISA, Western blot analysis) can 
be used to evaluate the results of basic tests in AE immunodiagnosis, as well as in the 
exclusion of cross reactivity in a positive serum (3). A Western blot test has been made 
available commercially (Echinococcus WB IgG, LDBIO Diagnostics, Lyons, France) and 
enables discrimination between AE and CE with a reliability of approximately 76% (1-5, 11, 
28). Serological tests have limited value in the evaluation of effectivity of surgical and 
chemotherapeutic treatment of AE, as well as the viability of E. multilocularis metacestode 
(1-5). 
Conclusion and prospects 
Literature data show that human echinococcosis is still a huge public health burden in many 
countries worldwide. Studies have so far demonstrated that the territory of the Niš 
municipality is endemic for echinococcosis, which is still a large public health issue. The 
indicants of rising health risks to humans regarding this parasitic disease are alarming. A 
globally coordinated health surveillance system and assessment of risks for contracting this 
parasitic disease is a task for the international community as a whole, as well as continued 
surveillance and improvement of control and measures of prevention of echinococcosis. 
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2. RADIOLOŠKA DIJAGNOSTIKA I INTERVENTNE RADIOLOŠKE METODE U 
LEČENJU EHINOKOKUSA JETRE 
2. RADIOLOGICAL DIAGNOSIS AND INTERVENTIONAL RADIOLOGICAL 
PROCEDURES IN TREATMENT OF HEPATIC HYDATID CYSTS 
 
Zlatko Širić1, A. Tasić1,  M. Stojanović2 
1Center of Radiology, Clinical Centre Niš 
2General Surgery Clinic, Clinical Centre Niš  
Introduction: Ultrasound examination is the first choice in radiological diagnostics of hepatic 
hydatid disease presenting with different ultrasound appearences of the cysts and the 
possibility of classification into six groups (WHO IWGR, 2001). Multi-detector computed 
tomography (MDCT) and magnetic resonance imaging (MRI) play a major role in diagnosing 
complicated cases, and especially in the diagnosis of postoperative recurrences.  
Method: In the past, surgery was the only acceptable therapeutic approach in treatment of 
cystic hydatid disease of the liver. Percutaneous treatment (PAIR - puncture, aspiration, 
injection and reaspiration)  has long been contraindicated because of possible complications, 
such as spillage, dissemination and anaphylactic shock. Numerous studies have not proven 
these claims. The indications for PAIR are multiple cysts, existing contraindications for 
surgical treatment, pregnancy and relapses following surgical procedures. Percutaneous 
treatment is often combined with prophylaxis by albendazole. 
Results: The success of percutaneous treatment for uncomplicated cysts ranges up to 88 % 
with a small number of recurrences, up to 10 %, and an average treatment duration of four 
days. 
Conclusion: Ultrasound examination is the method of choice in diagnosis and monitoring of 
patients after percutaneous treatment of cystic hydatid disease. PAIR is a successful 
alternative to surgical treatment due to the shorter duration of procedure, lower morbidity and 
insignificant number of complications. 
Key words: radiological diagnosis, PAIR, cystic hydatid disease 
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3. SURGICAL STRATEGIES AND TACTICS IN LIVER ECHINOCOCCIS 
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4. THERAPEUTIC STRATEGIES AND TACTICS IN ECHINOCOCCIS 
Carmen-Michaela Cretu, Romania 
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ORAL PRESENTATION  
 
1. EHINOKOKOZA U SRBIJI DANAS 
1. CURRENT STATUS OF ECHINOCOCCOSIS IN SERBIA 
 
Branko Bobić, Nikolić A, Klun I, Štajner T, Djurković-Djaković O 
Serbian Center for Parasitic Zoonoses, Institute for Medical Research, University of Belgrade 
Objectives: In Serbia, echinococcosis (CE) is mandatory reportable. We review the officially 
reports as well as the research data published between 1998 and 2012. 
Materials: Official data on human and animal infections were obtained from the Reports on 
Infectious Diseases in Serbia, the Statistical Office and the Ministry of Agriculture. Published 
data were obtained by searching the Medline, Scopus and Google databases using 
“echinococcosis”, “hydatidosis” and “Serbia” as keywords. In addition, the search included 
national journals, doctoral thesesand conference proceedings. 
Results: Inhumans only Echinococcus granulosus has been reported, with a total of 481 cases 
officially reportedbetween 1998 and 2012. Up to 2010, 409 cases wereofficially reported as 
opposed to 851 cases described in clinical studies. No trend in the incidence of infection was 
shown among adults, but the number of cases in children decreased over the period. Infections 
were more frequent in females (67%). A lower incidence of CE was noted in the central part 
of country. Among domestic animals asharp decrease in the CE prevalence was registered 
(from 14 to1% in sheep, 13 to 2% in cattle, 9 to 4% in swine).  
Conclusion: In Serbia,echinococcosis remains endemic butis currently not a re-emerging 
infection. 
 
Key words: Echinnococcosis, Serbia, epidemiological data 
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2. PROMOTION OF THE HERACLES FP7 PROJECT ON ECHINOCOCCOSIS 
Olgica Đurković-Đaković 












1. HEALTHY CITY NOVI SAD – HEALTH PROMOTION AND DISEASE 
PREVENTION PROGRAMMES 
 
Olja Nićiforović Šurković1, Ač Nikolić E1, Petrović V1.  
Public Health Institute of Vojvodina, Novi Sad 
 
A healthy city is one that continually creates and improves its physical and social 
environments and expands the community resources that enable people to mutually support 
each other in performing all the functions of life and developing to their maximum potential.  
A healthy city is defined by a process, not an outcome. A healthy city is not one that has 
achieved a particular health status. It is conscious of health and striving to improve it. Thus 
any city can be a healthy city, regardless of its current health status. The requirements are: a 
commitment to health and a process and structure to achieve it. WHO/Europe recommends a 
basic model for a healthy city. 
The WHO European Healthy Cities Network consists of cities around the WHO European 
Region that are committed to health and sustainable development: nearly 100 cities and towns 
from 30 countries. They are also linked through national, regional, metropolitan and thematic 
healthy cities networks. A city joins the WHO European Healthy Cities Network based on 
criteria that are renewed every five years. 
Each five-year phase focuses on core priority themes and is launched with a political 
declaration and a set of strategic goals. The overarching goal of the current Phase VI (2014–
2018) is implementing Health 2020 at the local level. 
The following two strategic goals of Health 2020 provide the overarching umbrella of Phase 
VI:  
• improving health for all and reducing health inequities; and 
• improving leadership and participatory governance for health  
Both strategic goals reinforce the strong standing commitment of the WHO European 
Network to addressing equity and the social determinants of health and striving to improve 
governance for health and promote health in all policies. 
Healthy Cities approach seeks to put health high on the political and social agenda of cities 
and to build a strong movement for public health at the local level. It strongly emphasizes 
equity, participatory governance and solidarity, inter-sector collaboration and action to 
address the determinants of health. 
Successful implementation of this approach requires innovative action addressing all aspects 
of health and living conditions, and extensive networking between cities across Europe and 
beyond. This entails explicit political commitment, leadership, institutional change and 
intersectoral partnerships. 
The Healthy Cities approach recognizes the determinants of health and the need to work in 
collaboration across public, private, voluntary and community sector organizations. This way 
of working and thinking includes involving local people in decision-making, requires political 
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commitment and organizational and community development, and recognizes the process to 
be as important as the outcomes. 
The WHO European Healthy Cities Network has six strategic goals: 
1. to promote policies and action for health and sustainable development at the local 
level and across the WHO European Region, with an emphasis on the determinants of 
health, people living in poverty and the needs of vulnerable groups; 
2. to strengthen the national standing of Healthy Cities in the context of policies for 
health development, public health and urban regeneration with emphasis on national–
local cooperation; 
3. to generate policy and practice expertise, good evidence, knowledge and methods that 
can be used to promote health in all cities in the Region; 
4. to promote solidarity, cooperation and working links between European cities and 
networks and with cities and networks participating in the Healthy Cities movement; 
5. to play an active role in advocating for health at the European and global levels 
through partnerships with other agencies concerned with urban issues and networks of 
local authorities; and 
6. to increase the accessibility of the WHO European Network to all Member States in 
the European Region 
The City of Novi Sad has become a member of WHO European Healthy Cities Network in 
December 2012, at the end of the phase V. Novi Sad fulfilled all requirements for designation 
into the Phase V. Sustained local support was acquired by signing a letter of commitment 
from the city mayor, council resolution supporting the city’s participation in Phase V, and 
forming a steering group. Steering group involved political and executive–level decision-
makers from the key sectors. The Healthy City coordinator was nominated and the Public 
Health Institute of Vojvodina was named as expert support for the project implementation. 
The City of Novi Sad enforces health promotion and disease prevention policy throughout its 
bylaw – Rules on Modality and Procedure of Allocation of Assets from the City of Novi Sad 
Budget for Health Programs and Projects (Official Herald of the City of Novi Sad no. 51/2009 
and 3/2011). This bylaw provides financial support for local health systems and NGO’s in 
addressing major health problems, public health issues. 
Based on the document „Health status of Novi Sad population“, policies, strategies and 
activities are recommended to address main public health issues and health problems in the 
City of Novi Sad.  
Relevant competitions are published in the following fields: public health, non-communicable 
diseases prevention, prevention of drugs abuse, procreative policy, separately for health 
institutions (both state and privately owned) and for NGOs. The City of Novi Sad has 
established Committees in the areas above mentioned (assembled of professionals who are 
recognized due to their professional and/or academic work in relevant areas on local, regional, 
national and/or international level) with help from more specialized working groups assess 
technical and professional quality of applications received and, after discussion and 
conclusions of working groups, decide on received competition applications and projects. 
Competitions are public (published in the official herald and on the City web page) as well as 
results. Application and report forms are standardized and professedly published.  
Public Health Programmes 
Committee for Public Health have given priority to the projects and programmes which are 
directed to: education of the citizens, especially vulnerable and hard to reach groups in the 
area of health promotion, disease prevention and use of health care services with the emphasis 
on the preventive services and increase of the encirclement of preventive checkups; education 
of educators especially preschool and school teachers in the area of health promotion and 
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disease prevention; continuing medical education for health care professionals in the area of 
health promotion, and capacity-building for health equity; education and capacity- building of 
decision and policy makers on health and health equity; education of the media. Priority 
topics are healthy lifestyle, healthy eating, physical activity, mental health, suicide prevention, 
smoking and alcohol prevention, HIV/AIDS prevention, preventive health care use, internet 
addiction, preventive checkups and screening etc.  
Non-communicable diseases prevention programmes  
Projects and programmes in the field of non-communicable diseases prevention are sorted in 
five groups: prevention and control of cardiovascular diseases, diabetes, cancers, chronic 
respiratory diseases and chronic muscle-skeletal diseases. Projects are directed to education of 
the citizens about healthy lifestyle, preventing and reducing risk factors, early detection and 
effective treatment etc, as well as continuing medical education of health professionals. 
Priority topics are: healthy heart, risk factors for NCD, healthy eating, physical activity, 
hypertension, educational materials, training in early detection of coronary event and use of 
defibrillators in public places etc. 
Drug Abuse Prevention Programmes  
Projects and programmes in the field of drug abuse prevention are sorted in five groups: 
promotion of healthy lifestyle and community involvement in the prevention, education of 
preschool and schoolchildren, youth, parents, schoolteachers and educators from other 
sectors, peer education, secondary and tertiary prevention, and, production of educational 
materials and tools. 
Procreative Policy Programmes  
Projects and programmes in the field of procreative Policy are sorted in two groups: education 
of children and youth and reproductive health promotion and prevention of women. Projects 
and programmes are directed to education about reproductive health aimed at target 
population groups such as adolescents, women in the reproductive period, pregnant women, 
schoolchildren, young parents and Roma women. Priority topics are contraception, STD 
prevention, reproductive hygiene, puberty and adolescence, psychological and emotional 
changes, relationships, responsible parenting, family planning, pregnancy and delivery, 
postpartum period, breastfeeding etc. 
Examples of good practice in year 2012 
 
Health Promotion Campaign „October – month of healthy eating“ 
Duration: 2004-2012 
Aim: Increasing knowledge and skills about healthy eating  
Target population groups: preschool and schoolchildren, teachers, parents, health 
professionals 
Partners: Public Health Institute of Vojvodina, Primary health care institutions, kindergartens, 
schools, City Health Administration, University of Novi Sad, Media 
Results in year 2012:  
- Health Education Tool “Fruits and vegetables cards” intended for children in all 
kindergartens and primary schools 
- Educational material for all preschool and schoolteachers 
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- Educational seminars for 60 preschool and schoolteachers 
- Educational seminars for 160 health professionals 
- Creative painting and writing about healthy eating Contest (45 kindergartens and 30 schools 
participated) 
- Public event in the City Hall Art and literary works show exhibition of awarded works with 
creative program prepared by preschool children „What we learned about fruits and 
vegetables“ 
- Public event “Let’s cook together” – demonstration of preparation of healthy meals in 
kindergartens and primary schools together with students of Gastronomy 
- Public event “Fruits and vegetables show” in the Shopping Center, with individual 
counseling of the visitors 
 
Promotion of preventive services of Primary Health Care Center „Open door day“ 
Duration: 2007-2012. 
Aim: Promotion of preventive checkups and detection of risk factors for NCD 
Target population: adult population 
Partners: Primary Health Care Center Novi Sad, Emergency Health Care Service, Public 
Health Institute of Vojvodina, City Health Administration, Local community, Media 
Results in year 2012: 
- Health professionals action in public places, outreaching citizens 
- 17 Actions in local community 
-  6307 citizens 
- Preventive checkups and measurements of blood pressure, blood sugar, cholesterol, BMI etc 
- Questionnaire about risk factors 
- ECG monitoring and cardiology counseling 
 
Health education of children Programme „ Healthy calendar“ 
Duration: 2004-2012. 
Aim: Increasing knowledge and skills about healthy lifestyle and safety 
Target population groups: preschool and schoolchildren, teachers, health professionals 
Partners: Public Health Institute of Vojvodina, kindergartens, schools, City Health 
Administration, Media 
Topics presented so far: healthy lifestyle, my body, healthy eating, physical activity, hygiene, 
risk behavior, traffic safety, injury and poisoning prevention, mental health, learning about 
feelings etc.  
Results in year 2012:  
- Production of health educational tool Healthy calendar containing illustrations, instructions, 
workshops and exercises 
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- Year 2012. topic was infectious diseases prevention „Look out of infections“ 
- Educational material for all preschool and schoolteachers containing workshops and the 
theoretical knowledge 
- Educational seminars for 98 preschool and schoolteachers 
- Educational seminars for 83 health professionals 
 
Health promotion actions for persons with intellectual disability „Learn and be active for 
health“ 
Duration: 2010-2012 
Aim: health education and promotion of physical activity  
Target population: persons with intellectual disability 
Principle organizer: NGO Association for support of persons with Down syndrome 
Partners: Persons with disability associations, volunteers, local community, health 
professionals, teachers 
Results: 
- Workshops, lectures about healthy lifestyle every month 
- Physical activity sessions – yoga, dancing, gymnastics, every week 
- Creative art expression sessions 
 
Conclusion 
Health promotion and disease prevention programmes in the City of Novi Sad are supported 
by City Administration for Health through its bylaw. Priority is given to the projects and 
programmes that are directed to health education and health promotion particularly for 
vulnerable population groups, educating educators, providing appropriate amount of health 
education tools and educational materials, facilitating partnership within health sector as well 
as interdisciplinary and multi-sector partnership, empowering health professionals in the area 
of public health and health promotion, empowering local community and NGO’s, and 
continuously providing information about public health issues for the public.  
The City of Novi Sad is dedicated in enforcing health promotion and disease prevention 
programs for over a decade through its policies, strategies and financial support. Since the 
City of Novi Sad has become Healthy City in December 2012, we expect to grow awareness 
and commitment to health, resulting in mobilizing all citizens to take a Whole of Society 
approach. 
Key words: Healthy cities, health promotion programmes, disease prevention programmes 
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2. THE IMPORTANCE AND ROLE OF PROGRAMS FOR THE PROMOTION OF 
REPRODUCTIVE HEALTH 
 
Olivera Radulovic1, Babić S1, Šagrić Č1 




Preserving and improving reproductive health is one of the most important prerequisite for 
getting healthy generations, what the basis of the survival and progress of civilization. 
Promotion of reproductive health is a special part of a overall health promotion. It involves 
educating individuals about the knowledge and skills for the healthy lifestyle selection in the 
area of sexuality, but also the wider social intervention with the aim of construction of 
appropriate public health policies supported by the social environment.  
Reproductive health is directly conditioned by the social, cultural and behavioral factors. 
Reproductive life may seem pleasant, and a supportive events and conditions such as A 
pleasure, intimacy, joy, love, giving birth and raising children and a happy family life, but 
also those that threaten health, such as inequality, abuse and disease. 
Among the many factors that affect reproductive health, fertility regulation is among the most 
important. The fundamental right of women is to have control over their fertility and to have 
secure protection during pregnancy, childbirth and abortion if the pregnancy is unwanted. 
This is especially important since we know that half of all pregnancies are unplanned, and 
one-quarters is unwanted (1). 
 
The importance of programs for the promotion of reproductive health 
 
By protecting women from the risk of pregnancy and its associated complications, programs 
for the promotion of reproductive health can play a vital role in the reduction of infant, child 
and maternal morbidity and mortality. By preventing unwanted pregnancies, programs can 
also reduce abortions by unskilled providers or under unhygienic conditions. However, the 
benefits go beyond improvements in maternal and child health. For girls and women, for 
example, programs for the promotion of reproductive health can result in higher educational 
attainment, better employment opportunities, higher socioeconomic status and empowerment.  
Despite extensive global efforts and investments to reduce maternal mortality, this remains 
high in many developing countries. The 22 million “unsafe” abortions that occur each year 
cause an estimated 47 000 maternal deaths – mostly in developing countries – and lead to 
short-term or lifelong disabilities in many women. It has been estimated that up to one third of 
maternal deaths could be averted through the use of effective contraception by women 
wishing to postpone or cease further childbearing. About 222 million women in developing 
countries are thought to have an unmet need for a modern method of family planning. This 
unmet need is particularly prevalent in certain populations, especially sexually active 
adolescents, individuals with low socioeconomic status, those living in rural communities and 
those coping with conflicts and disasters (1). 
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In some developing countries, increased contraceptive use has already cut the annual number 
of maternal deaths by 40% over the past 20 years and reduced the maternal mortality ratio by 
about 26% in little more than a decade. It has been estimated that a further 30% of the 
maternal deaths still occurring in these countries could be avoided if the unmet need for 
contraception could be fulfilled. Modern methods of contraception would prevent 54 milion 
unintended pregnancies and 26 milion abortions (of wich 16 milion would be unsafe) (2). 
Reduction in maternal and infant morbidity and mortality, access to and use of contraception 
also contributes to individuals being able to take control over their sexuality, health and 
reproduction, thus helping them to achieve a satisfying sexual life. 
WHO programs related to preservation of reproductive health include the following 
objectives:  
  reaching maturity and healthy sexual maturation in addition to creating opportunities for 
equitable and responsible relationships between the sexes, 
 achieving the desired number of children in a safe and healthy way by his own decision 
(when couples decide)  
 prevent diseases and health disorders related to sexuality and reproduction and obtaining 
appropriate care when it needed,  
 preventing violence and other harmful practices related to sexuality and reproduction. 
 
At the International Conference on Population and Development that was held in Cairo, 
Egypt, in 1994, representatives of 179 countries agreed to a programme of action to improve 
global sexual and reproductive health. The representatives called for universal access to 
comprehensive reproductive health services – including family planning information, services 
and supplies – by 2015. Research plays a critical role in the response to such global health 
challenges. It is also essential in identifying and overcoming the social and economic 
inequalities and health system deficiencies that obstruct the achievement of the highest 
attainable standards of sexual and reproductive health for all. Even when highly effective 
interventions exist, implementation research is needed to identify the most effective and 
efficient mechanisms for delivering those interventions. Effective mechanisms and strategies 
to prioritize investments in health-related research are particularly needed in resource-poor 
settings – in developing countries and elsewhere. In addition, any research priorities that are 
set need to be reviewed and updated at regular intervals (3).  
The “Family Planning 2020” initiative builds on the partnerships that were launched at the 
London Summit on Family Planning in July 2012. It is hoped that this initiative will sustain 
the momentum created at the Summit and ensure that all the “partners” are working together 
to achieve the main goal announced at the Summit: making contraceptive information, 
services and supplies available to an additional 120 million women and girls by 2020. The 
partners in the initiative have been tasked with both the identification of any obstacles to 
achieving the initiative’s aims and the recommendation of possible solutions. The plan is to 
identify gaps in our relevant knowledge and the global priorities for action to address the 
unmet need in family planning and growing demand for contraceptives (4).  
 
Historical development of programs for the promotion of reproductive health 
 
The first written records about family planning and methods of regulating fertility of women, 
are in the Ebers papyrus, to physical writings of ancient Babylonians and the scriptures of the 
Vedas. Many grasses, lichens and roots practiced by American Indians - Shoshone and 
Navajo. While in Sparta often practiced infanticide in Athens was known for contraception. 
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Aristotle advocated the legal limit family size and recommended olive and cedar oil as 
contraceptives (5). 
One of the oldest contraceptive method is withdrawal (Coitus interruptus). Biblical records 
state that Onan in preventing pregnancy using withdrawal. St. Augustine was practiced coitus 
interruptus during the 11 years during which time he had only one child. In the 17-century 
99.9% of men were applied interrupted intercourse to prevent conception in Siena (6). 
In the Middle Ages, science has not studied methods to prevent conception. Since 1800th-
1900th Information and counseling patients about contraception was illegal.   
Birth control begins in 1912 when Margaret Sanger, the nurse who has worked in public 
health, floated the pernicious effects of frequent abortions and birth and spread information 
about the types of contraception. She opened the first family planning counseling in New 
York in 1916 against the law. Police closed the counseling office, but after that, the president 
of the United States has allowed doctors to prescribe contraceptives for health reasons. In 
England, Mary Stops opened the first family planning in Europe in 1921 (7). 
Modern contraception begins in 1960 with the introduction of intrauterine devices in 
widespread use. Since 1965. pills have become the most popular contraceptive method, and 
after that there is increasing use of condoms and sterilization. Since 1970th-1980th number of 
services for family planning is growing rapidly. Since 1991., 96% of the governments through 
their policy directly support family planning programs, while in 1974 only 55% of them 
supported these programs (8). 
 
Programs for the promotion of reproductive health in the world 
 
Promotion of reproductive health is carried out in several ways:  
Through counseling (services) for family planning. Their task is the information, education 
and communication for the selection of appropriate contraceptive methods (9). 
 CBD (Community-based distribution) is a strategy where a trained non-
professionals (community members) participate in family planning. They explain the 
various methods of contraception to clients. CBD helps public and private services for 
family planning in order to make family planning more accessible, especially in rural 
areas. CBD has been performing for 20 years in 40 countries around the world (10). 
 In order to promote a method of family planning in underdeveloped and 
developing countries, media are often used in the form of radio-soap operas, radio 
drama and others, giving information about using of certain contraceptives. CSM 
program (social marketing of contraceptives) uses a commercial marketing techniques 
(especially massmedia) to promote the use of modern contraceptives. The program has 
been implemented since 1967 in 30 countries in Asia, Africa and Latin America, 
includes 5-15% of couples in reproductive ages and it is especially effective in areas 
where it is not well developed network of health care institutions (11). 
 Education of young people about HIV and sexually transmitted infections is 
carried out in the countries of the Middle East and North Africa, most often 
throughout the media (TV, Internet) and mobile phones. So called ‘’Hotline’’ is 
opened in Egypt and Oman in order to give information. ABC educational program is 
introduced that includes: A-abstinence as the first possible choice for young, B-Be 




 "South-to-South" cooperation, which includes 16 countries from Asia, Africa 
and Latin America has been launched in order to promote reproductive health in 
developing countries. The essence of this collaboration is to improve the reproductive 
health of the population in these countries, to define common goals, and interventions 
that need to be taken to achieve these goals (13). 
 Association for Family Planning in Tunisia initiated a program of improving 
the reproductive health of students in this country. The project included 6,000 students 
and consisted in increasing their knowledge about unwanted pregnancy and sexually 
transmitted infections ("double protection project") (14). 
 There is a regional strategy for the promotion of reproductive health in 
Northern Ireland. Its mission is to reduce the incidence of sexually transmitted 
infections, to reduce the number of unwanted pregnancies, to provide adequate and 
effective information about sexual health and to increase access to services for 
reproductive health  (15).  
 In Ukraine, which adopted a national reproductive health strategy in 2006, the 
main goals within the program were to implement services addressed to young people, 
to promote safe behaviour and to develop curricula for youth sex education on a 
national level. Latvia implemented sexuality education as a statutory part of school 
health education in 2005 (15).  
 In Uzbekistan, the action plan to introduce Youth-Friendly Services throughout 
the country and to implement school sex and reproductive health education was 
funded by the UNESCO in its initial phase (15).  
 As for the Western European Region, there is growing awareness of the need 
to develop approaches that address the diverse needs, attitudes, cultural and social 
backgrounds of young people, in order to gather experience regarding how to promote 
the inclusion of diverse groups, particularly young migrants, in sexual and 
reproductive health program and services (16). 
 
Reproductive health promotion in Serbia: 
Republican Center for Family Planning was founded as part of the Institute for Health 
Protection of Mother and Child. The counselling for pregnant women, counseling for children 
and adolescents and family planning counselling are formed  in primary health care, the 
department of health care for women and children. Counselling for family planning includes: 
improving human relations between the sexes; prevention and early detection of genetic 
disorders; prevention, early detection and treatment of infertility; prevention of unwanted 
pregnancy. 
Serbia, like many countries in the world, has defined  program for family planning as an 
instrument of the state population policy. The program was adopted in 1998. and named 
Information about family planning. It has been established eight targets of the program in 




For today's generation, reproductive health is part of overall health, and for the future ones, it 
will be a significant part of the socio-economic development. Therefore, it is necessary to 
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1. PSYCHOSOCIAL CONSEQUENCES OF ALCOHOL USE AMONG YOUTH 
Ana Stefanović1, Radulović O2, Jović S2, Šagrić Č2. 
1Public Health Institute Nis  
2Medical faculty Nis 
Any use of alcohol among juvenile persons shall be deemed abuse of alcohol and has great 
effects on the growth and development of youth.  
Objective: overview of the psychosocial consequences of alcohol use in relation to sex, age, 
place of residence and family social status of the respondents. 
Methods: This survey included 1,340 respondents, 680 girls and 660 boys from Nis district. 
Examinees were formed into four age groups: under 14 years (279), 15-17 years of age (308), 
18 to 20 years of age (324), and 21 and over (429 respondents). 
Results: 50.4% of respondents were drunk at a party (more boys than girls (χ2= 21.61, p 
<0.0001)). Respondents older than 18 years were more likely to have been drunk at the party 
than juveniles (χ2= 115.78, p <0.0001). 
46.6% of young people were in the car with a drunk driver (the largest number in the age 
group 15-17 years, at least the youngest (χ2= 166.95, p <0.0001)). Slightly more boys than 
girls traveled with a drunk driver (χ2= 6.16, p <0.05). 17.6% of respondents have driven 
drunk (more respondents with 21 or more years compared to other age groups (χ2= 166.95, p 
<0.0001)). Boys were driving drunk four times more often than girls (χ2= 100.69, p <0.0001). 
16.6% of respondents had been absent from school due to use of alcohol, two and a half times 
more boys than girls (χ2= 49.06, p <0.0001), more young people aged 18-20 years compared 
with other age groups (χ2= 41.65 p <0.0001) and more young people from the suburbs in 
relation to young people from town and country (χ2= 9.96, p <0.05). 
14.2% were drunk in classes (more young people aged 18-20 years compared with other age 
groups (χ2= 39.54, p <0.0001)). Boys were drunk at school three times more often than girls 
(χ2= 58.48, p <0.0001). 
13.6% of young people acted violently at the influence of alcohol, seven and a half times 
more boys than girls (χ2= 100.69, p <0.0001). Bullies were more in age from 18 to 20 years 
compared to other age groups (χ2= 14:45, p = 0.002, p <0.01). Violent behavior at the 
influence of alcohol was the most common among young people with poor economic 
conditions, while less was present among young people with good and medium finances (χ2= 
15.77, p <0.0005). 
9.3% of respondents had injuries as a consequence of alcohol consumption (more adults than 
juvenile (χ2= 1.17, p = 0.0007, p <0.001)). Boys are frequently injured twice as often as girls 
in a drunk state (χ2= 20:35, p <0.0001). 
11.4% of respondents had family problems due to alcohol, twice as many boys than girls (χ2= 
28.12, p <0.01), more respondents of 21 years and over compared with other age groups (χ2= 
28.12, p <0.01 ), more young people from rural villages and cities than young people from 
countryside (χ2= 6.62, p = 0.037, p <0.05). 
Conclusion: The more successful health education treatment aimed at reducing youth 
drinking, should be focused on gaining knowledge about the health consequences of alcohol.  
It is necessary to include peer education, through activities in locations where young people 
learn, where they spend their free time, with the use of the media, the internet and telephone 
counseling services.  
Key words: alcohol, young. 
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2. BELGRADE HIGH SCHOOL STUDENTS’ BEHAVIOUR DETERMINANTS AND 
ATTITUDES REGARDING ALCOHOL DRINKING HABBITS AND THEIR 
INFLUENCE ON HEALTH 
 
Anđelka Brković 
Public Health Institute, City of Belgrade 
 
Objectives: Getting insight into the drinking habits of Belgrade high school students and 
define appropriate public health interventions. 
Materials and methods: The research was carried out as a cross-sectional study. The sample 
used was composed of 202 first and fourth-grade students of the First Belgrade Gymnasium 
and Law-Business High School. The research instrument used was the questionnaire created 
in accordance with the ESPAD questionnaire. Methods of descriptive and inferential statistics 
were applied. 
Results: A total of 95,4% of the respondents have consumed alcohol at least once. The 
fourth-grade students drink more frequently than the first-grade students. A total of 40,3% of 
the students have reported heavy episode drinking during the past 30 days. Alcohol is more 
often consumed in bars than bought in supermarkets. The strongest peer influence on adopting 
drinking habits is shown among the fourth-grade girls. Significant number of students finds 
alcohol a factor of good fun and does not connect it with health risks. 
Conclusion: Widespread usage of alcohol among adolescents, combined with strong peer 
influence and low awareness of consequent health risks emphasizes the need for developing 
psychosocial programs in schools with active involvement of healthcare professionals. 
 





3. THE ROLE OF THE FAMILY DOCTOR IN HEALTH PROMOTION WITHIN 
THE TERITORY OF REPUBLIC OF SRPSKA 
 
Danijela Radulovic, Dubravac M., Vukovic M. 
 
Faculty of Medicine Foca,University of East Sarajevo 
 
Aim: The aim of this study was to compare the leading diseases groups in Republic of Srpska 
for a five-year period and to present the role of the family doctor in health promotion. 
Method: The facts by the Public Health Institute of Republic of Srpska are used for this 
study. These facts refer to analysis of population health in Republic of Srpska in 2007. and 
2012. 
Results: Five the most common diseases groups in Republic of Srpska and regions Banjaluka, 
Bijeljina and Zvornik in 2007. and 2012. were: diseases of the circulatory, respiratory and 
genitourinary system, factors influencing health status and contact with health services and 
diseases of the musculoskeletal system and connective tissue. In Foca region in 2007. and in 
Trebinje and East Sarajevo regions in 2007. and 2012. among five the most common diseases 
groups were digestive diseases. In Doboj region in 2012.  among the five most common group 
of diseases were diseases of endocrine glands, nutrition and metabolism. 
Conclusion: Chronic mass non-communicable diseases are the leading cause of morbidity 
and mortality in Republic of Srpska. The family doctor plays an important role in health 
promotion and education about healthy lifestyles in order to prevent morbidity and mortality 
of population. 








4. REPRESENTATION OF SMOKING BY HEALTH WORKERS 
 
Ifeta Erovic,  
Health Centre B.Polje 
 
Introduction: We want to piont out the percentage of the health workers smoking 
habits,smoking duration,the number of the daily smoked cigarettes, in regard to age 
,profession and sex. Knowing that fight against smoking is one of the most important mission 
of public health service. 
Goal: To tell the real representation of smoking by health workers. 
Method: The 38 doctors have been asked for an opinion and also 124 medical nurses and 
technicians with a poll. 
Results: Of the whole 162 health workers who filled in the questionnaire,65 of them are 
smokers (40,12%) ,21 (12,96%) ex-smokers and 76 (46,91%) are nonsmokers. The 
percentage of doctors nonsmokers is higher within men (68,42%) then within 
women(47,36%). The active smokers at highter rate are female doctors with lenght of service 
of 20-29 years. The percentage of ex smokers within doctors of both sexes is the same. The 
smoking duration between female  doctors is on the average 8,5 years(male doctors 4,5 yeras) 
and the average number of the smoked cigarettes is 13(male 11 smoked cigarettes). 
Conclusion: The number of smokers between health workers is inadmissible high (40,12%). 





5. INNOVATION OF HEALTH EDUCATION ACTIVITIES IN THE FIELD OF 
SEXUAL AND REPRODUCTIVE HEALTH OF ADOLESCENTS 
 
Šagrić Č1, Radulović O1, Babić S1, Stefanović A2, Šagrić M3, Veličković V1 
1Medical Faculty Nis 
2Public Health Institute of Nis 
3Institute for Student Health Care Nis 
 
Today, adolescents develop themselves in an era of free access of information through all 
means of media, especially internet and mobile telephony. Uncontrolled and free use of large 
number of disparate information, which are available to adolescents through these media, are 
leading and will lead to the increased number of reproductive and sexual health risk behavior 
in the future. At the same time, the mass use of modern electronic media by young people 
gives the opportunity to reduce the risk behavior of adolescents and youth by increasing the 
fund of applicable knowledge and level of motivation in everyday life. This kind of informing 
will help them maintain and improve their health.  Due to many changes of lifestyle of 
adolescents, there is a need to innovate the current approach of health education work to the 
previously mentioned topics, especially in the sense of greater exploitation of modern media, 
(like internet and mobile telephony), whose numerous users are actually adolescents and 
youth in general. The purpose of this study was to show the models of using the modern 
media in the field of health education work.  
 





6. SOCIAL CHARACTERISTICS AND THEIR RELATEDNESS WITH HEALTH 
CARE OF THE ELDERLY WITH DISABILITIES 
 
Ristović Katarina¹, Jović J.² 
1Bureau for Public Health, Užice 
2School of Medicine, University of Prishtina-Kosovska Mitrovica, Department of Preventive 
Medicine, Kosovska Mitrovica, Serbia 
 
The health condition of disabled people itself needs more care and looking after, especially 
when it comes to the eldrly. 
The aim of our project was determination of social characteristics and their relatedness with 
health care of the elderly with disabilities. 164 people were polled (107 women and 57 men) 
with the average age 80,49±6,76. 
Every second examinee (56.1%) was bedridden for more than a year. Most of the examinees 
(94.5%) have somebody to look after them. More the 50% of the examinees are satisfied with 
their economic status, more than a half (58.5% ) are satisfied with their social status, while 
only 5.5% of them are linked to the social service. Only 4.3% of them are members of the 
association of disabled people. Even 76.2% were not on rehabilitation during the previous 
years, 77.3% of them were not visited by a physician for home care, while 86.5% would 
firstly address a family member when they have any health problem. Only a third of the 
examinees (36.4% ) consider their health condition satisfactory.  
Our data indicate an unsatisfactory social relatedness and some omissions in giving health 
protection to this vulnerable population. Therefore it is necessary to work on amelioration of 
the existing capacities and making new ones to support disabled people. 
 






7. ACTUAL PUBLIC HEALTH ISSUES IN THE FIELD CONCERNING THE 
ELDERLY POPULATION 
 
Ljiljana Pešić1, Zoran Milošević Z1,2  
1Faculty of Medicine, Niš 
2Public Health Institute of Nis 
 
By studying the tendencies of demographic change, both on the global and at the national 
level, it can be noted that there has been a regular movement to a more prominent aging of the 
population. In the most developed countries, for 2025, the share of those older than 65 is 
expected to be 27.5% from the total population, while the share of the elderly in Southern 
Europe is expected to range from 9.1 to 17.7%. According to the predictions of 
demographers, the share of the elderly in Serbia will range from 18.7% to 27.5% in 2025. As 
a result, the segment of the elderly population exceeding the age of 75 will especially 
considerably increase, which will have significant health, economic and social repercussions. 
The aim of this paper is to emphasize the actual public health issues of the elderly 
population in our country, as well as in the area of the region of Nis, to point out the 
expectations regarding their movement in the future, as well as to instruct of the need to 
undertake adequate measures, primarily in the field of primary health care, as well as the 
community, with the aim of the irreduction and resolution. In the methodology, we used the 
information from present statistical and other public health research in the regions of Europe, 
Serbia, South-East Serbia and the region of Nis, as well as the results from our own research 
on the sample of 1295 people older than 65. The results are the following: the elderly 
population is in economic jeopardy, bearing in mind the amount of pensions and the 
orientation of the state towards the allocations for the funds of social-economic protection in 
the future, mortality from cardiovascular and malignant diseases in Serbia highly exceeds the 
values of the rates in the neighboring countries and countries in Europe; in terms of the 
treatment of malignant diseases (the rate of five-year survival), Serbia occupies the 25th place 
in Europe. In the mortality model, there is a predominance in the models whose cause stems 
from the frequently unhealthy lifestyle (diet, smoking, physical inactivity, low level of general 
culture and culture in healthcare). On average, every 5th elderly patient gets healthcare 
instructions from selected physicians. The advice is frequently judged as insufficiently clear, 
so that most people are oriented towards obtaining information on healthcare from non-
medical sources. The following trends are expected: further increase of poverty, increasingly 
weaker social support and the increase of pressure on the healthcare department by geriatric 
patients, primarily concerning chronic mass diseases, increase in the home care department 
services and a more prominent need for various types of geriatric care. In such conditions, the 
fulfillment of the aims of the WHO concerning active aging must be connected with the 
increase of measurements for the promotion of health at the level of primary healthcare and 
the community, by adopting geriatric standards, education of medical workers and a more 
intensive cooperation of all participants at the level of the community with regard to the 
realization of relevant programs for the promotion of healthcare in the elderly. 
 




8. SAFETY AND POTENTIAL RISK OF SELF-MEDICATION IN NIS REGION 
 
Aleksandra Catic-Djordjevic1, Stefanovic N1, Dimitrijevic M1, Damnjanovic I1, Sonja 
Pavlovic S2, Radmila Velickovic-Radovanovic R3 
1Faculty of Medicine, University of Nis 
2Pharmacy Nevenpharm Nis 
3Clinic of Nephrology, Clinical Center Nis 
 
Introduction: Drugs that are used in self-medication as well as do not  require a prescription, 
are known as “over-the-counter medicines” (OTC) products. These drugs are used to prevent 
and treat the symptoms of diseases, which are recognized by the patients themselves.  
Objective: The aim of this study was to evaluate the awareness of the self-medication in the 
adult population of the Nis region and to determine its benefit, safety and potential risk for 
people health.  
Respondents and methods: A cross-sectional study included 300 patients which were 
interviewed and divided into three age categories: aged 18 to 30, 31 to 65 and over 65. This 
research was performed using an anonymous questionnaire which contained 17 open-ended 
and closed-ended questions. 
Results: Using OTC product is the most common in the respondents aged 18 to 30 (98%). 
There was statistically significant difference among the groups regarding media influence on 
the selection of drug (p<0.05). The safety of the chosen therapy and awareness of the possible 
side effects was registered in 60% of the respondents. The idea that self-medication can 
“cover up” symptoms of some more serious diseases was most widespread among the 
respondents aged 18 to 30 (84%). 
Conclusion: Modern patient actively participate in the process of self - care and self - 
medication and therefore frequently uses the OTC products with or without pharmacist help. 
Self medication may provide money saving for the healthcare system, but also it represents 
the risks for the patients’ health. Hence, the role of the pharmacist in patients’ education on 
proper application of self-medication is vital.  
 








1. THE ROLE OF COMMUNITY PHARMACIST IN HEALTH PROMOTION 
 
Svetlana Goločorbin-Kon1,2, Lalić-Popović M1, Milošević N1, Milić N1, Jovičić-Bata J1, 
Stojančević M3 
1Medical faculty, Department of Pharmacy, University of Novi Sad 
2School of Pharmacy Podgorica, University of Montenegro 
3Medical faculty, Department of Pharmacology and toxicology and clinical pharmacology, 
University of Novi Sad 
 
Acknowledgements: This work has been done within the project of Ministry of Education, 
Science and Technology No 41012 
 
Aim: The aim of this paper is to emphasises a new role of pharmacist in health promotion 
according to the new regulation and a new focus to the pacietns and their welfare. 
Material and methods: It was used the data from literature and existing law on Health 
protection in Serbia. 
Results and disscusion: Community pharmacists are the health professionals always available 
to advice clients who presented with symptoms in the pharmacy. Pharmacist can provide 
primary health education through being involved in both individual and coordinated initiative to 
encourage Smoking Cessation, increase Sun Awareness, improve Sexual health, provide 
Contraception advice and remind young parents of Immunization Schedules. In secondary 
health education, pharmacist can advice ill people how to change diet in case of having high 
cholesterol levels, or how to avoid side-efects or how to use an inhaler correctly to someone 
suffering from asthma. In adition, pharmacist have to increase awareness of patients that 
counterfeit drugs exist on market and they have to inform their pharmacist if something goes 
wrong or if there are any adverse drugs reaction. 
The very important role of the pharmacist is to giving advice to someone who could not 
normally expect to be restored to full health as a part of tertiaty health education. For example, 
this would include advice to the elderly person with diabetes on how to prevent developing 
diabetic associated complication. 
Conclusion: The community pharmacists has many opportunities for Health promotion. The 
pharmacist shoul liaise with other health professionals and local health promotion units and 
cooperate with them in special Health promotion projects. 
 






2. STUDENTS' AWARENESS OF THE LINK BETWEEN SALT INTAKE AND 
HEALTH 
 
Jovičić-Bata J1, Grujičić M2, Novaković B1 
1
 Department of Pharmacy, Faculty of Medicine, University of Novi Sad, Novi Sad, Serbia 
2
 Department of General Education Subjects, Faculty of Medicine, University of Novi Sad, 
Novi Sad, Serbia 
 
Objectives: The objective of this research was to assess the awareness of the link between 
high salt intake and health among students from University of Novi Sad. 
Materials and methods: The research was carried out in a convenient sample of 1082 
students (mean age 20.9±1.9 years, 38.9% males) at the University of Novi Sad, Serbia. 
Students' awareness of the link between salt intake and health was assessed by a 
questionnaire. 
Results: Majority of the respondents (92.9%) were aware that high salt intake poses a health 
risk. This percentage was higher among females than among males (95.0% vs. 89.5%, 
p=0.001). Health problems associated with high salt intake were hypertension (82.9%) and 
heart problems (64.3%), followed by stroke (35.0%) and obesity (31.7%). Only 3.8% of 
students recognized stomach cancer as a salt-related health issue. Levels of awareness of 
specific salt-related health problems was consistently higher among female respondents 
(p<0.001). 
Conclusion: Awareness of the link between salt intake and health was high, but substantial 
knowledge gaps exist about specific salt-related health problems that need to be addressed in 
future students' education programs. 
 
Key words: Salt intake; Sodium intake; Students; Hypertension 
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